fluorodeoxyglucose f18 has been researched along with Local Neoplasm Recurrence in 1846 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (0.33) | 18.7374 |
| 1990's | 117 (6.34) | 18.2507 |
| 2000's | 667 (36.13) | 29.6817 |
| 2010's | 806 (43.66) | 24.3611 |
| 2020's | 250 (13.54) | 2.80 |
| Authors | Studies |
|---|---|
| OuYang, X; Zhang, X; Zheng, L | 1 |
| Emi, A; Kadoya, T; Kawamata, A; Masumoto, N; Sasada, S | 1 |
| Bloemen, JG; Burger, PJWA; Cnossen, JS; Creemers, GJ; Lardenoije, SGGF; Nederend, J; Nieuwenhuijzen, GAP; Roef, MJ; Rutten, HJT; van Lijnschoten, IG; van Zoggel, DMGI; Voogt, ELK | 1 |
| Baijens, LWJ; Krebbers, I; Kunst, HPM; van den Hout, MFCM; Waterval, JJ | 1 |
| Cheng, W; Hou, G; Jiang, Y; Li, F | 1 |
| Agarwal, A; Bankar, S; Desouza, A; Kazi, M; Mokal, S; Rangarajan, V; Saklani, A; Thomas, AE | 1 |
| Iwata, H; Kuroda, H; Nakada, T; Ohtsuka, T; Sakakura, N; Takahashi, Y | 1 |
| Choi, YJ; Kang, T; Kim, H; Kim, IJ; Kim, K; Pak, K; Seol, YM | 1 |
| Kumar, S; Parmar, KM; Singh, P; Thummala, Y | 1 |
| Pak, K; Yoon, HJ | 2 |
| Dejanovic, D; Elgaard, T; Loft, A; Mosgaard, BJ | 1 |
| Bordeau, K; Deshayes, E; Eberlé, MC; Fabbro, M; Fersing, C | 1 |
| Chen, L; Cornelius, LA; Fields, RC; Jaeger, ZJ; Mhlanga, JC; Williams, GA | 1 |
| Alavi, A; Baun, C; Duvnjak, S; Falch, K; Gerke, O; Hansen, JA; Hildebrandt, MG; Høilund-Carlsen, PF; Naghavi-Behzad, M | 1 |
| Aparisi Gómez, MP; Bazzocchi, A; Fanti, S; Farina, A; Gasperini, C; Nanni, C | 1 |
| Akaihata, M; Asakura, K; Ishida, Y; Takahashi, I; Takahashi, Y; Tsumura, Y | 1 |
| Alonso-Farto, JC; Churruca, J; Durán-Barquero, C; Foncillas, MÁ; Gómez-Fernández, I; González-Gascón-Y-Marín, I; Hernández-Rivas, JÁ; Infante, MS; Landete, E; Marín, K; Muñoz-Novas, C; Ramos-de-Ascanio, V | 1 |
| Cao, Q; Fang, Y; Ge, D; Hou, Y; Jiang, D; Lin, D; Liu, G; Shen, Y; Shi, H; Tan, L; Wang, H; Wang, Q; Yin, J; Yu, Y; Zhang, S | 1 |
| Cao, X; Li, J; Luo, Y; Pan, Q | 1 |
| Chiu, CH; Ko, KH; Li, YF; Tsai, CJ; Tsai, YK | 1 |
| Adinehpour, Z; Aghdam, RA; Haghighi, S; Kaghazchi, F; Vali, R | 1 |
| Çermik, TF; Ergül, N; Mercanoğlu, G; Yılmaz, B | 1 |
| Evans, J; Hardman, J; McLaren, O; Williams, R; Zhu, Y | 1 |
| Andersen, JAS; Bastholt, L; Gerke, O; Grupe, P; Hess, S; Hildebrandt, MG; Holdgaard, PC; Spatzek, AD; Vilstrup, MH | 1 |
| Kuang, A; Shen, G | 2 |
| Demir, H; Hekimsoy, T; Isgoren, S; Koroglu, E | 1 |
| Fujimura, M; Hatanaka, KC; Homma, A; Honda, T; Houkin, K; Ishi, Y; Kobayashi, H; Motegi, H; Takakuwa, E; Terasaka, S; Yamaguchi, S | 1 |
| Das, SS; Khanna, G; Malik, D; Patir, R; Sen, IB | 1 |
| Beaty, BM; Benefield, T; Chera, B; Jewells, VL; Muhleman, MA; Oldan, JD | 1 |
| Amrane, K; Campedel, L; Kharroubi, D; Le Meur, C | 1 |
| Lee, BM; Lee, CG | 1 |
| Chan, C; Cheng Lau, Y; Dempsey, MF; Dyab, H; Grose, D; Hendry, F; James, A; Lamb, C; Maxfield, C; Paterson, C; Rulach, R; Schipani, S; Wilson, C; Zhou, S | 1 |
| Borel Rinkes, IHM; Braat, AJAT; de Keizer, B; de Vries, LH; Lebbink, CA; Lodewijk, L; Valk, GD; van Leeuwaarde, RS; van Santen, HM; van Treijen, MJC; Vriens, MR | 1 |
| Allen, M; Anconina, R; Chen, EX; Darling, GE; Elimova, E; Jang, RW; Liu, ZA; Metser, U; Ortega, C; Swallow, CJ; Taylor, K; Veit-Haibach, P; Wong, R; Yeung, J | 1 |
| Fanti, S; Farolfi, A; Mei, R; Morigi, JJ | 1 |
| He, Q; Jiang, S; Liu, Z; Zhang, L; Zhang, R | 1 |
| Groheux, D | 1 |
| Kokkonen, SM; Kuittinen, O; Kuitunen, H; Rajamäki, A; Sorigue, M; Sunela, K | 1 |
| Akashi, K; Baba, S; Iawasaki, H; Ishigami, K; Kamesaki, K; Kato, K; Kikushige, Y; Kunisaki, Y; Miyamoto, T; Miyawaki, K; Mori, Y; Numata, A; Shima, T; Sugio, T; Takashima, S; Takenaka, K; Urata, S; Yoshimoto, G | 1 |
| Adinehpour, Z; Akbarian Aghdam, R; Amini, H; Divband, G; Kaghazchi, F | 1 |
| Donswijk, ML; Haarsma, R; Scholten, AN; van Duijnhoven, FH; van Loevezijn, AA; Vrancken Peeters, MTFD | 1 |
| Albano, D; Bertagna, F; Dondi, F; Giubbini, R | 1 |
| Angeles, MA; Attal, J; Bétrian, S; Chantalat, E; Daix, M; Ducassou, A; Ferron, G; Gabiache, E; Lusque, A; Martinez, A | 1 |
| Akhtar, F; Beadle, BM; Colevas, AD; Divi, V; Gensheimer, MF; Harandi, N; Holsinger, FC; Le, QT; Liang, R; Liu, Y; Miller, JA; Moradi, F; Nguyen, NK; Pollom, EL; Ren, Y; Sundaram, V; Weng, Y; Zhang, C | 1 |
| Emi, A; Ikejiri, H; Kadoya, T; Masumoto, N; Okada, M; Sasada, S | 1 |
| Bengtsson, T; Carano, RAD; de Crespigny, A; El-Galaly, TC; Hutchings, M; Jemaa, S; Kostakoglu, L; Nielsen, TG; Paulson, JN; Tracy, S; Trotman, J | 1 |
| Burton, C; Clark, M; Frangi, AF; Frood, R; Gleeson, F; Patel, C; Scarsbrook, A; Tsoumpas, C | 1 |
| Ba-Ssalamah, A; Hacker, M; Haug, AR; Herold, A; Lindenlaub, F; Mayerhoefer, ME; Rasul, S; Stift, A; Stift, J; Tamandl, D; Wassipaul, C; Weber, M | 1 |
| Berthelsen, AK; Brown, PN; Loft, A; Maraldo, MV; Meidahl Petersen, P; Nielsen, K; Specht, L; Vogelius, IR | 1 |
| Cattaneo, M; Chirindel, A; Hojski, A; Kaumanns, A; König, D; Lardinois, D; Rothschild, SI; Tamm, M; Wiese, M | 1 |
| Fan, L; Jia, Y; Ma, W; Sun, B; Wang, Z; Xu, J; Xu, K; Yang, H; Yao, F | 1 |
| Agrawal, A; Bedmutha, AS; Choudhury, S; Goel, M; Patkar, S; Purandare, NC; Puranik, AD; Ramadwar, M; Rangarajan, V; Shah, S | 1 |
| Byun, BH; Choi, CW; Choi, JH; Kang, HJ; Kim, BI; Lim, I; Lim, SM; Shin, DY | 1 |
| Barla, C; Binstok, Y; Cavani, M; Frachia, F; Fregeiro, MS; Lissarrague, E; Ranero, S; Riva, E; Servente, L | 1 |
| Kita, H; Onda, T; Yoshida, T | 1 |
| Bun, A; Fujimoto, Y; Fukui, R; Higuchi, T; Kanaoka, H; Kitajima, K; Miyoshi, Y; Nagahashi, M; Ozawa, H; Yamakado, K | 1 |
| Akan, S; Ediz, C; Terzi, NK; Yilmaz, O | 1 |
| Bang, S; Han, K; Hwang, HK; Hwang, SH; Kim, MJ; Kim, SS; Lee, HS; Park, MS; Yoon, JK; Yun, M | 1 |
| Cheriyalinkal Parambil, B; Chinnaswamy, G; Kembhavi, S; Khanna, N; Laskar, S; Prasad, M; Qureshi, S; Ramadwar, M; Rangarajan, V; Sankaran, H; Shah, S; Thakur, S; Vora, T | 1 |
| Ala Eddine, C; Beddok, A; Buvat, I; Calugaru, V; Champion, L; Créhange, G; Nioche, C; Orlhac, F | 1 |
| Aren, E; Berry, M; Deshpande, S; Estall, V; Fowler, A; Jameson, MG; Johnston, M; Lee, M; Trada, Y | 1 |
| Chaushu, H; Even-Sapir, E; Gutfeld, O; Holan, A; Horowitz, G; Kampel, L; Muhanna, N; Nachalon, Y; Nard-Carmel, N; Oestraicher, Y; Ospovat, I; Oz, YN; Shapira, U; Ungar, O; Warshavsky, A | 1 |
| Chen, CY; Fan, W; Guo, ZX; He, Y; Li, A; Li, J; Lin, QG; Liu, ZQ; OuYang, PY; Peng, QH; Wu, YS; Xiao, SM; Xie, CM; Xie, FY; Xu, SK; Yang, SS; Yao, WY; Zhang, BY; Zhang, X | 1 |
| Artiko, V; Odalovic, S; Petrovic, J; Popovic, M; Rankovic, N; Sobic Saranovic, D; Stojiljkovic, M; Veljkovic, M | 1 |
| Gavane, S; Hasanovic, A; Trak, J | 1 |
| Chen, DL; Coffey, D; Cowan, AJ; Green, DJ; Gulhane, A; Holmberg, LA; Kosydar, S; Kwok, M; Lee, SS; Libby, E; Tseng, YD | 1 |
| Hanaoka, K; Hattori, S; Ishii, K; Kaida, H; Kato, H; Kimura, Y; Kitajima, K; Matsukubo, Y; Shiraishi, O; Tsurusaki, M; Yamada, M; Yasuda, T | 1 |
| Alessi, A; Argiroffi, G; Bagnoli, F; Carniti, C; Chiappella, A; Corradini, P; Dodero, A; Guidetti, A; Lorenzoni, A; Marasco, V; Monfrini, C; Pennisi, M; Pizzamiglio, S; Seregni, E; Verderio, P | 1 |
| Chaika, M; Dittmann, H; Ebinger, M; Fuchs, J; Gassenmaier, S; Gatidids, S; Grimm, R; Hettmer, S; Maennlin, S; Schäfer, JF; Schmidt, A; Sparber-Sauer, M | 1 |
| Cui, Y; Deng, X; Fan, W; Jiang, Y; Li, Y; Liu, B; Long, W; Zhang, X | 1 |
| Hwang, JH; Kim, KU; Lim, CH; Park, SB; Park, YW | 1 |
| Albano, D; Bellini, P; Bertagna, F; Cerudelli, E; Dondi, F; Treglia, G | 1 |
| Goto, H; Harada, H; Hasegawa, H; Kakeji, Y; Kanaji, S; Matsuda, T; Oshikiri, T; Sawada, R; Urakawa, N; Yamashita, K | 1 |
| Chang, CW; Chang, WY; Chen, LY; Huang, YT; Huang, YY; Ou, YC; Peng, NJ; Tseng, NC | 1 |
| Borte, G; Denecke, T; Franke, GN; Georgi, TW; Herling, M; Hoffmann, S; Jentzsch, M; Kluge, R; Kurch, L; Merz, M; Metzeler, K; Perez-Fernandez, C; Petermann, N; Platzbecker, U; Sabri, O; Schwind, S; Vučinić, V | 1 |
| Doi, H; Hanaoka, K; Hosono, M; Inada, M; Ishii, K; Kaida, H; Komanishi, M; Nakamatsu, K; Nishimura, Y; Uehara, T | 1 |
| Belderbos, JSA; Cooke, SA; Damen, EMF; de Ruysscher, D; Dieleman, EMT; Faivre-Finn, C; Fredberg Persson, G; Lalezari, F; Lambrecht, M; Lewensohn, R; Reymen, B; Sikorska, K; Sonke, JJ; van Diessen, JNA; van Elmpt, W; Vogel, W | 1 |
| Li, S; Lu, X; Wang, G; Wang, H; Yang, J | 1 |
| Besson, FL; Durand, E; Golse, N; Pascale, A; Sebagh, M; Sivapathasundaram, A | 1 |
| Baiocchi, G; da Costa, AABA; Diniz, TP; Faloppa, CC; Mantoan, H; Nunes, RL; Teixeira, FR | 1 |
| Du Guesclin, A; Gaylard, A; Goai, XY; Hodgson, R | 1 |
| Bastholt, L; Bidstrup, PE; Bojesen, S; Chakera, AH; Ellebæk, E; Helvind, NM; Hendel, HW; Hölmich, LR; Johansen, C; Kjærskov, MW; Petersen, SK; Skyum, H; Svane, IM; Weitemeyer, MB | 1 |
| Hayano, K; Matsubara, H; Mori, M; Narushima, K; Ohira, G; Okazumi, S; Shuto, K; Yanagawa, N | 1 |
| Chen, Y; Liu, H; Liu, L; Qu, G; Yang, X | 1 |
| Bai, Y; Ding, Q; Jiang, X; Ju, H; Li, P; Lin, X; Wang, L; Wang, S | 1 |
| Chen, C; Chen, J; Ding, J; Fei, Z; Hong, H; Huang, C; Li, L; Liu, J; Qiu, X; Xu, T; Xu, Y | 1 |
| Agarwal, JP; Budrukkar, A; Ghosh-Laskar, S; Gupta, T; Joshi, A; Joshi, K; Kumar, A; Nair, S; Paul, S; Prabhash, K; Purandare, N; Rangarajan, V; Sinha, S; Swain, M | 1 |
| Chinot, O; Graillon, T; Guedj, E; Horowitz, T; Salgues, B; Tabouret, E; Verger, A | 1 |
| Barrington, SF; Boellaard, R; Ceriani, L; Chamuleau, MED; Czibor, S; de Vet, HCW; Dührsen, U; Eertink, JJ; Györke, T; Hanoun, C; Heymans, MW; Hoekstra, OS; Hüttmann, A; Kurch, L; Lugtenburg, PJ; Mikhaeel, NG; Pieplenbosch, S; Wiegers, SE; Zijlstra, JM; Zucca, E; Zwezerijnen, GJC | 1 |
| Fujimori, S; Ishihara, M; Kawabata, H; Kawaguchi, S; Kinowaki, K; Kobayashi, Y; Nishikawa, A; Ogura, T; Sato, J; Shibata, A; Shiiba, M; Suzuki, S; Tamura, N; Tanaka, K | 1 |
| Buyukkaya, F; Civan, C; Has Simsek, D; Isik, EG; Kuyumcu, S | 1 |
| Attarbaschi, A; Beishuizen, A; Buerke, B; Cepelova, M; Ceppi, F; Damek, A; Dieckmann, K; Fernández-Teijeiro, A; Fosså, A; Franke, FC; Georgi, TW; Hasenclever, D; Hraskova, A; Karlen, J; Klekawka, T; Kluge, R; Körholz, D; Kurch, L; Landman-Parker, J; Leblanc, T; Mauz-Körholz, C; Moellers, M; Steglich, J; Stoevesandt, D; Uyttebroeck, A; Vordermark, D; Wallace, WH; Wohlgemuth, WA | 1 |
| Beheshti, M; Grambozov, B; Kalantari, F; Karner, J; Rinnerthaler, G; Ruznic, E; Sedlmayer, F; Stana, M; Zehentmayr, F; Zellinger, B | 1 |
| Hartel, G; Khoo, D; Liu, ZY; Punyadeera, C; Vasani, S | 1 |
| Ansell, SM; Bansal, R; Breen, WG; Hathcock, MA; Hoppe, BS; Iqbal, M; Johnston, PB; Kharfan-Dabaja, MA; Khurana, A; Lester, SC; Lin, Y; Moustafa, MA; Munoz, J; Murthy, HS; Paludo, J; Peterson, JL; Rosenthal, A; Rule, WG; Saifi, O; Stish, BJ; Villasboas, JC; Wang, Y | 1 |
| Abbey, L; Abdelghany, TM; Abdellatif, MH; Abdelmohsen, UR; Abduljaleel Alzawar, NS; Abid, MF; Abu Kasim, AFB; Abu Saad, H; Adolpho, LF; Agostini, F; Agrizii, AP; Ahmed, S; Akce, M; Åkesson, D; Al-Awaadh, AM; Al-Mutar, DMK; Al-Odayni, AB; Al-Rajhi, AMH; Alaaeldin, R; Alam, M; Alam, MM; Alanazi, MA; Alattar, H; Alawlaqi, MM; Aldebis, HK; Algehainy, NA; Almeida, AA; Aloisi, F; Alrahlah, A; Alsenani, F; Alshabib, A; Altemani, FH; Althagafi, A; Amari, A; Andronesi, AG; Antonyuk, M; Arantes, TD; Araújo, R; Arrotti, S; Asakura, T; Asib, N; Atlaskin, AA; Aung, MS; Axiaq, A; Azekawa, S; Bacon, S; Bagalagel, A; Balbinot, GS; Barnet, LS; Baroyi, SAHM; Barreto, F; Barth, Y; Barysheva, AV; Bassa, E; Basu, R; Basu, S; Bates, C; Bautista, LS; Beitl, K; Beloti, MM; Benatti, G; Benavent-Celma, C; Bentaher, A; Bergsland, N; Bernardino, AF; Bernhardt, A; Bhandari, RK; Bhaskaran, K; Bhate, K; Bhattacharjee, A; Bian, X; Bien, EM; Birch, M; Bishara, K; Biswas, JP; Bleha, R; Bocale, R; Bona, S; Boriani, G; Bouyssi, A; Bradley, D; Bravo-Sánchez, MG; Bressan, GC; Brik, A; Brizuela, A; Brockbank, KGM; Buchner, F; Bunc, M; Buscombe, JR; Butler, AJ; Buzaleh, AM; Buzin, MI; Cabrera-Capetillo, CA; Calvo, AM; Camerota, A; Campagna, G; Campisi, M; Cano, K; Cao, HST; Cardellini, S; Carvalho, AP; Carvalho, BCR; Castillo-Baltazar, OS; Cataldo, P; Chai, P; Chakraborty, S; Chalo, DM; Chan, MY; Chander, S; Changbunjong, T; Chappuis, CJF; Chee, RCH; Chen, C; Chen, CJ; Chen, E; Chen, M; Chen, X; Chen, Y; Cheng, HT; Cheng, MC; Cheow, HK; Chi, Y; Chirikova, NK; Chiu, SH; Cho, G; Cho, HR; Cho, S; Cho, SJ; Choe, A; Choe, YH; Chun, BS; Chun, Z; Cinque, A; Ciopec, M; Cladas, Y; Cleary, SP; Clermont, O; Cléroux, M; Cockburn, J; Collares, FM; Colombini-Ishikiriama, BL; Conn, BN; Cortina, JL; Cox, DRA; Crini, G; Croker, R; Cursaru, DL; Curtis, HJ; da Silva, KJG; Dalla Costa, T; Davy, S; de Araújo, BV; de Cassia Ribeiro Gonçalves, R; de Gaetano, F; de Gregorio, C; de Oliveira, MG; De Vera, MAT; de Vos, M; de-la-Fuente, I; Dell'Oca, I; Delles, M; Déméautis, T; Dempster, M; Deng, YH; Denisenko, Y; Descombes, C; Desideri, G; Devarbhavi, H; Devouassoux, G; Di Bella, G; Di Marco, F; Diao, Y; Dias, BB; Dilgin, Y; Dimopoulou, I; Dionísio, TJ; Dobrovic, A; Dokin, ES; Dolby, T; Dong, X; Dong, Y; Dou, SX; Douglas, IJ; Dousset, S; Du, Z; Duan, M; Duan, SB; Duke-Williams, O; Duteanu, N; Dutertre, S; Dutta, S; Dwyer, MG; Ebenbauer, J; Eggo, RM; El-Mordy, FMA; Elbhnsawi, NA; Elrehany, MA; Elshewemi, SS; Elwakil, BH; Emadzadeh, D; Eraso, E; Ermolenko, E; Erten, K; Ettorre, E; Evans, D; Evans, SJ; Faheem, M; Fallanza, M; Faramarzi, M; Faria, FAC; Faro, DC; Fatma, YS; Fazil, S; Feng, Y; Ferguson, J; Fernandes, MH; Fernández-Domínguez, M; Ferrari, LAL; Ferraz, EP; Ferreira, LC; Ferri, C; Fikry, M; Floris, M; Forbes, H; Fotouh, B; Franke, K; Freitas, AC; Freitas, GP; Frieboes, HB; Fu, B; Fu, Y; Fukina, DG; Fukuda, DH; Fukunaga, K; Fulham, GJ; Furlan, L; Furtado Mesa, M; Furtunescu, FL; Gabbieri, D; Ganash, M; Gebers, JC; Gehman, V; Ghaedi, A; Ghazali, NSM; Ghebrekristos, Y; Gil, J; Gilbert, NM; Gimenes, R; Giordano, L; Glehen, O; Godeau, C; Goh, SK; Goldacre, B; Gomes, AM; Gomes, MPO; Gomes, PS; Gomes, RMODS; Gómez-Coma, L; Grenho, L; Gu, Q; Gu, T; Gu, YC; Guiducci, V; Guillemin, JP; Guo, W; Guo, YW; Gur, E; Guridi, A; Guzmán-López, A; Gvozdenko, T; H Elmaidomy, A; Hagar, M; Haider, S; Han, JM; Hanratty, J; Hans, R; Haque, N; Harharah, HN; Harharah, RH; Harper, S; Hasegawa, N; Hassanin, AH; Hastuti, YP; Hatem, AE; He, R; He, Y; Heinemann, C; Heinmaa, I; Heinzl, F; Helfer, VE; Hester, F; Hickman, G; Hill, MA; Hill, WG; Hintze, V; Ho, JSY; Ho, LY; Hoang, T; Holzer, I; Houbraken, J; Hsu, CN; Hu, J; Hu, X; Hu, Y; Hua, T; Huang, Z; Hulme, WJ; Hunter, A; Ianăşi, C; Ibañez, R; Iezzi, R; Iliuță, L; Im, YM; Imran, M; Inglesby, P; Inguimbert, N; Iqbal, A; Izawa, N; Jahaj, E; Jain, S; Jakimovski, D; Jalal, MM; Jaroszuk-Ściseł, J; Jasim, DJ; Jauregizar, N; Javle, MM; Jędryczka, M; Ji, H; Jiang, Y; Jin, J; Johnson, NT; Joshi, S; Jullok, N; Kachapulula, PW; Kaczmarek, J; Kaczmarek-Szczepańska, B; Kadota, K; Kaji, M; Kakeji, Y; Kakizoe, S; Kakudidi, E; Kalitukha, L; Kamata, H; Kang, YJ; Kapinos, AA; Karakaya, S; Kashchenko, NI; Kasyanov, S; Kataky, R; Katati, B; Kato, G; Katsina, AU; Kaya, A; Kaya, H; Kazarina, OV; Ke, Y; Keenan, C; Keilson, JM; Keshavan, A; Keskinidou, C; Khalifa, MA; Khan, R; Khan, S; Kim, D; Kim, K; Kim, MS; Kim, SM; Kim, WH; Kim, Y; Kim, YJ; Kishimura, H; Kitagawa, RR; Klemenkova, ZS; Kloss, F; Kobayashi, N; Kohlhoff, M; Kong, WKF; Konsek, H; Kornaros, M; Kotanidou, A; Kovacs, S; Kraska, J; Kruppke, B; Kumagai, Y; Kumar, S; Kumari, R; Kuruva, V; Kuster, RM; Kusumoto, T; Kutyła, M; Kwon, JH; Kwon, SH; Kwong, KY; Kyser, AJ; Lackner, M; Lass-Flörl, C; Lauri, C; Lavandera, JV; Lee, BH; Lee, ECY; Lee, HJ; Lee, J; Lee, PS; Lee, S; Lee, SE; Lee, SY; Lefort, F; Leite, JPV; Leo, G; Leonard, R; Leow, AST; Lepori, N; Leyden, K; Leys, L; Ležaić, L; Li, D; Li, H; Li, J; Li, S; Li, TYW; Li, X; Li, XH; Li, Y; Li, Z; Li, ZH; Liao, S; Liaqat, K; Lim, H; Lin, BS; Lin, MY; Lin, NH; Lin, X; Lin, Y; Liu, C; Liu, H; Liu, HK; Liu, HX; Liu, P; Liu, R; Liu, T; Liu, X; Liu, Y; Lock, GA; Lokaj, G; Lopes, HB; Losi, V; Lotsios, NS; Low, KE; Lu, Z; Luhana, S; Luo, X; Luo, XQ; Lutz, MB; Lysova, AA; Lyssenko, KA; Macit, M; MacIver, B; MacKenna, B; Magalhães, GAP; Magnavacchi, P; Mahadevan, J; Mahboubi, A; Maher, SA; Mahipal, A; Mahmoud, MY; Maithel, SK; Makhtar, MMZ; Makurat-Kasprolewicz, B; Malysheva, YB; Mansourizadeh, A; Marek, EJ; Maresca-Fichter, H; Martin, JT; Maslov, AA; Mastora, Z; Mastroiacovo, D; Mastropetros, SG; Matei, D; Mathur, R; Matos, AO; Matsuda, Y; Maurya, SK; Mayor, Á; Mayrhofer, D; Mazzuco, AC; McCaffrey, J; McClure, T; McDonald, HI; Mchunu, NP; McLaggan, D; Mehrkar, A; Meilik, B; Melito, VA; Mellem, J; Mengozzi, A; Menotti, J; Mesquita, V; Miao, Z; Mihai, S; Miller, S; Minassian, C; Mirabile, A; Mitra, S; Mladin, G; Mo, Z; Moawad, H; Mohamed, EM; Mohammed, TJ; Mohanlall, V; Mohyeldin, RH; Moldovan, H; Monneret, G; Monopoli, DE; Monte, IP; Monteiro, JRB; Morgante, V; Mori, M; Morin-Crini, N; Morita, A; Morton, CE; Mrak, M; Muhammed, AP; Mulick, A; Muralidharan, V; Murthy, P; Muselli, M; Mustafa, S; Mysore Visweswariah, A; Nagao, G; Naicker, S; Nakagawara, K; Namgoong, B; Namkoong, H; Namukobe, J; Nasir, AA; Nasreen, SA; Natarajan, P; Nchiozem-Ngnitedem, VA; Necozione, S; Negrea, A; Negrea, P; Ngubane, S; Nguyen, TT; Nicke, A; Nightingale, E; Nistor, CL; Nitsch, D; Njapau, H; Noman, M; Novgorodtseva, T; Nowak, A; O'Connor, SR; Ofoe, R; Oh, K; Oh, TH; Oki, E; Olama, ZA; Olennikov, DN; Oliveira, GM; Omar, D; Ong, SJ; Orfanos, SE; Origa-Oryem, H; Orita, H; Ortiz, I; Ota, M; Ott, J; Otvagina, KV; Pacheco, N; Pacheco, RR; Padmanabhan, D; Pagan, JD; Pagnotta, PA; Palangi, V; Palanisamy, G; Palanisamy, K; Palanisamy, S; Pan, SG; Panaitescu, E; Pang, X; Panoutsakopoulos, V; Parera, VE; Park, JI; Park, JS; Park, SW; Park, Y; Park, YS; Parkash, O; Parry, J; Parry, JP; Paul, SK; Pavšič, N; Pałubicka, A; Persat, F; Petriz-Prieto, MA; Petukhov, AN; Pham, T; Pillay, S; Poh, KK; Ponomarev, II; Pontons-Melo, JC; Posa, A; Powell, E; Priya, AK; Punekar, R; Puppin Rontani, RM; Purushottam, M; Pusphanathan, K; Qi, JY; Qin, J; Qin, Z; Qiu, B; Qiu, X; Quattrini, G; Quindós, G; Qureshi, F; Rabbany, MA; Rac-Albu, M; Rac-Albu, ME; Rădulescu, BC; Rafatullah, M; Rajab, TK; Rajna, S; Ramanathan, M; Rao, D; Raviglione, D; Razorenov, DY; Redd, MJ; Rehman, W; Reig, M; Rentsch, CT; Ribeiro, LMS; Robles, D; Rocchi, S; Rocha, FG; Rodrigues, C; Rodrigues, LA; Rodrigues, RP; Roh, GH; Ronowska, A; Root, A; Rosa, AL; Rossi, R; Roy, S; Roy, VC; Rupji, M; Saber, EA; Sadarat, F; Saed, Y; Saeed, WS; Saeki, H; Saha, B; Saiwichai, T; Sakowicz-Burkiewicz, M; Sampedro, T; Sands, K; Santos, CF; Sari, M; Sathi, FA; Sauro, S; Sazanova, TS; Scafa-Udriște, A; Schoustra, SE; Schultze, A; Seo, DJ; Sevillano, E; Sezmis, G; Sgura, FA; Shah, NNAK; Shani, N; Shankarappa, B; Sharkey, LM; Sharma, VK; Sharp, C; Shehata, N; Shelton, N; Shieh, PB; Shimokawa, M; Shin, J; Shin, SH; Shin, YN; Shin, YR; Shipilova, A; Shoparwe, NF; Shukor, H; Sia, CH; Siddiqui, MH; Siddiqui, MR; Siena, V; Signore, A; Silwane, B; Siqueira-Sandrin, VS; Siregar, A; Sirignano, P; Sit, NW; Skidmore, S; Skupov, KM; Smeeth, L; Smoczer, C; Smolyanskiy, E; Sohn, H; Solodeev, I; Solovyev, A; Şomoghi, R; Song, F; Song, H; Song, Z; Souf, YM; Sousa, SC; Souza, MT; Steinbach-Rankins, JM; Stockton, J; Stout, JR; Su, K; Su, MZ; Suarez-Lopez, YA; Sukkurd, R; Sultanov, R; Sun, Y; Sun, Z; Supernak, M; Supriyono, E; Suroshe, SS; Suvorov, SS; Svera M Ianăşi, P; Switchenko, JM; Syarif, NY; Synytsya, A; Taherzadeh, MJ; Tain, YL; Tamburino, C; Tammam, OY; Tan, BYQ; Tan, H; Tan, S; Tanaka, H; Tang, R; Tang, X; Tang, Z; Taurino, M; Tazare, J; Teresi, L; Testro, A; Thanasoponkul, W; Thangarasu, S; Thavaselvam, D; Theodoro, RC; Theron, G; Thomas, RH; Thomson, JJ; Tian, X; Tian, Y; Tomaszewski, CA; Tomlinson, LA; Torres, CMME; Tóth, M; Trecourt, A; Trevisani, F; Trimarchi, G; Tristán, C; Truong, VK; Tsigkou, K; Tsutsumi, S; Ubukata, Y; Uehara, H; Uwamino, Y; Vahedi-Shahandashti, R; Valberg, SJ; Valderrama, C; Valdovinos-García, EM; Valsecchi, D; van Diepeningen, AD; van West, P; Vargas-Osuna, E; Vassall, M; Vassilaki, N; Vassiliou, AG; Vecino, X; Velez-Irizarry, D; Venkatesh, YN; Vignali, L; Virdis, A; Viswanath, B; Voisin, AS; Volkova, YA; Vorotyntsev, AV; Vorotyntsev, IV; Vtyurina, ES; Vu, DH; Waldridge, B; Walker, AJ; Wallon, M; Wang, B; Wang, G; Wang, H; Wang, J; Wang, LJ; Wang, S; Wang, T; Wang, X; Wang, Z; Warren, RM; Warren-Gash, C; Wei, SH; Weinstock-Guttman, B; Wekwejt, M; Wessjohann, LA; Wiesmann, HP; Williams, ZJ; Williamson, EJ; Wilson, M; Wing, K; Wong, AY; Wong, BKL; Woodward, S; Wozniak, KL; Wu, C; Wu, K; Wu, S; Wu, Y; Xiang, D; Xie, H; Xiong, X; Xu, C; Xu, H; Xu, J; Xu, WH; Xu, Y; Xun, T; Yamaguchi, S; Yan, P; Yan, W; Yan, Z; Yang, B; Yang, F; Yang, L; Yao, XB; Yasui, H; Yenesew, A; Yeo, LLL; Yeo, TC; Yi, S; Yin, F; Yip, JWL; Yoon, SH; Yoon, SJ; Yoshida, M; Yoshizumi, T; Young, LA; Yu, C; Yu, DD; Yu, F; Yu, H; Yu, JD; Yu, NJ; Yu, X; Yuan, Y; Yurenko, A; Yusof, YA; Zahedipoor, A; Zahran, EM; Zainuddin, NI; Zanatta, AC; Zanotto, ED; Zanozin, ID; Zavascki, AP; Zenke, M; Zhang, F; Zhang, G; Zhang, H; Zhang, J; Zhang, L; Zhang, MX; Zhang, NY; Zhang, Q; Zhang, W; Zhang, X; Zhang, XM; Zhao, F; Zhao, Q; Zhao, R; Zhao, Y; Zheng, J; Zheng, S; Zhou, L; Zhou, X; Zhu, H; Zivadinov, R; Žižek, D; Zuccoli, JR; Zwaan, BJ | 1 |
| Albano, D; Annunziata, S; Bertagna, F; Dondi, F; Fenocchio, E; Garrou, F; Pellegrino, L; Racca, M; Rizzo, A; Treglia, G | 1 |
| Nemzow, G; Zuckier, LS | 1 |
| Ahmed, N; Atanackovic, D; Bukhari, A; Chen, W; Dahiya, S; Dureja, R; Goloubeva, O; Gryaznov, A; Hardy, NM; Kim, DW; Kocoglu, MH; Kowatli, A; Law, JY; Lee, ST; Lutfi, F; Margiotta, P; Matsumoto, LR; McGuirk, JP; Mushtaq, MU; Rapoport, AP; Yared, JA | 1 |
| Fijuth, J; Foks, M; Gottwald, L; Kalita, K; Kosinska, M; Kuncman, L; Misiewicz, P | 1 |
| Abgral, R; Clément, C; Gujral, DM; Le Gal, G; Le Pennec, R; Leclère, JC; Maheo, C; Marianowski, R; Salaun, PY; Schick, U | 1 |
| Einama, T; Ishida, J; Kishi, Y; Kouzu, K; Tamura, K; Tsujimoto, H; Ueno, H | 1 |
| Adam, JA; de Boer, JW; Diepstra, A; Jak, M; Kersten, MJ; Kleinjan, A; Koens, L; Kuipers, MT; Mutsaers, PGNJ; Niezink, AGH; Pennings, ERA; Spanjaart, AM; van der Poel, MWM; van Doesum, JA; van Dorp, S; van Meerten, T; Vermaat, JSP | 1 |
| Colbatzky, T; Giesel, FL; Glatting, FM; Gutjahr, E; Haberkorn, U; Hackert, T; Heger, U; Hielscher, T; Hoppner, J; Kratochwil, C; Lang, M; Liermann, J; Pausch, T; Röhrich, M; Spektor, AM; Sperling, L; van Genabith, L | 1 |
| Bagul, SD; Basu, S; Chandak, AR; Shelly, D; Singh, BK; Singh, RK; Soni, BK; Sudhan, MD; Verma, P | 1 |
| Iijima, Y; Ishikawa, M; Iwai, S; Mizoguchi, T; Motono, N; Uramoto, H | 1 |
| Burger, H; Holness, J; Twycross, SH | 1 |
| Kleiner, S; Weber, W | 1 |
| Kim, SJ; Lee, JW; Nam, SB | 1 |
| Dijkema, T; Doornaert, PAH; Hoeben, BAW; Kaanders, JHAM; Kasperts, N; Smid, EJ; Terhaard, CHJ; van den Bosch, S; Verhoef, LCG; Zwijnenburg, EM | 1 |
| Been, LB; Damude, S; Deckers, EA; Hoekstra, HJ; Kruijff, S; Muller Kobold, AC; van Ginkel, RJ; van Leeuwen, BL; Vrielink, OM; Wevers, KP | 1 |
| Burger, IA; Ghafoor, S; Vargas, AH | 1 |
| Cho, YS; Chung, IK; Lee, JW; Lee, MS; Lee, SM; Son, MW | 1 |
| Du, S; Gao, S; Lu, Z; Sun, H; Xin, J | 1 |
| Shahid, A; Younis, MN | 1 |
| Chung, MJ; Eom, KY; Kim, JH; Kim, WC; Lee, JH; Lee, JW; Oh, D | 1 |
| Barker, CA; Mahajan, S; Mauguen, A; Pandit-Taskar, N; Singh, B | 1 |
| Albano, D; Alongi, P; Familiari, D; Fornito, MC; Galia, M; Ganduscio, G; Grassedonio, E; Laudicella, R; Messina, M; Midiri, M; Ruggeri, A; Scalisi, S; Spada, M | 1 |
| Crudgington, D; Howman-Giles, R; Jessop, S; Kellie, S; London, K | 1 |
| Amaral, S; Carvalho, J; Costa, M; Davies, M; Domingues, I; Eufrásio, J; Garcia, R; Khouri, L; Pinheiro, S; Pires, I; Pratas, E; Teixeira, M | 1 |
| Araki, K; Handa, T; Harimoto, N; Higuchi, T; Igarashi, T; Ishii, N; Kubo, N; Oyama, T; Shirabe, K; Tsukagoshi, M; Watanabe, A; Yamanaka, T; Yokobori, T | 1 |
| Chong, S; Chua, W; Fernando, S; Ip, E; Lim, S; Lin, M; Lin, P; Ng, W; Pham, TT; Wong, K | 1 |
| Albano, D; Bertagna, F; Giubbini, R; Mattia, B | 1 |
| Berthelsen, AK; Friborg, J; Kjær, A; Loft, A; Loft, FC; Madsen, AR; Risør, LM; Vogelius, IR | 1 |
| Benedetti Panici, P; Di Donato, V; Di Pinto, A; Musella, A; Palaia, I; Petriglia, G; Santangelo, G | 1 |
| Inoue, H; Iwama, E; Nakanishi, Y; Okamoto, I; Ota, K; Otsubo, K; Tanaka, K; Tsutsumi, H; Yoneshima, Y | 1 |
| Christensen, JT; Fischer, BM; Friborg, J; Håkansson, K; Jensen, JS; Löfgren, J; Rasmussen, JH; Vogelius, IR; von Buchwald, C; Zamani, M | 1 |
| Ai, L; Chen, Q; Chen, Z; Fan, D; Li, X; Qiao, Z; Wang, K; Wang, X; Wu, T; Zhao, X | 1 |
| Choi, WH; Kang, JH; Kim, YS; Lee, HY; Park, JK; Sung, SW; Yoo, IR | 1 |
| Belmonte, G; Caldarella, C; Hohaus, S; Manfredi, R; Minordi, LM | 1 |
| Chen, J; Deivasigamani, A; Gao, H; Hui, KM; Kong, SN; Shi, M; Xia, H; Xie, T | 1 |
| Igarashi, T; Ikeda, T; Tsujisaki, M; Yawata, A; Yokoyama, Y | 1 |
| Castello, A; Lopci, E; Rossi, S | 1 |
| Luo, Y; Pan, Q | 1 |
| Amoedo, MK; Barbosa, PNV; Dantas, GC; Travesso, DJ; Tyng, CJ | 1 |
| Izutani, H; Mori, Y; Okazaki, M; Sakao, N; Sano, Y; Shigematsu, H; Yukumi, S | 1 |
| Angeles, MA; Chantalat, E; Courbon, F; Ducassou, A; Dupuis, N; Ferron, G; Gabiache, E; Gladieff, L; Hitzel, A; Lusque, A; Martinez, A; Martinez, C; Tanguy Le Gac, Y; Voglimacci, M | 1 |
| Grosse, J; Hellwig, D | 1 |
| Aikata, H; Akagi, M; Awai, K; Chayama, K; Fujino, H; Hiramatsu, A; Imamura, M; Kawaoka, T; Kobayashi, T; Kodama, K; Morio, K; Murakami, E; Nakahara, T; Nakamura, Y; Namba, M; Ohdan, H; Ohya, K; Tsuge, M; Uchikawa, S; Yamauchi, M | 1 |
| Baiocchi, G; Bencivenga, M; Colciago, E; Framarini, M; Fumagalli Romario, U; Giacopuzzi, S; Graziosi, L; Marino, E; Moretti, A; Morgagni, P; Mura, G; Rossi, V; Saragoni, L; Tringali, D; Verlato, G | 1 |
| Agrawal, A; Banavali, S; Mathew, B; Narula, G; Prasad, M; Purandare, NC; Puranik, A; Rangarajan, V; Shah, S; Vijayasekharan, K | 1 |
| Gu, B; Lian, W; Liu, C; Lu, L; Pan, H; Song, S; Wang, M; Yang, Z; Yao, Z; Zhang, J; Zhang, Y | 1 |
| Al-Kandari, F; Ghanem, M; Marafi, F; Rasheed, R; Usmani, S | 1 |
| Cook, SA; Pourghiasian, M; Tinker, AV; Wilson, D | 1 |
| Gao, Y; Huang, MW; Liu, SM; Wu, WJ; Zhang, JG; Zheng, L | 1 |
| Akashi, H; Imamura, T; Ishibashi, Y; Kodama, M; Matsumura, M; Morimitsu, Y; Muroya, D; Nishimura, T; Sato, H; Shimokobe, T; So, H; Taketani, S; Taniwaki, S; Wada, Y; Yoshimoto, Y | 1 |
| Hirose, M; Ishibashi, H; Ohta, S | 1 |
| Dong, P; Hu, W; Li, M; Liu, X; Tian, B; Wang, L; Wang, W | 1 |
| Guney, IB; Kucuker, KA; Teke, Z; Yalav, O | 1 |
| Bodet-Milin, C; Dréno, B; Eugène, T; Khammari, A; Mesnard, C; Nguyen, JM | 1 |
| Lerut, J; Li, QY; Luo, FZ; Wang, S; Xu, X; Yang, Z; Zheng, SS; Zhuang, L | 1 |
| Du, G; Fu, Z; Liu, L; Xue, M | 1 |
| Abe, T; Fujita, K; Fukuhara, S; Imamura, R; Kiuchi, H; Nonomura, N; Tani, M; Uemura, M | 1 |
| Emi, M; Furukawa, T; Hamai, Y; Ibuki, Y; Kurokawa, T; Murakami, Y; Nagata, Y; Nishibuchi, I; Ohsawa, M; Okada, M; Yoshikawa, T | 1 |
| Han, S; Jiang, L; Song, L; Zhang, W | 1 |
| Branstetter, BF; Duvvuri, U; Heron, DE; Ly, JD; Rath, TJ; Wangaryattawanich, P | 1 |
| Bagnardi, V; Corso, G; De Scalzi, AM; Gilardi, L; Girardi, A; Grana, CM; Montagna, G; Pagan, E; Pagani, G; Rossi, EMC; Veronesi, P | 1 |
| Cheong, JW; Cho, A; Cho, H; Chung, H; Jang, JE; Kim, JS; Kim, SJ; Kim, Y; Kim, YR; Min, YH; Yang, WI | 1 |
| Argnani, L; Bacci, F; Broccoli, A; Cappelli, A; Fanti, S; Gasbarrini, A; Ghermandi, R; Golfieri, R; Nanni, C; Piovani, C; Sabattini, E; Tabacchi, E; Zinzani, PL | 1 |
| Abgral, R; Bourhis, D; Calais, J; Leclère, JC; Lucia, F; Salaün, PY; Schick, U; Vera, P | 1 |
| Berthelsen, AK; de Nully Brown, P; Loft, A; Maraldo, MV; Nielsen, K; Petersen, PM; Specht, L; Vogelius, IR | 1 |
| Ahmed, G; El Semary, SF; Kenaai, NE; Nagy, N; Omar, W; Rahman, HA; Zaky, I | 1 |
| Mayerhoefer, ME; Schöder, H; Umutlu, L | 1 |
| Chapman, JS; Chen, LM; Hsu, IC; Peters, PN; Pierson, WE; Westphalen, AC | 1 |
| Aijun, Z; Benxin, Z; Chuanpei, X; Cong, H; Peng, W; Tian, Z; Vallières, M | 1 |
| Adachi, T; Fukuma, E; Machida, Y; Tateishi, U | 1 |
| Geol Lee, C; Kim, JS; Kim, N | 1 |
| Ahn, H; Berndt, M; Bullich, S; Chae, SY; Cho, YM; Gambhir, SS; Kim, HO; Koglin, N; Kumar, M; Mittra, ES; Moon, DH; Mosci, C; Mueller, A; Na, SJ; Park, SY; Stephens, AW; Wardak, M | 1 |
| Donswijk, ML; Einerhand, SMH; Hendricksen, K; Mertens, LS; van der Poel, HG; van Gennep, EJ; van Rhijn, BWG | 1 |
| Cui, XW; Gu, L; Li, YS; Sun, J; Wang, SY; Wang, XN; Yin, Q | 1 |
| Schrage, YM; Stahlie, EHA; Stokkel, MPM; van Akkooi, ACJ; van der Hiel, B; van Houdt, WJ; Wouters, MW | 1 |
| Gabata, T; Goi, T; Higuchi, S; Hosono, N; Ikeno, H; Kimura, H; Koneri, K; Kosaka, N; Ozaki, K | 1 |
| Brizel, DM; Choudhury, KR; Das, S; Mowery, YM; Niedzwiecki, D; Rushing, CN; Vergalasova, I; Wong, TZ; Wu, Q; Yoo, DS | 1 |
| Abbasi, S; Abd El-Wahab, A; Abdallah, M; Abebe, G; Aca-Aca, G; Adama, S; Adefegha, SA; Adidigue-Ndiome, R; Adiseshaiah, P; Adrario, E; Aghajanian, C; Agnese, W; Ahmad, A; Ahmad, I; Ahmed, MFE; Akcay, OF; Akinmoladun, AC; Akutagawa, T; Alakavuklar, MA; Álava-Rabasa, S; Albaladejo-Florín, MJ; Alexandra, AJE; Alfawares, R; Alferiev, IS; Alghamdi, HS; Ali, I; Allard, B; Allen, JD; Almada, E; Alobaid, A; Alonso, GL; Alqahtani, YS; Alqarawi, W; Alsaleh, H; Alyami, BA; Amaral, BPD; Amaro, JT; Amin, SAW; Amodio, E; Amoo, ZA; Andia Biraro, I; Angiolella, L; Anheyer, D; Anlay, DZ; Annex, BH; Antonio-Aguirre, B; Apple, S; Arbuznikov, AV; Arinsoy, T; Armstrong, DK; Ash, S; Aslam, M; Asrie, F; Astur, DC; Atzrodt, J; Au, DW; Aucoin, M; Auerbach, EJ; Azarian, S; Ba, D; Bai, Z; Baisch, PRM; Balkissou, AD; Baltzopoulos, V; Banaszewski, M; Banerjee, S; Bao, Y; Baradwan, A; Barandika, JF; Barger, PM; Barion, MRL; Barrett, CD; Basudan, AM; Baur, LE; Baz-Rodríguez, SA; Beamer, P; Beaulant, A; Becker, DF; Beckers, C; Bedel, J; Bedlack, R; Bermúdez de Castro, JM; Berry, JD; Berthier, C; Bhattacharya, D; Biadgo, B; Bianco, G; Bianco, M; Bibi, S; Bigliardi, AP; Billheimer, D; Birnie, DH; Biswas, K; Blair, HC; Bognetti, P; Bolan, PJ; Bolla, JR; Bolze, A; Bonnaillie, P; Borlimi, R; Bórquez, J; Bottari, NB; Boulleys-Nana, JR; Brighetti, G; Brodeur, GM; Budnyak, T; Budnyk, S; Bukirwa, VD; Bulman, DM; Burm, R; Busman-Sahay, K; Butcher, TW; Cai, C; Cai, H; Cai, L; Cairati, M; Calvano, CD; Camacho-Ordóñez, A; Camela, E; Cameron, T; Campbell, BS; Cansian, RL; Cao, Y; Caporale, AS; Carciofi, AC; Cardozo, V; Carè, J; Carlos, AF; Carozza, R; Carroll, CJW; Carsetti, A; Carubelli, V; Casarotta, E; Casas, M; Caselli, G; Castillo-Lora, J; Cataldi, TRI; Cavalcante, ELB; Cavaleiro, A; Cayci, Z; Cebrián-Tarancón, C; Cedrone, E; Cella, D; Cereda, C; Ceretti, A; Ceroni, M; Cha, YH; Chai, X; Chang, EF; Chang, TS; Chanteux, H; Chao, M; Chaplin, BP; Chaturvedi, S; Chaturvedi, V; Chaudhary, DK; Chen, A; Chen, C; Chen, HY; Chen, J; Chen, JJ; Chen, K; Chen, L; Chen, Q; Chen, R; Chen, SY; Chen, TY; Chen, WM; Chen, X; Chen, Y; Cheng, G; Cheng, GJ; Cheng, J; Cheng, YH; Cheon, HG; Chew, KW; Chhoker, S; Chiu, WN; Choi, ES; Choi, MJ; Choi, SD; Chokshi, S; Chorny, M; Chu, KI; Chu, WJ; Church, AL; Cirrincione, A; Clamp, AR; Cleff, MB; Cohen, M; Coleman, RL; Collins, SL; Colombo, N; Conduit, N; Cong, WL; Connelly, MA; Connor, J; Cooley, K; Correa Ramos Leal, I; Cose, S; Costantino, C; Cottrell, M; Cui, L; Cundall, J; Cutaia, C; Cutler, CW; Cuypers, ML; da Silva Júnior, FMR; Dahal, RH; Damiani, E; Damtie, D; Dan-Li, W; Dang, Z; Dasa, SSK; Davin, A; Davis, DR; de Andrade, CM; de Jong, PL; de Oliveira, D; de Paula Dorigam, JC; Dean, A; Deepa, M; Delatour, C; Dell'Aiera, S; Delley, MF; den Boer, RB; Deng, L; Deng, Q; Depner, RM; Derdau, V; Derici, U; DeSantis, AJ; Desmarini, D; Diffo-Sonkoue, L; Divizia, M; Djenabou, A; Djordjevic, JT; Dobrovolskaia, MA; Domizi, R; Donati, A; Dong, Y; Dos Santos, M; Dos Santos, MP; Douglas, RG; Duarte, PF; Dullaart, RPF; Duscha, BD; Edwards, LA; Edwards, TE; Eichenwald, EC; El-Baba, TJ; Elashiry, M; Elashiry, MM; Elashry, SH; Elliott, A; Elsayed, R; Emerson, MS; Emmanuel, YO; Emory, TH; Endale-Mangamba, LM; Enten, GA; Estefanía-Fernández, K; Estes, JD; Estrada-Mena, FJ; Evans, S; Ezra, L; Faria de, RO; Farraj, AK; Favre, C; Feng, B; Feng, J; Feng, L; Feng, W; Feng, X; Feng, Z; Fernandes, CLF; Fernández-Cuadros, ME; Fernie, AR; Ferrari, D; Florindo, PR; Fong, PC; Fontes, EPB; Fontinha, D; Fornari, VJ; Fox, NP; Fu, Q; Fujitaka, Y; Fukuhara, K; Fumeaux, T; Fuqua, C; Fustinoni, S; Gabbanelli, V; Gaikwad, S; Gall, ET; Galli, A; Gancedo, MA; Gandhi, MM; Gao, D; Gao, K; Gao, M; Gao, Q; Gao, X; Gao, Y; Gaponenko, V; Garber, A; Garcia, EM; García-Campos, C; García-Donas, J; García-Pérez, AL; Gasparri, F; Ge, C; Ge, D; Ge, JB; Ge, X; George, I; George, LA; Germani, G; Ghassemi Tabrizi, S; Gibon, Y; Gillent, E; Gillies, RS; Gilmour, MI; Goble, S; Goh, JC; Goiri, F; Goldfinger, LE; Golian, M; Gómez, MA; Gonçalves, J; Góngora-García, OR; Gonul, I; González, MA; Govers, TM; Grant, PC; Gray, EH; Gray, JE; Green, MS; Greenwald, I; Gregory, MJ; Gretzke, D; Griffin-Nolan, RJ; Griffith, DC; Gruppen, EG; Guaita, A; Guan, P; Guan, X; Guerci, P; Guerrero, DT; Guo, M; Guo, P; Guo, R; Guo, X; Gupta, J; Guz, G; Hajizadeh, N; Hamada, H; Haman-Wabi, AB; Han, TT; Hannan, N; Hao, S; Harjola, VP; Harmon, M; Hartmann, MSM; Hartwig, JF; Hasani, M; Hawthorne, WJ; Haykal-Coates, N; Hazari, MS; He, DL; He, P; He, SG; Héau, C; Hebbar Kannur, K; Helvaci, O; Heuberger, DM; Hidalgo, F; Hilty, MP; Hirata, K; Hirsch, A; Hoffman, AM; Hoffmann, JF; Holloway, RW; Holmes, RK; Hong, S; Hongisto, M; Hopf, NB; Hörlein, R; Hoshino, N; Hou, Y; Hoven, NF; Hsieh, YY; Hsu, CT; Hu, CW; Hu, JH; Hu, MY; Hu, Y; Hu, Z; Huang, C; Huang, D; Huang, DQ; Huang, L; Huang, Q; Huang, R; Huang, S; Huang, SC; Huang, W; Huang, Y; Huffman, KM; Hung, CH; Hung, CT; Huurman, R; Hwang, SM; Hyun, S; Ibrahim, AM; Iddi-Faical, A; Immordino, P; Isla, MI; Jacquemond, V; Jacques, T; Jankowska, E; Jansen, JA; Jäntti, T; Jaque-Fernandez, F; Jarvis, GA; Jatt, LP; Jeon, JW; Jeong, SH; Jhunjhunwala, R; Ji, F; Jia, X; Jia, Y; Jian-Bo, Z; Jiang, GD; Jiang, L; Jiang, W; Jiang, WD; Jiang, Z; Jiménez-Hoyos, CA; Jin, S; Jobling, MG; John, CM; John, T; Johnson, CB; Jones, KI; Jones, WS; Joseph, OO; Ju, C; Judeinstein, P; Junges, A; Junnarkar, M; Jurkko, R; Kaleka, CC; Kamath, AV; Kang, X; Kantsadi, AL; Kapoor, M; Karim, Z; Kashuba, ADM; Kassa, E; Kasztura, M; Kataja, A; Katoh, T; Kaufman, JS; Kaupp, M; Kehinde, O; Kehrenberg, C; Kemper, N; Kerr, CW; Khan, AU; Khan, MF; Khan, ZUH; Khojasteh, SC; Kilburn, S; Kim, CG; Kim, DU; Kim, DY; Kim, HJ; Kim, J; Kim, OH; Kim, YH; King, C; Klein, A; Klingler, L; Knapp, AK; Ko, TK; Kodavanti, UP; Kolla, V; Kong, L; Kong, RY; Kong, X; Kore, S; Kortz, U; Korucu, B; Kovacs, A; Krahnert, I; Kraus, WE; Kuang, SY; Kuehn-Hajder, JE; Kurz, M; Kuśtrowski, P; Kwak, YD; Kyttaris, VC; Laga, SM; Laguerre, A; Laloo, A; Langaro, MC; Langham, MC; Lao, X; Larocca, MC; Lassus, J; Lattimer, TA; Lazar, S; Le, MH; Leal, DB; Leal, M; Leary, A; Ledermann, JA; Lee, JF; Lee, MV; Lee, NH; Leeds, CM; Leeds, JS; Lefrandt, JD; Leicht, AS; Leonard, M; Lev, S; Levy, K; Li, B; Li, C; Li, CM; Li, DH; Li, H; Li, J; Li, L; Li, LJ; Li, N; Li, P; Li, T; Li, X; Li, XH; Li, XQ; Li, XX; Li, Y; Li, Z; Li, ZY; Liao, YF; Lin, CC; Lin, MH; Lin, Y; Ling, Y; Links, TP; Lira-Romero, E; Liu, C; Liu, D; Liu, H; Liu, J; Liu, L; Liu, LP; Liu, M; Liu, T; Liu, W; Liu, X; Liu, XH; Liu, Y; Liuwantara, D; Ljumanovic, N; Lobo, L; Lokhande, K; Lopes, A; Lopes, RMRM; López-Gutiérrez, JC; López-Muñoz, MJ; López-Santamaría, M; Lorenzo, C; Lorusso, D; Losito, I; Lu, C; Lu, H; Lu, HZ; Lu, SH; Lu, SN; Lu, Y; Lu, ZY; Luboga, F; Luo, JJ; Luo, KL; Luo, Y; Lutomski, CA; Lv, W; M Piedade, MF; Ma, J; Ma, JQ; Ma, JX; Ma, N; Ma, P; Ma, S; Maciel, M; Madureira, M; Maganaris, C; Maginn, EJ; Mahnashi, MH; Maierhofer, M; Majetschak, M; Malla, TR; Maloney, L; Mann, DL; Mansuri, A; Marelli, E; Margulis, CJ; Marrella, A; Martin, BL; Martín-Francés, L; Martínez de Pinillos, M; Martínez-Navarro, EM; Martinez-Quintanilla Jimenez, D; Martínez-Velasco, A; Martínez-Villaseñor, L; Martinón-Torres, M; Martins, BA; Massongo, M; Mathew, AP; Mathews, D; Matsui, J; Matsumoto, KI; Mau, T; Maves, RC; Mayclin, SJ; Mayer, JM; Maynard, ND; Mayr, T; Mboowa, MG; McEvoy, MP; McIntyre, RC; McKay, JA; McPhail, MJW; McVeigh, AL; Mebazaa, A; Medici, V; Medina, DN; Mehmood, T; Mei-Li, C; Melku, M; Meloncelli, S; Mendes, GC; Mendoza-Velásquez, C; Mercadante, R; Mercado, MI; Merenda, MEZ; Meunier, J; Mi, SL; Michels, M; Mijatovic, V; Mikhailov, V; Milheiro, SA; Miller, DC; Ming, F; Mitsuishi, M; Miyashita, T; Mo, J; Mo, S; Modesto-Mata, M; Moeller, S; Monte, A; Monteiro, L; Montomoli, J; Moore, EE; Moore, HB; Moore, PK; Mor, MK; Moratalla-López, N; Moratilla Lapeña, L; Moreira, R; Moreno, MA; Mörk, AC; Morton, M; Mosier, JM; Mou, LH; Mougharbel, AS; Muccillo-Baisch, AL; Muñoz-Serrano, AJ; Mustafa, B; Nair, GM; Nakanishi, I; Nakanjako, D; Naraparaju, K; Nawani, N; Neffati, R; Neil, EC; Neilipovitz, D; Neira-Borrajo, I; Nelson, MT; Nery, PB; Nese, M; Nguyen, F; Nguyen, MH; Niazy, AA; Nicolaï, J; Nogueira, F; Norbäck, D; Novaretti, JV; O'Donnell, T; O'Dowd, A; O'Malley, DM; Oaknin, A; Ogata, K; Ohkubo, K; Ojha, M; Olaleye, MT; Olawande, B; Olomo, EJ; Ong, EWY; Ono, A; Onwumere, J; Ortiz Bibriesca, DM; Ou, X; Oza, AM; Ozturk, K; Özütemiz, C; Palacio-Pastrana, C; Palaparthi, A; Palevsky, PM; Pan, K; Pantanetti, S; Papachristou, DJ; Pariani, A; Parikh, CR; Parissis, J; Paroul, N; Parry, S; Patel, N; Patel, SM; Patel, VC; Pawar, S; Pefura-Yone, EW; Peixoto Andrade, BCO; Pelepenko, LE; Peña-Lora, D; Peng, S; Pérez-Moro, OS; Perez-Ortiz, AC; Perry, LM; Peter, CM; Phillips, NJ; Phillips, P; Pia Tek, J; Piner, LW; Pinto, EA; Pinto, SN; Piyachaturawat, P; Poka-Mayap, V; Polledri, E; Poloni, TE; Ponessa, G; Poole, ST; Post, AK; Potter, TM; Pressly, BB; Prouty, MG; Prudêncio, M; Pulkki, K; Pupier, C; Qian, H; Qian, ZP; Qiu, Y; Qu, G; Rahimi, S; Rahman, AU; Ramadan, H; Ramanna, S; Ramirez, I; Randolph, GJ; Rasheed, A; Rault, J; Raviprakash, V; Reale, E; Redpath, C; Rema, V; Remucal, CK; Remy, D; Ren, T; Ribeiro, LB; Riboli, G; Richards, J; Rieger, V; Rieusset, J; Riva, A; Rivabella Maknis, T; Robbins, JL; Robinson, CV; Roche-Campo, F; Rodriguez, R; Rodríguez-de-Cía, J; Rollenhagen, JE; Rosen, EP; Rub, D; Rubin, N; Rubin, NT; Ruurda, JP; Saad, O; Sabell, T; Saber, SE; Sabet, M; Sadek, MM; Saejio, A; Salinas, RM; Saliu, IO; Sande, D; Sang, D; Sangenito, LS; Santos, ALSD; Sarmiento Caldas, MC; Sassaroli, S; Sassi, V; Sato, J; Sauaia, A; Saunders, K; Saunders, PR; Savarino, SJ; Scambia, G; Scanlon, N; Schetinger, MR; Schinkel, AFL; Schladweiler, MC; Schofield, CJ; Schuepbach, RA; Schulz, J; Schwartz, N; Scorcella, C; Seeley, J; Seemann, F; Seinige, D; Sengoku, T; Seravalli, J; Sgromo, B; Shaheen, MY; Shan, L; Shanmugam, S; Shao, H; Sharma, S; Shaw, KJ; Shen, BQ; Shen, CH; Shen, P; Shen, S; Shen, Y; Shen, Z; Shi, J; Shi-Li, L; Shimoda, K; Shoji, Y; Shun, C; Silva, MA; Silva-Cardoso, J; Simas, NK; Simirgiotis, MJ; Sincock, SA; Singh, MP; Sionis, A; Siu, J; Sivieri, EM; Sjerps, MJ; Skoczen, SL; Slabon, A; Slette, IJ; Smith, MD; Smith, S; Smith, TG; Snapp, KS; Snow, SJ; Soares, MCF; Soberman, D; Solares, MD; Soliman, I; Song, J; Sorooshian, A; Sorrell, TC; Spinar, J; Staudt, A; Steinhart, C; Stern, ST; Stevens, DM; Stiers, KM; Stimming, U; Su, YG; Subbian, V; Suga, H; Sukhija-Cohen, A; Suksamrarn, A; Suksen, K; Sun, J; Sun, M; Sun, P; Sun, W; Sun, XF; Sun, Y; Sundell, J; Susan, LF; Sutjarit, N; Swamy, KV; Swisher, EM; Sykes, C; Takahashi, JA; Talmor, DS; Tan, B; Tan, ZK; Tang, L; Tang, S; Tanner, JJ; Tanwar, M; Tarazi, Z; Tarvasmäki, T; Tay, FR; Teketel, A; Temitayo, GI; Thersleff, T; Thiessen Philbrook, H; Thompson, LC; Thongon, N; Tian, B; Tian, F; Tian, Q; Timothy, AT; Tingle, MD; Titze, IR; Tolppanen, H; Tong, W; Toyoda, H; Tronconi, L; Tseng, CH; Tu, H; Tu, YJ; Tung, SY; Turpault, S; Tuynman, JB; Uemoto, AT; Ugurlu, M; Ullah, S; Underwood, RS; Ungell, AL; Usandizaga-Elio, I; Vakonakis, I; van Boxel, GI; van den Beucken, JJJP; van der Boom, T; van Slegtenhorst, MA; Vanni, JR; Vaquera, A; Vasconcellos, RS; Velayos, M; Vena, R; Ventura, G; Verso, MG; Vincent, RP; Vitale, F; Vitali, S; Vlek, SL; Vleugels, MPH; Volkmann, N; Vukelic, M; Wagner Mackenzie, B; Wairagala, P; Waller, SB; Wan, J; Wan, MT; Wan, Y; Wang, CC; Wang, H; Wang, J; Wang, JF; Wang, K; Wang, L; Wang, M; Wang, S; Wang, WM; Wang, X; Wang, Y; Wang, YD; Wang, YF; Wang, Z; Wang, ZG; Warriner, K; Weberpals, JI; Weerachayaphorn, J; Wehrli, FW; Wei, J; Wei, KL; Weinheimer, CJ; Weisbord, SD; Wen, S; Wendel Garcia, PD; Williams, JW; Williams, R; Winkler, C; Wirman, AP; Wong, S; Woods, CM; Wu, B; Wu, C; Wu, F; Wu, P; Wu, S; Wu, Y; Wu, YN; Wu, ZH; Wurtzel, JGT; Xia, L; Xia, Z; Xia, ZZ; Xiao, H; Xie, C; Xin, ZM; Xing, Y; Xing, Z; Xu, S; Xu, SB; Xu, T; Xu, X; Xu, Y; Xue, L; Xun, J; Yaffe, MB; Yalew, A; Yamamoto, S; Yan, D; Yan, H; Yan, S; Yan, X; Yang, AD; Yang, E; Yang, H; Yang, J; Yang, JL; Yang, K; Yang, M; Yang, P; Yang, Q; Yang, S; Yang, W; Yang, X; Yang, Y; Yao, JC; Yao, WL; Yao, Y; Yaqub, TB; Ye, J; Ye, W; Yen, CW; Yeter, HH; Yin, C; Yip, V; Yong-Yi, J; Yu, HJ; Yu, MF; Yu, S; Yu, W; Yu, WW; Yu, X; Yuan, P; Yuan, Q; Yue, XY; Zaia, AA; Zakhary, SY; Zalwango, F; Zamalloa, A; Zamparo, P; Zampini, IC; Zani, JL; Zeitoun, R; Zeng, N; Zenteno, JC; Zepeda-Palacio, C; Zhai, C; Zhang, B; Zhang, G; Zhang, J; Zhang, K; Zhang, Q; Zhang, R; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, B; Zhao, D; Zhao, G; Zhao, H; Zhao, Q; Zhao, R; Zhao, S; Zhao, T; Zhao, X; Zhao, XA; Zhao, Y; Zhao, Z; Zheng, Z; Zhi-Min, G; Zhou, CL; Zhou, HD; Zhou, J; Zhou, W; Zhou, XQ; Zhou, Z; Zhu, C; Zhu, H; Zhu, L; Zhu, Y; Zitzmann, N; Zou, L; Zou, Y | 1 |
| Wang, Y; Yang, S | 1 |
| Sagir Kahraman, A | 1 |
| Gill, S; Loh, N; Tan, D | 1 |
| Fatima, N; Tahseen, R; Zaman, A; Zaman, MU; Zaman, S; Zaman, U | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Kawakita, N; Matsumoto, D; Otsuka, H; Takashima, M; Takizawa, H; Tangoku, A; Toba, H | 1 |
| Aparici, CM; Brown, R; Davidzon, G; Franc, BL; Girod, B; Guja, KE; Harrison, C; Iagaru, A; Moradi, F; Song, H | 1 |
| Asakage, T; Kawabe, H; Manabe, O; Oyama, J; Tateishi, U; Tateishi, Y; Tsuchiya, J; Yamamoto, K; Yokoyama, K | 1 |
| Alessi, A; Bandini, M; Calareso, G; Colecchia, M; Farè, E; Giannatempo, P; Marandino, L; Necchi, A; Padovano, B; Raggi, D; Serafini, G | 1 |
| Andreu-Arasa, VC; Fujima, N; Ito, K; Kaneda, T; Meibom, SK; Qureshi, MM; Sakai, O; Salama, AR; Takumi, K; Truong, MT | 1 |
| Broglie, MA; Hüllner, MW; Morand, GB; Stadler, TM | 1 |
| Chen, QY; Guo, SS; Jia, GD; Liu, LT; Liu, SL; Luo, DH; Mai, HQ; Sun, R; Sun, XS; Tang, LQ; Xie, HJ; Yu, YF | 1 |
| Brown, P; Currie, S; Frood, R; McDermott, G; Nelstrop, H; Prestwich, R; Scarsbrook, AF; Vaidyanathan, S; Zhong, J | 1 |
| Amini, A; Eguchi, MM; Goddard, JA; Karam, SD; McDermott, J; Morgan, RL; Mueller, AC; Trivedi, PS | 1 |
| Ikeda, K; Nishida, N; Sato, H; Uchino, M; Yoshikai, M | 1 |
| Cachin, F; Deluche, E; Labrunie, A; Lades, G; Lavau-Denes, S; Le Brun-Ly, V; Lecaille, C; Leobon, S; Monteil, J; Mundler, O; Rullier, E; Seitz, JF; Selvy, M; Smith, D; Terrebonne, E; Tubiana-Mathieu, N; Valli, N; Zasadny, X | 1 |
| Kang, S; Kim, SK; Kim, TS; Lim, MC; Park, S; Park, SY; Seo, SS; Yoo, CW | 1 |
| Bhosale, P; Ganeshan, D; Gulati, AT; Iyer, R; Palmquist, S; Virarkar, M | 1 |
| Kita, Y; Okamoto, T; Tokunaga, Y | 1 |
| Buvat, I; Capobianco, N; Casasnovas, O; Chartier, L; Clerc, J; Cottereau, AS; Meignan, M; Nioche, C; Thieblemont, C; Vercellino, L | 1 |
| Berg, HF; Bozickovic, O; Engerud, H; Forsse, D; Haldorsen, IS; Halle, MK; Hoivik, EA; Krakstad, C; Trovik, J; Werner, HMJ; Woie, K | 1 |
| Gemdzhian, EG; Kovrigina, AM; Krasil'nikova, IV; Kravchenko, SK; Lutsik, NS; Nesterova, ES; Sudarikov, AB; Yatsyk, GA | 1 |
| Beets-Tan, RGH; Lambregts, DMJ; Maas, M; Staal, FCR; Taghavi, M; van der Reijd, DJ | 1 |
| Danilenko, VV; Kmetyuk, YV; Solodyannikova, OI; Sukach, GG | 1 |
| Jaimini, A; Jain, A; Jain, M; John, AR; Kishore, B; Pandit, AG; Sharma, A; Singh, A; Vishnoi, MG | 1 |
| Lv, J; Mao, W; Shi, H; Yin, H | 1 |
| Dieng, M; Einstein, AJ; Emmett, L; Khanna, N; Lord, SJ; Menzies, AM; Morton, RL; Nguyen, M; Nieweg, OE; Nijhuis, AAG; Saw, RPM; Thompson, JF; Turner, RM; Zeng, J | 1 |
| Chen, QY; Fan, W; Guo, L; Guo, SS; Han, LJ; Li, JB; Li, XY; Liang, YJ; Lin, C; Lin, DF; Liu, LT; Liu, SL; Luo, DH; Lv, XF; Mai, HQ; Sun, R; Sun, XS; Tang, LQ; Tang, QN; Wen, YF; Xiao, BB; Yuan, L; Zhang, X | 1 |
| Goel, A; Patel, Y; Rana, D; Saini, SK; Srivastava, S; Suryanarayana, K | 1 |
| Calice, G; Gallicchio, R; Guarini, A; Guglielmi, G; Nardelli, A; Storto, G | 1 |
| Chen, W; Hong, X; Lu, L; Peng, L; Wang, Q; Yuan, Q | 1 |
| Cong, Y; Honma, K; Machida, Y; Nomori, H; Otsuki, A; Oyama, Y; Sugimura, H; Yamazaki, I | 1 |
| González Mínguez, C; Loras, C; Martín-Cardona, A; Vall-Llovera Calmet, F | 1 |
| Su, M; Wang, D; Xiao, J | 1 |
| Cheng, W; Hou, G; Huo, L; Jiang, Y; Li, F; Zhao, D; Zhu, Z | 1 |
| de Almeida, JR; Ferris, RL; Forner, D; Goldstein, DP; Metser, U; Noel, CW; Waldron, J | 1 |
| Dong, XB; Ge, Y; Huo, Z; Li, TS; Wang, Q; Zhang, T | 1 |
| Chitalia, R; Cohen, EA; Gastounioti, A; Karp, J; Kontos, D; Mankoff, DA; Muzi, M; Pantel, AR; Peterson, LM; Viswanath, V | 1 |
| Bjerring, OS; Fristrup, CW; Hess, S; Lundell, L; Mortensen, MB; Petersen, H | 1 |
| Parooie, F; Salarzaei, M; Sanei Sistani, S | 1 |
| Chang, H; Chen, YY; Chou, HP; Huang, HK; Huang, TW; Lee, SC; Lin, KH; Lin, LF; Wu, TH | 1 |
| Choi, KH; Hong, JH; Kim, MS; Kim, YS; Lee, YS; Park, EY; Song, JH; Sun, DI; Yoo, IR | 1 |
| Bernard, C; Decuypere, M; Ferreira, M; Hatt, M; Hermesse, J; Hustinx, R; Kridelka, F; Lambin, P; Leijenaar, RTH; Lovinfosse, P; Lucia, F; Meyer, PE; Reinhold, C; Robin, P; Rousseau, C; Schick, U; Visvikis, D | 1 |
| Bidard, FC; Buvat, I; Champion, L; Deleval, N; Guinebretiere, JM; Latouche, A; Rouzier, R; Seban, RD | 1 |
| Cao, C; Chen, X; Hu, Q; Hua, Y; Huang, S; Jiang, F; Jin, Q; Jin, T; Piao, Y; Xu, Y | 1 |
| Cosio, S; Depalo, T; Gadducci, A; Giorgetti, A; Guidoccio, F; Manca, G; Miccoli, M; Simonetti, E; Volterrani, D | 1 |
| Miao, W; Nie, P; Rao, W; Wang, Y; Wang, Z; Wu, F; Yan, L; Yang, G; Yu, M; Yu, T; Zhao, Y | 1 |
| Bredella, MA; Vicentini, JRT | 1 |
| Buck, A; Fassnacht, M; Fröhling, S; Fuss, CT; Germer, CT; Hübschmann, D; Kickuth, R; Kircher, S; Kroiss, M; Lenschow, C; Reibetanz, J; Schlegel, N; Stenzinger, A; Wiegering, A | 1 |
| Andersen, FL; Bentzen, SM; Fischer, BM; Hansen, AE; Johannesen, HH; Kjaer, A; Lelkaitis, G; Olin, AB; Rasmussen, JH; Specht, L; Vogelius, IR; von Buchwald, C; Wessel, I | 1 |
| Bharwani, N; Cunha, TM; Forstner, R; Gigli, S; Gui, B; Kido, A; Lakhman, Y; Manganaro, L; Nougaret, S; Rizzo, S; Rockall, A; Sala, E; Vinci, V | 1 |
| Ancın, B; Doğan, R; Köksal, D; Kumbasar, U; Tuncel, M; Uysal, S | 1 |
| Bekers, EM; Donswijk, ML; Lahaye, MJ; Mertens, LS; Stokkel, LE; Stokkel, MPM; van Rhijn, BWG | 1 |
| Chen, CC; Cheng, MF; Chuang, PJ; Hsieh, MS; Ko, CL; Lin, YJ; Tien, YW; Wang, HP; Wu, YW; Yang, SH; Yen, RF | 1 |
| Matloob, A; Mundi, N; Silberzweig, AM; Urken, ML; Xing, MH | 1 |
| Hattori, S; Hirata, K; Hung, A; Ishibashi, M; Ishii, K; Kaida, H; Kitajima, K; Matsunaga, T; Minamimoto, R; Nakajo, M; Nakatani, K; Yasuda, T | 1 |
| Bashir, H; Hassan, A; Siddiqui, N; Zafar, T | 1 |
| Barriere, J; Bondouy, M | 1 |
| Kawaguchi, T; Ota, M; Taniguchi, S; Tojo, T; Yasukawa, M | 1 |
| Cao, J; Yang, Y | 1 |
| Aoshima, H; Isaka, T; Kanzaki, M; Maeda, H; Matsumoto, T; Mitsuboshi, S; Shidei, H | 1 |
| Alitto, AR; Caldarella, C; Cocciolillo, F; Taralli, S | 1 |
| Chen, H; Fu, H; Fu, J; Huang, J; Pang, Y | 1 |
| Lee, HY; Lee, S; Park, S | 1 |
| Colandrea, M; Di Stasio, GD; Ferrari, ME; Galetta, D; Grana, CM; Maisonneuve, P; Sorbello, S; Spaggiari, L; Travaini, L; Travascio, L | 1 |
| Baek, JH; Chang, YH; Chen, WC; Chi, SY; Chiang, PL; Chou, CK; Huang, SC; Lin, WC; Luo, SD; Su, YY; Tung, YC | 1 |
| Behr, S; Glastonbury, C; Heaton, C; House, AE; Jacobs, J; Knott, PD; Likhterov, I; Seth, R; Zebolsky, AL | 1 |
| Isaka, M; Konno, H; Mizuno, T; Nagata, T; Ohde, Y | 1 |
| Nguyen, NC; Vasireddi, A | 1 |
| Antonoff, MB; Blumenthaler, AN; Hofstetter, WL; Mehran, RJ; Rajaram, R; Rice, DC; Roth, JA; Sepesi, B; Strange, CD; Swisher, SG; Vaporciyan, AA; Walsh, GL | 1 |
| Fukumitsu, K; Hamaguchi, Y; Hata, K; Ishii, T; Kaido, T; Nakamoto, Y; Ogiso, S; Seo, S; Taura, K; Uemoto, S; Yoh, T | 1 |
| Albano, D; Alongi, P; Cistaro, A; Formica, G; Frantellizzi, V; Laudicella, R; Piccardo, A; Pizzuto, DA; Quartuccio, N; Romagnolo, C; Stracuzzi, F | 1 |
| Champion, L; Dercle, L; Muneer, I; Schwartz, LH; Seban, RD; Synn, S | 1 |
| Chen, MYC; Hsu, JT; Lin, NC; Su, IH; Tsai, KY | 1 |
| Bardet, S; Ciappuccini, R; Clarisse, B; Dorbeau, M; Giffard, F; Licaj, I; Poulain, L; Saguet-Rysanek, V | 1 |
| Avigdor, A; Benjamini, O; Kedmi, M; Khaustov, P; Ribakovsy, E | 1 |
| Gong, W; Liao, T; Liu, Y; Wu, J; Zhang, C | 1 |
| Baldari, G; Gasparro, D; Guglielmo, P; Maestroni, U; Manuguerra, R; Migliari, S; Ruffini, L; Sammartano, A; Scarlattei, M; Silini, EM | 1 |
| Chang, HM; Hwang, DW; Jeong, JH; Jun, E; Kim, JS; Kim, KP; Kim, SC; Kwon, JW; Lee, JH; Lee, W; Oh, M; Park, SY; Park, Y; Ryoo, BY; Song, KB; Yoo, C | 1 |
| Agazzi, GM; Albano, D; Bertagna, F; Bosio, P; Farina, D; Giubbini, R; Grammatica, A; Lancini, D; Maroldi, R; Nicolai, P; Piazza, C; Ravanelli, M; Squassina, G; Zigliani, A | 1 |
| Ghosh, I; Sharma, P | 1 |
| Blum, S; Fritzmann, J; Hoberück, S; Hoffmann, RT; Kotzerke, J; Kühn, JP; Laniado, M; Michler, E; Nebelung, H; Platzek, I; Plodeck, V; Radosa, CG; Streitzig, J; Weitz, J; Zöphel, K | 1 |
| Boellaard, R; de Vet, HCW; Eertink, JJ; Hoekstra, OS; Lugtenburg, PJ; Pfaehler, EAG; van de Brug, T; van der Holt, B; Wiegers, SE; Zijlstra, JM; Zwezerijnen, GJC | 1 |
| Guo, CB; Liu, XJ; Peng, X; Yu, GY; Yu, Y; Zhang, WB | 1 |
| Acosta, O; De Crevoisier, R; Der Sarkissian, H; Devillers, A; Grossiord, E; Guzman, L; Leseur, J; Ospina, JD; Roman-Jimenez, G | 1 |
| McEwan, LM; Wong, D; Yaxley, J | 1 |
| Bayarri-Lara, CI; Cueto Ladrón de Guevara, A; de Miguel Pérez, D; Delgado-Rodríguez, M; Expósito Ruiz, M; Giraldo Ospina, CF; Lorente, JA; Moyano Rodriguez, MJ; Puche, JL; Rodriguez Fernández, A; Ruiz Zafra, J; Sánchez-Palencia Ramos, A; Serrano, MJ | 1 |
| Cheon, GJ; Chung, HH; Kang, SY; Lee, HJ; Lee, JJ; Lee, JW; Moon, SH; Park, JY | 1 |
| Fan, B; Fan, P; Fu, Z; Hu, M; Kong, L; Ma, L; Sun, X; Wang, S; Yu, J; Zhao, S; Zheng, J | 1 |
| Ahn, SG; Jeon, TJ; Jeong, J; Kim, KM; Kim, SI; Lee, HW; Lee, JH; Lee, SA; Ryu, YH; Sohn, J; Yun, M | 1 |
| Agrawal, A; Engineer, R; Guruchannabasavaiah, B; Ostwal, V; Rangarajan, V; Saklani, A; Vallam, KC | 1 |
| Berkovic, P; Coucke, PA; Dechambre, D; Gulyban, A; Jansen, N; Janvary, L; Lakosi, F; Martinive, P; Nguyen, PV | 1 |
| Meijerink, MR; Melenhorst, MCAM; Scheffer, HJ; van den Tol, MP; van Grieken, N; Vroomen, LGPH | 1 |
| Bertrand, AS; Cailleaux, M; Callonnec, F; Edet-Sanson, A; Le Cloirec, J; Lussey-Lepoutre, C; Menard, JF; Quieffin, F; Vera, P | 1 |
| Allinson, K; Candy, N; Carr, O; McMillen, J; Trivedi, R; Young, A | 1 |
| Alchawaf, A; Germetaki, T; Khoja, L; Kordatou, Z; Mansoor, W; Owen-Holt, V; Papaxoinis, G; Patrao, A; Stamatopoulou, S; Weaver, JMJ | 1 |
| Altorki, NK; Ghaly, G; Harrison, S; Kamel, MK; Lee, PC; Nasar, A; Nguyen, AB; Port, J; Rahouma, M; Stiles, BM | 1 |
| Bauer, S; Erfanian, Y; Forsting, M; Grueneisen, J; Herrmann, K; Kirchner, J; Podleska, LE; Poeppel, T; Umutlu, L; Wetter, A | 1 |
| Buvat, I; Chargari, C; Dercle, L; Deutsch, E; Escande, A; Gouy, S; Haie-Meder, C; Limkin, E; Nioche, C; Orlhac, F; Reuzé, S; Riet, F; Robert, C | 1 |
| Li, ZG; Mu, HY | 1 |
| Chiba, S; Hattori, Y; Kawahara, T; Miyoshi, Y; Mochizuki, T; Shimokihara, K; Takamoto, D; Teranishi, JI; Uemura, H | 1 |
| Baretton, G; Baumann, M; Bütof, R; Hofheinz, F; Jentsch, C; Kotzerke, J; Krause, M; Löck, S; Schmollack, J; Weitz, J; Zöphel, K; Zschaeck, S | 1 |
| Geng, L; Wang, T; Wang, W; Yan, S; Ye, YF; Yu, J; Yu, SF; Zheng, SS | 1 |
| Cheon, GJ; Chung, JK; Kang, KW; Kim, YI; Kim, YJ; Lee, DS; Paeng, JC | 1 |
| Hattori, A; Matsunaga, T; Oh, S; Suzuki, K; Takamochi, K | 1 |
| Chiou, YR; Chou, KT; Huang, TC; Yang, SN; Zhang, GG | 1 |
| Cheng, ZB; Jin, YN; Ma, J; Mo, HY; Sun, Y; Wang, SY; Yao, JJ; Zhang, F; Zhang, WJ; Zhou, GQ | 1 |
| Appelt, AL; Borissova, S; Brink, C; Drøgemüller Lund, M; Hansen, O; Hoffmann, L; Josipovic, M; Khalil, AA; Knap, MM; Lutz, CM; Møller, DS; Nielsen, TB; Nyhus, CH; Ottosson, W; Persson, G; Schytte, T; Sibolt, P | 1 |
| Koparal, H; Korkmaz, E; Ozbilek, E; Yalcın, B; Yasar, Z; Yılmaz, U | 1 |
| An, YS; Han, SU; Lee, D; Lee, JH; Lee, KM; Lee, SJ; Park, S; Yoon, JK | 1 |
| Badve, C; Faulhaber, P; Garg, V; Hojjati, M; Rogers, L; Ros, PR; Sloan, A; Tatsuoka, C; Wolansky, LJ | 1 |
| Amaya, K; Kaji, M; Maeda, K; Matsui, K; Mochizuki, K; Saito, J; Shimizu, K; Takeshita, M; Terai, S; Tsukada, T; Uchiyama, A; Watanabe, T | 1 |
| Aristophanous, M; Awan, MJ; Belal, AM; Brandon Gunn, G; Cardenas, CE; El-Gowily, AG; Fuller, CD; Garden, AS; Lai, SY; Mohamed, ASR; Rock, CD; Rosenthal, DI; Westergaard, SA | 1 |
| Macbeth, F; Treasure, T | 1 |
| Becker, CD; Becker, M; Burkhardt, K; Caparrotti, F; Combescure, C; Delattre, BMA; Dulguerov, N; Dulguerov, P; Katirtzidou, E; Pusztaszeri, M; Rager, O; Ratib, O; Varoquaux, AD; Zaidi, H | 1 |
| Chang-Halpenny, C; Diehn, M; Eclov, NCW; Gensheimer, MF; Graves, EE; Hara, WY; Hong, JC; Le, QT; Loo, BW; Maxim, PG; Murphy, JD; Neal, JW; Olson, MR; Quon, A; To, J; Wakelee, HA; Zhu, H | 1 |
| Gelfand, MJ; McCarville, MB; Sharp, SE; Shulkin, BL | 1 |
| Balachandran, A; Bhosale, P; Katz, M; Rayamajhi, S; Reddy, A; Rohren, E | 1 |
| Castro, GJ | 1 |
| Chaddha, U; English, R; Panchabhai, TS; Patil, PD | 1 |
| Abraham, T; Benchekroun, MT; Garg, G | 1 |
| Akimoto, E; Emi, A; Kadoya, T; Kajitani, K; Masumoto, N; Ohara, M; Okada, M; Shigematsu, H | 1 |
| Belfiori, G; Crippa, S; Falconi, M; Partelli, S; Pergolini, I; Pucci, A; Ruffo, G; Salgarello, M; Zamboni, G | 1 |
| Alifano, M; Charpentier, MC; Cusumano, G; Damotte, D; Fournel, L; Galia, A; Nicolosi, M; Regnard, JF; Strano, S; Terminella, A | 1 |
| Asaka, T; Hirata, K; Kitagawa, Y; Ohga, N; Sato, J; Satoh, A; Shiga, T; Tamaki, N; Watanabe, S | 1 |
| Qin, L; Zhang, C; Zhang, Y | 1 |
| Abou Yehia, Z; Akhtari, M; Andraos, TY; Chuang, H; Dabaja, BS; Dong, W; Fanale, M; Garg, N; Gunther, J; Khoury, JD; Mawlawi, O; Milgrom, SA; Oki, Y; Osborne, EM; Pinnix, CC; Reddy, JP; Rohren, E; Smith, GL; Wogan, CF | 1 |
| Antonucci, MU; Day, TA; Hansen, RM | 1 |
| Amit, A; Hodes, A; Keidar, Z; Lavie, O; Lowenstein, L; Matanes, E | 1 |
| Capurso, G; Delle Fave, G; Falconi, M; Iannicelli, E; Merola, E; Muffatti, F; Panzuto, F; Partelli, S; Pizzichini, P; Prosperi, D; Rinzivillo, M; Salgarello, M; Schillaci, O; Scopinaro, F | 1 |
| Bogowicz, M; Guckenberger, M; Konukoglu, E; Lambin, P; Leijenaar, RTH; Pruschy, M; Riesterer, O; Studer, G; Tanadini-Lang, S; Unkelbach, J | 1 |
| Betancourt Cuellar, SL; Carter, BW; Correa, AM; Hofstetter, WL; Marom, EM; Palacio, DP; Wu, CC | 1 |
| Gallamini, A | 1 |
| Aktas, B; Antoch, G; Forsting, M; Grueneisen, J; Herrmann, K; Kirchner, J; Ruhlmann, V; Sawicki, LM; Schaarschmidt, BM; Umutlu, L | 1 |
| Oldan, J; Patel, TV | 1 |
| Buchpiguel, CA | 1 |
| Chung, YA; Eo, JS; Hong, IK; Hyun, SH; Kim, TS; Lee, JW; Na, SJ; Oh, JK; Song, BI; Yun, M | 1 |
| Hatano, E; Higashi, T; Ishii, T; Kaido, T; Kawai, T; Nakamoto, Y; Ogiso, S; Okuda, Y; Seo, S; Taura, K; Uemoto, S; Yoh, T | 1 |
| Colville, D; Han, S; Horgan, PG; Khor, BY; McMillan, DC; McSorley, ST; Tsang, K | 1 |
| Ayadi, M; Claude, L; Douillard, JY; Dupuy, C; Goulon, D; Isnardi, V; Jouglar, E; Mahé, MA; Ségura-Ferlay, C | 1 |
| Desseroit, MC; Hatt, M; Lucia, F; Malhaire, JP; Miranda, O; Pradier, O; Robin, P; Schick, U; Visvikis, D | 1 |
| Bai, HX; Cao, Y; Deng, L; Farwell, MD; Li, H; States, LJ; Sun, J; Tao, Y; Xiao, B; Yang, L; Zhang, P | 1 |
| Bockisch, A; Herrmann, K; Hoffmann, TK; Nagarajah, J; Poeppel, TD; Ruhlmann, V; Sauerwein, W; Umutlu, L; Veit, J | 1 |
| Briganti, A; Castellucci, P; Colicchia, M; Evangelista, L; Fallanca, F; Fanti, S; Ficarra, V; Gallina, A; Incerti, E; Karnes, JR; Lowe, V; Moschini, M; Panareo, S; Picchio, M; Rambaldi, I; Schiavina, R; Zattoni, F | 1 |
| Anderson, C; Bayon, R; Buatti, J; Clamon, G; Ginader, T; Hoover, A; Marquardt, M; Pagedar, N; Parkhurst, J | 1 |
| Ge, D; Gu, J; He, J; Huang, Y; Jin, X; Lu, C; Shi, S; Xu, F; Ye, L; Zeng, Z | 1 |
| Banjar, A; Becker, S; Desbordes, P; Gardin, I; Jardin, F; Ruminy, P; Tilly, H; Toledano, MN; Vera, P | 1 |
| Fukayama, M; Ishihara, S; Kawai, K; Koyama, K; Momose, T; Morikawa, T; Okuno, T; Takahashi, M; Watanabe, T | 1 |
| Jung, PS; Kim, JK; Kim, YM; Kim, YT; Lee, JJ; Lee, YJ; Nam, JH | 1 |
| Alavi, A; Emamzadehfard, S; Gholami, S; Paydary, K; Seraj, SM; Shamchi, SP; Werner, TJ; Zadeh, MZ | 1 |
| Chan, AT; Chan, CM; Chan, KCA; Hui, EP; Kam, MK; King, A; Leung, SF; Li, L; Lo, YMD; Loong, H; Ma, B; Mo, F; Wang, K; Wong, A; Wong, SCC | 1 |
| Berwouts, D; De Gersem, W; De Kerf, G; De Neve, W; De Ost, B; Duprez, F; Goethals, I; Olteanu, AML; Rottey, S; Schatteman, J; Van Gestel, D; Vercauteren, T | 1 |
| Abemayor, E; Chen, AM; St John, M; TenNapel, M; Velez, MA; Veruttipong, D; Wang, PC | 1 |
| Beauregard, JM; Bergeron, M; Blouin, AC; Buteau, FA; Duchesnay, N; Dujardin, T; Fradet, V; Fradet, Y; Lacombe, L; Lavallée, E; Makao-Nguile, M; Pouliot, F; Tiguert, R | 1 |
| Bourhis, J; Castelli, J; Depeursinge, A; Herrera, FG; Ozsahin, M; Prior, JO; Scher, N | 1 |
| Cho, S; Jheon, S; Kang, YK; Kim, K; Kim, SE; Lee, WW; Song, YS | 1 |
| Chua, M; Donahoe, S; Estall, V; Gyorki, D; Henderson, M; Herschtal, A; Hicks, RJ; Kee, D; Lewin, J; McArthur, GA; McCormack, CJ; Pohl, M; Pope, K; Sandhu, S; Sanelli, A; Sayers, L; Shackleton, M; Speakman, D; Spillane, J; Te Marvelde, L; Walpole, I | 1 |
| Kim, BS; Kim, Y; Lee, KE; Moon, CM; Yoo, J; Yoon, HJ | 1 |
| Aranda Aguilar, E; Cordero García, JM; García Vicente, AM; Jiménez Londoño, GA; Palomar Muñoz, A; Pena Pardo, FJ; Soriano Castrejón, Á; Talavera Rubio, MDP | 1 |
| Bailly, C; Bodet-Milin, C; Carlier, T; Jamet, B; Kraeber-Bodéré, F; Moreau, P; Planche, L; Touzeau, C | 1 |
| Asai, S; Fujioka, T; Harada, H; Michi, Y; Nakamura, S; Tateishi, U; Toriihara, A; Yamaga, E; Yoshimura, R | 1 |
| Abdollahi, A; Adeberg, S; Afshar-Oromieh, A; Bendszus, M; Bougatf, N; Debus, C; Debus, J; Floca, R; Haberkorn, U; Heiland, S; Knoll, M; Rieken, S; Waltenberger, M; Wick, W | 1 |
| Alavi, A; Baun, C; Falch, K; Gerke, O; Hansen, J; Hildebrandt, MG; Høilund-Carlsen, PF; Nguyen, T | 1 |
| Baek, S; Han, YM; Kim, ES; Moon, JY; Seo, YL; Yoon, DY; Yun, EJ | 1 |
| Dong, C; Tan, Y; Wang, Y; Xiao, Z; Yang, X; Zhang, H | 1 |
| Doi, H; Fujita, M; Fujiwara, M; Katsuura, T; Kitajima, K; Noguchi, K; Tamaki, Y; Terada, T; Tsuchitani, T; Uwa, N; Yamakado, K; Yoshida, R | 1 |
| Koizumi, M; Koyama, M; Sato, Y; Tanaka, H; Terauchi, T | 1 |
| Bezjak, A; Bissonnette, JP; Bratman, S; Le, L; Leighl, N; Palma, D; Raman, S; Schellenberg, D; Sun, A; Warner, A | 1 |
| Fujiwara, M; Fukushima, K; Hashimoto, T; Kamikonya, N; Kanematsu, A; Kitajima, K; Kobayashi, K; Nakanishi, Y; Nojima, M; Odawara, S; Suzuki, T; Yamada, Y; Yamakado, K; Yamamoto, S | 1 |
| Beriwal, S; Comerci, JT; Courtney-Brooks, M; Edwards, RP; Gebhardt, BJ; Glaser, SM; Houser, CJ; Kelley, JL; Kim, H; Olawaiye, AB; Sukumvanich, P; Vargo, JA | 1 |
| Maki, Y; Nakata, K; Nishimura, R; Sugawara, Y; Sugimoto, R; Teramoto, N; Ueno, T; Yamashita, M | 1 |
| Chen, P; He, W; Li, J; Ouyang, R; Peng, H; Zong, D | 1 |
| Beuthien-Baumann, B; Hoffmann, RT; Kotzerke, J; Laniado, M; Platzek, I; Plodeck, V; Radosa, CG; Rahbari, NN; van den Hoff, J; Weitz, J; Zöphel, K | 1 |
| Doroudinia, A; Dorudinia, A; Kaghazchi, F; Mehrian, P | 1 |
| Barbour, AP; Burmeister, BH; Burmeister, E; Effeney, R; Harvey, J; Mai, GT; Pryor, DI; Shaw, T; Smithers, BM; Thomas, J | 1 |
| Ahn, BC; Chong, GO; Hong, CM; Jeong, JH; Jeong, SY; Lee, CH; Lee, J; Lee, SW; Lee, YH; Park, SH; Son, SH | 1 |
| Inoue, S; Ito, K; Kasai, Y; Kume, S; Masuya, D; Monden, K; Okada, N; Suzuki, Y; Takata, N; Tanaka, Y; Yoshimatsu, H | 1 |
| Adkins, DR; Chin, RI; Dehdashti, F; DeWees, TA; Floberg, JM; Garsa, AA; Gay, HA; Nussenbaum, B; Oppelt, PJ; Thorstad, WL | 1 |
| Cha, SI; Hahm, MH; Jeong, JY; Kim, CH; Lee, H; Lee, HJ; Lee, J; Lim, JK; Park, TI; Shin, KM | 1 |
| Ahmed, S; Elahmadawy, MA; Elazab, MSS; Salama, M | 1 |
| Borm, KJ; Combs, SE; Duma, MN; Düsberg, M; Oechsner, M; Vag, T; Voppichler, J; Weber, W | 1 |
| Li, Q; Li, Y; Liao, S; Liao, X; Liu, Z; Wei, C; Wei, J; Zhong, J | 1 |
| Borel Rinkes, IH; Daamen, LA; Goense, L; Groot, VP; Intven, MPW; Molenaar, IQ; van Santvoort, HC; Wessels, FJ | 1 |
| Branstetter, BF; Clump, DA; Heron, DE; Hughes, M; Rath, TJ; Wangaryattawanich, P | 1 |
| Abayaweera, G; Abou-Taleb, HA; AbouElhassan, KM; AbouTaleb, HA; Adair, LS; Adams, E; Addison, O; Addy, I; Akhtar, N; Alten, B; Anesini, J; Añez, R; Angaridis, PA; Aouba, A; Arakawa, K; Aumeeruddy-Elalfi, Z; Bao, LP; Basu, E; Bayraktar, E; Bekkelund, CS; Bell, J; Beraldo, H; Bermúdez, V; Betenbaugh, MJ; Bhattacharya, R; Bienvenu, B; Bolzoni, M; Bootz, F; Borja, JB; Bove, DG; Bowden, ME; Bradsher, C; Brockstedt, D; Brothers, RM; Buschauer, A; Calandriello, L; Caporossi, A; Carba, DB; Carratalà, J; Castella, B; Caviezel, D; Ceccato, R; Charalambidis, G; Charisiadis, A; Chattopadhyay, P; Chen, Q; Chen, W; Chen, Y; Chen, YT; Chen, ZJ; Chen, ZY; Cheng, MA; Cheng, ZB; Cherevko, S; Cheung, IY; Cheung, NV; Chiappini, A; Chiu, YL; Choi, IG; Chough, S; Chung, CY; Cobb, A; Colotto, A; Continentino, MA; Cook, AJMC; Costa, F; Coutsolelos, AG; Cuperus, N; Curtis, BM; Davenport, AJ; de Boysson, H; Dela, F; Deng, XP; Deshayes, S; Dhara, K; Dietrich, D; Dietrich, J; Dilhari, A; Ding, R; Ding, Y; Dirè, S; Dohlmann, TL; Dotsenko, A; Doubrovina, E; Du, K; Du, ZJ; Duvic, M; Eastman, A; Eliakim-Raz, N; Elz, S; Emile, JF; Emmerling, C; Engelhard, MH; Eriksson, JG; Etzold, BJM; Faini, AC; Falsini, B; Farmer, E; Fei, JJ; Ferreira, IP; Föttinger, K; Franconieri, F; Fryda, NJ; Fuentes, I; Galateau-Sallé, F; Ganguly, M; Gani, BA; Gao, X; Gao, XF; Gao, XJ; García-Mendiola, T; Garg, A; Gascon, J; Gayani, B; Gevensleben, H; Gilbert, M; Giudiceandrea, A; Giuliani, N; Gocmen, AY; Goldman, DA; Goltz, D; Gombert, AK; Gomila, A; Goodwin, P; Górnicki, K; Gostin, PF; Graterol, M; Gremillet, C; Grier, S; Grün, AL; Gusakov, A; Halldórsdóttir, HR; Han, L; Han, Z; Hävecker, M; Helge, JW; Heo, K; Hernández, JD; Hindsø, M; Holmen Olofsson, G; Hong, CE; Hong, J; Horenstein, AL; Hosenally, M; Hruz, P; Hsu, HL; Hsu, KC; Hu, SF; Hu, Y; Huang, K; Huang, S; Huang, WH; Humaira, A; Hung, CF; Hung, WS; Huo, XK; Huvinen, E; Idorn, M; Ignatyev, K; Im, WT; Ismaël, IS; Jakobsson, JG; Janaszek-Mańkowska, M; Jeong, GT; Ji, L; Ji, X; Jiang, Y; Jo, IH; Jo, SH; Johnson, AC; Johnson, LE; Kadirvelu, K; Kahnt, A; Kaleta, A; Kamiya, T; Kang, DH; Kang, XH; Kashiwagi, T; Katayama, E; Kawachi, N; Keller, M; Kellermann, L; Khan, T; Khan, ZA; Kharshoum, RM; Khim, JS; Kikuchi, M; Kim, BS; Kim, DS; Kim, DW; Kim, JH; Kim, JJ; Kim, JU; Kim, SK; Kim, WS; Kimura, J; Kiss, C; Knop-Gericke, A; Kobayashi, S; Koivusalo, SB; Kolar, E; Kottegoda, N; Kramer, K; Kristiansen, G; Kruger, AA; Kumar, S; Kumar, V; Kumarage, S; Kursungoz, C; Kushner, BH; Kuwahara, F; Kuzawa, C; Kwon, BO; Landsberg, J; Larsen, S; Lauer, P; Le Luduec, JB; Lee, DW; Lee, H; Lee, HY; Lee, JW; Lee, MJ; Lee, SW; Lefrançois, P; Leibovici, L; Leong, KK; Leong, M; Li, B; Li, D; Li, G; Li, J; Li, YZ; Liang, JH; Liang, X; Liens, A; Ligorio, G; Lin, JD; Lindholm, MG; Liou, MJ; List-Kratochvil, EJW; Litvinov, IV; Liu, F; Liu, S; Liu, Y; Liu, Z; Lohar, S; Lopes, MTP; Lorenzo, E; Lu, X; Lukashuk, L; Lukens, WL; Luo, HR; Luo, L; Luttik, MAH; Ma, Y; MacGowan, A; Mahomoodally, MF; Maissen, S; Malavasi, F; Malhotra, M; Mallik, S; Manna, D; Mans, R; Marangoni, D; Marimpietri, D; Marques, F; Marques, WL; Marsaa, K; Martin Silva, N; Martinez, A; Martínez, MS; Massaia, M; Mayrhofer, KJJ; McDade, T; McNeel, DG; Met, Ö; Micalizio, GC; Modak, S; Morandi, F; Moreau, L; Morla, S; Morrell, AP; Morris, S; Mubarak, Z; Muchlisin, ZA; Munoz, M; Nagao, Y; Nakama, T; Nakamura, H; Nakano, T; Nardi, MV; Nasirian, A; Nelson, MD; Netchiporouk, E; Ni, X; Niess, JH; Nijenhuis, JM; Nikolaou, V; O'Connor, BJ; O'Reilly, RJ; Odobel, F; Ohata, C; Ohyama, B; Olivar, LC; Ordoñez, MG; Ostrovnaya, I; Palmar, J; Panda, S; Pandiyarajan, S; Park, B; Park, H; Park, JH; Park, S; Pasquali, L; Patik, JC; Pearce, CI; Peele, ME; Peng, S; Perera, IC; Petty, JT; Pidko, EA; Pinheiro, CB; Pistoia, V; Pita, M; Planchat, A; Plass, F; Pockes, S; Pradhan, N; Premasudha, P; Pronk, JT; Provost, N; Pujol, M; Qi, P; Qiu, J; Qiu, Z; Quan, J; Quaranta, A; Ra, CH; Rameshan, R; Ranglack, DH; Rausch-Fan, X; Rieger, E; Rivas, JR; Roberts, SS; Rocha, WR; Rodrigues, GLS; Rojas, J; Roy, P; Rozhkova, A; Rufo, S; Rupprechter, G; Saeui, CT; Saha, A; Sakai, M; Salazar, J; Salem, HF; Salgarello, T; Samarakoon, SR; Sandau, C; Sandbeck, DJS; Santos, AF; Santos, VG; Sara, Y; Saslow, SA; Sasseville, D; Sato, S; Sauer, JD; Schlögl, R; Schweiger, MJ; Shashkov, I; Shaw, E; Shen, WQ; Shim, J; Shu, J; Singh, C; Sinha Babu, SP; Sinitsyn, A; Sinitsyna, O; Skadborg, SK; Song, Q; Song, W; Stach-Lempinen, B; Stoddart, M; Stoica, M; Street, SR; Sukwong, P; Sun, CP; Sun, J; Sunwoo, IY; Suresh, S; Szécsényi, Á; Takahashi, T; Takeda, S; Tang, D; Tas, ST; Tebé, C; Teixeira, LR; Teixidor, F; Terrier, B; Teschner, D; Tetzlaff, MT; Theisen, E; Thor Straten, P; Tiitinen, A; Timpel, M; Toccoli, T; Torikai, K; Torres, W; Toscani, D; Trad, S; Tsai, HJ; Tseng, CP; Tucker, WJ; Um, W; Vallejo-Torres, L; van den Broek, M; Van den Heuvel, L; van der Woude, LN; van Maris, AJA; Van Schepdael, A; Vank, C; Verucchi, R; Vigo, JM; Viñas, C; Vogt, TJ; Vuong, C; Wai, H; Wang, B; Wang, D; Wang, H; Wang, JJ; Wang, K; Wang, L; Wang, Q; Wang, YR; Watanabe, S; Watters, AK; Weerasekera, MM; Wei, L; Wheeler, DA; Wiegand, I; Wifling, D; Wijesinghe, GK; Winiczenko, R; Wolker, T; Wu, J; Wu, TC; Wu, YY; Xie, P; Xie, YP; Xu, A; Xu, E; Xu, L; Xu, Z; Yamaguchi, M; Yang, A; Yang, G; Yang, J; Yang, TM; Yang, W; Yang, Y; Yarema, KJ; Yesiltepe, M; Yi, KJ; Yigit, N; Yim, UH; Yin, B; Yu, S; Zengin, G; Zhang, B; Zhang, C; Zhang, GR; Zhang, H; Zhang, J; Zhang, L; Zhang, TY; Zhang, X; Zhang, Y; Zhang, YX; Zhao, H; Zhao, JC; Zhao, Z; Zheng, R; Zhou, W; Zorn Morales, N | 1 |
| Abele, J; Biron, V; Cooper, T; Harris, J; Isaac, A; O' Connell, DA; Puttagunta, L; Seikaly, H; Sivarajah, S; Zhang, H | 1 |
| Araki, K; Arima, K; Baba, H; Harimoto, N; Kuwano, H; Shirabe, K; Tetsuya, H; Watanabe, A; Yamashita, Y; Yoshizumi, T | 1 |
| Bagetakos, I; Becker, M; Botsikas, D; Boudabbous, S; Da Cunha Afonso Barisits, AC; Kalovidouri, A; Lam, GT; Mainta, I; Montet, X; Picarra, M | 1 |
| Boerner, B; Bruehlmeier, M; Frey, LD; Gambazzi, F; Graber, SM; Heuberger, J; Irani, S; Janthur, WD; Springer, OS; Tini, GM; Zweifel, R | 1 |
| Chen, WY; Cui, YP; Gao, XR; Hu, JX; Hu, K; Li, ZZ; Zhang, YY | 1 |
| Cui, R; Sun, H; Wang, J; Zhang, Y | 1 |
| de Bree, R; Hoekstra, OS; Pruim, J; van der Laan, BFAM; van der Putten, L; van Dijk, BAC; Wedman, J | 1 |
| Bokemeyer, C; Fisch, M; Hartmann, M; Klutmann, S; Meyer, CP; Oechsle, K; Oing, C; Schriefer, P | 1 |
| Kidd, EA; Koenig, JL; Kozak, MM; von Eyben, R | 1 |
| Azoulay, D; Chalaye, J; Costentin, CE; Feray, C; Itti, E; Lahat, E; Lim, C; Osseis, M; Salloum, C | 1 |
| Gorin, MA; Joice, GA; Pierorazio, PM; Rowe, SP | 1 |
| Dong, P; Li, L; Wang, L; Zhu, H | 1 |
| Dehdashti, F; Grigsby, PW; Kidd, E; Lin, AJ; Markovina, S; Massad, LS; Mutch, DG; Mutic, S; Powell, MA; Schwarz, J; Siegel, BA; Thaker, PH | 1 |
| Aleman, BMP; Andraos, TY; Balogh, A; Binkley, MS; Brady, JL; Bratman, SV; Chau, K; Chelius, M; Choi, SH; Constine, LS; Dabaja, B; Eich, HT; El-Galaly, TC; Filippi, AR; Hajj, C; Hardy, S; Hodgson, DC; Hoppe, RT; Jones, M; Kirova, Y; Levis, M; Mac Manus, M; Mikhaeel, NG; Ng, AK; Oguchi, M; Reinartz, G; Ricardi, U; Suh, CO; Vistisen, AK; Wirth, A; Yahalom, J | 1 |
| Bailey, JJ; Brown, RKJ; Hutchinson, RJ; Kaminski, MS; Sedig, LK; Wong, KK | 1 |
| Cai, X; Dong, J; Huang, T; Li, F; Liu, F; Ma, Y; Xiong, F; Yan, Z; Zhang, Q | 1 |
| de Haas, RJ; de Jong, KP; Dierckx, RAJO; Kwee, TC; Murshid, KJA; Pennings, JP | 1 |
| Klinghuber, M; Müller, G; Pabst, A; Vandersee, S; Werkmeister, R | 1 |
| Bernard, A; Brown, E; Foote, M; Gandhi, M; Liu, HY; Lock, G; McGrath, M; Milne, R; Panizza, BJ; Porceddu, SV | 1 |
| Antonowicz, S; Bradley, KM; El Kafsi, J; Findlay, JM; Gillies, RS; Maynard, ND; Middleton, MR; Segaran, A; Zhang, A | 1 |
| Broski, SM; DeVries, AH; Howe, BM; Spinner, RJ | 1 |
| Berkowitz, AS; Eliashar, R; Frenkel, S; Hirshoren, N; Neuman, T; Weinberger, JM | 1 |
| de Bree, R; Driessen, JP; Huijbregts, JE; Janssen, LM; Pameijer, FA; Peltenburg, B; Philippens, MEP; Terhaard, CHJ | 1 |
| Al-Ibraheem, A; Barakat, A; Dergham, MY; Haddad, H; Haidar, MB; Hourani, M; Khoury, N; Maroun, G; Saleh, A; Yacoub, B | 1 |
| Anderson, C; Graham, M; Mallak, N; Mayo, Z; Menda, Y; Mott, SL; Seyedin, SN | 1 |
| Bakr, S; Davidzon, GA; Echegaray, S; Horng, G; Leung, ANC; Mattonen, SA; Nair, VS; Napel, S; Vasanawala, M | 1 |
| Liu, S; Wu, X; Xiang, L; Yang, H; Ye, S | 1 |
| de Haas, RJ; de Jong, KP; Dierckx, RAJO; Kwee, TC; Pennings, JP | 1 |
| Cho, YS; Choi, JY; Hyun, SH; Lee, KH; Lim, CH; Moon, SH | 1 |
| Fujimori, Y; Kashiwagi, T; Kitajima, K; Okada, M; Sawada, A; Tokugawa, T; Yamakado, K; Yoshihara, K; Yoshihara, S | 1 |
| Grigsby, PW; Lin, AJ; Ma, S; Markovina, S; Mutch, DG; Powell, MA; Schwarz, J | 1 |
| Kim, HS; Lee, JW; Lee, S; Lee, SM | 1 |
| Ahrweiller, F; Castelli, J; Cuvilliers, C; Palard-Novello, X; Vauléon, E | 1 |
| de Greef, BTA; Jansen, FH; Maaskant-Braat, AJG; Nieuwenhuijzen, GAP; Poodt, IGM; Schipper, RJ; Voogd, AC; Vugts, G; Wyndaele, DNJ | 1 |
| Cho, DH; Cho, SG; Kang, SR; Kim, J; Kwon, SY; Na, MH; Song, HC; Yoo, SW | 1 |
| Doll, C; Duimering, A; Fairchild, A; Ghosh, S; Joseph, K; MacEwan, R; Mulder, K; Nijjar, T; Nijjar, Y; Riauka, T; Schiller, D; Severin, D; Tankel, K; Usmani, N; Warkentin, H; Wong, C | 1 |
| Allen, PK; Bhosale, PR; Cardenas, CE; Fang, P; Frumovitz, MM; Fuller, CD; Ho, JC; Jhingran, A; Klopp, AH; Mohamed, ASR | 1 |
| Beddell, G; Ivanov, N; Vaiciunaite, D | 1 |
| Dierickx, D; Gheysens, O; Goffin, K; Laenen, A; Tousseyn, T; Van Keerberghen, CA; Vandenberghe, P; Vergote, V; Verhoef, G | 1 |
| Amorim, BJ; Bernardo, WM; Brito, AET; Esteves, FP; Gomes, GDV; Martello, M; Matushita, CS | 1 |
| Amorim, BJ; Bernardo, WM; Brito, AET; Esteves, F; Gomes, G; Matushita, C | 1 |
| Broccoli, A; Fanti, S; Fonti, C; Lambertini, A; Lodi, F; Nanni, C; Pellegrini, C; Stefoni, V; Zanoni, L; Zinzani, PL | 1 |
| Hatazawa, J; Isohashi, K; Kanakura, Y; Kato, H; Matsunaga, K; Tatsumi, M; Watabe, T | 1 |
| Garg, I; Goenka, AH; Halfdanarson, TR; Johnson, GB; Panda, A; Truty, MJ | 1 |
| Asmussen, JT; Bjørndal, K; Diaz, A; Døssing, H; Gerke, O; Godballe, C; Gyldenkerne, N; Høilund-Carlsen, PF; Johansen, J; Nielsen, AL; Pareek, M; Rohde, M; Sørensen, JA; Thomassen, A | 1 |
| Carpenter, DJ; Chino, JP; Craciunescu, O; Jacobs, CD; Wong, TZ | 1 |
| Bradley, KM; Dickson, E; Findlay, JM; Fiorani, C; Gillies, RS; Maynard, ND; Middleton, MR; Mukherjee, S | 1 |
| Charabi, B; Fischer, BM; Friborg, J; Gram, SB; Håkansson, K; Nøhr, A; Rasmussen, JH; Tvedskov, JF; von Buchwald, C; Wessel, I | 1 |
| Aerts, J; Biesma, B; Dingemans, AC; Groen, HJM; Hoekstra, O; Klinkenberg, TJ; Kloosterziel, C; Pieterman, R; Schramel, FMNH; Smit, EF; Smit, HJM; van den Borne, B; van der Heijden, EHFM; van der Noort, V; van Tinteren, H; Verhagen, A | 1 |
| Haga, N; Inoue, S; Ito, K; Kasai, Y; Kume, S; Masuya, D; Miyoshi, K; Monden, K; Okada, N; Ootsuka, K; Suzuki, Y; Takata, N; Tanaka, Y | 1 |
| Kandathil, A; Sibley, RC; Subramaniam, RM | 1 |
| Capp, A; Gallagher, S; Holder, C; Hruby, G; Jones, MP; Kumar, M; Martin, J; Metser, U; Oldmeadow, C; Rutherford, N; Sridharan, S | 1 |
| Chen, JH; Chen, WT; Chien, CR; Kao, CH; Lin, WY; Lu, YY; Tsai, SC | 1 |
| Kim, HH; Kim, SE; Kim, YH; Lee, HY; Lee, KH; Lee, SJ; Lee, WW; Park, DJ; So, Y; Yoon, HJ | 1 |
| Chae, YS; Choi, GS; Kang, BW; Kim, JG; Lee, SJ; Lee, SW; Lee, YJ; Park, JS | 1 |
| Chan, JY; Chow, VL; Wei, WI; Wong, ST | 1 |
| Fukukura, Y; Jinguji, M; Kajiya, Y; Koriyama, C; Nakabeppu, Y; Nakajo, M; Tanabe, H; Tani, A | 1 |
| Akiyama, H; Hirai, K; Ibi, T; Okada, D; Shimizu, K; Yoshino, N | 1 |
| Adachi, S; Miyata, Y; Nakayama, H; Okada, M; Okumura, S; Tsutani, Y; Yoshimura, M | 1 |
| Liu, Y | 1 |
| Amrami, KK; Babu, MA; Dyck, PJ; Howe, BM; Kawashima, A; Nathan, MA; Spinner, RJ | 1 |
| Halac, M; Kabasakal, L; Kanmaz, B; Maecke, H; Önsel, Ç; Sager, S; Uslu, L | 1 |
| Fardanesh, MR; Fatterpekar, G; Genden, EM; Kim, J; Kostakoglu, L; Park, EE; Patel, Z; Rangaswamy, B; Som, PM | 1 |
| Kato, H; Kimura, T; Kishimoto, T; Mabuchi, S | 1 |
| Alvarez Secord, A; Case, AS; Cohn, DE; Dehdashti, F; Eisenhauer, EL; Gao, F; Lippmann, LT; Massad, LS; Mutch, DG; Powell, MA; Rader, JS; Thaker, PH; Valea, FA; Wright, JD; Zighelboim, I | 1 |
| Banzo, I; Carril, JM; Del Castillo-Matos, R; Ibáñez-Bravo, S; Jiménez-Bonilla, JF; Martínez-Amador, N; Martínez-Rodríguez, I; Ortega-Nava, F; Quirce, R; Rubio-Vassallo, AS | 1 |
| Byun, BH; Koh, JS; Kong, CB; Lim, SM; Yoo, JY | 1 |
| Gotoh, M; Hasegawa, T; Higuchi, M; Osugi, J; Suzuki, H | 1 |
| Alafate, A; Fujiwara, T; Gobara, H; Hiraki, T; Ishii, H; Kaji, M; Kanazawa, S; Kato, K; Miyoshi, S; Okumura, Y; Sato, S; Shinya, T | 1 |
| Apisarnthanarax, S; Christodouleas, JP; Corradetti, MN; Evans, TL; Fernandes, AT; Grover, S; Kim, M; Langer, CJ; Lee, TT; Lin, LL; Mitra, N; Pryma, DA; Rengan, R; Simone, CB; Stevenson, JP; Xanthopoulos, EP | 1 |
| Chen, D; Chen, ZF; Hu, AB; Wang, XY; Zhang, XS | 1 |
| Qiao, W; Wang, C; Wang, T; Xing, Y; Zhao, J | 1 |
| Cody, HS; D'Andrea, G; Ulaner, GA | 1 |
| Buriánková, E; Flodr, P; Formánek, R; Henzlová, L; Indrák, K; Jarošová, M; Kapitáňová, Z; Mysliveček, M; Papajík, T; Procházka, V; Turcsányi, P; Urbanová, R | 1 |
| Kaseda, S; Kawamura, M; Nemoto, E; Sugiura, Y | 1 |
| Drescher, R; Freesmeyer, M; Lesser, T; Müller, A | 1 |
| Bae, JS; Baek, KH; Cha, BY; Jung, CK; Kang, MI; Kim, MH; Kim, SH; Ko, SH; Lee, JM; Lee, SH; Lim, DJ | 1 |
| de Bree, R; Ferlito, A; Rinaldo, A; Takes, RP; Zbären, P | 1 |
| Balogova, S; Kaliska, L; Kunikowska, J; Montravers, F; Slavikova, K; Talbot, JN; Treglia, G; Vereb, M | 1 |
| Zhao, Y; Zou, H | 1 |
| Abdelsalam, M; Abouzied, M; Akhtar, S; Al-Sugair, AS; Alkadhi, Y; Darwish, A; Dingle, M; Elhassan, TA; Eltigani, A; Maghfoor, I; Nabil-Ahmed, M; Soudy, H | 1 |
| Akkas, BE; Demirel, BB; Vural, GU | 1 |
| Cheon, GJ; Chung, HH; Kim, HS; Kim, JW; Lee, I; Park, NH; Song, YS | 1 |
| Guler, OC; Onal, C; Oymak, E; Parlak, C; Reyhan, M | 1 |
| Iwanaka, T; Kanamori, Y; Momose, T; Takahashi, M | 1 |
| Dunsky, KA; Osman, MM; Thornberry, BM; Varvares, MA; Wehrmann, DJ | 1 |
| Baumann, T; Dovi-Akue, PA; Hopt, UT; Langer, M; Rischke, HC; Schäfer, AO | 1 |
| Chu, Q; Hamidian Jahromi, A; Martin, B; Sangster, G; Shi, R; Shokouh-Amiri, H; Takalkar, A; Zibari, G | 1 |
| Wang, N; Zhu, L | 1 |
| Logeswaran, P; Mercier, G; Mhlanga, JC; Mirpour, S; Russo, G; Subramaniam, RM | 1 |
| Beigelman, C; Boulanger, X; Brun, AL; Ledoux, JB | 1 |
| Ding, Q; Ding, QC; Dong, P; Gu, J; Li, ML; Liu, YB; Lu, JH; Tan, ZJ; Weng, H; Wu, WG; Wu, XS; Yang, JH; Zhang, L | 1 |
| Khoo, JB; Tan, NC; Teo, PT | 1 |
| Kumagai, K; Ohmichi, M; Okamura, T; Senzaki, H; Toyoda, M; Watanabe, C | 1 |
| Giovanella, L; Hasanzadeh, M; Kadkhodayan, S; Sadeghi, R; Treglia, G; Zakavi, SR | 1 |
| Bandiera, A; Gajate, AM; Gallivanone, F; Gianolli, L; Landoni, C; Melloni, G; Muriana, P; Sestini, S; Zannini, P | 1 |
| Apisarnthanarak, P; Chiewvit, P; Chiewvit, S; Hannanthawiwat, C; Jiranantanakorn, T; Kanchaanapiboon, P; Phongsawat, N; Ubolnuch, K | 1 |
| Adusumilli, PS; Bograd, AJ; Dunphy, MP; Morales, EA; Nitadori, J; Rizk, NP; Rusch, VW; Sima, CS | 1 |
| Bille, A; Chicklore, S; Cook, GJ; Landau, D; Lang-Lazdunski, L; Okiror, L; Spicer, J | 1 |
| Altenbernd, J; Bockisch, A; Klode, J; Nagarajah, J; Rosenbaum-Krumme, S; Tekin, G; Wieder, HA | 1 |
| Banks, KP; Song, WS | 1 |
| Allen-Auerbach, M; Czernin, J; de Vos, S | 1 |
| Escott, EJ | 1 |
| Brunetti, J | 1 |
| Boér, K; Borbély, K; Kásler, M; Németh, Z | 1 |
| Fan, W; Li, J; Wang, GH; Zhang, WD; Zhang, WG | 1 |
| Ahmad, AZ; Donnemiller, E; Fikri, AS; Kendler, D; Kroiss, A; Lau, WF; Nordin, AJ; Uprimny, C; Virgolini, IJ; Zanariah, H | 1 |
| Doucette, J; Fardanesh, R; Genden, E; Gupta, V; Kostakoglu, L; Misiukiewicz, K; Park, E; Posner, M; Rao, S; Som, P; Stein, EG | 1 |
| Bonichon, F; Cazeau, AL; de Baère, T; Descat, E; Devillers, A; Galy-Lacour, C; Godbert, Y; Lagoarde-Segot, L; Leboulleux, S; Meunier, C; Palussière, J; Pulido, M | 1 |
| Ahn, BC; Hong, CM; Jeong, SY; Kim, CY; Kim, DH; Kim, HW; Lee, J; Lee, SW; Oh, JR; Son, SH; Song, BI | 1 |
| Bruno, A; Cavalleri, L; Chinaglia, D; Collini, P; Conter, V; Foglia, C; Giraldi, E; Provenzi, M; Saettini, F; Spreafico, F; Vai, P | 1 |
| Kataoka, M; Kiyoto, S; Mochizuki, T; Nakajima, N; Ochi, T; Ohsumi, S; Sugawara, Y | 1 |
| Ekmekcioglu, O; Elicin, O; Halac, M; Uzel, EK; Uzel, OE | 1 |
| Allen, CE; Bollard, CM; Dreyer, Z; Eissa, HM; Goradia, P; Guillerman, RP; Kamdar, K; McClain, KL; Simko, S; Steuber, P | 1 |
| Hao, H; Hirota, S; Ikeda, Y; Inoue, K; Kawata, S; Oku, N; Tsubamoto, H | 1 |
| Asa, S; Halaç, M; Kabasakal, L; Kanmaz, B; Maecke, H; Ocak, M; Önsel, Ç; Sager, G; Sager, S; Uslu, L | 1 |
| Cho, KJ; Joo, YH; Kim, CS; Kim, MS; Nam, IC; Park, JO; Yoo, IeR | 1 |
| Ebina, Y; Kanda, T; Kitajima, K; Maeda, T; Makihara, N; Suenaga, Y; Sugimura, K; Takahashi, S; Ueno, Y; Yamada, H | 1 |
| Cho, KJ; Choi, SH; Kim, JS; Kim, JW; Kim, SY; Lee, JH; Nam, SY; Roh, JL | 1 |
| Abhyankar, A; Basu, S | 1 |
| Bai, L; Chen, Y; Chu, Y; Han, L; Lin, W; Wang, F; Yang, X; Zheng, A | 1 |
| Almond, LM; Fry, J; Lyburn, ID; Torrance, AD; Wadley, MS | 1 |
| Chen, SW; Hsieh, TC; Kao, CH; Liang, JA; Yen, KY | 1 |
| Chao, JW; Otterburn, DM; Pitcher, AA; Swistel, AJ; Varma, S | 1 |
| Bernsdorf, M; Graff, J | 2 |
| Al Bunni, F; Cervino, AR; Evangelista, L; Muzzio, PC; Pomerri, F | 1 |
| Fukui, T; Ishiguro, F; Kawaguchi, K; Nakamura, S; Taniguchi, T; Usami, N; Yokoi, K | 1 |
| Kosaka, T; Kuwano, H; Mogi, A; Tanaka, S; Yamaki, E | 1 |
| Berthelsen, AK; Binderup, T; Brinch, K; Brünner, N; Engelmann, BE; Gerds, TA; Højgaard, L; Høyer-Hansen, G; Kjær, A; Kristensen, MH; Kurt, EY; Latocha, JE; Lindblom, G; Loft, A; Nielsen, HJ; Sloth, C | 1 |
| Asano, Y; Iwama, T; Miwa, K; Nomura, Y; Shinoda, J; Takenaka, S; Yano, H; Yonezawa, S | 1 |
| Benz, MR; Buck, AK; Chen, W; Cloughesy, T; Czernin, J; Herrmann, K; Lai, A; Phelps, ME; Pomykala, KL | 1 |
| Avril, N; Gaeta, CM; Kohan, A; Rubbert, C; Sher, AC; Vercher-Conejero, JL | 1 |
| Chatziioannou, SN; Georgakopoulos, AT; Kafiri, GT; Kallergi, M; Pavlou, SN; Pianou, NK | 1 |
| Khiewvan, B; Nopmaneejumruslers, C; Pusuwan, P; Tojinda, N; Tuchinda, P; Ubolnuch, K | 1 |
| Hatano, E; Hayakawa, N; Higashi, T; Nakamoto, Y; Nakatani, K; Saga, T; Seo, S; Togashi, K; Uemoto, S | 1 |
| Bauerschlag, DO; Behrendt, FF; Hebel, CB; Heinzel, A; Krohn, T; Mottaghy, FM; Verburg, FA | 1 |
| Gao, S; Li, S; Tang, Q; Yang, X | 1 |
| Bottoni, C; Chiantera, V; Costantini, B; Fagotti, A; Fanfani, F; Gallotta, V; Petrillo, M; Scambia, G; Turco, LC | 1 |
| Bradford, CR; Carey, T; Chepeha, DB; Eisbruch, A; McHugh, JB; Spector, ME; Stenmark, MH; Vainshtein, JM; Wolf, GT; Wong, KK; Worden, FP | 1 |
| Droeser, RA; Jundt, G; Kettelhack, C; Kirchhoff, P; Oertli, D; Rothschild, SI; Tornillo, L | 1 |
| Kim, DY; Kim, JH; Kim, YM; Kim, YT; Lee, DY; Lee, JJ; Lee, SW; Nam, JH; Park, JY; Shim, SH | 1 |
| Bal, C; Dhull, VS; Kumar, R; Maharjan, S; Patel, C; Sharma, DN; Sharma, P; Suman Kc, S | 1 |
| MacRae, R; Nair, VJ; Pantarotto, JR; Sirisegaram, A | 1 |
| Beale, T; Bomanji, J; Dileo, P; Frezza, AM; Jay, A; Kalavrezos, N; Strauss, SJ; Whelan, J | 1 |
| Conrad, EU; Eary, JF; Hawkins, DS; O'Sullivan, F; O'Sullivan, J; Schuetze, SM | 1 |
| Bal, C; Jain, S; Julka, PK; Karunanithi, S; Kumar, R; Malhotra, A; Pal, S; Sharma, P; Thulkar, S | 1 |
| Alabed, YZ; Lisbona, R; Novales-Diaz, JA; Rakheja, R | 1 |
| Choi, JS; Choi, Y; Han, KH; Kang, WJ; Kim, EK; Kwak, JY; Moon, HJ; Yoon, JH; Youk, JH | 1 |
| Cho, A; Choi, YJ; Hwang, HS; Jeong, YH; Kang, WJ; Kim, HJ; Lee, JD; Lee, JH; Yun, M | 1 |
| Ansaloni, L; Baiocchi, GL; Capponi, MG; Coniglio, A; D'Ugo, D; De Manzoni, G; Di Leo, A; Giacopuzzi, S; Giulini, SM; Marchet, A; Marrelli, D; Morgagni, P; Nitti, D; Pacelli, F; Rosa, F; Roviello, F; Saragoni, L; Tiberio, GA; Verlato, G | 1 |
| Coleman, RL; Gershenson, DM; Lucchini, M; Macapinlac, HA; Munsell, MF; Ramirez, PT; Schmeler, KM; Takeuchi, S | 1 |
| Hong, YS; Kim, HO; Kim, JC; Kim, JS; Kim, TW; Lee, HS; Yu, CS | 1 |
| Fernandez, M; Garcia, RA; Maya, S; Noor, A; Pawha, PS; Pina, S; Som, PM | 1 |
| Avril, N; Bergstrom, D; Brenton, JD; Iannone, R; Lam, R; McNeish, IA; Mozley, PD; Parkinson, C; Rockall, AG; Sala, E; Sarker, SJ | 1 |
| Coleman, RE; Duan, F; Hanna, L; Hillner, BE; Shields, AF; Siegel, BA | 1 |
| Choi, D; Choi, JY; Jang, KM; Kang, TW; Kim, SH; Park, CK | 1 |
| Endo, M; Kaira, K; Kenmotsu, H; Murakami, H; Naito, T; Ono, A; Takahashi, T; Yamamoto, N | 1 |
| Fiore, MR; Fossati, P; Iannalfi, A; Orecchia, R; Tuan, J; Vischioni, B; Vitolo, V | 1 |
| Baas, IO; Bulten, BF; de Haas, MJ; de Klerk, JM; Rodenburg, CJ; van Ooijen, B | 1 |
| Aebersold, DM; Cihoric, N; Klaeser, B; Krüger, K; Lössl, K; Tapia, C | 1 |
| Aksoy, SY; Asa, S; Erdoğan, EB; Halac, M; Ozhan, M | 1 |
| Bluemel, C; Buck, AK; Germer, CT; Herrmann, K; Wiegering, A | 1 |
| Beckert, S; Claussen, CD; Gatidis, S; Klumpp, B; Koenigsrainer, A; Koenigsrainer, I; Mueller, M; Pfannenberg, C; Schwenzer, NF | 1 |
| Ciancia, G; Cirillo, M; Cozzolino, I; Pane, F; Pettinato, G; Picardi, M; Pugliese, N; Quintarelli, C; Salvatore, C; Zeppa, P | 1 |
| Grabiec, M; Malkowski, B; Marszalek, A; Pietrzak, T; Sadlecki, P; Walentowicz, P; Walentowicz-Sadlecka, M | 1 |
| Burbury, KL; Carney, DA; Cheah, CY; Dickinson, M; Harrison, SJ; Herbert, KE; Hofman, MS; Januszcewicz, EH; Prince, HM; Ritchie, DS; Seymour, JF; Tam, CS; Wirth, A; Wolf, M | 1 |
| Cho, J; Choi, NC; Sharp, GC; Shusharina, N | 1 |
| Eisbruch, A; Vainshtein, JM | 1 |
| Sabour, S | 1 |
| Lee, SM; Park, MS | 1 |
| Chang, D; Harris, C; Kauser, A; Lake, ES; Lapsia, S; Subar, D; Wadhwani, S | 1 |
| Wu, CX; Zhu, ZH | 1 |
| Hu, X; Li, W; Li, X; Ma, L; Wang, X; Xie, P | 1 |
| Ding, XP; Feng, L; Ma, L | 1 |
| Aktas, B; Beiderwellen, K; Buderath, P; Forsting, M; Gratz, M; Grueneisen, J; Heusch, P; Lauenstein, T; Ruhlmann, V; Umutlu, L | 1 |
| Jo, HJ; Kim, IJ; Kim, SJ; Lee, HY | 1 |
| Li, S; Li, W; Sun, L; Sun, X; Xing, L; Zhang, X; Zhao, F | 1 |
| Chae, BJ; Jung, NY; Kang, BJ; Kim, SH; Seo, YY; Yoo, IR | 1 |
| Iwata, T; Mizobuchi, T; Nakajima, T; Nakatani, Y; Sakairi, Y; Suzuki, H; Tagawa, T; Yamamoto, T; Yoshida, S; Yoshino, I | 1 |
| Li, F; Wang, R; Xiao, J; Xing, B; Zhao, X; Zhu, Z | 1 |
| Deroose, CM; Gheysens, O; Lips, N; Moerman, P; Peetermans, WE; Schöffski, P; Slabbaert, K; Vancleynenbreugel, B | 1 |
| Bal, C; Jain, TK; Julka, PK; Karunanithi, S; Kumar, R; Parida, GK; Patel, C; Sharma, A; Sharma, P; Thulkar, S | 1 |
| de Keizer, B; Hoekstra, OS; Kist, JW; Stokkel, MP; Vogel, WV | 1 |
| Feng, B; Fu, Z; Hu, M; Kong, L; Yu, JM; Zhang, GL; Zhang, XL; Zhang, Y; Zhao, F | 1 |
| Balink, H; Hoogendoorn, M | 1 |
| Gotoh, M; Higuchi, M; Honjo, H; Shigihara, T; Shishido, F; Suzuki, H | 1 |
| Lee, CH; Lee, DY; Lee, JJ; Lee, SH; Ryu, JS; Seo, MJ | 1 |
| Ibe, T; Igai, H; Kamiyoshihara, M; Kawatani, N; Shimizu, K | 1 |
| Freesmeyer, M; Reissig, A; Tauhardt, E; Winkens, T | 1 |
| Bal, C; Julka, PK; Karunanithi, S; Kc, SS; Khangembam, BC; Kumar, R; Sharma, P | 1 |
| Aznar, MC; Bentzen, SM; Berthelsen, AK; Due, AK; Korreman, SS; Kristensen, CA; Loft, A; Specht, L; Vogelius, IR | 1 |
| Beiderwellen, K; Forsting, M; Gratz, M; Grueneisen, J; Heubner, M; Heusch, P; Kinner, S; Lauenstein, T; Ruhlmann, V; Schulze-Hagen, A; Umutlu, L | 1 |
| Chang, JS; Cho, A; Choi, SH; Kim, KH; Lee, JD; Lee, Y; Park, JY; Seong, J; Song, SY; Yun, M | 1 |
| Gotoh, M; Higuchi, M; Muto, S; Ohsugi, J; Okabe, N; Sakuma, H; Suzuki, H; Teranishi, Y; Yonechi, A | 1 |
| Chen, SW; Chien, CR; Hsieh, TC; Kao, CH; Liang, JA; Wang, YC; Yang, SN; Yen, KY | 1 |
| Kang, H; Marcus, C; Mohandas, A; Subramaniam, RM; Truong, MT | 1 |
| Chirindel, A; Chung, CH; Koch, W; Paidpally, V; Quon, H; Richmon, J; Subramaniam, RM | 1 |
| Borms, M; Cocquyt, V; Kruse, V; Maes, A; Pottel, H; Sathekge, M; Van de Wiele, C | 1 |
| Decker, J; Dunzinger, A; Kieberger, A; Pichler, R; Weis, S | 1 |
| Aksoy, SY; Aliyev, A; Asa, S; Halac, M; Ozhan, M; Sager, S; Sonmezoglu, K; Uslu, L; Vatankulu, B | 1 |
| De Raedt, N; De Ruysscher, D; Deroose, CM; Dooms, C; Gheysens, O; Nackaerts, K | 1 |
| Bérczi, V; Györke, T; Kalina, I; Kaposi, PN; Kozák, LR; Masszi, T; Mikala, G; Rudas, G | 1 |
| Machida, Y; Maeda, S; Matoba, M; Motomo, N; Sagawa, M; Sakuma, T; Tanaka, M; Tonami, H; Ueda, Y; Ueno, M; Usuda, K | 1 |
| Lam, MGEH; Lips, IM; Meijer, GJ; Reerink, O; Ruurda, JP; van Hillegersberg, R; van Lier, ALHMW; van Rossum, PSN; van Vulpen, M | 1 |
| Aramaki, T; Endo, M; Mizuno, T; Okamura, Y; Sugiura, T; Uesaka, K; Yamamoto, T | 1 |
| Brunotte, F; Cochet, A; Cormier, L; Créhange, G; Humbert, O; Kanoun, S; Walker, PM | 1 |
| Créhange, G; Feutray, S; Humbert, O; Maingon, P; Martin, E; Peignaux-Casasnovas, K; Truc, G; Vulquin, N | 1 |
| Caglar, M; Karabulut, E; Yener, C | 1 |
| Kollias, SS; Maggio, EM; Purohit, B; Winder, T | 1 |
| Berry, MF; D'Amico, TA; Englum, BR; Erhunmwunsee, L; Onaitis, MW | 1 |
| Bastos, CR; Braga, JU; Caetano, R; da Silva, RM; de Oliveira, IA; Fortes, CP; Pepe, VL; Reis, LG | 1 |
| Ito, R; Ito, S; Iwano, S; Kato, K; Kishimoto, M; Naganawa, S | 1 |
| Doudouh, A; El Hammoumi, M; El Marjany, M; Kabiri, el H; Mansouri, H; Moussaoui, D | 1 |
| Cano Cano, JM; Domínguez Ferreras, E; Espinosa Arranz, J; García Vicente, AM; Gómez López, OV; Jiménez Aragón, F; Jiménez Londoño, GA; León Martin, A; Sánchez Pérez, V; Soriano Castrejón, ÁM | 1 |
| Beheshti, M; Dinkelborg, L; Haim, S; Kunit, T; Langsteger, W; Loidl, W; Schiller, C; Stephens, A; Zakavi, R | 1 |
| Ameye, L; Awada, A; Flamen, P; Garcia, C; Lalami, Y; Paesmans, M | 1 |
| Evangelista, L; Farsad, M; Pelizzo, MR; Piotto, A | 1 |
| Dieckmann, W; Kebebew, E; Mehta, A; Nilubol, N; Pacak, K; Patel, D | 1 |
| Chang, KJ; Cho, WH; Jeon, DG; Kong, CB; Lee, SY; Lim, I; Lim, SM | 1 |
| Dieckmann, K; Kluge, R; Körholz, D; Mauz-Körholz, C; Vordermark, D | 1 |
| Berveling, MJ; Beukema, JC; Groen, H; Hospers, GA; Langendijk, JA; Muijs, CT; Mul, VE; Plukker, JT; Pruim, J; van der Jagt, EJ; Woutersen, D | 1 |
| Ando, K; Kim, WS; Niitsu, N; Ogura, M; Suh, C; Tateishi, U; Tatsumi, M; Terauchi, T; Tobinai, K | 1 |
| Ahn, HK; Cho, EY; Choi, JY; Hyun, SH; Im, YH; Kil, WH; Lee, JE; Nam, SJ; Park, YH | 1 |
| Chang, HT; Chiu, YL; Hu, C; Liu, RS; Peng, NJ | 1 |
| Chan, SC; Chang, CJ; Chang, JT; Ko, SF; Liao, CT; Lin, CY; Lin, YC; Ng, SH; Wang, HM; Wang, JJ; Yen, TC | 1 |
| Fan, M; Fu, Z; Huang, W; Li, B; Li, H; Liu, B; Zhang, Z; Zhou, T | 1 |
| Ahn, SG; Dong, SM; Han, K; Jeon, TJ; Jeong, J; Lee, HM; Lee, HW; Lee, SA; Park, JT; Ryu, YH; Son, EJ | 1 |
| Castelijns, JA; de Bree, R; Hoekstra, OS; Leemans, CR; Peters, TT; Senft, A; Witte, BI | 1 |
| Burmeister, BH; Burmeister, E; Chua, B; Foote, MC; Panizza, B; Porceddu, SV; Pryor, D; Sjövall, J | 1 |
| Machida, Y; Motono, N; Sagawa, M; Sakuma, T; Tanaka, M; Ueno, M; Usuda, K | 1 |
| Ahn, BC; Chong, GO; Jeong, SY; Jung, JH; Kim, CY; Kim, DH; Lee, J; Lee, SW; Son, SH | 1 |
| Cho, YL; Chong, GO; Hong, DG; Lee, YH; Lee, YS | 1 |
| Calais, J; Dubray, B; Gardin, I; Modzelewski, R; Thiberville, L; Thureau, S; Vera, P | 1 |
| Hugo, G; Saraiya, S; Weiss, E | 1 |
| Choi, NC; Sharp, GC; Shusharina, N | 1 |
| An, YS; Lee, DH; Lee, SJ; Yoon, JK; Yoon, SH | 1 |
| Chua, B; Cochet, A; David, S; Drummond, E; Dutu, G; Hicks, RJ; MacManus, M; Moodie, K | 1 |
| Chen, SW; Hsieh, TC; Kao, CH; Lin, YC; Wang, YC; Yang, SN; Yen, KY | 1 |
| Davis, G; Hardy, TG; Kurniawan, ED; McKelvie, P | 1 |
| Chang, WC; Chen, JH; Cheng, CY; Chu, CM; Gao, HW; Hsu, HH; Hsu, YC; Huang, TW; Ko, KH; Lee, SC | 1 |
| Mimae, T; Mimura, T; Miyata, Y; Nakayama, H; Okada, M; Okumura, S; Tsutani, Y; Yoshimura, M | 1 |
| Groen, HJM; Klinkenberg, TJ; van den Berg, LL; Widder, J | 1 |
| Friess, H; Kornberg, A; Kornberg, J; Thrum, K; Witt, U | 1 |
| Catalano, OA; Dehdashti, F; Lee, SI | 1 |
| Bhasin, D; Bhattacharya, A; Gupta, R; Kang, M; Kapoor, R; Mittal, BR; Rana, S; Santhosh, S | 1 |
| Bernshaw, D; Drummond, E; Hicks, RJ; Narayan, K; Simcock, B; Wells, E | 1 |
| Calais, J; Di Fiore, F; Dubray, B; Gardin, I; Lemarignier, C; Michel, P; Modzelewski, R; Nkhali, L; Thureau, S; Vera, P | 1 |
| Anderson, CM; Buatti, JM; Button, A; Chang, T; Graham, MM; Marquardt, MD; Menda, Y; Pagedar, NA; Smith, BJ; Sun, W | 1 |
| Bartenstein, P; Chalkidis, RP; Cyran, CC; Fendler, WP; Hacker, M; Herrmann, K; Ilhan, H; Issels, RD; Knösel, T; Lindner, LH | 1 |
| Huber, GF; Hüllner, M; Kollias, S; Meerwein, CM; Queiroz, M; Veit-Haibach, P | 1 |
| McCarville, MB; Navid, F; Ostermeier, A; Shulkin, BL; Snyder, SE | 1 |
| Fujiwara, T; Inada, R; Kishimoto, H; Kondou, Y; Mori, Y; Nagasaka, T; Watanabe, A | 1 |
| Chi, D; Luo, Y; Meng, N; Wang, K; Yu, T; Zhao, Y | 1 |
| Gandikota, N; Hartridge-Lambert, S; Migliacci, JC; Portlock, CS; Schöder, H; Yahalom, J | 1 |
| Cahen-Doidy, L; Delaloge, S; Espié, M; Giacchetti, S; Groheux, D; Nikpayam, M; Rivera, S; Uzan, C | 1 |
| Karasawa, Y; Kitahara, H; Okumura, M; Orii, T; Yoshimura, M | 1 |
| Alberini, JL; Cacheux, W; Gauthé, M; Jouve, JL; Lièvre, A; Michel, P; Mitry, E; Richard-Molard, M | 1 |
| Chen, L; Li, Z; Xu, G; Yu, Y; Zhang, H | 1 |
| Bletard, N; Delwaide, J; Deroover, A; Detry, O; Govaerts, L; Honoré, P; Hustinx, R; Lamproye, A; Malenga, S; Mbendi, C; Meunier, P; Meurisse, N; Vandermeulen, M | 1 |
| Fujiwara, K; Harada, H; Hino, M; Itoh, K; Kikuchi, M; Kishimoto, I; Naito, Y; Shinohara, S; Suehiro, A; Tona, R | 1 |
| An, YS; Jung, YS; Kang, DK; Kim, TH; Lee, SJ; Yim, H; Yoon, JK | 1 |
| Herndon, JE; Howard, BA; Kwon, W; Patz, EF | 1 |
| Ahlgren, G; Almquist, H; Bratt, O; Kjölhede, H; Liedberg, F; Lyttkens, K; Ohlsson, T | 1 |
| Greenspan, D; Lebron, L; Pandit-Taskar, N | 1 |
| Kwee, RM; Marcus, C; Sheikhbahaei, S; Subramaniam, RM | 1 |
| Rohren, EM | 1 |
| Chen, QY; Guo, SS; Guo, X; Li, PJ; Liu, LT; Luo, DH; Mai, DM; Mai, HQ; Mo, HY; Qian, CN; Shen, T; Tang, LQ; Zeng, MS | 1 |
| Catalano, M; Catalano, OA; Guimaraes, A; Iannace, C; Luongo, A; Mahmood, U; Nicolai, E; Rosen, BR; Salvatore, M; Soricelli, A; Vangel, MG | 1 |
| Amer, S; Dong, Y; Hou, H; Li, J; Tian, M; Wang, C; Yao, Q | 1 |
| de Cremoux, P; de Roquancourt, A; Espié, M; Giacchetti, S; Groheux, D; Hatt, M; Hindié, E; Majdoub, M; Merlet, P; Resche-Rigon, M; Sanna, A; Teixeira, L; Visvikis, D | 1 |
| Barber, PV; Booton, R; Califano, R; Crosbie, PA; Evison, M; Martin, J; Summers, Y | 1 |
| Burger, IA; Haerle, SK; Huber, GF; Hüllner, M; Müller, J; Strobel, K | 1 |
| Andratschke, N; Bundschuh, RA; Essler, M; Mayer, B; Papp, L; Pyka, T; Specht, HM; Zsótér, N | 1 |
| Hoshikawa, M; Kimura, H; Kurimoto, N; Marushima, H; Nakamura, H; Saji, H; Tagaya, R; Takagi, M | 1 |
| Burger, IA; Chi, DS; Goldman, DA; Hricak, H; Miccò, M; Sala, E; Sosa, RE; Vargas, HA; Weber, W | 1 |
| Chan, AM; Cline, KJ; Dayes, IS; Dhesy-Thind, SK; Freeman, MA; Gu, CS; Gulenchyn, KY; Inculet, RI; Julian, JA; Levine, MN; Pritchard, KI; You, JJ | 1 |
| Goense, L; Lam, MG; Meijer, GJ; Reitsma, JB; Ruurda, JP; van Hillegersberg, R; van Rossum, PS; van Vulpen, M | 1 |
| Aiello, M; Cavaliere, C; Cianelli, MS; Covello, M; Iorio, B; Mesolella, M; Nicolai, E; Rossi, A | 1 |
| Chen, L; Hu, W; Wang, Y; Wei, G; Xian, W; Zhang, N | 1 |
| Cao, DY; Peng, P; Shen, K; Yang, JX; Zheng, K; Zhong, ZJ; Zhu, ZH | 1 |
| Fakhry, C; Kang, H; Kiess, AP; Marcus, C; Pasha, MA; Subramaniam, RM | 1 |
| Cho, E; Choi, SK; Choi, WS; Jun, CH; Kim, BS; Son, DJ | 1 |
| Steinke, K; Thomas, PA; Whitley, JM; Zaheer, SN | 1 |
| Donswijk, ML; Hess, S; Lam, MG; Mulders, T | 1 |
| Alavi, A; El-Haddad, GE; Lam, MG; Molenaar, IQ; Prevoo, W; Samim, M; van den Bosch, MA | 1 |
| Ito, H; Mimae, T; Mimura, T; Miyata, Y; Nakayama, H; Okada, M; Okumura, S; Yoshimura, M | 1 |
| Huang, B; Khong, PL; Kwong, DL; Lai, V; Wong, CY | 1 |
| Adamiak, P; Czepczyński, R; Fularz, M; Jarząbek-Bielecka, G; Kędzia, W; Rewers, A; Ruchała, M | 1 |
| Din, SU; Downey, R; Foster, A; Kohutek, ZA; Rimner, A; Rosenzweig, KE; Weber, WA; Wu, AJ; Yorke, ED; Zhang, Z | 1 |
| Bowen, S; Bradshaw, T; Forrest, L; Fu, R; Jeraj, R; Zhu, J | 1 |
| Cho, DG; Jeong, S; Kim, HK; Kim, SH; Kwak, YK; Lee, GJ; Lee, JH; Park, YH; Yoon, SC; Yu, M | 1 |
| Dershaw, DD; Gibbons, G; Goldman, DA; Jochelson, MS; Morris, EA; Moskowitz, CS; Sutton, EJ; Watson, EJ | 1 |
| Hickeson, M; Lisbona, R; Malibari, N | 1 |
| Laurens, ST; Oyen, WJ | 1 |
| Mena, E; Meoded, A; Solnes, L; Subramaniam, RM; Wray, R | 1 |
| Galoforo, S; Grills, IS; Kane, JL; Krueger, SA; Marples, B; Wilson, GD; Wobb, J | 1 |
| Cho, KJ; Choi, SH; Choi, YJ; Kim, JS; Kim, SY; Lee, JH; Lee, JR; Nam, SY; Roh, JL | 1 |
| Biermann, M; Brauckhoff, K; Haslerud, T; Heinecke, A; Küfner Lein, R; Reisæter, L; Varhaug, JE | 1 |
| Advani, RH; Hoppe, RT; Iberri, DJ | 1 |
| Ishihara, T; Kitajima, K; Kiyota, N; Minamikawa, T; Nibu, K; Otsuki, N; Sasaki, R; Suenaga, Y; Sugimura, K | 1 |
| Ban, MJ; Chang, JW; Choi, EC; Hong, HJ; Kim, WS; Koh, YW; Shin, YS | 1 |
| Chen, CC; Huang, AT; Huang, KC; Huang, YY; Lee, PI; Liu, MC | 1 |
| Chang, S; Kim, SJ | 2 |
| Bednarek, C; Bosset, JF; Cerda, T; Chevalier, C; Crehange, G; Cueff, A; Maingon, P; Mazoyer, F; Petegnief, Y; Quivrin, M; Servagi Vernat, S; Vulquin, N | 1 |
| Abruzzese, E; Bocchia, M; Bono, R; Bosi, A; Cencini, E; Cox, MC; Di Lollo, S; Di Napoli, A; Fabbri, A; Fratoni, S; Gini, G; Goteri, G; Kovalchuk, S; Lazzi, S; Leoncini, L; Mancuso, S; Rigacci, L | 1 |
| Cho, A; Jo, K; Lee, JD; Lee, JW; Noh, SH; Yun, M | 1 |
| Fisker, RV; Gade, M; Kubik, M; Petersen, LJ; Thorlacius-Ussing, O | 1 |
| Alongi, P; Evangelista, L; Gianolli, L; Picchio, M; Saladini, G; Spallino, M; Zattoni, F | 1 |
| De Leeuw, AA; Fokdal, LU; Gormsen, LC; Jürgenliemk-Schulz, IM; Kroon, PS; Lindegaard, JC; Ramlov, A; Tanderup, K | 1 |
| Goh, BC; Khor, LK; Loh, KS; Loi, HY; Lu, SJ; Sinha, AK; Tong, KT | 1 |
| Ishihara, Y; Matsuki, T; Miura, K; Miura, N; Miyoshi, F; Ogawa, T; Ping, B; Shinohara, Y; Shiota, G; Tanabe, Y; Tanaka, N; Tsuno, S; Wang, X; Yamashita, T | 1 |
| Dieckmann, W; Kebebew, E; Nilubol, N; Patel, D; Satoh, K | 1 |
| Akyel, R; Ekmekcioglu, O; Ozbayrak, M; Sonmezoglu, K; Vatankulu, B | 1 |
| Ahmad, R; Chung, CH; Fakhry, C; Kiess, AP; Sheikhbahaei, S; Subramaniam, RM; Taghipour, M | 1 |
| Choi, CM; Kim, GH; Kim, MY; Koo, HJ; Song, JS | 1 |
| Castetbon, V; de Clermont-Galleran, H; de Monès, E; Digue, L; Fernandez, P; Ghafouri, A; Haaser, T; Sagardoy, T | 1 |
| Chu, YH; Hsu, CC; Huang, WY; Lee, JC; Lin, CK; Shu, YC; Tsai, MC | 1 |
| Damhuis, RA; Derks, JL; Dingemans, AM; Hendriks, LE; Hochstenbag, MM; Houben, RM; Postmus, PE; Smit, EF; Troost, EG | 1 |
| Bao, M; Chen, Q; Han, Y; Li, J; Li, Z; Lin, Q; Lin, Z; Liu, S; Peng, M; Xiong, L; Xu, B; Ye, B; Zhu, W | 1 |
| Ardito, A; Arena, V; Basile, V; Brambilla, R; Duregon, E; Massaglia, C; Pelosi, E; Penna, D; Perotti, P; Terzolo, M; Vigna-Taglianti, F; Zaggia, B | 1 |
| Dong, J; Li, J; Li, Z; Liu, F; Wang, B; Zhang, Q; Zhou, D; Zhu, D | 1 |
| Da, J; Di, J; Guo, Y; Liang, C; Liu, D; Liu, J; Qiang, G; Shi, B; Xu, R; Xu, Y; Yan, J | 1 |
| Bach, AM; Fish, SA; Tuttle, RM; Yang, SP | 1 |
| Andersen, LJ; Brunø, AH; Carl, J; Sand, HM | 1 |
| Kim, DK; Kim, MY; Koo, HJ; Lee, HN; Lee, JW; Lim, S; Song, JS; Xu, H | 1 |
| Kim, SJ; Lee, CH; Pak, K; Yun, MS | 1 |
| Boers, M; Comans, EF; de Bree, R; Hobbelink, MG; Hoekstra, OS; Janssen, LM; Leemans, CR; Oyen, WJ; Pruim, J; Takes, RP; Valdés Olmos, R; van den Brekel, MW; van der Laan, BF; van der Putten, L; van Tinteren, H; Wedman, J | 1 |
| Chang, JS; Keum, KC; Kim, HJ; Kim, KH; Kim, SI; Kim, YB; Lee, J; Suh, CO; Yun, M | 1 |
| Bousquet, F; Cathelinaud, O; Fakhry, N; Giovanni, A; Morvan, JB; Rivière, D; Vatin, L; Verdalle, P | 1 |
| Cai, H; Li, L; Shen, G; Zhang, W; Zhou, H; Zhou, Y | 1 |
| Bailly, M; Orain, I; Ribeiro, MJ; Salamé, E; Venel, Y | 1 |
| Pei, S; Wei, J; Zhu, X | 1 |
| Barthel, H; Brandmaier, P; Bremicker, K; Höckel, M; Kahn, T; Kluge, R; Purz, S; Sabri, O; Stumpp, P | 1 |
| Kim, SE; Lee, JS; Lee, WW; Song, YS | 1 |
| Law, P; McQueen, L; Miles, K; Ngai, S | 1 |
| Gotoh, M; Higuchi, M; Suzuki, H | 1 |
| Choi, Y; Hong, G; Kim, H; Lee, KW; Paeng, JC; Park, MS; Suh, KS; Suh, SW; Yi, NJ; Yoo, T | 1 |
| Bae, JM; Cho, YS; Choe, YS; Kim, BT; Kim, S; Kim, SJ; Lee, KH; Moon, SH | 1 |
| Kiyohara, H; Nakano, T; Ohno, T; Saito, K; Takagishi, K; Yanagawa, T | 1 |
| Biard, L; Cuvier, C; de Cremoux, P; de Roquancourt, A; Espié, M; Giacchetti, S; Groheux, D; Hindié, E; Merlet, P; Resche-Rigon, M; Teixeira, L; Vercellino, L | 1 |
| de Galiza Barbosa, F; Haerle, SK; Hany, TF; Huber, GF; Hüllner, MW; Pietsch, C; Schmid, DT; Studer, G; Veit-Haibach, P | 1 |
| Doi, H; Fukushima, K; Hirota, S; Igarashi, Y; Katsuura, T; Kawanaka, Y; Kitajima, K; Maruyama, K; Miyoshi, Y; Mouri, M; Yamakado, K; Yamano, T | 1 |
| Acosta, O; De Crevoisier, R; Devillers, A; Le Gouestre, J; Leseur, J; Ospina, JD; Roman-Jimenez, G; Simon, A; Terve, P | 1 |
| Cheon, GJ; Chung, HH; Ha, S; Kang, SY; Kim, JW; Park, NH; Song, YS | 1 |
| Chang, J; Chang, YR; Jang, JY; Jung, W; Kang, MJ; Kim, SW; Shin, YC | 1 |
| Antoch, G; Buchbender, C; Grueneisen, J; Kinner, S; Nagarajah, J; Sawicki, LM; Schaarschmidt, BM; Umutlu, L | 1 |
| Igai, H; Kaira, K; Kakegawa, S; Kamiyoshihara, M; Nagashima, T; Nakazawa, S; Nishiyama, M; Obayashi, K; Ohtaki, Y; Shimizu, K; Takeyoshi, I | 1 |
| Dhull, VS; Khangembam, BC; Kumar, R; Kumar, S; Rana, N; Shamim, SA; Sharma, D; Sharma, P; Verma, S | 1 |
| Huang, J; Xie, P | 1 |
| Binse, I; Bockisch, A; Rosenbaum-Krumme, SJ; Ruhlmann, M | 1 |
| Bochev, P; Chaushev, B; Dancheva, Z; Klisarova, A; Yordanova, T | 1 |
| Higashi, T; Mikami, Y; Minami, S; Miyake, KK; Nakamoto, Y; Saga, T; Tadamura, E; Tanaka, S; Togashi, K | 1 |
| Hasumi, H; Ikeda, I; Inoue, T; Kaneta, T; Kishida, T; Kobayashi, K; Kondo, K; Kubota, Y; Makiyama, K; Minamimoto, R; Nakaigawa, N; Namura, K; Tateishi, U; Ueno, D; Yao, M | 1 |
| Fukushima, K; Hirota, S; Igarashi, Y; Katsuura, T; Kawanaka, Y; Kitajima, K; Mouri, M; Yamakado, K; Yamamoto, S | 1 |
| Hindié, E; Mesguich, C; Zanotti-Fregonara, P | 1 |
| Cheon, GJ; Chung, HH; Heo, EJ; Kim, HS; Lee, H; Lee, JW; Lee, M; Moon, SH | 1 |
| Healy, MA; Reddy, RM; Wong, SL; Yin, H | 1 |
| Chan, I; Etemad-Rezai, R; Johnson, C; Landis, M; Louie, AV; Mattonen, SA; Palma, DA; Rodrigues, G; Senan, S; Ward, AD; Yeung, TP | 1 |
| Cornelis, F; Durack, JC; Humm, J; Maybody, M; Schoder, H; Siegelbaum, RH; Sofocleous, CT; Solomon, SB; Sotirchos, V; Violari, E | 1 |
| Bouttens, F; D'Haene, N; Du Four, S; Duerinck, J; Everaert, H; Le Mercier, M; Michotte, A; Neyns, B; Salmon, I; Van Binst, AM; Vandervorst, F; Verschaeve, V | 1 |
| Hwang, HK; Kang, CM; Lee, SH; Lee, WJ; Yun, M | 1 |
| Eo, JS; Hong, JH; Jung, US; Kim, S; Lee, JK; Min, KJ; So, KA | 1 |
| Cheon, GJ; Chung, JK; Kang, KW; Kim, YI; Lee, DS; Paeng, JC; Suh, KS | 1 |
| Jones, S; Marcus, C; Sarangi, R; Subramaniam, RM; Taghipour, M; Trahan, TJ | 1 |
| Alavi, A; Baun, C; Bektas, S; Buskevica, I; Duvnjak, S; Ewertz, M; Falch, K; Farahani, ZA; Gerke, O; Hansen, JA; Hildebrandt, MG; Høilund-Carlsen, PF; Jylling, AM; Larsen, LB; Petersen, H; Søe, K | 1 |
| Sheikhbahaei, S; Subramaniam, RM; Taghipour, M; Wray, R; Wright, JL | 1 |
| Ahn, SG; Choi, SE; Jeong, J; Jung, WH; Lee, HM; Lee, HW; Lee, MK; Yoo, H | 1 |
| Aggarwal, S; Brizel, DM; Bui, T; Durkee, BY; Hara, WY; Le, QT; Li, R; Loo, BW; Pollom, EL; Song, J; von Eyben, R | 1 |
| Eo, JS; Hong, JH; Jung, US; Kim, S; Lee, JK; Min, KJ | 1 |
| Cano-Valderrama, O; Caruso, R; Díaz, E; Durán, HJ; Fabra, I; Garcia, L; Ielpo, B; Malavé, L; Quijano, Y; Vicente, E | 1 |
| Bi, GC; Fang, Y; Li, XM; Liang, Y; Liu, Y; Wu, N; Zhang, DS; Zhang, WJ; Zheng, R | 1 |
| Aoki, D; Banno, K; Fujii-Nishimura, Y; Hibi, T; Morishima, Y; Murakami, K; Nogami, Y; Sugiyama, H; Susumu, N; Suzuki, A; Yamada, T | 1 |
| Cho, SK; Hwang, HK; Kang, CM; Kim, C; Lee, WJ; Park, J; Yun, M | 1 |
| Cheon, GJ; Chung, JK; Im, HJ; Jang, JY; Jung, W; Kang, KW; Kim, EE; Kim, SW; Lee, DS; Oo, S | 1 |
| Abele, JT; Dziegielewski, PT; Harris, JR; Nguyen, NT; O'Connell, DA; Seikaly, H; Zhang, H | 1 |
| Albano, D; Bertagna, F; Bosio, G; Dib, B; Giubbini, R; Piccardo, A | 1 |
| Mattonen, SA; Palma, DA; Ward, AD | 1 |
| Cavalli, F; Ceriani, L; Zucca, E | 1 |
| Fujii, T; Higuchi, T; Horiguchi, J; Kuwano, H; Nagaoka, R; Obayashi, S; Takata, D; Tokiniwa, H; Tsuboi, M; Yajima, R | 1 |
| Cheon, GJ; Chung, JK; Kang, KW; Kim, EE; Kim, YI; Lee, DS; Moon, WK; Paeng, JC; Yoon, HJ | 1 |
| Chan, YC; Chen, CL; Cheng, YF; Eng, HL; Hsu, CC; Lee, WF; Lin, CC; Lin, TL; Lin, YH; Liu, YW; Wang, CC; Wang, SH; Wu, YJ; Yong, CC | 1 |
| Chang, S; Kim, SJ; Koo, PJ; Pak, K | 1 |
| Mena, E; Mirpour, S; Sheikhbahaei, S; Subramaniam, RM; Taghipour, M; Xiao, J | 1 |
| Czepczynski, R; Jodlowska, E; Kaznowski, J; Kubiak, K; Michaliszyn, P; Ruchala, M; Stangierski, A; Wolinski, K | 1 |
| Behrendt, FF; Eble, MJ; Heinzel, A; Mohammadkhani Shali, S; Mottaghy, FM; Schmitt, V; Verburg, FA; Winz, OH | 1 |
| He, L; Hu, G; Jiang, X; She, W; Wang, L; Xiao, Y | 1 |
| Ahn, SJ; Marashdeh, W; Marcus, C; Mena, E; Subramaniam, RM; Taghipour, M; Wray, R | 1 |
| Benisvy, D; Dufour, M; Gastaud, L; Iannessi, A; Kogay, M; Saada, E; Thariat, J; Thyss, A | 1 |
| Bae, JS; Jeon, HS; Ki, YK; Kim, DH; Kim, KH; Kim, WT; Lee, JH; Lee, JY; Nam, JH; Park, D; Suh, DS | 1 |
| Czuczman, MS; Graf, DA; Lamonica, D; Munteanu, MC | 1 |
| Kang, DY; Lee, JW; Lee, SM; Lee, SY; Na, JO | 1 |
| Gubała, E; Jarząb, B; Kalemba, M; Kołosza, Z; Krajewska, J; Król, A; Kropin Ska, A; Kukulska, A; Paliczka-Cies Lik, E; Puch, Z | 1 |
| Cho, YS; Choe, YS; Im, YH; Kim, BT; Lee, KH; Lim, CH; Moon, SH | 1 |
| Chiang, GC; Ferraro, R; Galla, N; Kovanlikaya, I | 1 |
| Chung, HW; Hwang, TS; Kim, B; Kim, SK; Lee, WW; Park, KS; So, Y; Yoo, YB | 1 |
| Baumann, M; Bergmann, R; Beuthien-Baumann, B; Brüchner, K; Jentsch, C; Kotzerke, J; Krause, M; Löck, S; Mosch, B; Steinbach, J; Thames, H; Troost, EGC; Yaromina, A; Zips, D | 1 |
| Baek, KH; Cho, JK; Choi, JY; Choi, N; Hyun, SH; Jeong, HS; Kim, MJ; Lee, SH | 1 |
| Giordano, S; Kemppainen, J; Koskivuo, I; Minn, H; Seppänen, M; Veräjänkorva, E; Vihinen, P | 1 |
| Choi, MG; Lee, HH; Lee, SH; Na, SJ; o, JH; Park, CH; Park, JM; Song, KY | 1 |
| Albano, D; Alongi, P; Baldari, S; Caobelli, F; Gentile, R; Gilardi, MC; Midiri, M; Russo, G; Stefano, A | 1 |
| Fujimoto, Y; Fukushima, K; Higuchi, T; Imamura, M; Kitajima, K; Miyagawa, Y; Miyoshi, Y; Murase, K; Nishimukai, A; Ozawa, H; Takatsuka, Y; Yanai, A | 1 |
| Hashizume, A; Kawai, M; Kishida, T; Mizuno, N | 1 |
| Acosta, O; Castelli, J; De Crevoisier, R; Devillers, A; Garin, E; Lavoue, V; Lejeune, F; Leseur, J; Ospina-Arango, JD; Roman-Jimenez, G; Terve, P; Williaume, D | 1 |
| Chen, X; Liu, CC; Qiao, WL; Song, JH; Wang, TS; Xing, Y; Zhao, JH | 1 |
| Boni, R; Castellucci, P; Coraggio, G; Erba, PA; Galeandro, M; Lazzeri, E; Paiar, F; Pasqualetti, F; Perri, M; Roncali, M; Sollini, M; Versari, A | 1 |
| Fukuhara, M; Hasegawa, T; Higuchi, M; Inoue, T; Owada, Y; Suzuki, H; Watanabe, Y; Yamaura, T | 1 |
| Aide, N; Babin, E; Bardet, S; Blanchard, D; Ciappuccini, R; de Raucourt, D; Michels, JJ; Rame, JP | 1 |
| Hosono, M; Ishikawa, K; Kanamori, S; Matsuura, T; Nakamatsu, K; Nishimura, Y; Shibata, T; Tachibana, I | 1 |
| Jang, WY; Jung, S; Kim, IY; Kim, YS; Lee, KH; Moon, KS | 1 |
| Bazan, JG; Duan, F; Graves, EE; Horng, D; Loo, BW; Machtay, M; Siegel, BA; Snyder, BS | 1 |
| Hansen, AF; Jensen, MR; Nordholm-Carstensen, A | 1 |
| Chillura, I; Migliore, M; Milazzotto, R; Militello, C; Pagana, A; Pergolizzi, S; Privitera, G; Raffaele, L; Salamone, V; Spatola, C; Tocco, A | 1 |
| Ahn, MJ; Ahn, YC; Cho, YS; Choi, JY; Kim, BT; Lee, KH; Moon, SH; Son, YI | 1 |
| Andrade, RJ; Cascales-Campos, PA; Feliciangeli, E; Frutos, L; Fuster-Quiñonero, M; Gil, E; Gil, J; Lopez-Lopez, V; Parrilla, P | 1 |
| Meignan, M | 1 |
| Ahnesjö, A; Grönlund, E; Johansson, S; Montelius, A | 1 |
| Mena, E; Reddy, S; Sheikhbahaei, S; Solnes, LB; Subramaniam, RM; Wachsmann, J; Yanamadala, A | 1 |
| Balogova, S; Jorgov, L; Landman-Parker, J; Montravers, F; Talbot, JN | 1 |
| Cho, KS; Kim, BS; Kim, IJ; Pak, K; Roh, HJ; Yi, KI | 1 |
| Avanesov, M; Derlin, T | 1 |
| Georgi, T; Hasenclever, D; Kluge, R; Kurch, L | 1 |
| Chen, Y; Li, J; Qiu, L; Tu, G | 1 |
| Ahn, HK; Choi, JY; Hyun, SH; Im, YH; Kim, BT; Lee, JE; Lee, JH; Lee, KH; Nam, SJ; Park, YH | 1 |
| Akamatsu, N; Egawa, H; Endo, I; Furukawa, H; Gotoh, M; Hakamada, K; Honda, M; Inomata, Y; Ishiyama, K; Ito, E; Kaido, T; Kawagishi, N; Kenjo, A; Kokudo, N; Ku, Y; Kubo, S; Kuramitsu, K; Maehara, Y; Miyazaki, M; Nagano, H; Nakanishi, C; Ohdan, H; Ohtsuka, M; Okajima, H; Shirabe, K; Sugawara, Y; Takada, T; Takada, Y; Takahara, T; Takamura, H; Takeda, K; Taketomi, A; Toyoki, Y; Uemoto, S; Wada, H; Wakabayashi, G; Yamaue, H | 1 |
| Bisdas, S; Boeßert, P; Fottner, C; Hempel, JM; Kloeckner, R; Krick, S; Miederer, M; Musholt, TJ; Pinto Dos Santos, D; Schadmand-Fischer, S; Schreckenberger, M; Weber, MM | 1 |
| Balev, B; Bochev, P; Bocheva, Y; Chaushev, B; Dancheva, J; Ivanova, D; Klisarova, A; Krasnaliev, I; Lozanova, R; Mechmed, M; Micheva, I | 1 |
| Goto, T; Kurita, A; Matsuzaki, N; Nishimura, S; Nishimura, T; Okada, H; Terajima, H; Uchida, Y; Yazumi, S | 1 |
| Anees K, M; Jayaprakash, PG; Joy, A; Madhavan, J; Nair, S; Nanabala, R; Pillai, MR; Sasikumar, A | 1 |
| Annunziata, S; Caldarella, C; De Stefano, V; Pagano, L; Rufini, V | 1 |
| Abuodeh, Y; Ahmed, KA; Anaya, DA; Biebel, B; Choi, J; El-Haddad, G; Frakes, JM; Hoffe, SE; Kim, R; Kim, Y; Kis, B; Malafa, M; Naghavi, AO; Sweeney, J; Venkat, PS | 1 |
| Bradley, KM; Findlay, JM; Franklin, JM; Gillies, RS; Gleeson, FV; Maynard, ND; Middleton, MR; Teoh, EJ; Wang, LM | 1 |
| Brar, H; Han, K; Langer, D; MacCrostie, P; May, T; Metser, U; Tau, N | 1 |
| Dong, X; Huang, Y; Li, W; Sun, L; Sun, X; Wan, H; Xing, L; Yu, J; Zhao, X; Zhu, W | 1 |
| Boshomane, T; Lawal, I; Lengana, T; Modiselle, M; Ololade, K; Reyneke, F; Sathekge, M; Vorster, M | 1 |
| Chino, Y; Kiyono, Y; Kurokawa, T; Mori, T; Okazawa, H; Shinagawa, A; Tsujikawa, T; Yamada, S; Yamamoto, M; Yoshida, Y | 1 |
| Kong, L; Shi, F; Zhang, NS; Zhu, H | 1 |
| Aktas, B; Antoch, G; Deuschl, C; Forsting, M; Grueneisen, J; Herrmann, K; Kirchner, J; Ruhlmann, V; Sawicki, LM; Suntharalingam, S; Umutlu, L | 1 |
| Flors, L; Leiva-Salinas, C; Patrie, JT; Rehm, PK; Schiff, D | 1 |
| Ahn, CS; Hwang, S; Jung, DH; Kang, WH; Kim, KH; Lee, SG; Lee, YJ; Moon, DB; Park, GC; Song, GW | 1 |
| Kohli, PS; Mittal, BR; Roop, MJ; Singh, B; Singh, G; Singh, H; Watts, A | 1 |
| Aktas, B; Forsting, M; Grueneisen, J; Kinner, S; Kirchner, J; Ruhlmann, V; Sawicki, LM; Umutlu, L; Wetter, A | 1 |
| Chong, S; Coupe, N; Lee, S; Lin, M; Manoharan, V; Merrett, N; Ng, W; Wilson, R; Yap, J | 1 |
| Antoch, G; Bockisch, A; Forsting, M; Freudenberg, LS; Hauth, EA; Heusner, TA; Kuehl, H; Veit-Haibach, P | 1 |
| Amthauer, H; Denecke, T; Furth, C; Hautzel, H; Henze, G; Misch, D; Schönberger, S; Steffen, IG; Stöver, B; Voelker, T | 1 |
| Lenglinger, J; Riegler, M; Ringhofer, C | 1 |
| Ameshima, S; Demura, Y; Ishizaki, T; Mizuno, S; Morikawa, M; Okazawa, H | 1 |
| Cohn, DE; Farrar, WB; Hall, NC; Martin, EW; Povoski, SP; Seamon, LG | 1 |
| Choi, JY; Kim, BT; Lee, WJ; Lim, HK; Park, KW; Park, MJ | 1 |
| Doi, R; Hatano, E; Higashi, T; Ikai, I; Iwaisako, K; Mori, A; Nakajima, A; Nakamoto, Y; Seo, S; Tada, M; Tamaki, N; Uemoto, S | 1 |
| Belinc, D; Chen, DT; Eikman, EA; Farma, JM; Malafa, M; Melis, M; Santillan, AA; Walters, J | 1 |
| Emmering, J; Hoekstra, OS; Krak, NC; Meijer, S; Pinedo, HM; Spreeuwenberg, MD; Twisk, JW; Van der Hoeven, JJ | 1 |
| Higashi, K; Ishida, C; Kotani, T; Okino, S; Shima, K; Yamada, M | 1 |
| Allen, TW; Davison, JM; Holley, TS; Jurgens, JS; Montilla-Soler, JL; Stack, AL; Stocker, DJ | 1 |
| Chen, YJ; Lai, CR; Liu, RS; Shen, SH; Shieh, HJ; Sung, PL; Wang, PH; Wen, KC; Yen, MS; Yuan, CC | 1 |
| Doki, Y; Fujiwara, Y; Fukunaga, H; Hatazawa, J; Higuchi, I; Miyata, H; Monden, M; Takiguchi, S; Tatsumi, M; Yano, M; Yasuda, T | 1 |
| Hoshikawa, H; Mitani, T; Mori, N; Nishiyama, Y; Ohkawa, M; Yamamoto, Y | 1 |
| Comans, EF; de Bree, R; Hoekstra, OS; Kuik, DJ; Langendijk, JA; Leemans, CR; van der Putten, L | 1 |
| Higashi, T; Nakamoto, Y; Saga, T; Yoshikawa, K | 1 |
| Cammilleri, S; Colavolpe, C; Coze, C; Guedj, E; Mundler, O; Taïeb, D | 1 |
| Guan, YS; Luo, ZM; Pan, WM; Su, XH; Sun, L; Wei, JH; Wu, H | 1 |
| Balestreri, L; Borsatti, E; Cimitan, M; Comoretto, M; Franchin, G; Lise, M | 1 |
| Alavi, A; Basu, S; Cermik, TF; Dhuriraj, T; Kumar, R; Mavi, A; Torigian, D; Urhan, M; Wasik, M | 1 |
| Bonomo, L; Calcagni, ML; De Gaetano, AM; Giordano, A; Gui, B; Rufini, V; Valentini, AL | 1 |
| Bar-Shalom, R; Gorenberg, M; Israel, O | 1 |
| Havlioglu, N; Hueser, CN; Nguyen, NC; Osman, M; Patel, AJ | 1 |
| Ahuja, AT; Choi, FP; Lee, YY; Wong, KT | 1 |
| De Gaetano, AM; Fagotti, A; Fanfani, F; Giordano, A; Lorusso, D; Rossitto, C; Scambia, G; Vizzielli, G | 1 |
| Dehdashti, F; Fernandez, FG; Finkelstein, SE; Hawkins, WG; Linehan, DC; Siegel, BA; Strasberg, SM | 1 |
| Fu, Z; Han, A; Li, K; Sun, X; Xu, X; Yang, G; Yu, J; Zheng, J | 1 |
| Brooks, RA; Dehdashti, F; Grigsby, PW; Mutch, DG; Powell, MA; Rader, JS; Siegel, BA; Thaker, PH | 1 |
| Higashi, K; Ito, K; Kato, T; Kobayashi, T; Niho, S; Sakuma, T; Sekiguchi, R; Takahashi, T; Tonami, H; Ueda, Y | 1 |
| Domeki, Y; Kaji, Y; Kitajima, K; Morita, S; Murakami, K; Suganuma, N; Sugimura, K; Yamasaki, E | 1 |
| Ishigame, K; Kato, S; Miyazawa, N; Satoh, Y; Shinohara, T | 1 |
| Agrawal, A; Hall, NC; Martin, EW; Povoski, SP; Ringel, MD | 1 |
| Byun, BH; Cheon, GJ; Choi, CW; Kang, HJ; Kim, KM; Lee, SS; Lim, SM; Na, II; Ryoo, BY; Yang, SH | 1 |
| Buist, MR; Comans, EF; Hoekstra, OS; Molthoff, CF; van Baal, MW; van der Veldt, AA | 1 |
| Angeletti, G; Avenia, N; Caracò, C; Chiofalo, MG; Colao, A; Faggiano, A; Ferolla, P; Grimaldi, F; Lombardi, G; Mozzillo, N; Pezzullo, L; Santeusanio, F | 1 |
| Jo, MK; Lee, HM; Park, JW | 1 |
| Atmani, A; Bail, JP; Cheze Le Rest, C; Jestin-Le Tallec, V; Lozac'h, P; Metges, JP; Pradier, O; Teyton, P; Visvikis, D; Volant, A | 1 |
| Hatazawa, J; Higuchi, I; Inoue, A; Ishikawa, J; Isohashi, K; Kanakura, Y; Nakajo, K; Nakamura, H; Shimosegawa, E; Tatsumi, M | 1 |
| Jun, JY; Manni, A | 1 |
| Brouwer, J; de Bree, R; Hoekstra, OS; Leemans, CR; Uyl-de Groot, CA; van Hooren, AC | 1 |
| Barnes, N; Kokai, G; Losty, P; Mc Dowell, H | 1 |
| Chen, TH; Chien, CR; Hong, RL; Tzen, KY; Yen, MF; Yen, RF | 1 |
| Kang, S; Kim, M; Kim, SK; Lim, MC; Park, SY; Seo, SS | 1 |
| Aksu, G; Altun, E; Bilici, A; Karci, E; Ozkara, SK; Ustaalioglu, BB; Uygun, K | 1 |
| Abgral, R; Bizais, Y; Kraeber-Bodéré, F; Le Duc-Pennec, A; Le Roux, PY; Marianovski, R; Potard, G; Pradier, O; Querellou, S; Salaun, PY | 1 |
| Anazawa, S; Eto, K; Ogawa, M; Takao, Y; Ushigome, T; Watanabe, M; Yamagata, T; Yanaga, K | 1 |
| Ariji, E; Ariji, Y; Fuwa, N; Kodaira, T; Nakamura, T; Satoh, Y; Tachibana, H | 1 |
| Balogh, J; Dahele, M; Ehrlich, L; Silverberg, J; Ung, YC; Wong, CS | 1 |
| Arslan, N; Ataergin, S; Ozet, A; Ozguven, MA | 1 |
| Baldey, A; Carter, J; Fulham, MJ; Gibson, M; Hicks, RJ; Ramshaw, JE | 1 |
| Beorlegui, C; García-Velloso, MJ; Gil-Rendo, A; Martínez-Regueira, F; Rodriguez-Spiteri, N; Zornoza, G | 1 |
| Abolmaali, N; Abramyuk, A; Gillham, C; Herrmann, T; Koch, A; Szluha Lazanyi, K; Tokalov, S; Zöphel, K | 1 |
| Beheshti, M; Dirisamer, A; Flöry, D; Halpern, BS; Langsteger, W; Mayerhoefer, ME; Wolf, F | 2 |
| Herbertson, RA; Lee, ST; Scarsbrook, AF; Scott, AM; Tebbutt, N | 1 |
| Cheng, MF; Hong, RL; Ting, LL; Tzen, KY; Wu, YW; Yen, RF | 1 |
| Baur-Melnyk, A; Becker, CR; Haug, A; Hermann, KA; Reiser, MF; Schmidt, GP; Tiling, R; Utzschneider, S | 1 |
| Batty, V; Wong, WL | 1 |
| Bumpous, JM | 1 |
| Reske, SN | 1 |
| Chiari, F; Eckel, HE; Gaggl, A; Hausegger, K; Kohlfürst, S; Kresnik, E; Lind, P; Markitz, M; Raunik, W; Salzwimmer, M | 1 |
| Denecke, T; Rothe, JH; Röttgen, R | 1 |
| Bang, YJ; Heo, DS; Im, SA; Kang, WJ; Kim, DW; Kim, TY; Kim, WH; Kim, YJ; Lee, SH; Oh, DY; Sim, SH | 1 |
| Baillet, G; Barre, E; Groheux, D; Hennequin, C; Hindie, E; Misset, JL; Moretti, JL; Sarandi, F; Toubert, ME | 1 |
| Morita, N; Nishitani, H; Otomi, Y; Otsuka, H; Terazawa, K; Yamashita, K | 1 |
| Fujii, H; Fukuda, H; Kaneta, T; Kitajima, K; Kubota, K; Murakami, K; Nakajima, K; Nakamoto, Y; Satake, M; Senda, M; Tateishi, U; Togashi, K | 1 |
| Brown, G; Houghton, SL; Husband, JE; Potter, KC; Thomas, K | 1 |
| Chu, JN; Filion, EJ; Graves, EE; La, TH; Le, QT; Lee, P; Loo, BW; Maxim, P; Nguyen, K; Quon, A; Turnbull, BB | 1 |
| Futatsubashi, M; Kanno, T; Naitou, K; Ouchi, Y; Tanizaki, Y; Torizuka, T; Ueda, Y | 1 |
| Fields, R; McWhorter, A; Mercante, DE; Nuss, D; Pou, AM; Rabalais, AG; Walvekar, R; Wood, C | 1 |
| Domeki, Y; Kaji, Y; Kitajima, K; Murakami, K; Suganuma, N; Sugimura, K; Sunagawa, M; Tsubaki, M; Yamasaki, E | 1 |
| Chung, JK; Kang, KW; Kwon, HW; Lee, DS; Lee, JW; Lee, MC; Paeng, JC; Suh, KS | 1 |
| Chung, JK; Kang, KW; Lee, DS; Lee, JW; Lee, MC; Lee, SM; Paeng, JC; Park, SH | 1 |
| Ando, M; Fujiwara, Y; Hirata, T; Iwasa, S; Katsumata, N; Kouno, T; Nakano, E; Ono, M; Shimizu, C; Tamura, K; Yonemori, K; Yunokawa, M | 1 |
| Koyama, H; Matsumoto, K; Matsumoto, S; Nogami, M; Ohno, Y; Onishi, Y; Sugimura, K; Takenaka, D; Yoshikawa, T | 1 |
| Esteva, D; Jiménez Alonso, J; Llamas-Elvira, JM; López de la Torre, M; Muros, MA; Muros, T; Villar, JM | 1 |
| Hiyama, A; Kawakami, Y; Matsunaga, N; Suga, K | 1 |
| Andrade, RS; Argiris, A; Branstetter, BF; Burton, S; Deeb, EL; Ferris, RL; Gooding, WE; Grandis, JR; Heron, DE; Johnson, JT; Karamouzis, M; Lai, SY; Mountz, JM | 1 |
| Billiet, I; Lesage, K; Maes, A; Pottel, H; Swinnen, G; Vanneste, A; Werbrouck, P | 1 |
| Berthelsen, AK; Engelholm, SA; Høgdall, C; Høgdall, E; Jensen, F; Loft, A; Markova, E; Risum, S; Roed, H | 1 |
| Che, WJ; Qiao, WL; Wang, TS; Xing, Y; Zhao, JH | 1 |
| Baglin, AC; Le Stanc, E; Tainturier, C; Vilain, D | 1 |
| García-Velloso, MJ; Garrastachu, P; Martí-Climent, J; Peñuelas, I; Quincoces, G; Richter, JA; Rioja, J; Rodríguez, M; Zudaire, J | 1 |
| Genden, EM; Kao, J; Kostakoglu, L; Mocherla, B; Packer, S; Park, EE; Som, PM; Vu, HL | 1 |
| Dellapasqua, S | 1 |
| Choi, JY; Kim, BT; Kim, SJ; Kim, WS; Ko, YH; Yi, JH | 1 |
| Bae, DS; Choi, CH; Kang, H; Kim, BG; Kim, CJ; Kim, TJ; Lee, JH; Lee, JW; Lee, YY | 1 |
| Chisholm, EJ; Tolley, NS | 1 |
| Baek, CH; Choi, JY; Chung, MK; Hyun, SH; Jeong, HS; Kim, HJ; Ko, YH; Park, GY; So, YK; Son, YI | 1 |
| Gallagher, DJ; Kemeny, N; Libby, DM | 1 |
| Bastiaannet, E; Hoekstra, HJ; Kobold, AC; Kruijff, S; Suurmeijer, AJ; van Ginkel, RJ | 1 |
| Bomanji, JB; Caplin, M; Conry, BG; Kayani, I; Mahmood, S; Papathanasiou, ND; Prakash, V | 1 |
| Been, LB; Elsinga, PH; Hoekstra, HJ; Jager, PL; Suurmeijer, AJ; van der Laan, BF | 1 |
| Bisdas, S; Chambron-Pinho, N; Mack, M; Middendorp, M; Sader, R; Seitz, O; Vogl, TJ | 1 |
| Fan, W; Hu, YY; Liang, PY; Lin, XP; Sun, XR; Zhang, X | 1 |
| Evanson, J; Kelly, PA; Metcalfe, K; Monson, JP; Plowman, PN; Sabin, I | 1 |
| Ahn, BC; Lee, J; Lee, SW; Seo, JH | 1 |
| Bihan, H; Cohen, R; des Guetz, G; Martin, A; Wind, P | 1 |
| Isobe, M; Iwamiya, T; Kobayashi, E; Masaki, H; Miyake, T; Nakashima, R; Shiki, Y; Yamagata, A; Yamasaki, M | 1 |
| Boin, C; Bousquet, G; Cuvier, C; Espié, M; Giacchetti, S; Groheux, D; Hindié, E; Misset, JL; Moretti, JL; Teyton, P | 1 |
| Hakenberg, OW; Protzel, C | 1 |
| Chao, TC; Hsueh, C; Lin, JD | 1 |
| Gottschild, D; Kornberg, A; Küpper, B; Sappler, A; Thrum, K; Wilberg, J | 1 |
| Bissoli, S; Chierichetti, F; Liessi, G; Pasquali, C; Pedrazzoli, S; Sperti, C | 1 |
| Buchegger, F; Casanova, N; Dipasquale, G; Miralbell, R; Nouet, P; Ratib, O; Rouzaud, M; Vees, H; Weber, DC; Zilli, T | 1 |
| Antoch, G; Buck, AK; Herrmann, K; Heusner, TA | 1 |
| Carlson, D; Groshen, S; Han, MM; Hawkins, R; Jackson, HA; Mari Aparici, C; Maris, J; Matthay, KK; Quach, A; Taggart, DR; Villablanca, JG; Ye, W | 1 |
| Brooks, RA; Powell, MA | 1 |
| Kubota, K; Kurata, A; Murata, Y; Osanai, T; Shibuya, H | 1 |
| Dehdashti, F; Grigsby, PW; Kidd, EA; Mutch, DG; Mutic, S; Powell, MA; Rader, JS; Siegel, BA | 1 |
| Irei, T; Kobashi, Y; Mouri, K; Oka, M; Shimizu, H | 1 |
| Kim, BS; Kim, IJ; Kim, SJ; Kim, YK; Nam, HY; Park, K; Rho, HJ | 1 |
| Berián Polo, JM; Martínez-Monge, R; Richter, JA; Rincón Mayans, A; Rioja Zuazu, J; Rodríguez, M; Sansi, AS; Zudaire Bergera, JJ | 1 |
| Mercier, G; Peller, P; Sakai, O; Subramaniam, RM; Truong, M | 1 |
| Feng, R; Fu, Z; Xie, P; Yu, JM; Yue, JB | 1 |
| Hany, TF; Knuth, A; Mischo, A; Petrausch, U; Renner, C; Samaras, P; Schaefer, NG; Soyka, JD; Tschopp, A; Veit-Haibach, P | 1 |
| Chuang, KW; Coakley, FV; Hawkins, RA; Konety, BR; Patil, VV; Sollitto, RA; Wang, ZJ | 1 |
| Anthony, MP; Khong, PL; Zhang, J | 1 |
| Grahek, D; Hassan-Sebbag, N | 1 |
| Baldus, SE; Bollschweiler, E; Dietlein, M; Hölscher, AH; Metzger, R; Mönig, SP; Schicha, H; Schmidt, M; Vallböhmer, D | 1 |
| Amador, R; Galeano, I; Lucas, A; Martín, M; Martínez, JC; Prat, R; Reynés, G | 1 |
| Aukema, TS; Oldenburg, HS; Russell, NS; Rutgers, EJ; Teertstra, HJ; Valdés Olmos, RA; Vogel, WV; Vrancken Peeters, MT; Wesseling, J | 1 |
| Hata, Y; Homma, S; Isobe, K; Shibuya, K; Takagi, K; Takai, Y | 1 |
| Higashi, T; Nakamoto, Y; Nakatani, K; Saga, T; Togashi, K | 1 |
| Basuyau, JP; d'Anjou, J; Edet-Sanson, A; Hapdey, S; Hitzel, A; Kuhn-Lansoy, C; Modzelewski, R; Vera, P | 1 |
| Abe, K; Baba, S; Hatakenaka, M; Honda, H; Isoda, T; Kaneko, K; Sasaki, M; Yabuuchi, H | 1 |
| Dua, S; Gupta, K; Purandare, NC; Rangarajan, V; Shah, S; Sharma, AR | 1 |
| Ament, C; Gonzalez, RG; Hochberg, FH; Kwong, K; Lev, MH; Mullins, ME; Ozsunar, Y; Schaefer, PW | 1 |
| Hyodo, M; Kasahara, N; Koizumi, M; Morishima, K; Sakuma, Y; Sasanuma, H; Sata, N; Shimizu, A; Yasuda, Y | 1 |
| Hama, Y; Nakagawa, K | 1 |
| Concannon, R; Larcos, GS; Veness, M | 1 |
| Barrington, S; Cane, P; Landau, D; Lang-Lazdunski, L; Pilling, J; Rankin, S; Spicer, J; Tan, C | 1 |
| Erturk, SM; Madan, R; Shyn, PB; Silverman, SG; Wu, C | 1 |
| Al-Nahhas, A; Ambrosini, V; Fanti, S; Ferdeghini, M; Gross, MD; Marzola, MC; Massaro, A; Pelizzo, MR; Rubello, D; Toniato, A | 1 |
| Fanti, S; Marzola, MC; Musto, A; Nanni, C; Rampin, L; Rubello, D | 1 |
| Freeman, M; Hendler, A; McSweeney, S; Metser, U; You, J | 1 |
| Basu, S; Menon, S | 1 |
| Chung, DH; Goo, JM; Jang, BG; Kang, CH; Kang, KW; Kim, YT; Lee, CH; Lee, HJ; Lee, HY; Park, CM | 1 |
| Hasegawa, Y; Higashiyama, M; Hosoki, T; Kanzaki, R; Kodama, K; Maeda, J; Okami, J; Takami, M | 1 |
| Ariga, H; Jingu, K; Kaneta, T; Koto, M; Nemoto, K; Ogawa, Y; Sakayauchi, T; Takahashi, S; Takai, Y; Takeda, K; Yamada, S | 1 |
| Berger, F; Issels, R; Reiser, MF; Rist, C; Schlemmer, M; Schramm, N | 1 |
| Chen, YK; Huang, LW; Lee, SL; Pan, HS | 1 |
| Chao, TB; Chen, CJ; Shih, DF | 1 |
| Chamroonrat, W; Cheng, G; Zhuang, H | 1 |
| Ansquer, C; Bodet-Milin, C; Bourbouloux, E; Bridji, B; Campion, L; Kraeber-Bodéré, F; Oudoux, A; Pallardy, A; Resche, I; Rousseau, C; Sagan, C; Testard, A | 1 |
| Bilici, A; Canpolat, N; Gumus, M; Salepci, T; Seker, M; Tekinsoy, B; Ustaalioglu, BB | 1 |
| Ariga, H; Fujimoto, K; Jingu, K; Kaneta, T; Katja, L; Koto, M; Matsufuji, N; Metoki, T; Mitsuya, M; Narazaki, K; Nemoto, K; Ogawa, Y; Takahashi, S; Takai, Y; Takeda, K; Umezawa, R; Yamada, S | 1 |
| Balogova, S; Giannesini, C; Gutman, F; Huchet, V; Izrael, V; Kerrou, K; Muresan, IP; Nataf, V; Pene, F; Prignon, A; Schlienger, M; Talbot, JN | 1 |
| Chan, SC; Chang, JT; Chang, KP; Ko, SF; Liao, CT; Lin, CY; Lin, YC; Ng, SH; Wang, HM; Yen, TC | 1 |
| Chin, KJ; Finger, PT | 1 |
| Borbenyi, Z; Deak, B; Galuska, L; Illes, A; Keresztes, K; Marton, I; Miltenyi, Z; Molnar, Z; Rosta, A; Schneider, T; Simon, Z; Tron, L; Varady, E | 1 |
| Blake, MA; Cronin, CG; Prakash, P | 1 |
| Lin, M; London, K | 1 |
| Carrasquillo, JA; Larson, SM; Nehmeh, SA; Schoellnast, H; Solomon, SB; Thornton, RH | 1 |
| Hong, L; Li, HB; Li, Y; Wang, JL; Wang, Q; Yue, MG | 1 |
| Cho, SY; Han, SS; Kim, SH; Kim, SK; Kim, YK; Lee, KW; Park, SJ | 1 |
| Kavanagh, E; Moynagh, M; O'Dwyer, T; O'Neill, JP | 1 |
| Koyama, H; Maniwa, Y; Matsumoto, K; Matsumoto, S; Nishimura, Y; Nogami, M; Ohno, Y; Onishi, Y; Sugimura, K; Takenaka, D; Yoshikawa, T | 1 |
| Akiyama, T; Choong, PF; Clark, JC; Miki, Y; Ngan, S | 1 |
| Kumar, R; Shandal, V | 1 |
| Laible, M; Lettau, M | 1 |
| Caamaño, AG; Figueiras, RG; Goh, V; Martin, CV; Naveira, AB; Padhani, AR | 1 |
| Abe, W; Narahara, H; Nasu, K; Takai, N; Tomonari, K | 1 |
| Choi, SC; Kim, BI; Kim, BJ; Kim, K; Kim, MH; Kim, Y; Lee, ED; Lee, KH; Park, SI; Ryu, SY | 1 |
| Cameron, D; Fleming, IN; Gilbert, FJ; Miles, KA | 1 |
| Chang, KH; Jung, HW; Kang, KW; Kim, YH; Lee, SH; Lim, YJ; Oh, SW; Park, CK | 1 |
| Abouzied, MM; Alkattan, KM; El-Bawab, HY; Hajjar, WM; Rafay, MA; Saleh, WM | 1 |
| Boterberg, T; Ceelen, W; Goethals, I; Ham, H; Smeets, P; Verstraete, K | 1 |
| Giesel, FL; Haberkorn, U; Kratochwil, C | 1 |
| Bamba, Y; Itabashi, M; Kameoka, S | 1 |
| Chan, WS; Khong, PL; Zhang, J | 1 |
| Bhosale, P; Iyer, RB; Levenback, CF; Macapinlac, HA; Peungjesada, S; Rohren, E; Schmeler, K; Wei, W | 1 |
| Cen, XN; Dong, YJ; Li, Y; Liang, ZY; Ou, JP; Qiu, ZX; Ren, HY; Wang, MJ; Wang, WS; Xu, WL; Yao, H; Yin, Y | 1 |
| Aznar, M; Bender, E; Bentzen, SM; Berthelsen, AK; Due, AK; Korreman, S; Kristensen, CA; Specht, L; Tomé, W; Vogelius, I | 1 |
| Drappatz, J; Gerbaudo, VH; Horky, LL; Hsiao, EM; Weiss, SE | 1 |
| Castellucci, P; Ceccarelli, C; Cola, B; Cuicchi, D; Di Fabio, F; Di Tullio, P; Fanti, S; Giaquinta, S; Iacopino, B; Lombardi, R; Martoni, AA; Pini, S; Pinto, C; Tardio, L | 1 |
| Ding, HJ; Kao, CH; Liang, JA; Sun, SS; Wang, CH; Yang, SN; Yen, KY | 1 |
| Baek, JH; Choi, BS; Choi, JW; Jeong, KS; Kim, TY; Kim, WB; Lee, JH; Ryu, JS; Shong, YK | 1 |
| Aikawa, M; Imabayashi, E; Koyama, I; Matsuda, H; Miyazawa, M; Okada, K; Okamoto, K; Toshimitsu, Y | 1 |
| Bang, YJ; Han, SW; Im, SA; Kim, TY; Oh, DY; Shin, DY | 1 |
| Bertin, F; Bonnaud, F; Dalmay, F; Gaillard, S; Melloni, B; Monteil, J; Vergnenègre, A | 1 |
| Di Donato, V; Giorgini, M; Manci, N; Marchetti, C; Panici, PB; Tesei, J | 1 |
| Sahdev, A | 1 |
| Schönberg, S | 1 |
| Bruce, I; Ghosal, N; Hastings, D; Homer, J; Julyan, P; Mais, K; Ryder, WD; Shenjere, P; Slevin, NJ; Ward, T | 1 |
| Gönen, M; Larson, SM; Schöder, H; Singnurkar, A; Solomon, SB | 1 |
| Abiko, M; Sato, T; Shiono, S | 1 |
| Hamakawa, H; Katakami, N; Kokubo, M; Neri, S; Takahashi, Y; Terashi, T; Tomii, K | 1 |
| Segall, GM | 1 |
| Ahn, DH; Hong, SP; Hwang, SG; Jeon, TJ; Kang, MK; Ko, KH; Kwon, CI; Lee, JE; Park, PW; Rim, KS | 1 |
| Ishizawa, K; Ogura, M; Tateishi, U; Tatsumi, M; Terauchi, T; Tobinai, K | 1 |
| Jentzmik, F; Müller, J; Schrader, AJ; Schrader, M | 1 |
| Bordenave, L; de Clermont, H; Laffon, E | 1 |
| Ahmadzadehfar, H; Biermann, K; Biersack, HJ; Sabet, A | 1 |
| Kim, J; Visioni, A | 1 |
| Elliott, BM; Isola, L; Kostakoglu, L; Lee, D; Osman, K; Peti, S; Scigliano, E | 1 |
| Gerbaudo, VH; Hatabu, H; Mamede, M; Sugarbaker, DJ; Trotman-Dickenson, B | 1 |
| Ahn, BC; Hong, CM; Jeong, SY; Kang, S; Lee, HJ; Lee, J; Lee, SJ; Lee, SW; Song, BI | 1 |
| Routledge, T; Scarci, M; Sharif, S; Zahid, I | 1 |
| Björo, T; Bogsrud, TV; Hay, ID; Karantanis, D; Kasperbauer, JL; Lowe, VJ; Mullan, BP; Nathan, MA; Reading, CC; Wiseman, GA | 1 |
| Han, A; Xue, J; Yu, J; Yue, J; Zheng, J; Zhu, D | 1 |
| Buecher, B; Deleau, C; des Varannes, SB; Flamant, M; Frampas, E; Galmiche, JP; Kraeber-Bodéré, F; Matysiak-Budnik, T; Rousseau, C | 1 |
| Koyama, M; Murakami, K; Okazumi, S; Shimada, H | 1 |
| Steinert, HC | 3 |
| Herrmann, K; Krause, BJ; Wieder, HA | 1 |
| Delbeke, D; Martin, WH | 2 |
| Campbell, P; Clark, JR; Depcynzski, B; Ho Shon, I; Lin, M; Lin, P; Wong, V | 1 |
| Bannier, M; Bats, AS; Brenot-Rossi, I; Ferron, G; Gauthier, H; Ghazzar, N; Houvenaeghel, G; Leblanc, E; Lecuru, F; Lumbroso, S; Morice, P; Narducci, F; Querleu, D; Uzan, C; Zerdoud, S | 1 |
| Abolmaali, N; Abramyuk, A; Appold, S; Baumann, M; Dörr, W; Hentschel, M; Kotzerke, J; Schreiber, A; Zöphel, K | 1 |
| Bal, C; Julka, PK; Kumar, A; Kumar, R; Malhotra, A; Santra, A; Sharma, P | 1 |
| Doot, RK; Dunnwald, LK; Ellis, GK; Gadi, VK; Gralow, JR; Kurland, BF; Linden, HM; Livingston, RB; Mankoff, DA; Muzi, M; Schubert, EK; Specht, JM | 1 |
| Lang, BH; Law, TT | 1 |
| Kim, IJ; Kim, SJ; Kim, YD; Kim, YK; Kim, YS; Lee, MK | 1 |
| Aldridge, M; Almuhaideb, A; Bomanji, JB; Gaze, MN; Papathanasiou, ND; Sullivan, K; Waddington, W | 1 |
| Fabregat, J; Gamez, C; Lladó, L; Martinez, L; Rafecas, A; Ramos, E; Ruiz, S; Serrano, T; Torras, J; Valls, C | 1 |
| Horky, LL; Treves, ST | 1 |
| Chen, KW; Jiang, RS; Liang, KL; Lin, JC; Lin, WY; Shih, YT; Twu, CW; Wang, WY; Wu, CT | 1 |
| Kato, H; Kikawa, S; Minobe, S; Sakuragi, N; Todo, Y; Yamashiro, K | 1 |
| Cameron, K; Golan, S; Kostakoglu, L; Labow, D; Peti, S; Roayaie, S; Simpson, W | 1 |
| Bilici, A; Cinaral, F; Dogusoy, I; Kefeli, U; Oven Ustaalioglu, BB; Seker, M; Ustaalioglu, R | 1 |
| Akhurst, TJ; Chessin, DB; Guillem, JG; Larson, SM; Leibold, T; Macapinlac, H; Mazumdar, M; Minsky, BD; Paty, PB; Riedel, E; Saltz, LB; Shia, J; Weiser, MR; Wong, WD; Yeung, HW | 1 |
| Kao, YH; Magsombol, BM; Padhy, AK; Saad, U; Tan, AE | 1 |
| Beadsmoore, C; Geropantas, K; Loo, SW; Martin, WM; Montgomery, PQ; Roques, TW | 1 |
| Dianchao, Y; Weian, C; Xiangsong, Z; Xiaoyan, W; Xiongchong, S; Zhifeng, C | 1 |
| Hu, C; Liou, WS; Liu, CB; Liu, RS; Peng, NJ; Tsay, DG | 1 |
| Chan, JY; Chow, VL; Ho, AC; Mok, VW; Wei, WI | 1 |
| Cafarotti, S; Granone, P; Margaritora, S; Porziella, V | 1 |
| Krause, BJ; Lordick, F; Ott, K | 1 |
| Aogi, K; Hara, F; Inoue, T; Kiyoto, S; Ohsumi, S; Takabatake, D; Takahashi, M; Takashima, S | 1 |
| Bang, YJ; Chie, EK; Ha, SW; Han, SW; Im, SA; Jang, JY; Kim, SW; Kim, TY; Lee, YG; Oh, DY | 1 |
| Abgral, R; Cavarec, MB; Le Duc-Pennec, A; Le Roux, PY; Marianovski, R; Nowak, E; Potard, G; Querellou, S; Salaün, PY; Valette, G | 1 |
| Dahele, M; Lagerwaard, F; Palma, D; Senan, S; Slotman, B | 1 |
| Carpentier, P; Kolesnikov-Gauthier, H; Leblond, P; Rocourt, N | 1 |
| Fukuda, H | 1 |
| Hoshikawa, H; Kishino, T; Mori, N; Nishiyama, Y; Yamamoto, Y; Yonezaki, M | 1 |
| Kim, CG; Kim, DW; Park, SA | 1 |
| Bal, C; Julka, PK; Kumar, R; Malhotra, A; Santra, A; Sharma, P | 1 |
| Doki, Y; Fujiwara, Y; Hatazawa, J; Higuchi, I; Miyata, H; Takiguchi, S; Yamasaki, M; Yano, M; Yasuda, T | 1 |
| Bazan, J; Diehn, M; Donington, JS; Graves, EE; Hara, WY; Hoang, CD; Kozak, MM; Le, QT; Loo, BW; Maxim, PG; Murphy, JD; Quon, A; Schipper, ML; Shrager, JB; Wakelee, HA; Whyte, RI; Zhou, L | 1 |
| English, J; Evans, WC; Gilmore, D | 1 |
| Heiss, WD; Lanfermann, H; Raab, P | 1 |
| Ng, DC; Tan, AE | 1 |
| Abbott, RA; Acland, KM; Harries, M; O'Doherty, M | 1 |
| Hatano, E; Higashi, T; Iida, T; Kitamura, K; Nakamoto, Y; Seo, S; Taura, K; Uemoto, S; Yamanaka, K; Yasuchika, K | 1 |
| Castellani, M; Ceriani, L; De Palma, D; Giovanella, L; Suriano, S; Verburg, FA | 1 |
| Guillevin, R; Noël, G | 1 |
| Fukuda, I; Hatanaka, R; Kimura, D; Sakai, T; Tsushima, T; Yamada, Y | 1 |
| Aoki, Y; Fujii, H; Koike, N; Kunieda, E; Ohashi, T; Ozawa, Y; Sanuki, N; Takeda, A; Yokosuka, N | 1 |
| Chen, JH; Jeng, LB; Kao, CH; Liang, JA; Lin, CC; Lin, CY | 1 |
| Ahn, SG; Cho, HJ; Choi, SB; Jeon, TJ; Kim, KS; Kim, SH; Lee, JD; Yun, MJ | 1 |
| Gu, HY; Hu, JN; Hua, J; Wu, LM; Xu, JR; Zhu, J | 1 |
| Erbay, G; Ibis, E; Kucuk, ON; Ozkan, E; Soydal, C | 1 |
| Bodenner, D; Fan, C; Francis, CL; Nalley, C; Stack, BC | 1 |
| Hu, SL; Shi, W; Xu, JY; Yang, ZY; Zhang, YJ; Zhu, BL | 1 |
| Chang, Y; Xiangsong, Z; Xiaoyan, W; Xingchong, S; Zhifeng, C | 1 |
| Dehdashti, F; Grigsby, PW; Schwarz, JK; Siegel, BA | 1 |
| Chang, CF; Gould, MK; Rashtian, A | 1 |
| Hakozaki, K; Iida, S; Ishihara, K; Kiriyama, T; Kumita, S; Murakami, R; Tsuchiya, S; Yanagihara, K; Yoshida, T | 1 |
| Kotek, A; Parlak, C; Pehlivan, B; Topkan, E; Yapar, AF | 1 |
| Kundu, M; Metzger, ML; Otto, M; Sandlund, JT; Shulkin, BL; Snyder, SE | 1 |
| Cheng, J; Pan, L; Yao, Z; Zhang, Y; Zhou, M | 1 |
| Corry, J; Ferlito, A; Grégoire, V; Hamoir, M; Hanin, FX; Machiels, JP; Rinaldo, A; Robbins, KT; Schmitz, S; Silver, CE; Strojan, P; Takes, RP; Thariat, J; Weynand, B | 1 |
| Ichimura, K; Matsuo, T; Yoshino, T | 1 |
| Beswick, DM; Branstetter, BF; Ferris, RL; Gooding, WE; Maxwell, JH; Zhang, I | 1 |
| Bal, C; Jain, SK; Jeph, S; Kumar, R; Malhotra, A; Sharma, DN; Sharma, JB; Sharma, P; Singh, H | 1 |
| Aubard, Y; Fermeaux, V; Genet, D; Leobon, S; Marin, B; Maubon, A; Monteil, J; Renaudie, J; Roux, S; Tubiana-Mathieu, N | 1 |
| Bahnson, EE; Chow, AZ; Gaglani, JR; Hall, NC; Hitchcock, CL; Knopp, MV; Kuhrt, MP; Martin, EW; Mojzisik, CM; Murrey, DA; Povoski, SP | 1 |
| Chung, HH; Chung, JK; Kang, KW; Kang, SB; Kim, JW; Kwon, HW; Park, NH; Song, YS | 1 |
| Aoki, S; Araki, T; Araya, M; Komiyama, T; Kuriyama, K; Maehata, Y; Marino, K; Nambu, A; Oguri, M; Onishi, H; Saito, R; Satoh, Y; Sawada, E; Tominaga, L | 1 |
| Carpentier, P; Kolesnikov-Gauthier, H | 1 |
| Rankin, S | 1 |
| Fujiwara, T; Gobara, H; Harada, S; Hiraki, T; Kaji, M; Kanazawa, S; Mimura, H; Okumura, Y; Sato, S; Suzuki, E | 1 |
| Atsumi, J; Hirato, J; Kakegawa, S; Kamiyoshihara, M; Nakano, T; Nakazawa, S; Shimizu, K; Takeyoshi, I | 1 |
| Bae, JS; Baek, KH; Cha, BY; Kang, MI; Kim, MH; Kim, SH; Ko, SH; Lee, JM; Lee, KW; Lim, DJ; O, JH | 1 |
| Bal, J; Jaimini, A; Jain, J; Kumar, N; Mishra, AK; Mondal, A; Pandey, S; Sharma, R; Souza, MM; Tripathi, M; Varshney, R | 1 |
| Salem, SS; Shahin, MA | 1 |
| de Casso, C; Kane, T; Nigam, A; Soni-Jaiswall, A; Visvanathan, V | 1 |
| Bamias, A; Datseris, IE; Exarhos, D; Panagiotidis, E; Skilakaki, M; Skoura, E | 1 |
| Bhattacharya, A; Kashyap, R; Manohar, K; Mittal, BR; Senthil, R; Singh, G | 1 |
| Bakir, B; Has, D; Iyibozkurt, C; Mudun, A; Ozel, S; Sanli, Y; Topuz, S; Turkmen, C; Unal, SN; Yavuz, E; Yilmaz, E | 1 |
| Araz, M; Ibis, E; Kir, KM; Ozkan, E; Soydal, C | 1 |
| Chowdhury, FU; Culverwell, AD; Scarsbrook, AF | 1 |
| Barrie, M; Bequet-Boucard, C; Chinot, O; Colavolpe, C; Figarella-Branger, D; Guedj, E; Mancini, J; Metellus, P; Mundler, O; Tabouret, E | 1 |
| Blanchard, P; Dumas, I; Haie-Meder, C; Leboulleux, S; Lhomme, C; Mazeron, R; Morice, P; Paumier, A | 1 |
| Clemenceau, S; Ferrand, R; Feuvret, L; George, B; Habrand, JL; Kerrou, K; Lot, G; Mammar, H; Mazure, N; Mokhtari, K; Nataf, V; Polivka, M; Pontvert, D; Pouysségur, J; Talbot, JN | 1 |
| Arrangoiz, R; Cooper, H; Farma, JM; Konski, A; Li, T; Nitzkorski, JR; Shanmugan, S; Sigurdson, ER; Yu, JQ | 1 |
| Bollineni, VR; Langendijk, JA; Pruim, J; Widder, J; Wiegman, EM | 1 |
| Chondrogiannis, S; Evangelista, L; Gross, MD; Laird, AM; Marzola, MC; Moubayed, A; Rubello, D; Wong, KK | 1 |
| Halanaik, D; Kumar, R; Kumari, A; Malhotra, A; Sharma, P | 1 |
| Alexander, HR; Cao, Q; Chen, W; Dilsizian, V; Hausner, PF; Heath, J; Lu, M | 1 |
| Bal, C; Kumar, R; Malhotra, A; Reddy, RM; Sharma, P; Singh, H; Suman K C, S | 1 |
| Marzola, MC; Rubello, D | 1 |
| Bao, L; Cheng, X; Li, D; Li, Y; Wang, J; Xu, Z | 1 |
| Balogova, S; Fartoux, L; Huchet, V; Kerrou, K; Nataf, V; Rosmorduc, O; Talbot, JN | 1 |
| Colavolpe, C; Dessi, P; Fakhry, N; Giovanni, A; Michel, J; Varoquaux, A | 1 |
| Bal, C; Kumar, R; Lata, S; Malhotra, A; Naswa, N; Sharma, P; Suman Kc, S | 1 |
| Ebina, Y; Kita, M; Kitajima, K; Maeda, T; Senda, M; Sugimura, K; Suzuki, K; Ueno, Y; Yamada, H | 1 |
| Baek, S; Chung, EJ; Koh, SH; Ku, YJ; Rho, YS; Seo, YL; Yoon, DY | 1 |
| Allen, PK; Balter, P; Chang, JY; Chuang, HH; Komaki, R; Liu, H; Pan, T; Zhang, X | 1 |
| Chung, HH; Chung, JK; Kang, KW; Kang, SB; Kim, JW; Park, NH; Song, YS | 1 |
| Abgral, R; Barberot, C; Chinellato, S; Garetier, M; Le Bivic, T; Potard, G; Rousset, J; Salaun, PY; Valette, G | 1 |
| Bochev, P; Bocheva, Y; Chaushev, B; Dancheva, J; Ivanov, S; Klisarova, A | 1 |
| Adusumilli, PS; Colovos, C; Dunphy, MP; Kadota, K; Rizk, NP; Rusch, VW; Sima, CS; Suzuki, K; Travis, WD; Yoshizawa, A; Zabor, EC | 1 |
| Alkonyi, B; Bahl, G; Barger, GR; Chakraborty, PK; Chugani, DC; Juhász, C; Kupsky, WJ; Mittal, S; Muzik, O; Robinette, NL | 1 |
| Choi, SH; Kim, JS; Kim, SY; Lee, JH; Nam, SY; Roh, JL; Yi, JS | 1 |
| Asagi, A; Iguchi, H; Inoue, T; Nadano, S; Nasu, J; Nishimura, R; Ohta, K; Tanada, M; Teramoto, N; Yamamoto, K | 1 |
| Botta, F; Botteri, E; De Cicco, C; Di Dia, GA; Fracassi, SL; Gilardi, L; Lombardo, D; Paganelli, G; Prisco, G; Rotmensz, N; Veronesi, U | 1 |
| Doxani, C; Poulou, LS; Thanos, L; Vakrinos, G; Voulgarelis, M; Xyla, V; Ziakas, PD; Ziogas, DC | 1 |
| Haasbeek, CJ; Lagerwaard, FJ; Senan, S; Senthi, S; Slotman, BJ | 1 |
| Costouros, NG; Groome, T; Kashani-Sabet, M; Lee, GO; Leong, SP | 1 |
| Buda, A; Crivellaro, C; De Ponti, E; Dolci, C; Fruscio, R; Guerra, L; Messa, C; Pirovano, C; Signorelli, M; Todde, S | 1 |
| Axelrod, R; Champ, C; Fogh, SE; Intenzo, C; Keane, WM; Kubicek, GJ; Machtay, MM | 1 |
| Aras, G; Araz, M; Ibis, E; Ozkan, E; Soydal, C | 1 |
| Fathinul, F; Lau, WF; Nordin, AJ | 1 |
| Henne-Bruns, D; Hillenbrand, A; Luster, M; Ohlhauser, D; Reske, SN; Weber, T | 1 |
| Scappaticci, AA; Yoo, DC | 1 |
| Berthelsen, AK; Engelholm, SA; Høgdall, C; Høgdall, E; Loft, A; Lundvall, L; Nedergaard, L; Risum, S | 1 |
| Akkas, BE; Ucmak Vural, G | 1 |
| Goichot, B; Hubele, F; Imperiale, A; Rust, E; Taieb, D; Taquet, MC; Veillon, F | 1 |
| Gallowitsch, HJ; Malle, P; Sorschag, M | 1 |
| Abgral, R; Gouders, D; Keromnes, N; Le Roux, PY; Leleu, C; Mollon, D; Nowak, E; Querellou, S; Rousset, J; Salaün, PY; Valette, G | 1 |
| Wiggins, RH; Zollinger, LV | 1 |
| Funk, GF | 1 |
| Kawakami, Y; Kenzaki, K; Kondo, K; Otsuka, H; Sakiyama, S; Takizawa, H; Tangoku, A; Toba, H | 1 |
| Carrington, BM; Kochhar, R; Plumb, AA; Saunders, M | 1 |
| Ambrosini, V; Castaldi, P; Cremonini, N; Fanti, S; Filice, A; Giordano, A; Perotti, G; Rufini, V; Treglia, G; Versari, A; Villani, MF | 1 |
| Chang, JY; Cox, JD; Erasmus, J; Komaki, R; Xiang, ZL | 1 |
| Fujita, H; Minatani, Y; Miyagaki, T; Ohmatsu, H; Ohno, Y; Sato, S; Sugaya, M; Sumida, H; Uwajima, Y; Yamashita, H | 1 |
| Lai, CH; Ng, KK; Yen, TC | 1 |
| Dennis, K; Hay, JH; Wilson, DC | 1 |
| Basu, S; Kembhavi, S | 1 |
| Gerrard, G; Patel, CN; Prestwich, RJ; Scarsbrook, AF; Viner, S | 1 |
| Clark, OH; Duh, QY; Gosnell, J; Guerrero, MA; Munoz-Perez, N; Rinkes, IH; Schreinemakers, JM; Shen, WT; Suh, I; Vriens, MR | 1 |
| Kochhar, R; Liong, SY; Manoharan, P; Renehan, AG | 1 |
| Cioc, AM; Dvorak, LA; Hart, MK; Jessurun, J; Pambuccian, SE; Schmechel, SC | 1 |
| Krajewski, KM; Ramaiya, N; Saboo, SS; Shinagare, AB; Zukotynski, K | 1 |
| Almeida, LY; Almeida, OP; Feio, Pdo S; Gomes, CB; León, JE; Nogueira, AS; Soares, FA; Vassallo, J | 1 |
| Baretta, Z; Bezzon, E; Cervino, AR; De Carolis, V; Evangelista, L; Ghiotto, C; Gregianin, M; Muzzio, PC; Pomerri, F; Saladini, G; Vinante, L | 1 |
| Choi, KY; Kang, WK; Kim, JS; Kim, SH; Kim, SW; Lee, JE; Oh, ST; Yoo, IeR | 1 |
| Aloj, L; Avallone, A; Budillon, A; Caracò, C; Casaretti, R; Delrio, P; Di Gennaro, F; Lastoria, S; Montano, M; Pecori, B; Scott, N; Silvestro, L; Tatangelo, F | 1 |
| Belka, C; Büsing, K; Eigenbrod, S; Ganswindt, U; Geisler, J; Jansen, N; la Fougère, C; Niyazi, M; Schnell, O; Schwarz, SB | 1 |
| Casanova, N; Imperiano, H; Miralbell, R; Popowski, Y; Ratib, O; Vees, H; Wang, H; Zaidi, H; Zilli, T | 1 |
| Ferrari, C; Losco, M; Niccoli Asabella, A; Nicoletti, A; Rubini, D; Rubini, G | 1 |
| Han, SS; Kim, C; Kim, SH; Kim, SK; Kim, YK; Lee, SD; Park, SJ | 1 |
| Ben-Arush, M; Ben-Barak, A; Ilivitzki, A; Israel, O; Radan, L | 1 |
| Aghi, MK; El-Sayed, IH; Jahangiri, A; Jian, B; Miller, L | 1 |
| Chen, W; Chen, Z; Liang, H; Rao, L; Shi, X; Wang, X; Yi, C; Zhang, X | 1 |
| Espié, M; Giacchetti, S; Groheux, D; Hindié, E | 1 |
| Baik, SH; Hur, H; Kang, J; Kim, H; Kim, NK; Lee, KY; Min, BS; Sohn, SK | 1 |
| Al-Ibraheem, A; Beer, AJ; Benz, MR; Buck, AK; Haller, B; Herrmann, K; Juenger, H; Mansour, A; Pomykala, KL; Rudert, M; Scheidhauer, K; Schwaiger, M | 1 |
| Capitain, O; Cellier, P; Denis, F; Girault, S; Hamy, A; Mahé, MA; Mesgouez-Nebout, N; Paumier, A; Poirier, AL; Rousseau, D | 1 |
| Blake, MA; Cronin, CG; McDermott, S; O'Connor, OJ; Prakash, P | 1 |
| Anaissie, E; Barlogie, B; Bartel, T; Brown, T; Crowley, J; Hoering, A; Mitchell, A; Petty, N; Usmani, SZ; van Rhee, F; Waheed, S | 1 |
| Chen, SA; Godette, K; Liu, T; Mister, D; Schuster, DM; Torres, MA | 1 |
| Kahr, HS; Lund, B; Mejlgaard, E | 1 |
| Andikyan, V; Burger, IA; Chi, DS; Donati, OF; Goldman, DA; Gonen, M; Hricak, H; Sala, E; Schöder, H; Vargas, HA | 1 |
| Crucitti, A; Giordano, A; Grossi, U; Leccisotti, L; Maggi, F; Mazzari, A; Ricci, R; Tomaiuolo, PM | 1 |
| Detry, R; Gigot, JF; Kartheuser, A; Lonneux, M; Pauwels, S; Reffad, AM | 1 |
| Carreras, JL; Domper, M; Jiménez, A; Montz, R; Pérez-Castejón, MJ; Ruiz, G; Suárez, M | 1 |
| Belhocine, T; Foidart, J; Hustinx, R; Najjar, F; Quatresooz, P; Rigo, P; Thiry, A | 1 |
| Huang, H; Lang, J; Pan, L; Shen, K; Wu, M; Zhu, X | 1 |
| Byun, JY; Cho, SM; Ha, HK; Kim, CJ; Lee, JM; Nam-Koong, SE | 1 |
| Delbeke, D; Vitola, J | 1 |
| Abella-Columna, E; Valk, PE | 1 |
| Lowe, VJ; Stack, BC | 1 |
| Dehdashti, F; Siegel, BA | 2 |
| Bongers, V; Hobbelink, MG; Hordijk, GJ; van Rijk, PP | 1 |
| Aufschnaiter, M; Heinisch, M; Jörg, L; Langsteger, W; Panholzer, PJ; Rechberger, E; Sega, W; Tausch, C; Wieser, B | 1 |
| Kresnik, E | 1 |
| Jörg, L; Langsteger, W | 1 |
| Alavi, A; Bhargava, P; Hickeson, M; Zhuang, H | 1 |
| Bender, LW; Francisco, R; Ojha, B; Scott, JW | 1 |
| Cheng, KY; Kao, CH; Lin, WY; Tsai, SC; Yen, RF | 1 |
| Chen, T; Hayashi, K; Kaneko, K; Koga, H; Kuwabara, Y; Masuda, K; Nakagawa, M; Nakamura, K; Sasaki, M | 1 |
| Bruns, J; Dobrowolskij, D; Jenicke, L; Niggemeyer, O | 1 |
| Kao, CH; Lin, CC; Liu, CS; Shen, YY; Yen, RF | 1 |
| Becherer, A; Hoffmann, M; Kletter, K; Oberhuber, G; Raderer, M | 1 |
| Carrió, I; Castellucci, P; Costansa, JM; Doménech-Torné, F; Lomeña, F; Pérez, G; Setoain, J; Setoain-Quinquer, J; Simó, M | 1 |
| Gonen, M; Kraus, DH; Larson, SM; Lin, DT; Patel, SG; Pfister, DG; Schöder, H; Shah, JP; Wolden, S; Wong, RJ | 1 |
| Bredella, MA; Caputo, GR; Steinbach, LS | 1 |
| Brouwers, AH; Mulders, PF; Oyen, WJ; Steffens, MG | 1 |
| Colombet-Lamau, C; De Beco, V; Grahek, D; Kerrou, K; Mabille, L; Montravers, F; Petegnief, Y; Talbot, JN; Younsi, N; Zerbib, E | 1 |
| Corstens, FH; Jager, GJ; Langenhoff, BS; Oyen, WJ; Ruers, TJ; Strijk, SP; Wobbes, T | 1 |
| Chin, BB; Cohade, C; Patel, PV | 1 |
| Belohlávek, O; Kantorová, I; Liscák, R; Novotný, J; Simonová, G | 1 |
| Di Martino, E; Gagel, B; Hausmann, R; Krombach, GA; Nowak, B; Tietze, L; Westhofen, M; Zimny, M | 1 |
| Beguin, Y; Belhocine, T; Fassotte, MF; Fillet, G; Hustinx, R; Jerusalem, G; Rigo, P | 1 |
| Brinkbaeumer, K; Dresel, S; Hahn, K; Hautmann, H; Kellner, W; Moisseev, A; Poellinger, B; Schmid, RA; Weiss, M | 1 |
| Fujibayashi, Y; Kawahara, K; Kotsuji, F; Kurokawa, T; Tsuchida, T; Yonekura, Y; Yoshida, Y | 1 |
| Bingham, JB | 1 |
| Maisey, MN | 1 |
| Maisey, MN; O'doherty, MJ; Shon, IH | 1 |
| Ackermann, R; Coenen, HH; Hautzel, H; Herzog, H; Krause, BJ; Müller-Gärtner, HW; Müller-Mattheis, V; Roden, W | 1 |
| Siggelkow, W; Zimny, M | 1 |
| Dimitrakopoulou-Strauss, A; Kontaxakis, G; Pavlopoulos, S; Santos, A; Strauss, LG; Thireou, T | 2 |
| Chen, LH; Wu, DH | 1 |
| Bergh, S; Boerner, AR; Brunkhorst, T; Fricke, E; Hofmann, M; Karstens, JH; Knapp, WH; Machtens, S; Meyer, GJ; van den Hoff, J | 1 |
| Bachmann, LM; Goerres, GW; Mosna-Firlejczyk, K; Steurer, J; von Schulthess, GK | 1 |
| Alavi, A; Anderson, GS; Brinkmann, F; Soulen, MC; Zhuang, H | 1 |
| Higashiyama, S; Inoue, Y; Ishizu, H; Kawabe, J; Kawamura, E; Koyama, K; Okamura, T; Shiomi, S; Torii, K | 1 |
| Bascom, D; Fukui, M; Johnson, JT; McCook, B; Meltzer, C; Snyderman, C; Townsend, DW; Zimmer, LA | 1 |
| Dehdashti, F; Grigsby, PW; Mutch, DG; Siegel, BA | 1 |
| Alavi, A; Hickeson, M; Lau, C; Rebenstock, A; Zhuang, H | 1 |
| Nguyen, BD | 1 |
| Choi, CW; Choi, SC; Kim, MH; Lee, KH; Ryu, SY | 1 |
| Conti, PS; Garcia, AA; Jadvar, H; Tatlidil, R | 1 |
| Chapman, WC; Delbeke, D; Morris, D; Pinson, CW; Rice, M; Shyr, Y; Washington, MK; Wudel, LJ | 1 |
| Chander, S; Lay Ergun, E; Shields, AF | 1 |
| Dehdashti, F; Grigsby, PW; Lewis, JS; Mintun, MA; Siegel, BA; Welch, MJ | 1 |
| Bredow, J; Franke, WG; Grüning, T; Kropp, J; Tiepolt, C; Zöphel, K | 1 |
| Gallowitsch, HJ; Kresnik, E; Lind, P; Mikosch, P; Würtz, FG | 1 |
| Andriole, GL; Dehdashti, F; Fischer, KC; Kibel, AS; Michalski, JM; Miller, TR; Oyama, N; Picus, J; Siegel, BA; Welch, MJ | 1 |
| Guo, J; Higashi, K; Ikeda, R; Matsunari, I; Oguchi, M; Tonami, H; Ueda, Y; Yamamoto, I | 1 |
| Fehr, MK; Goerres, GW; Kamel, EM; von Schulthess, GK; Wyss, MT | 1 |
| Dimitrakopoulou-Strauss, A; Rudi, J; Strauss, LG | 1 |
| Fukuda, H; Ido, T; Kanamaru, R; Kubota, K; Saginoya, T; Takahashi, H; Yamaguchi, K; Yamaura, G; Yamazaki, T; Yoshioka, T | 1 |
| Brinkbäumer, K; Dresel, S; Grammerstorff, J; Hahn, K; Pfluger, T; Schmid, R; Schwenzer, K | 1 |
| Bourguet, P | 3 |
| Gallowitsch, HJ; Gasser, J; Igerc, I; Kresnik, E; Kumnig, G; Lind, P; Mikosch, P | 1 |
| Gerbaudo, VH | 1 |
| Bohuslavizki, KH; Brenner, W; Eary, JF | 1 |
| Berchuck, A; Clarke-Pearson, DL; Havrilesky, LJ; Jones, EL; Secord, AA; Wong, TZ | 1 |
| Akhurst, T; Guillem, JG; Larson, SM; Mazumdar, M; Minsky, BD; Moore, HG | 1 |
| Fehr, MK; Goerres, GW; Kaim, AH; Kubik-Huch, RA; Michel, SC; Seifert, B; Steinert, HC; von Schulthess, GK | 1 |
| Futatsubashi, M; Kanno, T; Maeda, M; Nakamura, F; Okada, H; Ouchi, Y; Takekuma, M; Torizuka, T; Yoshikawa, E | 1 |
| Fujii, S; Fujita, T; Higashi, T; Higuchi, T; Ishimori, T; Kita, M; Konishi, J; Mamede, M; Mukai, T; Nakamoto, Y; Saga, T; Togashi, K; Yura, S | 1 |
| Aletti, G; De Cobelli, F; De Marzi, P; Del Maschio, A; Fazio, F; Ferrari, A; Gianolli, L; Landoni, C; Mangili, G; Messa, C; Picchio, M; Sironi, S; Viganò, R; Zangheri, B | 1 |
| Huang, KM; Hung, RL; Kao, CH; Lui, LT; Pan, MH; Wang, YH; Yen, RF | 1 |
| Adler, LP; Israel-Mardirosian, N | 1 |
| Blodgett, TM; Fukui, MB; Meltzer, CC | 1 |
| Chun, H; Kim, CK; Krynckyi, BR; Machac, J | 1 |
| Bénard, F; Guay, C; Lépine, M; Verreault, J | 1 |
| Cuocolo, A; Giuliani, A; Mainolfi, C; Maurea, S; Sciaudone, G; Selvaggi, F | 1 |
| Cohen, O; Goshen, E; Karasik, A; Oksman, Y; Rotenberg, G; Zwas, ST | 1 |
| Eyrich, GK; Grätz, K; Hugenin, P; Sigg, MB; Steinert, H; Stoeckli, S | 1 |
| Hurwitz, R | 1 |
| Dehdashti, F; Grigsby, PW; Herzog, TJ; Siegel, BA; Tran, BN | 1 |
| Alavi, A; Chiang, SB; Johnson, GR; Khan, J; Zhuang, H | 1 |
| Endo, K; Higuchi, T; Khan, N; Oriuchi, N; Zhang, H | 1 |
| Borson-Chazot, F; Bournaud, C; Desuzinges, C; Giammarile, F; Hafdi, Z; Houzard, C; Itti, R; Janier, M; Sassolas, G | 1 |
| Döbert, N; Grünwald, F; Hamscho, N; Kovács, AF; Menzel, C; Podda, M; Wolter, M | 1 |
| Ham, H; Loose, D; Otte, A; Van de Wiele, C; Vermeersch, H | 1 |
| Uno, K | 1 |
| Albani, JM; Bukowski, RM; Elson, P; Kanvinde, MH; Majhail, NS; Mekhail, TM; Novick, AC; Olencki, TE; Rice, TW; Urbain, JL | 1 |
| Bartenstein, P; Benz, P; Förster, GJ; Jeong, JH; Kunkel, M; Reichert, TE; Wagner, W; Whiteside, TL | 1 |
| Fukunaga, H; Hosokawa, K; Ikeda, M; Ikenaga, M; Monden, M; Nakai, K; Ohue, M; Sekimoto, M; Yamamoto, H; Yano, K | 1 |
| Fukunaga, H; Hata, Y; Higuchi, I; Hujie, Y; Ikeda, M; Ikenaga, M; Kitani, K; Monden, M; Ohue, M; Seki, Y; Sekimoto, M; Takayama, H; Yamamoto, H; Yasui, M | 1 |
| Hata, M; Inoue, T; Kinbara, K; Koike, I; Lee, J; Ogino, I; Ohmura, M; Oka, T; Ozawa, Y; Takahashi, N; Umezawa, T; Watai, K | 1 |
| Britz-Cunningham, S; Gerbaudo, VH; Sugarbaker, DJ; Treves, ST | 1 |
| Bartenstein, P; Helisch, A; Kunkel, M; Reichert, TE; Wagner, W | 1 |
| DePeri, ER; McDonough, MD; Mincey, BA | 1 |
| Berlangieri, SU; Ollenberger, GP | 1 |
| Barrington, SF; Leslie, MD; Plunkett, TA; Tutt, AN | 1 |
| Even-Sapir, E; Figer, A; Gutman, M; Lerman, H; Livshitz, G; Miller, E | 1 |
| Aide, N; Balogova, S; Grahek, D; Jacob, T; Kerrou, K; Montravers, F; Talbot, JN; Younsi, N | 1 |
| Bares, R; Bokemeyer, C; Claussen, CD; Dohmen, BM; Kollmannsberger, C; Oechsle, K; Pfannenberg, AC; Vontheim, R | 1 |
| Cui, RX; Zhou, Q | 1 |
| Chin, BB; Cohade, C; Ewertz, M; Ladenson, P; Patel, P; Wahl, R | 1 |
| Kawahara, K; Naito, A; Nishio, M; Tamaki, T | 1 |
| Fukuda, H; Itoh, M; Kubota, K; Ono, S; Qureshy, A; Yamaguchi, K; Yokoyama, J | 1 |
| Gayed, I; Iyer, R; Johnson, M; Macapinlac, H; Podoloff, D; Swanston, N; Vu, T | 1 |
| Chen, JT; Chen, WJ; Hsueh, S; Lai, CH; Lai, CR; Lin, WJ; Ma, SY; Ng, KK; See, LC; Yah-Huei, CW; Yen, TC | 1 |
| Delbeke, D; Martin, WH; Scanga, DR | 1 |
| Larson, SM; Schöder, H; Yeung, HW | 1 |
| Al-Nahhas, AM | 1 |
| Dietz, A; Dollner, R; Harms, W; Henze, M; Jungehülsing, M; Rudat, V | 1 |
| Hudson, MM; Kaste, SC; Krasin, MJ | 1 |
| Chang, TC; Chou, HH; Hong, JH; Hsueh, S; Huang, KG; Lai, CH; Ng, KK; See, LC; Tsai, CS; Yen, TC | 1 |
| Chin, BB; Hammoud, D; Patel, P | 1 |
| Donckier, V; Feron, P; Gelin, M; Goldman, S; Ickx, B; Van Gansbeke, D; Van Laethem, JL; Wikler, D | 1 |
| Carp, L; De Beeck, BO; Tjalma, WA | 1 |
| Cobben, DC; Elsinga, PH; Hoekstra, HJ; Jager, PL; Maas, B; Suurmeijer, AJ; Vaalburg, W; van der Laan, BF | 1 |
| Inoue, T; Noguchi, S; Shiba, E; Taguchi, T; Tamaki, Y; Yutani, K | 1 |
| De Santis, M; Pont, J | 1 |
| Baillet, G; Moretti, JL; Tamgac, F; Tofighi, M; Weinmann, P | 1 |
| Arulampalam, TH; Costa, DC; Croasdale, I; Ell, PJ; Francis, DL; Luthra, SK; Taylor, I; Visvikis, D | 1 |
| Boán, JF; Redondo, P | 1 |
| Koumanis, DJ; Meterissian, S; Tzimas, GN | 1 |
| Debus, J; Eisenhut, M; Haberkorn, U; Haufe, S; Henze, M; Herfarth, KK; Hoffner, S; Mier, W; Mohammed, A; Schlemmer, HP | 1 |
| Greven, KM | 1 |
| Cistaro, A; Fazio, F; Giraldi, E; Landoni, C; Messa, C; Provenzi, M; Sironi, S; Sonzogni, A | 1 |
| Daraï, E; Dormont, D; Madelenat, P; Zylberberg, B | 1 |
| Chung, JK; Jeong, JM; Kang, SB; Kim, MH; Kim, S; Lee, DS; Lee, MC | 1 |
| Aide, N; Grahek, D; Kerrou, K; Lotz, JP; Montravers, F; Talbot, JN | 1 |
| Buell, U; Rath, W; Siggelkow, W; Zimny, M | 1 |
| Colombet-Lamau, C; de Beco, V; Grahek, D; Kerrou, K; Montravers, F; Petegnief, Y; Talbot, JN; Younsi, N | 1 |
| Alavi, A; Talati, E; Xiu, Y; Yu, JQ; Zhuang, H | 1 |
| Dehdashti, F; Grigsby, PW; Rader, J; Siegel, BA; Zoberi, I | 1 |
| Flamen, P | 2 |
| Bloom, DA; Chander, S; Getzen, TM; Joyrich, RN; Littrup, PJ; Taub, JW; Westphal, SM; Zak, IT; Zingas, AP | 1 |
| Coebergh, JW; Hoekstra, OS; van de Poll-Franse, LV; van der Hoeven, JJ; van Oost, FJ; Voogd, AC | 1 |
| Chang, WC; Hung, YC; Kao, CH; Lin, CC; Shen, YY | 1 |
| Dietlein, M; Eschner, W; Jungehülsing, M; Schicha, H; Schmalenbach, M; Schmidt, M; Schröder, U; Stennert, E; Theissen, P | 1 |
| Bar-Shalom, R; Israel, O; Keidar, Z | 1 |
| Schöder, H; Yeung, HW | 1 |
| Eubank, WB; Mankoff, DA | 3 |
| Chang, TC; Chang, YC; Chao, A; Chen, MY; Chou, HH; Hong, JH; Hsueh, S; Huang, KG; Lai, CH; Law, KS; Lin, CT; Liou, JD; Ma, SY; Ng, KK; See, LC; Tsai, CS; Wu, TI; Yen, TC | 1 |
| Ampil, FL; Charrier, A; Connor, P; Ivy, JJ; Monsour, RP; Ramaswamy, MR; Unger, JB | 1 |
| Austin-Seymour, M; Bhattacharya, M; Ellis, G; Eubank, WB; Gralow, J; Linden, H; Lindsley, S; Livingston, R; Mankoff, D | 1 |
| Oyen, WJ; Ruers, TJ; Wiering, B | 1 |
| Helmberger, T; Linke, R; Schroeder, M; Voltz, R | 1 |
| Fukuchi, M; Kato, H; Kuwano, H; Manda, R; Miyazaki, T; Nakajima, M | 1 |
| Alavi, A; Chiang, S; Fuster, D; Johnson, G; Schuchter, LM; Zhuang, H | 1 |
| Reiman, RE | 1 |
| Bormans, G; Ceyssens, S; de Groot, T; Flamen, P; Menten, J; Mortelmans, L; Van Calenbergh, F; Van Laere, K | 1 |
| Graves, A; Hutchins, EB; Shelton, B | 1 |
| Halkar, RK; Schuster, DM | 1 |
| Dooms, C; Fischer, BM; Mortensen, J; Vansteenkiste, J | 1 |
| Alberti, W; Beck-Bornholdt, HP; Buchert, R; De Wit, M; Hossfeld, DK; Raabe, A; Seegers, B | 1 |
| Canessa, JA; Galaz, R; González, P; Humeres, P; Jofré, J; Larach, JA; Massardo, T; Morales, B; Parra, J; Sierralta, P | 1 |
| Bar-Shalom, R; Ben-Nun, A; Guralnik, L; Haim, N; Israel, O; Keidar, Z; Wollner, M | 1 |
| Chang, TC; Chang, YC; Chao, A; Fan, CC; Fu, YK; Hong, JH; Hsueh, S; Huang, KG; Lai, CH; Lin, CT; Lin, WJ; Ma, SY; Ng, KK; See, LC; Tang, SG; Tsai, CS; Yen, TC | 1 |
| Chan, SC; Chang, YC; Fu, YK; Joseph, CT; Ko, SF; Liao, CT; Lin, WJ; Ng, SH; Wang, HM; Yen, TC | 1 |
| Alavi, A; Kumar, R; Mandel, S; Zhuang, H | 1 |
| Alavi, A; Kumar, R | 1 |
| Friedman, KP; Wahl, RL | 1 |
| Conti, PS; Gamie, S; Jadvar, H; Ramanna, L | 1 |
| Larson, SM; Schöder, H | 1 |
| Berkhof, J; Hoekstra, OS; Hooft, L; Molthoff, CF; Teule, GJ; van der Veldt, AA; van Diest, PJ | 1 |
| Biersack, HJ; Jaeger, U; Palmedo, H; Reichmann, K; Reinhardt, MJ; Rödel, R; Straehler-Pohl, HJ | 1 |
| Rummeny, E; Schwaiger, M; Stollfuss, J; Wieder, H | 1 |
| Alavi, A; Dadparvar, S; Dhurairaj, T; Kumar, R; Mavi, A; Potenta, S; Xiu, Y; Yu, JQ; Zhuang, H | 1 |
| Aguzzi, A; Buck, A; Hermann, DM; Kaser-Hotz, B; Lutz, A; Pahnke, J; Radovanovic, I; Scheidegger, S; Spaeth, N; Verwey, J; Weber, B; Weishaupt, D; Westera, G; Wild, D; Wyss, MT | 1 |
| Dai, JZ; Dong, MJ; Guan, YH; Lin, XT; Yu, DF; Zhao, J; Zuo, CT | 1 |
| Clavien, PA; Hany, TF; Kadry, Z; McCormack, L; Selzner, M; Wildbrett, P | 1 |
| Bar-Shalom, R; Epelbaum, R; Gaitini, D; Guralnik, L; Hermoni, N; Israel, O; Keidar, Z; Mor, M | 1 |
| Barranger, E; Cortez, A; Daraï, E; David-Montefiore, E; Kerrou, K; Petegnief, Y | 1 |
| Buatti, JM; Dornfeld, KJ; Funk, GF; Graham, MM; Graham, SM; Hoffman, HT; Menda, Y; Skwarchuk, M; Smith, RB; Yao, M | 1 |
| Kula, Z; Pietrzak, T; Romanowicz, G; Szefer, J; Zuchora, Z | 1 |
| Ball, DL; Hicks, RJ; Manus, MP; Rischin, D; Roberts, KB; Wirth, A; Wright, GM | 1 |
| Hain, SF | 1 |
| Choi, SJ; Kim, HT; Park, YH; Ryoo, BY | 1 |
| Fukui, MB; Kapoor, V; McCook, BM | 1 |
| Alavi, A; Hustinx, R; Kaschten, B; Pourdehnad, M | 1 |
| Blokhuis, TJ; Comans, EF; Manoliu, RA; van den Tol, MP; van der Schaaf, MC; van der Sijp, JR | 1 |
| Farag, I; Hain, SF; Jones, J; McGurk, M | 1 |
| Goldman, S; Levivier, M; Massager, N; Wikler, D | 1 |
| Boethius, J; Hautanen, K; Kraepelien, T; Lippitz, BE; Rähn, T; Ritzling, M; Ulfarsson, E | 1 |
| Dietl, B; Marienhagen, J | 1 |
| Kraus, DH; Kutler, DI; Wong, RJ | 1 |
| Allen, P; Cox, JD; Erasmus, J; Forster, K; Herbst, RS; Komaki, R; Macapinlac, H; Moran, CA; Podoloff, DA; Putnam, JB; Roth, JA; Sasaki, R | 1 |
| Lewis, PJ; Siegel, A; Siepmann, DB | 1 |
| Cho, SB; Chung, KY; Lee, MG; Roh, MR; Yun, M; Yun, SK | 1 |
| Chan, SC; Chang, JT; Chang, YC; Fu, YK; Lin, CY; Lin, KJ; Lin, WJ; Ng, SH; Yen, TC | 1 |
| Gambhir, SS; Quon, A | 1 |
| Havrilesky, LJ; Kulasingam, SL; Matchar, DB; Myers, ER | 1 |
| Blaufox, MD; Isasi, CR; Moadel, RM | 1 |
| Lonneux, M | 2 |
| Fee, WE; Le, QT; Pinto, HA; Ryan, WR | 1 |
| Allen-Auerbach, MS; Czernin, J; Fueger, BJ; Halpern, BS; Hecht, JR; Kim, JH; Phelps, ME; Ratib, O; Weber, WA | 1 |
| Hung, GU; Lin, WY; Tsai, SC | 2 |
| Celsing, F; Jacobsson, H; Siösteen, AK | 1 |
| Howman-Giles, R; McCowage, G; Philip, I; Shun, A | 1 |
| Amthauer, H; Felix, R; Lopez Hänninen, E; Oettle, H; Pelzer, U; Plotkin, M; Ruf, J; Stroszczynski, C | 1 |
| Blodgett, TM; Branstetter, BF; Johnson, JT; Meltzer, CC; Raman, S; Snyderman, CH; Zimmer, LA | 1 |
| Antoch, G; Bockisch, A; Forsting, M; Kuehl, H; Stergar, H; Veit, P | 1 |
| Chen, TH; Hong, RL; Pan, MH; Tzen, KY; Yen, RF | 1 |
| Fukunaga, H; Hatazawa, J; Higuchi, I; Ikeda, M; Ikenaga, M; Monden, M; Nishimura, T; Ohue, M; Sekimoto, M; Seshimo, I; Takayama, O; Tatsumi, M; Yamamoto, H; Yasui, M | 1 |
| Kim, MW; Lee, NR; Lim, ST; Sohn, MH; Song, EK; Yim, CY | 1 |
| De Iaco, P; Erba, P; Fanti, S; Farsad, M; Mariani, G; Nanni, C; Rampin, L; Rubello, D; Sansovini, M | 1 |
| Coppage, L; Hazelton, TR | 1 |
| Ng, DC; Ong, SC; Sundram, FX | 1 |
| Choi, MY; Chung, JK; Jeong, JM; Kim, JH; Lee, DS; Lee, KM; Lee, MC; Park, JG | 1 |
| Endo, K; Higuchi, T; Kanuma, T; Khan, N; Oriuchi, N; Yoshizaki, A | 1 |
| De Giorgi, U; Fiorentini, G; Marangolo, M; Pupi, A; Rosti, G | 1 |
| Barranger, E; Daraï, E; Grahek, D; Talbot, JN; Uzan, S | 1 |
| Bong, JK; Choi, HS; Lee, JD; Ryu, YH; Yoo, E; Yun, M | 1 |
| Chen, TH; Hong, RL; Pan, MH; Ting, LL; Tzen, KY; Yen, RF | 1 |
| Bénard, F; Turcotte, E | 1 |
| Bentzen, SM; Boersma, L; Buell, U; De Ruysscher, D; Dohmen, J; Geeraedts, W; Hochstenbag, M; Lambin, P; Minken, A; Rhami, A; Simons, J; Snoep, G; Thimister, P; Utama, I; van Baardwijk, A; van Haren, E; Verschueren, T; Wanders, S | 1 |
| Maeda, M; Ozawa, T; Takekuma, M; Torizuka, T; Yasumi, K | 1 |
| Changchien, CR; Chen, JS; Ho, KC; Liu, FY; Liu, SH; Yeh, CY; Yen, TC | 1 |
| Bristow, RE; Díaz-Montes, TP; Jacene, HA; Wahl, RL | 1 |
| Baehre, M; Gerl, J; Horstmann, O; Meller, B; Meller, J; Sahlmann, C | 1 |
| Eberhard, S; Gönen, M; Herrmann, K; Hricak, H; Larson, SM; Scardino, P; Scher, HI; Schöder, H | 1 |
| Ezuddin, S; Fragkaki, C | 1 |
| de Klerk, JM; Quarles van Ufford, HM; van Herk, G; van Waes, PF; Zoon, PJ | 1 |
| Goshen, E; Oksman, Y; Rotenberg, G; Talmi, YP; Yahalom, R; Zwas, ST | 1 |
| Macapinlac, HA | 2 |
| Chang, TC; Chen, MY; Lai, CH; Ma, SY; Ng, KK; Wu, TI | 1 |
| Graeter, TP; Gröschel, A; Hellwig, AP; Hellwig, D; Kirsch, CM; Nestle, U; Schäfers, HJ; Sybrecht, GW | 1 |
| Chang, TC; Chao, A; Chou, HH; Hsueh, S; Huang, HJ; Lai, CH; Ng, KK; Tsai, CS; Wu, TI; Yen, TC | 1 |
| Figarola, MS; McQuiston, SA; Powell, R; Wilson, F | 1 |
| Döbert, N; Engels, K; Grünwald, F; Hamscho, N; Kovács, AF; Menzel, C; Walendzik, H; Yuen Yuen, H | 1 |
| Klinkenbijl, JH; Landheer, ML; Oyen, WJ; Steffens, MG; Westenberg, AH | 1 |
| Momose, T | 1 |
| Hasegawa, M; Ishikawa, H; Katoh, H; Kiyohara, H; Nakano, T; Nakayama, Y; Nonaka, T; Sakurai, H; Shioya, M; Suzuki, Y | 1 |
| Amit, A; Bar Shalom, R; Beck, D; Israel, O; Kedar, Z; Lavie, O; Lowenstein, L | 1 |
| Gor, DM; Langer, JE; Loevner, LA | 1 |
| Akhurst, T; Chessin, DB; Guillem, JG; Kiran, RP | 1 |
| Butrynski, JE; Conrad, EU; Eary, JF; Hawkins, DS; Rajendran, JG; Schuetze, SM; Vernon, CB | 1 |
| Jager, GJ; Krabbe, PF; Oyen, WJ; Ruers, TJ; Wiering, B | 1 |
| Franc, BL; Johnson, D; Leong, SP; Mari, C | 1 |
| Ciernik, IF; Eyrich, GK; Goerres, GW; Schuknecht, B; Stoeckli, SJ; Wild, D | 1 |
| Cheng, DW; Cooper, DL; Kuo, PH | 1 |
| Chen, LH; Ding, Y; Wu, DH | 1 |
| Alavi, A; Bhutain, C; Chamroonrat, W; El-Haddad, G; Houseni, M; Mavi, A; Zhuang, H | 1 |
| Drummond, EG; Duong, C; Hicks, RJ; Kalff, V; Matthews, JP | 1 |
| Gong, HY; Yu, JM | 1 |
| Alberini, JL; Collignon, MA; Corone, C; Gutman, F; Pecking, AP; Pichon, MF; Rouëssé, J; Wartski, M | 1 |
| Cheson, BD; Juweid, ME | 1 |
| Erturk, SM; Fujii, H; Ichikawa, T; Ros, PR; Yasuda, S | 1 |
| Sarbia, M; Stein, HJ; von Rahden, BH | 1 |
| Coche, E; Daumerie, C; De Nayer, P; Godart, V; Weynand, B | 1 |
| Boethius, J; Ericson, K; Wang, SX | 1 |
| Esteves, FP; Halkar, RK; Schuster, DM | 1 |
| Kubo, A; Suzuki, T; Uno, K | 1 |
| Haug, AR; Reiser, MF; Schmidt, GP; Schoenberg, SO | 1 |
| Aschoff, P; Bihl, H; Hagen, R; Schneider, K | 1 |
| Kraus, DH; Kutler, DI; Schoder, H; Wong, RJ | 1 |
| Guest, P; Isaac, J; John, A; Khan, S; Mirza, DF; Singhvi, S; Tan, YM | 1 |
| Driedger, AA; McDonald, T; Pavlosky, W; Saab, G; Urbain, JL; Wong, CY; Yoo, J | 1 |
| Chung, HH; Kang, KW; Kim, JY; Kim, SK; Kim, TH; Lee, S; Park, SY | 1 |
| Biersack, HJ; Bucerius, J; Hortling, N; Jaeger, U; Joe, A; Meyka, S; Palmedo, H; Roedel, R; Strunk, H; Wardelmann, E; Wolff, M | 1 |
| Inoue, K; Inoue, Y; Koyama, K; Matsuoka, T; Nakamura, K; Okamura, T; Okuma, T; Oyama, Y; Toyoshima, M; Yamamoto, A | 1 |
| Biswal, S; Do, B; Gambhir, SS; Kalinyak, J; Mari, C; Quon, A | 1 |
| Alvarez Pérez, RM; Borrego Dorado, I; Ceballo Pedraja, JM; Esteban Ortega, F; Ruiz Franco-Baux, J; Vázquez Albertino, R | 1 |
| Carames, MA; Carreras, JL; Clavo, B; Domper, M; Hernandez, MA; Montz, R; Morera, J; Pinar, B; Robaina, F; Santullano, V | 1 |
| Connolly, LP; Gauger, PG; Hurwitz, CA; Kunter, G; Mackie, GC; Mody, RJ; Ribeiro, RC; Rodriguez-Galindo, C; Schteingart, DE; Shulkin, BL; Wallis, JW; Worden, FP | 1 |
| Chan, SC; Chang, JT; Chang, YC; Chen, YC; Hsu, CL; Liao, CT; Lin, CY; Ng, SH; Wang, HM; Yen, TC | 1 |
| Ampil, F; Burton, G; Chu, QD; Johnson, LW; Li, BD; Lilien, D; Turnage, RH; Wolfort, RM | 1 |
| Freeman, HJ | 1 |
| Kohlfürst, S; Lind, P | 1 |
| Muzik, O; Peng, F; Rabkin, G | 1 |
| Byun, JY; Cho, SM; Kim, HS; Lee, BY; Lee, JM; Lee, KH; Lee, KY; Park, GS; Park, YG; Song, KS | 1 |
| Bastiaannet, E; Hoekstra, HJ; Hoekstra, OS; Jager, PL; Oyen, WJ; Wobbes, T | 1 |
| Chauhan, A; Dadparvar, S; Jana, S; Kumar, R | 1 |
| Brenner, W; Conrad, EU; Eary, JF; Hwang, W; Vernon, C | 1 |
| Barnett, CM; Brock, C; Bydder, GM; Charnley, N; Glaser, M; Matthews, J; Newlands, ES; Price, P; Swindell, R; West, CM | 1 |
| Hama, Y | 1 |
| Iwamoto, S; Kamisaki, Y; Kawabe, H; Kawano, M; Noguchi, K; Seto, H; Shimizu, M; Takada, M; Watanabe, N | 1 |
| Chan, SC; Chang, JT; Chen, IH; Cheng, AJ; Fan, KH; Huang, SF; Kang, CJ; Liao, CT; Lin, CY; Lin, WJ; Ng, SH; Wang, HM; Yen, TC | 1 |
| Daghighian, F; Essner, R; Gulec, SA | 1 |
| Gong, G; Hong, SJ; Kim, JM; Kim, SC; Kim, SY; Kim, TY; Kim, WB; Lee, S; Rhee, YS; Shong, YK; Song, JY | 1 |
| Chang, U; Cheon, GJ; Gwak, HS; Kim, HJ; Kim, K; Lee, DH; Rhee, CH; Youn, SM | 1 |
| Bjurberg, M; Brun, E; Gustavsson, A; Ohlsson, T | 1 |
| Chang, CC; Hsu, CH; Lin, YH; Liu, JD; Tai, CJ | 1 |
| Li, H; Wang, QS; Wang, XL; Zhang, XL | 1 |
| Chan, SC; Chang, JT; Fan, KH; Liao, CT; Lin, CY; Ng, SH; Wang, HM; Yen, TC | 1 |
| Fukuda, H; Isogami, K; Ito, H; Kaneta, T; Kondo, T; Shimada, K; Takahashi, S | 1 |
| Cho, EH; Cho, JY; Cho, YB; Lee, HW; Lee, KU; Suh, KS; Yang, SH; Yi, NJ | 1 |
| Becker, K; Busch, R; Fink, U; Herrmann, K; Lordick, F; Ott, K; Schwaiger, M; Siewert, JR; Weber, WA; Wieder, H | 1 |
| Balogova, S; Grahek, D; Gutman, F; Kerrou, K; Montravers, F; Périé, S; Saint Guily, JL; Talbot, JN | 1 |
| Fukuda, H; Iwasaki, T; Katsura, H; Kawahara, K; Nakagawa, K; Nakane, S | 1 |
| Geinitz, H; Molls, M; Nieder, C; Schill, S; Schratzenstaller, U; Thamm, R; Zimmermann, FB | 1 |
| Ho, L; Jadvar, H; Seto, J | 1 |
| Pruim, J; Schot, BW; Sluiter, WJ; Vaalburg, W; van Imhoff, GW; Vellenga, E; Zijlstra, JM | 1 |
| Buchert, R; de Wit, M; Raabe, A; Seegers, B | 1 |
| Baba, H; Chikamoto, A; Kanemitsu, K; Takamori, H; Tsuji, T; Uozumi, H; Yamashita, Y | 1 |
| Dam, HQ; Manzone, TM; Sagar, VV | 1 |
| Broome, J; du Plessis, DG; Fildes, D; Haylock, B; Husband, D; Jenkinson, MD; Joyce, KA; Kopitzki, K; Prosser, J; Smith, T; Vinjamuri, S; Walker, C; Warnke, PC | 1 |
| Chung, HH; Chung, JK; Jo, H; Kang, SB; Kang, WJ; Kim, JW; Lee, HP; Park, NH; Song, YS | 1 |
| Endoh, K; Gotoh, M; Hasegawa, T; Higuchi, M; Kanno, R; Suzuki, H; Teranishi, Y | 1 |
| Bar-Shalom, R; Ben-Haim, S; Guralnik, L; Israel, O; Radan, L | 1 |
| Juergens, KU; Kliesch, S; Stegger, L; Weckesser, M; Wormanns, D | 1 |
| Chung, HH; Chung, JK; Kang, SB; Kang, WJ; Kim, JW; Lee, HP; Park, NH; Song, YS | 1 |
| Gallowitsch, HJ; Gomez, I; Igerc, I; Kohlfuerst, S; Kresnik, E; Lind, P; Zoller, M | 1 |
| Bettinardi, V; Fazio, F; Galimberti, S; Landoni, C; Mangioni, C; Messa, C; Perego, P; Picchio, M; Signorelli, M; Sironi, S | 1 |
| Fulham, MJ; Mohamed, A; O' Neill, GF; Thambugala, GM | 1 |
| Choi, SH; Kim, JS; Kim, SB; Kim, SY; Lee, JC; Lee, JH; Lee, SW; Nam, SY | 1 |
| Rankin, SC | 1 |
| Corstens, FH; de Geus-Oei, LF; Leer, JW; Oyen, WJ; Punt, CJ; Ruers, TJ | 1 |
| Frizelle, FA; Lolohea, S; Robertson, GM; Watson, AJ | 1 |
| Weian, C; Xiangsong, Z | 1 |
| Deandreis, D; Pelosi, E | 1 |
| Cabrera Martín, MN; Calvo Manuel, F; Carreras Delgado, JL; Pasamontes Pingarrón, JA; Pérez Castejón, MJ; Scola Yurrita, B | 1 |
| Higashi, T; Nakamoto, Y; Okada, T; Saga, T; Sakamoto, S; Senda, M; Togashi, K | 1 |
| Bettinardi, V; Bornaghi, D; Crivellaro, C; Fazio, F; Mangili, G; Messa, C; Picchio, M; Rabaiotti, E; Sironi, S; Viganò, R | 1 |
| Israel, O; Kuten, A | 1 |
| Avril, N; DeLoia, JA; Gallion, H; Thrall, MM | 1 |
| Groshar, D; Gurion, R; Raanani, P; Schindel, A; Shpilberg, O | 1 |
| Grabiec, M; Nowicki, P; Walentowicz, M | 1 |
| Allen-Auerbach, M; Czernin, J; Fueger, BJ; Halpern, BS; Lufkin, RB; Yeom, K | 1 |
| Cabrera Martín, MN; Calvo Manuel, F; Carreras Delgado, JL; Delgado Bolton, RC; Pasamontes Pingarrón, JA; Scola Yurrita, B | 1 |
| Pelosi, E; Pirro, V; Skanjeti, A | 1 |
| Ladenson, PW; Leboulleux, S; Schlumberger, M; Schroeder, PR | 1 |
| Hallfeldt, K; Mueller-Lisse, U; Pfluger, T; Reincke, M; Schlamp, A | 1 |
| Chung, JH; Chung, JK; Kim, SE; Kim, YK; Lee, DS; Lee, MC; Lee, WW; Nguyen, XC; Park, SY; So, Y; Sung, SW | 1 |
| Arush, MW; Bar-Shalom, R; Israel, O; Meller, I; Militianu, D; Postovsky, S; Sapir, AE; Zaidman, I | 1 |
| Avril, N; Bencherif, B; Bencherif, BB; Branstetter, B; Carty, SE; Degirmenci, B; Joyce, JM; Kuffner, HA; McCook, BM; Mountz, JM; Shammas, A | 1 |
| Al-Kattan, K; Al-Sugair, AA; El-Bawab, H; Hajjar, W; Mahdy, M; Rafay, M | 1 |
| Choi, SH; Kim, JS; Kim, SB; Kim, SY; Lee, S; Nam, SY; Pae, KH; Roh, JL | 1 |
| Heffernan, EJ; Skehan, SJ | 1 |
| Bar-Shalom, R; Daitzchman, M; Golz, A; Gordin, A; Israel, O; Keidar, Z; Kuten, A | 1 |
| Aide, N; Bardet, S; Delozier, T; Hardouin, A; Heutte, N; Huchet, V; Switsers, O | 1 |
| Fields, P; Hofman, MS; Ireland, R; Mikhaeel, NG; Nunan, T; Yung, L | 1 |
| Anniko, M; Blomquist, E; Ekberg, T; Engström, M; Sörensen, J; Sundin, A | 1 |
| Acikgoz, G; Alavi, A; Cermik, TF; Dadparvar, S; Houseni, M; Mavi, A | 1 |
| Albrecht, S; Buchegger, F; Hany, TF; Husarik, D; Khan, H; Miralbell, R; Soloviev, D; Vees, H; Zaidi, H | 1 |
| Huang, XM; Li, WH; Zeng, L | 1 |
| Herbertson, RA; Lee, ST; Scott, AM; Tebbutt, N | 1 |
| Beuthien-Baumann, B; Bredow, J; Kotzerke, J; Strumpf, A; Zessin, J | 1 |
| Hayasaka, K; Ishigaki, T; Ito, K; Ito, Y; Itou, T; Kato, R; Naganawa, S; Nihashi, T; Sobajima, T | 1 |
| Akhurst, T; Alektiar, K; Barakat, RR; Chi, DS; Husain, A; Larson, S | 1 |
| Asenbaum, S; Becherer, A; Dudczak, R; Karanikas, G; Kletter, K; Marosi, C; Pötzi, C; Szabo, M | 1 |
| Anderlini, P; Ayers, G; Fayad, L; Hagemeister, F; Hosing, C; Jabbour, E; Khouri, I; Kwak, L; Nunez, R; Pro, B; Younes, A | 1 |
| Banti, E; Capirci, C; Crepaldi, G; Erba, PA; Fanti, S; Galeotti, F; Gava, M; Mariani, G; Muzzio, PC; Rampin, L; Rubello, D | 1 |
| Barbet, J; Bodet-Milin, C; Carlier, T; Curtet, C; Kraeber-Bodéré, F; Mirallié, E; Rousseau, C | 1 |
| Balogova, S; Cussenot, O; Gattegno, B; Grahek, D; Gutman, F; Huchet, V; Kerrou, K; Kerrouche, N; Montravers, F; Talbot, JN; Thibault, P | 1 |
| Antoch, G; Beyer, T; Bockisch, A; Hauth, EA; Schleucher, R; Stergar, H; Veit-Haibach, P | 1 |
| Coleman, RE; Gauger, J; Herndon, JE; Patz, EF | 1 |
| Cerny, T; Gillessen, S; Joerger, M; Klaeser, B; Kluckert, T; von Rohr, L | 1 |
| Hamanaka, N; Hata, Y; Homma, S; Isobe, K; Kato, N; Kimura, K; Sasamoto, S; Shimizu, K; Takagi, K | 1 |
| Bloomston, M; Hall, NC; Knopp, MV; Martin, EW; Povoski, SP; Sarikaya, I; Zhang, J | 1 |
| Binns, DS; Drummond, E; Hicks, RJ; Hogg, A; Lau, EW; Shakher, R; Wang, GH | 1 |
| Fu, Z; Guo, H; Huang, Y; Li, L; Xi, Y; Yang, G; Yu, J; Yuan, S; Zhang, B; Zhang, J; Zhu, H | 1 |
| Daugaard, G; Hain, SF; Harland, SJ; Huddart, RA; Joffe, JK; Kirk, SJ; Logue, J; MacKewn, JE; Mead, GM; O'Doherty, MJ; Padhani, A; Rustin, GJ; Stenning, SP; Vasey, P | 1 |
| Abgral, R; Bizais, Y; Couturier, O; Kraeber-Bodéré, F; Querellou, S; Salaun, PY; Valette, G | 1 |
| Boellaard, R; Hoekstra, OS; Meijer, GA; Molthoff, CF; Reitsma, JB; Sloof, GW; Ten Kate, FJ; van Lanschot, JJ; Westerterp, M | 1 |
| Bazzi, L; Bellomi, M; Paganelli, G; Radice, D; Rizzo, S; Travaini, LL; Trifirò, G; Zampino, MG | 1 |
| Galanski, M; Gratz, KF; Rosenthal, H; von Falck, C | 1 |
| Fujii, T; Kaida, Y; Shirouzu, K; Tayama, K; Toh, U | 1 |
| Cunha, ML; Daniel, MM; Funari, MB; Thom, AF; Wagner, J; Yamaga, LY | 1 |
| Brepoels, L; De Wever, W; De Wolf-Peeters, C; Mortelmans, L; Spaepen, K; Stroobants, S; Thomas, J; Uyttebroeck, A; Vandenberghe, P; Verhoef, G | 2 |
| Armitage, JO; Bishu, S; Bishu, SR; Hankins, JH; Holdeman, KP; Olsasky, SM; Paknikar, S; Quigley, JM; Shostrom, VK; Stem, RA | 1 |
| Chen, W | 1 |
| Eubank, WB | 1 |
| Bar-Shalom, R | 1 |
| Aupérin, A; Baudin, E; Bonniaud, G; Chami, L; Dromain, C; Giraudet, AL; Hartl, D; Lassau, N; Leboulleux, S; Lumbroso, J; Ny Tovo, N; Schlumberger, M; Travagli, JP; Vanel, D | 1 |
| Grigsby, PW | 1 |
| Cheng, MF; Huang, YH; Tzen, KY; Wu, YW; Yen, RF | 1 |
| Bjurberg, M; Brun, E; Kjellén, E; Ohlsson, T; Ridderheim, M | 1 |
| Chen, LB; Song, HZ; Tong, JL; Wang, YC; Zhu, H | 1 |
| Chen, LH; Chen, YQ; Li, QS; Wang, HM; Wang, QS; Wu, HB; Xu, YK; Yan, WP; Zheng, XK | 1 |
| Chen, GB; Guan, YS; Luo, ZM; Pan, WM; Sun, L; Wu, H | 1 |
| Dehdashti, F; Finkelstein, SE; Grigsby, PW; Hall, BL; Moley, JF; Siegel, BA | 1 |
| Israel, DA; Sheehy, N | 1 |
| Arsos, G; de Klerk, J; van der Weel, F; van Ooijen, B; Weijs, L | 1 |
| Brown, PD; Foote, RL; Garces, YI; Kasperbauer, JL; Lowe, VJ; Shintani, SA | 1 |
| Hall, NC; Kloos, RT | 1 |
| Al-Nahhas, A; Banti, E; Fanti, S; Ferdeghini, M; Gross, MD; Nanni, C; Rampin, L; Rubello, D | 1 |
| Becker, K; Fink, U; Lordick, F; Ott, K; Peschel, C; Schwaiger, M; Siewert, JR; Stein, HJ; Weber, WA | 1 |
| Karantanis, D; Lowe, VJ; Mullan, BP; Nathan, MA; O'eill, BP; Peller, PJ; Subramaniam, RM; Wiseman, GA; Witte, RJ | 1 |
| Balogova, S; Chater, PE; Grahek, D; Hugentobler, A; Kerrou, K; Montravers, F; Périé, S; St Guily, JL; Susini, B; Talbot, JN | 1 |
| Collins, CD | 1 |
| Burkill, G; Miles, K | 1 |
| Avci, ME; Duman, Y; Ertopcu, K; Sayhan, S; Sehirali, S; Tinar, S; Yildirim, Y; Yilmaz, C | 1 |
| Adam, Z; Bolcak, K; Buchler, T; Hajek, R; Krejci, M; Neubauer, J; Pour, L; Prasek, J; Stanicek, J; Vorlicek, J | 1 |
| Andre, T; Grahek, D; Grange, JD; Gutman, F; Houry, S; Huchet, V; Kerrou, K; Montravers, F; Poupon, R; Rosmorduc, O; Rougier, P; Ruszniewski, P; Talbot, JN; Touboul, E | 1 |
| Alberini, JL; Alexandre, J; Callet, N; Cherel, P; Fourme, E; Goupil, A; Le Stanc, E; Pecking, AP; Soussan, M; Wartski, M | 1 |
| Berthelsen, AK; Bisgaard, C; Graff, J; Jakobsen, A; Kristiansen, C; Lindebjerg, J; Loft, A | 1 |
| Antoch, G; Bockisch, A; Freudenberg, LS; Frilling, A; Jentzen, W; Kühl, H; Müller, SP | 1 |
| Agoff, N; Lin, E | 1 |
| Jeon, DG; Kim, MS; Lee, SY; Sim, YS | 1 |
| Bai, YR; Huang, G; Liu, T; Xu, W; Yan, WL; Ye, M | 1 |
| Bentzen, SM; Boersma, L; De Ruysscher, D; Geraedts, W; Hochstenbag, M; Lambin, P; Minken, A; Pitz, C; Simons, J; van Haren, E; Verschueren, T; Wanders, R | 1 |
| Ansquer, C; Bodet-Milin, C; Bridji, B; Carnaille, B; Charbonnel, B; Curtet, C; Guillan, T; Kraeber-Bodéré, F; Mirallié, E; Murat, A; Resche, I; Rousseau, C | 1 |
| He, ZY; Qiao, WL; Wang, C; Wang, TS; Xing, Y; Zhao, JH | 1 |
| Bauerfeind, I; Baur-Melnyk, A; Haug, A; Heinemann, V; Reiser, MF; Schmidt, GP; Schoenberg, SO | 1 |
| Aigner, RM; Feichtinger, M; Kärcher, H | 1 |
| Haji, A | 1 |
| Chen, T; Guo, W; Huang, G; Li, SJ; Ren, GX; Song, SL | 1 |
| Chernov, MF; Hayashi, M; Hori, T; Izawa, M; Kubo, O; Muragaki, Y; Ono, Y; Takakura, K; Usukura, M; Yoshida, S | 1 |
| Hustinx, R; Jerusalem, G; Rorive, A; Withofs, N | 1 |
| Bom, HS; Chung, TW; Kim, IY; Min, JJ; Seo, YS | 1 |
| Akhurst, T; Blumgart, LH; Corvera, CU; D'Angelica, M; DeMatteo, RP; Fong, Y; Jarnagin, WR | 1 |
| Avisar, E; Molina, M | 1 |
| Gómez-Río, M; Llamas-Elvira, JM; López-Ramírez, E; Ramos-Font, C; Rodríguez-Fernández, A | 1 |
| Chung, HH; Chung, JK; Kang, SB; Kang, WJ; Kim, JW; Park, NH; Song, YS | 1 |
| Hall, NC; Martin, EW; Povoski, SP; Walker, MJ | 1 |
| Ben-Arie, Y; Gaitini, D; Israel, O; Levy, Z; Shalom, RB; Soudack, M | 1 |
| Demeaux, H; Fernandez, P; Gindre, A; Guyot, M; Laurentjoye, M; Majoufre-Lefebvre, C; Ricard, AS; Siberchicot, F | 1 |
| Abhyankar, A; Awasare, S; Malhotra, G; Moghe, SH; Nair, N | 1 |
| Brouwer, J; Castelijns, JA; de Bree, R; Hoekstra, OS; Hooft, L; Leemans, CR; Riphagen, II | 1 |
| Campbell, BH; Maheshwari, M; Massey, BL; Michel, MA; Schultz, CJ; Vernon, MR; Wang, D; Wilson, JF; Wong, SJ | 1 |
| Atkins, F; Burman, K; Butler, C; Jonklaas, J; Ousman, Y; Seiboth, L; Van Nostrand, D; Wartofsky, L | 1 |
| Breitenstein, S; Hany, TF; Lago, MP; Mende, KA; Soyka, JD; Strobel, K; Tschopp, A; Veit-Haibach, P | 1 |
| Cnaral, F; Halac, M; Kerim, S; Sait, S; Sergülen, D; Uslu, I; Ylmaz, S | 1 |
| André, T; Aparicio, T; Cherqui, D; Delbaldo, C; Gornet, JM; Itti, E; Le Guludec, D; Lebtahi, R; Meignan, M; Montravers, F; Panis, Y; Rougier, P; Sobhani, I; Talbot, JN; Tiret, E; Vaylet, C | 1 |
| Conti, PS; Henderson, RW; Jadvar, H; Quan, V | 1 |
| Fukasawa, I; Hagiwara, S; Inaba, N; Kaji, Y; Kitajima, K; Murakami, K; Sugimura, K; Yamasaki, E | 1 |
| Bae, DS; Huh, SJ; Lee, JA; Oh, D | 1 |
| Akarriou, M; Brouwer, J; Castelijns, JA; Comans, EF; de Bree, R; Hoekstra, OS; Langendijk, JA; Leemans, CR | 1 |
| Chua, SC; Ganatra, RH; O'Connor, SR; Wong, WL | 1 |
| Khatcheressian, J; Swainey, C | 1 |
| Gelblum, D; Greco, C; Jackson, A; Rosenzweig, KE; Sura, S; Yorke, ED | 1 |
| Johnston, PB; Micallef, IN; Wiseman, GA | 1 |
| Buchmann, I; Ganten, TM; Haberkorn, U | 1 |
| Chan, AT; Hui, EP; King, AD; Leung, SF; Lo, YM; Ma, BB; Mo, FK; Yau, YY | 1 |
| Domeki, Y; Fukasawa, I; Inaba, N; Kaji, Y; Kitajima, K; Murakami, K; Suganuma, N; Sugimura, K; Yamasaki, E | 1 |
| Domeki, Y; Kaji, Y; Kitajima, K; Murakami, K; Sugimura, K; Yamasaki, E | 1 |
| El-Haddad, G; Lilien, DL; Mathew, AS; Takalkar, AM | 1 |
| Choi, H | 1 |
| Van den Abbeele, AD | 1 |
| Hicks, RJ; Toner, GC | 1 |
| Cabrera Martín, MN; Carreras Delgado, JL; Delgado Bolton, RC; Fernández Pérez, C; Pasamontes Pingarrón, JA; Scola Yurrita, B | 1 |
| Hosoi, Y; Igaki, H; Momose, T; Muto, T; Nagawa, H; Nakagawa, K; Nakamura, N; Ohtomo, K; Tago, M; Yamashita, H | 1 |
| Bashir, H; Nunan, TO; Shabo, G | 1 |
| Bisdas, S; Rumboldt, Z; Spicer, K | 1 |
| Ghossein, RA; Gomez, D; Larson, SM; Rivera, M; Schoder, H; Tuttle, RM | 1 |
| Alexiou, GA; Fotopoulos, AD; Kyritsis, AP; Polyzoidis, KS; Tsiouris, S | 1 |
| Wong, RJ | 1 |
| Akaki, S; Gobara, H; Higaki, F; Hiraki, T; Kanazawa, S; Mimura, H; Okumura, Y; Sato, S; Tsuda, T | 1 |
| Brooks, RA; Channing, M; DeLaPaz, RL; Di Chiro, G; Kessler, RM; Kornblith, PL; Manning, RG; O'Connor, CM; Patronas, NJ; Rizzoli, HV; Smith, BH; Wolf, AP | 1 |
| Brooks, RA; DeLaPaz, RL; Di Chiro, G; Johnston, GS; Kessler, RM; Kornblith, PL; Kufta, CV; Manning, RG; Patronas, NJ; Smith, BH; Sokoloff, L; Wolf, AP | 1 |
| Darcourt, J; Lagrange, JL; Maublant, J | 1 |
| Bonasera, TJ; Cutler, PD; Dehdashti, F; Detert, DD; Fusselman, MJ; Griffeth, LK; Katzenellenbogen, JA; Mortimer, JE; Siegel, BA; Welch, MJ | 1 |
| Chevretton, E; Croft, D; McGurk, M; Wong, WL | 1 |
| Austin, JR; Kim, EE; Wong, FC | 1 |
| Grénman, R; Haaparanta, M; Joensuu, H; Kurki, T; Lapela, M; Leskinen, S; Lindholm, P; Minn, H; Ruotsalainen, U | 1 |
| Argenyi, EE; Dogan, AS; Hichwa, RD; Ponto, LL; Urdaneta, LF; Watkins, GL | 1 |
| Coleman, RE; Duhaylongsod, FG; Lowe, VJ; Patz, EF; Vaughn, AL; Wolfe, WG | 1 |
| Meyer, MA | 1 |
| Bassa, P; Endo, K; Inoue, T; Kim, EE; Komaki, R; Podoloff, DA; Wong, FC; Wong, WH; Yang, DJ | 1 |
| Bohdiewicz, PJ; Dworkin, HJ; Fink-Bennett, D; Juni, JE; Nagle, C; Scott, GC; Wilner, F | 1 |
| Buonocore, E; Cotten, DW; Gould, HR; Hübner, KF; Singh, SK | 1 |
| Alavi, A; Alavi, JB; Buchpiguel, CA; Kenyon, LC | 1 |
| Bicik, I; Di Chiro, G; Fulham, MJ; Knightly, JJ; Raman, R | 1 |
| Aerts, R; Beets, G; De Roo, M; Filez, L; Kerremans, R; Mortelmans, L; Penninckx, F; Schiepers, C | 1 |
| Hatazawa, J; Iida, H; Kowada, M; Mineura, K; Ogawa, T; Sasajima, T; Shioya, H; Uemura, K | 1 |
| Bushnell, DL; Follett, KA; Kahn, D; Kirchner, PT; Madsen, M; Nathan, MA; Piper, JG | 1 |
| Enomoto, K; Fukunaga, T; Isono, K; Kikuchi, T; Koide, Y; Okazumi, S; Yamamoto, H | 1 |
| Black, M; Gjedde, A; Yamamoto, YL; Zeitouni, AG | 1 |
| Cappellari, JO; Frazier, LC; Geisinger, KR; Greven, KM; Harkness, BA; Keyes, JW; McGuirt, WF; Raben, M; Watson, NE; Williams, DW | 1 |
| Drane, WE; Mancuso, AA; Mukherji, SK | 1 |
| Cappellari, JO; Geisinger, KR; Greven, KM; Keyes, JW; McGuirt, WF; Raben, M; Randall, ME; Watson, NE; Williams, DW | 1 |
| Goodman, PC; Harris, LK; Hoffman, JM; Lowe, VJ; Paine, SS; Patz, EF | 1 |
| De Maeght, S; Labar, D; Lambotte, L; Laterre, C; Pauwels, S; Stroobandt, G; Vander Borght, T | 1 |
| Anzai, Y; Chaiken, L; Choi, Y; Hoh, CK; Juillard, G; Lufkin, R; Maass, A; Maddahi, J; Phelps, ME; Rege, S | 1 |
| Cane, P; Glaspy, J; Hawkins, R; Hoh, C; Karlan, BY; Lee, M; Tse, N | 1 |
| Ishikawa, M; Kikuchi, H; Miyatake, S; Nishizawa, S; Oda, Y; Yonekura, Y | 1 |
| Chaiken, L; Choi, Y; Hawkins, R; Hoh, C; Jabour, B; Juillard, G; Parker, R; Rege, S | 1 |
| Castle, VP; Hutchinson, RJ; Shapiro, B; Shulkin, BL; Sisson, JC; Yanik, GA | 1 |
| Anzai, Y; Bradford, CR; Carroll, WR; Minoshima, S; Quint, DJ; Wahl, RL; Wolf, GT | 1 |
| Blahd, WH; Brown, CV; Coyle, JJ; Farahi, JB; Glass, EC; Khonsary, SA; Mandelkern, MA; Quinones, N; Ribe, JY | 1 |
| Chu, KM; Fulham, M; Lai, DT; Sheldon, DM; Solomon, M; Stephen, MS; Storey, DW; Thompson, JF | 1 |
| Gambhir, S; Ikeda, M; Ishigaki, T; Ito, K; Kato, T; Nishino, M; Ohta, T; Tadokoro, M; Yamada, T | 1 |
| Feine, U; Hanke, JP; Held, J; Lietzenmayer, R; Müller-Schauenburg, W; Wöhrle, H | 1 |
| Bassa, P; Hicks, K; Inoue, T; Kim, EE; Korkmaz, M; Podoloff, DA; Tansey, W; Wong, FC; Wong, WH; Yang, DJ | 1 |
| Garcia, R; Kim, EE; Korkmaz, M; Podoloff, DA; Wong, FC; Wong, WH; Yang, DJ | 1 |
| Akashi, Y; Fukumura, T; Ichiya, Y; Kawashima, A; Kuwabara, Y; Masuda, K; Omagari, J; Sasaki, M; Yoshida, T | 1 |
| Kim, EE; Korkmaz, M; Podoloff, DA; Wong, FC | 1 |
| Brotchi, J; Damhaut, P; De Witte, O; Goldman, S; Hildebrand, J; Levivier, M; Salmon, I; Violon, P; Wikler, D | 1 |
| Deshmukh, A; Fischman, AJ; Gruber, M; Hochberg, FH; Palmer, EL; Scott, JA | 1 |
| Chevretton, EB; Hemingway, R; McGurk, M; Wong, W | 1 |
| Blount, CL; Dworkin, HJ | 1 |
| Esselstyn, CB; Kim, EY; Neumann, DR | 1 |
| Hoekstra, HJ; Kole, AC; Koops, HS; Nieweg, OE; Paans, AM; Pruim, J; Vaalburg, W; van Ginkel, RJ | 1 |
| Avril, N; Dose, J; Herz, M; Jänicke, F; Kuhn, W; Römer, W; Schwaiger, M; Ziegler, S | 1 |
| Dimitrakopoulou-Strauss, A; Goldschmidt, H; Hegenbart, U; Irngartinger, G; Oberdorfer, F; Strauss, LG; van Kaick, G | 1 |
| Bartenstein, P; Daschner, H; Feldmann, HJ; Gross, MW; Kinzel, D; Lumenta, C; Molls, M; Reidel, G; Schwaiger, M; Weber, W; Ziegler, SI | 1 |
| Baddeley, H; Beaney, R; Chevretton, EB; Davis, J; Hussain, K; Maisey, M; McGurk, M; Tierney, P; Wong, WL | 1 |
| Alpert, NM; Fischman, AJ; Frosch, MP; Gonzalez, RG; Swearinger, B; Thornton, AF | 1 |
| Alger, JR; Bonavita, S; Di Chiro, G; Duyn, JH; Lundbom, N; Raman, R; Tedeschi, G | 1 |
| Bender, H; Biersack, HJ; Kozak, B; Oehr, P; Robertz-Vaupel, GM; Ruhlmann, J; Schomburg, A; Vaupel, H; Wolter, H | 1 |
| Ferlin, G; Gasparoni, P; Rubello, D | 1 |
| Birnbaum, EH; Dehdashti, F; Flanagan, FL; Fleshman, JW; Kodner, IJ; Ogunbiyi, OA; Philpott, GW; Read, TE; Siegel, BA; Trask, DD | 1 |
| Büll, U; Cremerius, U; Rath, W; Schröder, W; Wolters, S; Zimny, M | 1 |
| Adler, LP; Faulhaber, PF; Leisure, GP; Miraldi, F; Vesselle, H | 1 |
| Ali, A; Alibazoglu, H; Lamonica, G; Megremis, D | 1 |
| Dehdashti, F; Flanagan, FL; Kodner, IJ; Ogunbiyi, OA; Siegel, BA | 1 |
| Glaspy, JA; Hoh, CK; Maddahi, J; Moon, DH; Phelps, ME; Silverman, DH | 1 |
| Alavi, A; Alavi, JB; Bénard, F | 1 |
| Bice, AN; Drayer, BP; Fram, EK; Heiserman, JE; Karis, JP; Ricci, PE | 1 |
| Bryan, RN | 1 |
| Abdel-Dayem, HM; Abujudeh, H; Atay, S; El-Zeftawy, HM; Luo, JQ; Marans, HY; Mithilesh, K; Naddaf, SY; Omar, WS; Radin, AI; Wong, S | 1 |
| Greven, KM; Keyes, JW; McGuirt, WF; Watson, N; Williams, DW | 1 |
| Cappellari, JO; Geisinger, KR; Greven, K; Keyes, JW; McGuirt, WF; Watson, N; Williams, D | 1 |
| Ahuja, V; Coleman, RE; Erasmus, JJ; Goodman, PC; McAdams, HP; Patz, EF | 1 |
| Bingham, JB; Fletcher, CD; Lucas, JD; McKee, PH; O'Doherty, MJ; Smith, MA; Wong, JC | 1 |
| Beyer, W; Clausen, M; Grimm-Riepe, C; Lübeck, M; Schirren-Bumann, K; Schlüter, B | 1 |
| Rodriguez, M | 1 |
| Agresti, R; Giovanazzi, R; Greco, M | 1 |
| Lowe, VJ; Naunheim, KS | 1 |
| Jadali, F; Kottapally, S; Meltzer, CC; Townsend, DW | 1 |
| Adamietz, IA; Adams, S; Baum, RP; Bormeth, SB; Böttcher, HD; Hör, G; Mose, S; Rahn, AN; Sengupta, S | 1 |
| Hordijk, GJ; Mertens, IJ; Stokkel, MP; Terhaard, CH; van Rijk, PP | 1 |
| AAssar, OS; Caputo, GR; Dillon, WP; Fischbein, NJ; Hawkins, RA; Kaplan, MJ; Price, DC; Singer, MI | 1 |
| Donald, PJ; Manolidis, S; Pounds, TR; Volk, P | 1 |
| Al Suhaibani, H; Bakheet, SM; Ezzat, A; Powe, J; Rostom, A; Tulbah, A | 1 |
| Bockisch, A; Brandt-Mainz, K; Müller, SP; Sonnenschein, W | 1 |
| Eary, JF; Eubank, WB; Fisher, ER; Graham, MM; Mankoff, DA; Olshen, AB; Schmiedl, UP; Winter, TC | 1 |
| Collignon, J; Deneufbourg, JM; Hustinx, R; Moreau, P; Paulus, P; Rigo, P; Sambon, A; Vivegnis, D | 1 |
| Boyd, J; Dunphy, F; Kim, HJ; Lowe, V | 1 |
| ChangLai, SP; Chieng, PU; Kao, CH; Yen, RF; Yen, TC | 1 |
| James, C; MacGillivray, DC; Starks, M; White, J | 1 |
| Bausart, R; Declerck, P; Delval, D; Jamar, F; Lonneux, M; Moens, R; Pauwels, S; Van Mael, P; Willockx, R; Zreik, H | 1 |
| Drane, WE; Jimenez, LA; Maria, BL; Mastin, ST | 1 |
| Saunders, M; Wong, WL | 1 |
| Bader, JB; Feiden, W; Kirsch, CM; Kremp, S; Moringlane, JR; Samnick, S; Schaefer, A | 1 |
| Ivancevic, V | 1 |
| Austin-Seymour, MM; Cortese, AA; Ellis, GK; Gralow, JR; Hathaway, PB; Hayes, CE; Mankoff, DA; Maravilla, KR; Moe, RE | 1 |
| Godwin, HA; Zuger, JH | 1 |
| Block, T; Breul, J; Hartung, R; Hofer, C; Laubenbacher, C; Schwaiger, M | 1 |
| Hanasono, MM; Ku, GH; Kunda, LD; Segall, GM; Terris, DJ | 1 |
| Alavi, A; Benard, F; Chalian, AA; Farber, LA; Machtay, M; Rosenthal, DI; Smith, RJ; Weber, RS; Weinstein, GS | 1 |
| Brink, I; Moser, E; Nitzsche, EU; Schumacher, T | 1 |
| Hordijk, GJ; Stokkel, MP; Terhaard, CH; van Rijk, PP | 1 |
| Koh, JH; Pai, M; Park, CH; Suh, JH | 1 |
| Anzai, Y; Minoshima, S; Wahl, RL; Wolf, GT | 1 |
| Ali, A; Alibazoglu, B; Alibazoglu, H; Hollinger, EF; Ingram, SA; LaMonica, G; Willoughby, WA | 1 |
| Becherer, A; Kletter, K | 1 |
| Boyd, JH; Dunphy, FR; Eisenbeis, JF; Fletcher, JW; Kim, H; Lowe, VJ | 1 |
| Coel, MN; Johnson, DS; Wong, JT | 1 |
| Kuwert, T | 1 |
| Bacqai, F; Conti, PS; Durski, JM; Grafton, ST; Singer, PA | 1 |
| Delbeke, D | 1 |
| Dinges, HP; Gallowitsch, HJ; Gomez, I; Kresnik, E; Kumnig, G; Lind, P; Matschnig, S; Mikosch, P; Starlinger, M; Unterweger, O | 1 |
| Hain, SF; Lucas, JD; O'Doherty, MJ; Smith, MA | 1 |
| Arocena, J; Berián, JM; Giménez, M; Richter, JA; Robles, JE; Rodriguez-Rubio, F; Rosell, D; Sánchez, D; Sanz, G | 1 |
| Erasmus, JJ; Patz, EF | 1 |
| Bongers, V; Hordijk, GJ; Stokkel, MP; van Rijk, PP | 1 |
| Adam, G; Büll, U; Cremerius, U; Di Martino, E; Jänicke, S; Nowak, B; Reinartz, P; Zimny, M | 1 |
| Barthelemy, N; Bartsch, P; Bury, T; Corhay, JL; Daenen, F; Duysinx, B; Ghaye, B; Rigo, P | 1 |
| Hoekstra, A; Stokkel, MP; van Rijk, PP | 1 |
| Costa de Beauregard, MA; Doublet, JD; Gattegno, B; Grahek, D; Kerrou, K; Montravers, F; Rossert, J; Talbot, JN; Thibault, P; Younsi, N | 1 |
| Akhurst, T; Berlangieri, SU; Feigen, M; Hannah, A; McKay, WJ; Quong, G; Scott, AM; Zalcberg, J; Zimet, A | 1 |
| Boyd, JH; Collins, BT; Dunleavy, T; Dunphy, FR; Fletcher, JW; Hollenbeak, C; Kim, H; Lowe, VJ; Martin, D; Stack, BC | 1 |
| Brock, CS; Evans, H; Matthews, J; Newlands, ES; O'Reilly, SM; Osman, S; Price, PM; Young, H | 1 |
| Attigah, N; Dimitrakopoulou-Strauss, A; Herfarth, C; Hinz, U; Lehnert, T; Mechtersheimer, G; Schwarzbach, MH; Strauss, LG; Willeke, F; Zhang, YM | 1 |
| Hellwig, AP; Hellwig, D; Kirsch, CM; Leutz, M; Palm, I; Rentz, K; Sybrecht, GW; Ukena, D | 1 |
| Li, YF; Liu, RS; Ng, HT; Wang, PH; Yuan, CC | 1 |
| Chaiken, L; Hoh, C; Juillard, G; Rege, S; Safa, AA; Withers, HR | 1 |
| Allal, A; Bang, P; Becker, M; Dulguerov, P; Guyot, JP; Haenggeli, CA; Lehmann, W; Slosman, D | 1 |
| Bjornskov, I; Bretlau, P; Eigtved, A; Friberg, L; Grénman, R; Holm, S; Jensen, M; Jyrkkiö, S; Kurki, T; Lapela, M; Lindholm, P; Minn, H; Nuutinen, J; Sand Hansen, H; Solin, O; Sutinen, E | 1 |
| Baier, P; Dingeldey, A; Einert, A; Farthmann, EH; Imdahl, A; Mix, M; Nitzsche, EU; Reinhardt, MJ | 1 |
| Erasmus, JJ; Marom, EM; Patz, EF | 1 |
| Dörffler, W; Haller, U; Köchli, OR; Kubik-Huch, RA; Marincek, B; Seifert, B; Steinert, HC; von Schulthess, GK | 1 |
| Alavi, A; Alavi, J; Newberg, AB | 1 |
| Benz, P; Förster, GJ; Kuffner, HD; Kunkel, M; Reichert, TE; Wagner, W | 1 |
| Alnafisi, NS; Coates, G; Driedger, AA; Moote, DJ; Raphael, SJ | 1 |
| Birnbaum, EH; Dehdashti, F; Fleshman, JW; Kodner, IJ; Ogunbiyi, OA; Read, TE; Siegel, BA; Whiteford, HM; Whiteford, MH; Yee, LF | 1 |
| Beattie, BJ; Blasberg, RG; Malkin, MG; Thiessen, B; Vlassenko, AG | 1 |
| Czernin, J; Gambhir, SS; Huebner, RH; Park, KC; Phelps, ME; Schwimmer, J; Shepherd, JE | 1 |
| Amthauer, H; Beier, J; Felix, R; Herbel, A; Hosten, N; Kreissig, R; Lemke, AJ; Puls, R; Rohlfing, T; Stroszczynski, C | 1 |
| Czernin, J; Essner, R; Gambhir, SS; Jahan, SA; Park, K; Patel, A; Phelps, ME; Schwimmer, J; Shepherd, JE | 1 |
| Hain, SF; Harper, PG; Huddart, RA; Leslie, MD; O'Doherty, MJ; Timothy, AR | 1 |
| Bausart, R; Ide, C; Lawson, G; Lonneux, M; Pauwels, S; Remacle, M | 1 |
| Allaoua, M; Barghouth, G; Goerres, GW | 1 |
| Beger, HG; Reske, SN; Schirrmeister, H; Staib, L | 1 |
| Bangard, M; Bender, H; Biersack, HJ; Decker, P; Grünwald, F; Willkomm, P | 1 |
| Hwang, K; Kim, H; Kim, HC; Kim, S; Pai, M; Park, CH; Yoon, S | 1 |
| Flamen, P; Mortelmans, L; Van Cutsem, E | 1 |
| Bender, H; Biersack, HJ; Grünwald, F; Guhlke, S; Oehr, P; Ruhlmann, J | 1 |
| Cambier, JP; De Leyn, P; De Wever, W; Flamen, P; Lerut, A; Maes, A; Mortelmans, L; Peeters, M; Van Cutsem, E; Van Raemdonck, D | 1 |
| Bockhorn, M; Broelsch, CE; Clausen, M; Frilling, A; Gassmann, P; Görges, R; Tecklenborg, K | 1 |
| Hahn, K; Knesewitsch, P; Linke, R; Manthey, N; Moog, F; Tatsch, K; Tiling, R | 1 |
| Arulampalam, TH; Costa, DC; Ell, PJ; Loizidou, M; Taylor, I; Visvikis, D | 1 |
| Albrecht, SR; Allal, AS; Allaoua, M; Becker, M; Dulguerov, P; Goerres, GW; Haenggeli, CA; Lehmann, W; Slosman, DO | 1 |
| Beyer, W; Bohuslavizki, KH; Buchert, R; Clausen, M; Plotkin, M; Schlüter, B | 1 |
| Abdel-Dayem, HM; el-Zeftawy, H; Heiba, SI; Jana, S; Rosen, G; Salem, S; Santiago, JF | 1 |
| Bihl, H; Hültenschmidt, B; Lang, O; Sautter-Bihl, ML | 1 |
| Andersson, LC; Capdeville, R; Demetri, GD; Dimitrijevic, S; Druker, B; Joensuu, H; Roberts, PJ; Sarlomo-Rikala, M; Silberman, S; Tervahartiala, P; Tuveson, D | 1 |
| Ahn, IM; Cho, BY; Chung, JK; Hong, SJ; Kim, S; Lee, DS; Lee, E; Lee, MC; So, Y; Yeo, JS; Youn, YK | 1 |
| Bleichrodt, RP; Filez, L; Flamen, P; Hoekstra, OS; Homans, F; Maes, A; Mortelmans, L; Peeters, M; Penninckx, F; Stroobants, S; Van Cutsem, E | 1 |
| Hwang, KH; Kim, MK; Kim, S; Park, CH; Yoon, SN | 1 |
| DePalatis, LR; Desai, DC; Martin, EW; Soble, D; Zervos, EE | 1 |
| Kato, T; Katoh, C; Kuge, Y; Mabuchi, M; Morita, K; Nakada, K; Shiga, T; Tamaki, N; Tsukamoto, E; Yoshinaga, K | 1 |
| Burger, C; Dimitrakopoulou-Strauss, A; Heichel, T; Lehnert, T; Mechtersheimer, G; Schwarzbach, M; Strauss, LG; Willeke, F | 1 |
| Ackermann, R; Börner, AR; Coenen, HH; Hamacher, K; Herzog, H; Langen, KJ; Müller-Mattheis, V | 1 |
| Borges-Neto, S; Ravizzini, GC; Wagner, M | 1 |
| Fujii, S; Higuchi, T; Ishimori, T; Konishi, J; Mamede, M; Mandai, M; Nakamoto, Y; Saga, T; Sakahara, H; Togashi, K | 1 |
| Franzius, C; Schober, O; Schürmann, G; Senninger, N; Twelker, L | 1 |
| Cho, BY; Chung, JK; Jang, JJ; Jeong, JM; Lee, DS; Lee, MC; Lee, YJ; Min, JJ | 1 |
| Bajzik, G; Dabasi, G; Esik, O; Füzy, M; Kásler, M; Lengyel, Z; Perner, F; Repa, I; Szakáll, S; Szavcsur, P; Szentirmay, Z; Trón, L | 1 |
| Abdul-Karim, FW; Faulhaber, P; Miraldi, F; Rose, PG | 1 |
| Knoll, P; Kohn, H; Mirzaei, S | 1 |
| Avril, N; Link, T; Peschel, C; Sandherr, M; Stock, K; von Bubnoff, N; von Schilling, C | 1 |
| Ho, ST; Ho, YJ; Kao, CH; Tsai, SC; Wang, JJ; Yen, RF | 1 |
| Choe, KJ; Chung, JK; Kim, TS; Lee, DS; Lee, MC; Moon, WK; Noh, DY; Oh, SK; Youn, YK | 1 |
| Haberkorn, U | 1 |
| Bockisch, A; Franzius, C; Hillmann, A; Jürgens, H; Schober, O; Schulte, M; Winkelmann, W | 1 |
| Amthauer, H; Felix, R; Schlag, PM; Stroszczynski, C | 1 |
| Fukuchi, K; Hayashida, K; Horita, Y; Inenaga, T; Ishida, Y; Suzuki, Y | 1 |
| Coates, G; Nahmias, C; Rawlinson, J; Skehan, SJ; Somers, S; Zealley, IA | 1 |
| Arnold, MW; Badgwell, BD; Burak, WE; Martin, EW; Zervos, EE | 1 |
| Biemann, S; Buell, U; Nowak, B; Rath, W; Schröder, W; Siggelkow, W; Zimny, M | 1 |
| Derlon, JM | 1 |
| Courtois, A; De Dreuille, O; Foehrenbach, H; Gaillard, JF; Garcia, D; Kossowski, M; Maszelin, P; Merlet, P; Poncet, JL | 1 |
| Ball, DL; Hicks, RJ; Kalff, V; MacManus, MP; Matthews, JP; McKenzie, AF; Ware, RE | 1 |
| Ansén, S; Bischoff, S; Bohlen, H; Diehl, V; Dietlein, M; Re, D; Scheidhauer, K; Schicha, H; Tesch, H; Weihrauch, MR; Wolf, J | 1 |
| Fukunaga, H; Furukawa, J; Ikenaga, M; Katsumoto, Y; Maruyama, K; Maruyama, N; Nakaguchi, K; Nakamura, M; Okajima, S; Sekimoto, K; Shingai, T; Sue, F | 1 |
| Broelsch, EC; Clausen, M; Frilling, A; Görges, R; Tecklenborg, K; Weber, F | 1 |
| Chao, HT; Cho, YH; Liu, RS; Ng, HT; Wang, PH; Yuan, CC | 1 |
| Arulampalam, T; Boulos, P; Costa, D; Ell, P; Taylor, I; Visvikis, D | 1 |
| Alavi, A; Aronchick, JM; Lee, J | 1 |
| Bongers, V; Hordijk, GJ; Terhaard, CH; van Rijk, PP | 1 |
| Arulampalam, TH; Bomanji, JB; Costa, DC; Ell, PJ | 1 |
| Bombardieri, E; Crippa, F | 1 |
| Arisaka, Y; Higashi, K; Nambu, Y; Oguchi, M; Sakuma, T; Seki, H; Taki, S; Tonami, H; Ueda, Y; Yamamoto, I | 1 |
| Gambhir, SS; Park, KC; Schwimmer, J | 1 |
| Colder, CD; Herder, GJ; Hoekstra, OS; Postmus, PE; Smit, EF; Teule, GJ; van den Bergh, JH; van Mansom, I; van Mourik, JC; van Velthoven, PC; Verboom, P | 1 |
| Achtyes, ED; Eisbruch, A; Johnston, CM; Nakamoto, Y; Reynolds, KR; Sugawara, Y; Wahl, RL | 1 |
| Kubota, K | 1 |
| Gallowitsch, HJ; Gasser, J; Haselbach, H; Heinisch, M; Igerc, I; Kresnik, E; Kumnig, G; Lind, P; Mikosch, P | 1 |
| Alavi, A; Bénard, F; Hustinx, R | 1 |
| Becherer, A; Dudczak, R; Greinix, HT; Jaeger, U; Kalhs, P; Karanikas, G; Kletter, K; Mitterbauer, M; Pötzi, C; Raderer, M | 1 |
| Arslan, N; Rydzewski, B | 1 |
| Daldrup-Link, HE; Franzius, C; Heindel, WL; Jürgens, H; Schober, O; Sciuk, J; Wagner-Bohn, A | 1 |
| Bares, R; Bokemeyer, C; Claussen, CD; Dohmen, BM; Kanz, L; Kollmannsberger, C; Oechsle, K; Pfannenberg, A | 1 |
| Ricart, Y | 1 |
| Cabrera Villegas, A; Gámez Cenzano, C; Martín Urreta, JC | 1 |
| Fukunaga, H; Higuchi, I; Ikeda, M; Ikenaga, M; Monden, M; Ohue, M; Sekimoto, M; Seshimo, I; Takayama, O; Tatsumi, M; Yamamoto, H; Yasui, M | 1 |
| Alberini, JL; Bertrand-Kermorgant, F; Floiras, JL; Goupil, A; Mechelany-Corone, C; Pecking, AP; Pichon, MF | 1 |
| Aquino, SL; Asmuth, JC; Fischman, AJ; Moore, RH; Weise, SB | 1 |
| Laking, GR; Price, PM | 1 |
| Conessa, C; Foehrenbach, H; Gaillard, JF; Kossowski, M; Maszelin, P; Poncet, JL | 1 |
| Aitken, CL; Kramer, EL; Maguire, GQ; Mahmoud, F; McGuinness, G; Noz, ME | 1 |
| Bormans, G; De Potter, T; Filez, L; Flamen, P; Maes, A; Mortelmans, L; Penninckx, F; Van Cutsem, E | 1 |
| Grahek, D; Kerrou, K; Mayaud, C; Montravers, F; Regnard, JF; Talbot, JN; Younsi, N | 1 |
| Chung, JK; Jeong, JM; Jung, HW; Kim, SK; Kim, YK; Lee, DS; Lee, MC; Lee, YJ; Paek, S; Yeo, JS | 1 |
| Kao, CH; Shen, YY; Shiau, YC; Yen, RF | 1 |
| Binns, D; Hicks, RJ; Hogg, A; Kalff, V; McKenzie, AF; Ware, RE | 1 |
| Markman, M | 1 |
| Adèr, HJ; Boers, M; Comans, EF; De Gast, GC; Hoekstra, OS; Mijnhout, GS; Raijmakers, P; Teule, GJ | 1 |
| Even-Sapir, E; Figer, A; Gutman, M; Inbar, M; Lerman, H; Livshitz, G; Rabau, M | 1 |
| Arocena, J; Berian, JM; Fernandez, JM; Gimenez, M; Lopez, J; Robles, JE; Rosell, D; Sanchez, D; Sanz, G; Zudaire, JJ | 1 |
| Grigsby, PW; Miller, TR | 1 |
| Futatsubashi, M; Kanno, T; Maeda, M; Nobezawa, S; Okada, H; Ouchi, Y; Takekuma, M; Torizuka, T; Yoshikawa, E | 1 |
| Dagdelen, O; Hahn, K; Jäger, L; Lang, S; Pöpperl, G; Tatsch, K; Tiling, R | 1 |
| Garg, K; Lynch, DA | 1 |
| Avril, N; Dose, J; Rosé, C | 1 |
| Cho, BJ; Chung, SK; Haynie, TP; Kim, CG; Kim, EE; Moser, RP; Podoloff, DA; Tilbury, RS; Yang, DJ; Yung, WK | 1 |
| Dimitrakopoulou, A; Engenhart, R; Haberkorn, U; Oberdorfer, F; Ostertag, H; Romahn, J; Strauss, LG; van Kaick, G | 1 |
| Ishigaki, T; Ishiguchi, T; Ito, K; Kato, T; Oshima, M; Sakuma, S; Tadokoro, M | 1 |
| Fukumura, T; Ichiya, Y; Jingu, K; Kuwabara, Y; Masuda, K; Otsuka, M; Tahara, T; Yoshikai, T | 1 |
| Burger, PC; Coleman, RE; Friedman, AH; Glantz, MJ; Hanson, MW; Herndon, JE; Hoffman, JM; Meisler, WJ; Schold, SC | 1 |
| Fujita, H; Higano, S; Inugami, A; Kanno, I; Mineura, K; Murakami, M; Ogawa, T; Shishido, F; Uemura, K; Yasui, N | 1 |
| Dimitrakopoulou, A; Herfarth, C; Lehner, B; Schlag, P; Strauss, L | 1 |
| Georgi, P; Herfarth, C; Lehner, B; Schlag, P; Strauss, LG | 1 |
| Budinger, TF; Doyle, WK; Gutin, PH; Levin, VA; Silver, P; Valk, PE | 1 |
| De Michele, D; Di Chiro, G; Doppman, JL; Ito, M; Katz, DA; Kufta, CV; Larson, SM; Oldfield, E; Patronas, NJ; Wright, DC | 1 |
| De Michele, DJ; Di Chiro, G; Hatazawa, J; Katz, DA; Rizzoli, HV | 1 |
294 review(s) available for fluorodeoxyglucose f18 and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Impact of Follow-up 18F-FDG PET on the Management in Patients With Lung Cancer: A Meta-analysis.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Neoplasm Recurrence, Local | 2021 |
The Role of FDG-PET and Whole-Body MRI in High Grade Bone Sarcomas With Particular Focus on Osteosarcoma.
Topics: Adolescent; Bone Neoplasms; Child; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Osteosarcoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Young Adult | 2022 |
Systematic review and meta-analysis of the diagnostic effectiveness of positron emission tomography-computed tomography versus magnetic resonance imaging in the post-treatment surveillance of head and neck squamous cell carcinoma.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck | 2023 |
The role of prostate-specific membrane antigen PET/computed tomography in the management of prostate cancer patients: could we ask for more?
Topics: Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prospective Studies; Prostate; Prostatic Neoplasms | 2022 |
FDG-PET/CT for Primary Staging and Detection of Recurrence of Breast Cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
Comparison of the Detection Performance Between FAP and FDG PET/CT in Various Cancers: A Systemic Review and Meta-analysis.
Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2023 |
Contribution of nuclear medicine to the diagnosis and management of primary brain tumours.
Topics: Amino Acids; Brain Neoplasms; Fluorodeoxyglucose F18; Glioma; Humans; Lymphoma; Meningeal Neoplasms; Meningioma; Neoplasm Recurrence, Local; Nuclear Medicine; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
Effectiveness of PET/CT and VATS for detecting and treating internal mammary lymph node metastasis: a case series.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Thoracic Surgery, Video-Assisted | 2023 |
Topics: Acetogenins; Acute Disease; Acute Kidney Injury; Administration, Intravenous; Aged; Albumins; Alcoholism; Aldehyde Dehydrogenase; Aldehyde Dehydrogenase, Mitochondrial; alpha-Glucosidases; Anemia; Animals; Anthozoa; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bacterial; Antigens, Bacterial; Antihypertensive Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Ascites; Asthma; Bacteria; beta-Lactamases; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Binding Sites; Biological Availability; Biomass; Borderline Personality Disorder; Brain; Brucella abortus; Brucella melitensis; Brucellosis; Calcium; Carbapenems; Case-Control Studies; Caseins; Cattle; CD8-Positive T-Lymphocytes; Ceftaroline; Cell Line; Cell Line, Tumor; Cell Physiological Phenomena; Cell Proliferation; Cephalosporins; Chemotherapy, Adjuvant; China; Chitin; Chlorella; Chlorophyll; Chlorophyll A; Chlorophyta; Cholangiocarcinoma; Cisplatin; Conotoxins; Contrast Media; Conus Snail; Cross-Sectional Studies; Cytokines; Decapodiformes; Deoxycytidine; Diagnostic and Statistical Manual of Mental Disorders; Dietary Fiber; Diterpenes; DNA Methylation; Dogs; Double-Blind Method; Drug Design; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Screening Assays, Antitumor; Eicosapentaenoic Acid; Enzyme-Linked Immunosorbent Assay; Epidermis; Escherichia coli; Escherichia coli Infections; Extraintestinal Pathogenic Escherichia coli; Fatty Acids; Fatty Acids, Unsaturated; Fatty Acids, Volatile; Feasibility Studies; Feces; Female; Ferritins; Fluorodeoxyglucose F18; Gastrectomy; Gastrointestinal Microbiome; Gemcitabine; Glomerular Filtration Rate; Glucose; Glycerol; Granulocyte-Macrophage Colony-Stimulating Factor; HeLa Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia-Inducible Factor-Proline Dioxygenases; Immunoassay; Immunoglobulin G; India; Infant, Newborn; Infertility; Inflammation; Intensive Care Units; Iron; Iron Deficiencies; Kidney; Lacticaseibacillus rhamnosus; Laurencia; Leukocytes; Lipids; Liver Cirrhosis; Long Interspersed Nucleotide Elements; Longitudinal Studies; Male; Mesenchymal Stem Cells; Methicillin-Resistant Staphylococcus aureus; Mice; Microalgae; Microbial Sensitivity Tests; Microscopy; Middle Aged; Minerals; Molecular Conformation; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Myeloid Cells; Myeloid-Derived Suppressor Cells; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Nephropidae; Nicotinic Antagonists; Nitrogen; Obesity; Oxaliplatin; Paclitaxel; Panax; Pancreatic Neoplasms; Pancreatitis; Personality; Personality Disorders; Personality Inventory; Photobioreactors; Plant Extracts; Plasmalogens; Plasmids; Polymorphism, Genetic; Polynesia; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prebiotics; Predictive Value of Tests; Prognosis; Prolyl-Hydroxylase Inhibitors; Rabbits; Radiopharmaceuticals; Rats; Rats, Wistar; Receptors, Nicotinic; Recombinant Proteins; Retrospective Studies; Rifampin; Risk Factors; RNA, Ribosomal, 16S; Salinity; Seaweed; Sensitivity and Specificity; Sepsis; Sesquiterpenes; Severity of Illness Index; Shock, Septic; Silicones; Single Photon Emission Computed Tomography Computed Tomography; Skin; Snails; Solubility; Solvents; Sputum; Staphylococcal Infections; Stomach Neoplasms; Stramenopiles; Structure-Activity Relationship; Technetium Tc 99m Exametazime; Technology; Terpenes; Tuberculosis; Tuberculosis, Multidrug-Resistant; Urinary Catheters; Urinary Tract Infections; Vascular Endothelial Growth Factor A; Virulence Factors; Water; Wound Healing | 2023 |
Diagnostic Performance of Positron Emission Tomography with Fibroblast-Activating Protein Inhibitors in Gastric Cancer: A Systematic Review and Meta-Analysis.
Topics: Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Stomach Neoplasms | 2023 |
Impact of 18 F-FDG PET on the Management in Patients With Recurrent Gynecologic cancer : A Meta-analysis.
Topics: Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2023 |
[Importance of FDG-PET/computed tomography in colorectal cancer].
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2019 |
Role of 18F-Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for the Detection of Recurrent Disease after Treatment of Malignant Melanoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Young Adult | 2019 |
Multimodality Imaging of Prostate Cancer.
Topics: Aged; Antigens, Surface; Carboxylic Acids; Choline; Cyclobutanes; Disease Progression; Fluorodeoxyglucose F18; Glutamate Carboxypeptidase II; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Multiparametric Magnetic Resonance Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Radionuclide Imaging; Theranostic Nanomedicine; Tomography, X-Ray Computed; Whole Body Imaging | 2019 |
18F-FDG PET/CT in Restaging and Evaluation of Response to Therapy in Lung Cancer: State of the Art.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals | 2020 |
Recurrence of nasal type NK/T cell lymphoma presenting as neurolymphomatosis on 18F-FDG PET/CT: A case report and literature review.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Neurolymphomatosis; Nose Neoplasms; Positron Emission Tomography Computed Tomography | 2020 |
Diagnostic Evaluation of 18F-FDG PET/CT Imaging in Recurrent or Residual Urinary Bladder Cancer: A Meta-Analysis.
Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Urinary Bladder Neoplasms | 2020 |
Correlation between fluorodeoxyglucose hotspots on preradiotherapy PET/CT and areas of cancer local relapse: Systematic review of literature.
Topics: Anatomic Landmarks; Esophageal Neoplasms; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasms; Patient Positioning; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Rectal Neoplasms; Retrospective Studies | 2020 |
Functional imaging using radiomic features in assessment of lymphoma.
Topics: Diffusion Magnetic Resonance Imaging; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphoma; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Progression-Free Survival; Radiopharmaceuticals; Risk Assessment; Tumor Burden | 2021 |
18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in muscle-invasive bladder cancer.
Topics: Cystectomy; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Muscles; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Urinary Bladder Neoplasms | 2020 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea | 2022 |
Radiomics in Hepatocellular Carcinoma.
Topics: Carcinoma, Hepatocellular; Clinical Decision-Making; Early Detection of Cancer; Fluorodeoxyglucose F18; Genomics; Humans; Image Processing, Computer-Assisted; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Precision Medicine; Prognosis; Risk Assessment; Survival Rate; Tomography, X-Ray Computed | 2020 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Diagnostic performance of PET/CT and PET/MR in the management of ovarian carcinoma-a literature review.
Topics: Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2021 |
Radiomics for the Prediction of Treatment Outcome and Survival in Patients With Colorectal Cancer: A Systematic Review.
Topics: Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Rectal Neoplasms; Rectum; Risk Assessment; Treatment Outcome | 2021 |
Diagnostic Accuracy of 18F-FDG-PET/CT and MRI in Predicting the Tumor Response in Locally Advanced Cervical Carcinoma Treated by Chemoradiotherapy: A Meta-Analysis.
Topics: Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2021 |
Role of FDG PET in the staging of multiple myeloma.
Topics: Fluorodeoxyglucose F18; Humans; Multiple Myeloma; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
First reported PET positive, FDG avid free flap pedicle ossification and review of the literature.
Topics: Fluorodeoxyglucose F18; Free Tissue Flaps; Humans; Neoplasm Recurrence, Local; Ossification, Heterotopic; Osteogenesis; Plastic Surgery Procedures; Positron Emission Tomography Computed Tomography | 2021 |
PET/CT Limitations and Pitfalls in Urogenital Cancers.
Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Urogenital Neoplasms | 2021 |
The Role of PET in Supratentorial and Infratentorial Pediatric Brain Tumors.
Topics: Brain Neoplasms; Child; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
Spleen Glucose Metabolism on [18F]-FDG PET/CT for Cancer Drug Discovery and Development cannot be Overlooked.
Topics: Drug Discovery; Fluorodeoxyglucose F18; Glucose; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Spleen; Tumor Microenvironment | 2021 |
FDG-PET/CT in the Postoperative Period: Utility, Expected Findings, Complications, and Pitfalls.
Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postoperative Period; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2017 |
Diagnostic Accuracy of Amino Acid and FDG-PET in Differentiating Brain Metastasis Recurrence from Radionecrosis after Radiotherapy: A Systematic Review and Meta-Analysis.
Topics: Brain Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiation Injuries; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity | 2018 |
The Evolving Role of FDG-PET/CT in the Diagnosis, Staging, and Treatment of Breast Cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Sensitivity and Specificity | 2019 |
Concurrent benign metastasizing leiomyoma in the lung and lumbar spine with elevated standardized uptake value level in positron-emission tomography computed tomography: A case report and literature review.
Topics: Diagnosis, Differential; Estrogen Antagonists; Female; Fluorodeoxyglucose F18; Humans; Leiomyoma; Lumbar Vertebrae; Lung Neoplasms; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Spinal Neoplasms; Tamoxifen; Uterine Neoplasms | 2018 |
18F-FDG PET with or without CT in the diagnosis of extrahepatic metastases or local residual/recurrent hepatocellular carcinoma.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2018 |
The diagnostic performance of CT versus FDG PET-CT for the detection of recurrent pancreatic cancer: a systematic review and meta-analysis.
Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Pancreas; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2018 |
[Positron emission tomography in germ cell tumors in men : Possibilities and limitations].
Topics: Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Testicular Neoplasms | 2019 |
Molecular Imaging for Evaluation of Viable Testicular Cancer Nodal Metastases.
Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Molecular Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Positron-Emission Tomography; Radiopharmaceuticals; Retroperitoneal Space; Seminoma; Testicular Neoplasms | 2018 |
Effectiveness of 18F-FDG PET/CT in the diagnosis, staging and recurrence monitoring of Ewing sarcoma family of tumors: A meta-analysis of 23 studies.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Odds Ratio; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; ROC Curve; Sarcoma, Ewing; Sensitivity and Specificity; Young Adult | 2018 |
Case report of epithelioid osteoblastoma of the mandible: findings on positron emission tomography/computed tomography and review of the literature.
Topics: Adult; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Mandible; Mandibular Neoplasms; Neoplasm Recurrence, Local; Osteoblastoma; Positron Emission Tomography Computed Tomography | 2019 |
Emerging role of
Topics: Biomarkers, Tumor; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Selection; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Treatment Outcome; Tumor Burden | 2019 |
Relapsed ovarian cancer - diagnosis using 18F-FDG PET/CT; 4.
Topics: Brazil; Clinical Decision-Making; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2019 |
Cervical cancer - staging and restaging with 18F-FDG PET/CT.
Topics: Brazil; Clinical Decision-Making; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Uterine Cervical Neoplasms | 2019 |
Molecular radionuclide imaging of pancreatic neoplasms.
Topics: Carcinoma, Pancreatic Ductal; Fluorodeoxyglucose F18; Forecasting; Genes, Neoplasm; Humans; Mutation; Neoplasm Recurrence, Local; Neoplasm Staging; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals | 2019 |
Lung Cancer Recurrence:
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2019 |
Use of FDG-PET or PET/CT to detect recurrent colorectal cancer in patients with elevated CEA: a systematic review and meta-analysis.
Topics: Carcinoembryonic Antigen; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; ROC Curve; Tomography, X-Ray Computed | 2013 |
What is currently the best radiopharmaceutical for the hybrid PET/CT detection of recurrent medullary thyroid carcinoma?
Topics: Amines; Blood Glucose; Bone and Bones; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiation Dosage; Radiopharmaceuticals; Receptors, Somatostatin; Thyroid Neoplasms; Tomography, X-Ray Computed | 2013 |
18FDG PET-CT for detecting gastric cancer recurrence after surgical resection: a meta-analysis.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Meta-Analysis as Topic; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Complications; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
18F-fluorodeoxyglucose positron emission tomography-computed tomography as a diagnostic tool in patients with cervical nodal metastases of unknown primary site: a meta-analysis.
Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Meta-Analysis as Topic; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
The role of PET/CT in the management of cervical cancer.
Topics: Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Risk Factors; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2013 |
Imaging of the non-traumatic brachial plexus.
Topics: Brachial Plexus; Brachial Plexus Neuropathies; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Nerve Compression Syndromes; Neurilemmoma; Neurofibroma; Neurologic Examination; Peripheral Nervous System Neoplasms; Positron-Emission Tomography; Radiation Injuries; Reference Values; Sensitivity and Specificity; Syndrome; Thoracic Outlet Syndrome | 2013 |
Imaging appearances for recurrent nasopharyngeal carcinoma and post-salvage nasopharyngectomy.
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Nasopharynx; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2013 |
Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography imaging in uterine sarcomas: systematic review and meta-analysis of the literature.
Topics: Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Uterine Neoplasms | 2013 |
Role of positron emission tomography-computed tomography in gastrointestinal malignancies.
Topics: Contrast Media; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals | 2013 |
PET/computed tomography and lymphoma.
Topics: Artifacts; Fluorodeoxyglucose F18; Humans; Lymphoma; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals | 2013 |
Role of positron emission tomography/computed tomography (PET/CT) in head and neck cancer.
Topics: Contrast Media; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity | 2013 |
PET/CT in gynecologic malignancies.
Topics: Contrast Media; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals | 2013 |
[Clinical use of 18F-FDG PET/CT in colorectal carcinoma].
Topics: Carcinoma; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Is there a role for FDG-PET for the assessment of treatment efficacy in Wilms' tumor? A case report and literature review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Time Factors; Wilms Tumor | 2013 |
Diagnostic value of 18F-FDG-PET or PET-CT in recurrent cervical cancer: a systematic review and meta-analysis.
Topics: Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2014 |
Clinical application of 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Mammography; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Recurrent and metastatic breast cancer PET, PET/CT, PET/MRI: FDG and new biomarkers.
Topics: Biomarkers, Tumor; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
18FDG PET-CT for distant metastases in patients with recurrent head and neck cancer after definitive treatment. A meta-analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Salvage Therapy; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2014 |
Radiation therapy for retroperitoneal sarcoma.
Topics: Chemotherapy, Adjuvant; Dose-Response Relationship, Radiation; Evidence-Based Medicine; Fluorodeoxyglucose F18; Histiocytoma, Malignant Fibrous; Humans; Leiomyosarcoma; Liposarcoma; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Retroperitoneal Neoplasms; Risk Assessment; Risk Factors; Sarcoma; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
[FDG-PET/CT in staging of breast carcinoma: use in tumour stage III and locoregional recurrent breast carcinoma].
Topics: Aged; Breast Neoplasms; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
[Importance of FDG-PET/CT for surgery of rectal cancer].
Topics: Diagnosis, Differential; Disease Progression; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Molecular Imaging; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Rectal Neoplasms; Rectum; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Diagnosis and evaluation of gastric cancer by positron emission tomography.
Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Comparison of magnetic resonance spectroscopy and positron emission tomography in detection of tumor recurrence in posttreatment of glioma: A diagnostic meta-analysis.
Topics: Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Spectroscopy; Neoplasm Recurrence, Local; Positron-Emission Tomography | 2015 |
Diagnosis of recurrent uterine cervical cancer: PET versus PET/CT: a systematic review and meta-analysis.
Topics: Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2014 |
FDG PET/CT in the management of nasopharyngeal carcinoma.
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2014 |
Imaging of oesophageal cancer with FDG-PET/CT and MRI.
Topics: Antineoplastic Protocols; Diffusion Magnetic Resonance Imaging; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Magnetic Resonance Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
[Multimodality MRI and PET for restaging prostate cancer after biochemical failure of the treatment].
Topics: Adenocarcinoma; Brachytherapy; Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Radiopharmaceuticals; Salvage Therapy | 2014 |
[Radiological evaluation of the tumour response after lung stereotactic radiotherapy].
Topics: Aftercare; Algorithms; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Disease-Free Survival; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Incidence; Lung Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiation Injuries; Radiation Pneumonitis; Radiopharmaceuticals; Radiosurgery; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Aggressive primary olfactory neuroblastoma of the sphenoclival region: a case report and literature review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Disease Progression; Esthesioneuroblastoma, Olfactory; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiotherapy, Adjuvant; Rare Diseases; Skull Base; Sphenoid Sinus; Tomography, X-Ray Computed | 2015 |
Accuracy of positron emission tomography and positron emission tomography-CT in the detection of differentiated thyroid cancer recurrence with negative (131) I whole-body scan results: A meta-analysis.
Topics: Adenocarcinoma, Follicular; Carcinoma, Papillary; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2016 |
18F-DOPA and 18F-FDG PET/CT, scintigraphic localization and radioguided surgery of recurrent medullary thyroid cancer: two case reports.
Topics: Adult; Aged; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Surgery, Computer-Assisted; Thyroid Neoplasms; Tomography, Emission-Computed | 2014 |
Evaluation of gynecologic cancer with MR imaging, 18F-FDG PET/CT, and PET/MR imaging.
Topics: Coordination Complexes; Estradiol; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Neoplasm Recurrence, Local; Organometallic Compounds; Ovarian Neoplasms; Positron-Emission Tomography; Prognosis; Salvage Therapy; Thiosemicarbazones; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Uterine Neoplasms | 2015 |
Diagnostic Value of (18)F-FDG PET/CT in Detecting Local Recurrent Colorectal Cancer: A Pooled Analysis of 26 Individual Studies.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2015 |
Role of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography in gastrointestinal cancers.
Topics: Digestive System Neoplasms; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Recurrence, Local; Neuroendocrine Tumors; Patient Care Planning; Positron-Emission Tomography; Practice Guidelines as Topic; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
A meta-analysis comparing 18F-FLT PET with 18F-FDG PET for assessment of brain tumor recurrence.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Young Adult | 2015 |
PET Imaging of Breast Cancer: Role in Patient Management.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Estradiol; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
PET with Fluorodeoxyglucose F 18/Computed Tomography in the Clinical Management and Patient Outcomes of Esophageal Cancer.
Topics: Aged; Chemoradiotherapy, Adjuvant; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Outcome Assessment; Positron-Emission Tomography; Radiography, Interventional; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
PET/Computed Tomography and Patient Outcomes in Melanoma.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Outcome Assessment; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Skin Neoplasms; Survival Analysis; Tomography, X-Ray Computed | 2015 |
Diagnostic Performance of ¹⁸F-FDG PET and PET/CT for the Detection of Recurrent Esophageal Cancer After Treatment with Curative Intent: A Systematic Review and Meta-Analysis.
Topics: Biopsy; Esophageal Neoplasms; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Quality Control; Recurrence; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
FDG PET/CT for Management and Assessing Outcomes of Squamous Cell Cancer of the Oral Cavity.
Topics: Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Mouth Neoplasms; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Squamous Cell; Patient Care Planning; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Analysis; Tomography, X-Ray Computed | 2015 |
[18F]Fluorodeoxyglucose PET/Computed Tomography in Gastrointestinal Malignancies.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2014 |
[18F]Fluorodeoxyglucose PET for Interventional Oncology in Liver Malignancy.
Topics: Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
PET/Computed Tomography in the Diagnosis and Staging of Gastric Cancers.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Gastrointestinal Diseases; Humans; Lymph Nodes; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2015 |
Impact of Fluorodeoxyglucose PET/Computed Tomography on the Management of Patients with Colorectal Cancer.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
(18)F-Flourodeoxy-Glucose PET/Computed Tomography in Brain Tumors: Value to Patient Management and Survival Outcomes.
Topics: Brain Neoplasms; Early Detection of Cancer; Fluorodeoxyglucose F18; Glioma; Humans; Lymphoma; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Precancerous Conditions; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
F18-FDG-PET for recurrent differentiated thyroid cancer: a systematic meta-analysis.
Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2016 |
Hodgkin Lymphoma: the Changing Role of Radiation Therapy in Early-Stage Disease—the Role of Functional Imaging.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Combined Modality Therapy; Disease-Free Survival; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Tomography, X-Ray Computed | 2015 |
Diagnostic Accuracy of Follow-Up FDG PET or PET/CT in Patients With Head and Neck Cancer After Definitive Treatment: A Systematic Review and Meta-Analysis.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Performance of Positron Emission Tomography and Positron Emission Tomography/Computed Tomography Using Fluorine-18-Fluorodeoxyglucose for the Diagnosis, Staging, and Recurrence Assessment of Bone Sarcoma: A Systematic Review and Meta-Analysis.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Osteosarcoma; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
[Role of positron emission tomography and CT with 18F-FDG PET-CT in follow-up of patients treated for head and neck squamous cell carcinoma].
Topics: Carcinoma, Squamous Cell; Early Detection of Cancer; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
18F-FDG PET/CT for the Diagnosis of Residual or Recurrent Nasopharyngeal Carcinoma After Radiotherapy: A Metaanalysis.
Topics: Adolescent; Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Young Adult | 2016 |
Comparison of 18F-FDG PET/CT, MRI and SPECT in the diagnosis of local residual/recurrent nasopharyngeal carcinoma: A meta-analysis.
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2016 |
Evidence-based medicine and clinical fluorodeoxyglucose PET/MRI in oncology.
Topics: Early Detection of Cancer; Evidence-Based Medicine; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
Role of PET/Computed Tomography in Radiofrequency Ablation for Malignant Pulmonary Tumors.
Topics: Catheter Ablation; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
Pulmonary imaging after stereotactic radiotherapy-does RECIST still apply?
Topics: Ablation Techniques; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Observer Variation; Oncologists; Perfusion Imaging; Positron Emission Tomography Computed Tomography; Radiologists; Radiopharmaceuticals; Radiosurgery; Response Evaluation Criteria in Solid Tumors; Tomography, X-Ray Computed; Treatment Outcome | 2016 |
Functional Imaging Using 18-Fluorodeoxyglucose PET in the Management of Primary Mediastinal Large B-Cell Lymphoma: The Contributions of the International Extranodal Lymphoma Study Group.
Topics: Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2016 |
Diagnostic efficacy of 18F-FDG-PET or PET/CT in breast cancer with suspected recurrence: a systematic review and meta-analysis.
Topics: Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
[Positron emission tomography/computed tomography in follow-up programmes for patients with colorectal cancer].
Topics: Aftercare; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Practice Guidelines as Topic; Radiopharmaceuticals | 2016 |
The Value of FDG PET/CT in Treatment Response Assessment, Follow-Up, and Surveillance of Lung Cancer.
Topics: Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Outcome Assessment, Health Care; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Rate; Treatment Outcome | 2017 |
The role of 18F-FDG PET and PET/CT in the evaluation of primary cutaneous lymphoma.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Skin Neoplasms | 2017 |
18F-FDG PET/CT in the diagnosis of an extranodal relapse of diffuse large B-cell lymphoma (DLBCL): a clinical case with a literature review.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
Positron emission tomography for the diagnosis and management of patients with gastrointestinal malignancies.
Topics: Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed | 2008 |
Imaging of gynecologic malignancies with FDG PET-CT: case examples, physiologic activity, and pitfalls.
Topics: Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Neoplasm Recurrence, Local; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole Body Imaging | 2009 |
Medical management of persistent or recurrent differentiated thyroid carcinoma.
Topics: Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Risk Management; Thyroid Neoplasms; Thyroidectomy | 2008 |
Established, emerging and future roles of PET/CT in the management of colorectal cancer.
Topics: Colonoscopy; Colorectal Neoplasms; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Sensitivity and Specificity; Tomography, X-Ray Computed; United Kingdom | 2009 |
Surgical salvage of cancer of the oropharynx after chemoradiation.
Topics: Carcinoma, Squamous Cell; Combined Modality Therapy; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Positron-Emission Tomography; Quality of Life; Salvage Therapy; Treatment Failure | 2009 |
[PET and PET-CT of malignant tumors of the exocrine pancreas].
Topics: Adenocarcinoma; Carcinoma, Acinar Cell; Carcinoma, Pancreatic Ductal; Diagnosis, Differential; Disease Progression; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Pancreas; Pancreatic Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
[Advantages of PET-CT in the work-up of cervical cancer].
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Uterine Cervical Neoplasms | 2009 |
Investigations after adjuvant therapy.
Topics: Breast Neoplasms; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Genetic Counseling; Humans; Mammography; Neoplasm Recurrence, Local; Radiotherapy | 2009 |
F-18 FDG PET detection of a medullary thyroid carcinoma in a patient with metastatic colonic cancer; literature review.
Topics: Aged; Biopsy, Fine-Needle; Calcitonin; Carcinoembryonic Antigen; Carcinoma, Medullary; Colonic Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Thyroid Neoplasms; Thyroidectomy; Ultrasonography | 2009 |
[PET/CT in breast cancer: an update].
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Dideoxynucleosides; Estradiol; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sodium Fluoride; Treatment Outcome | 2009 |
Emerging apoptosis agonists for bladder cancer.
Topics: Antibodies, Monoclonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biomarkers, Tumor; Chemotherapy, Adjuvant; Clinical Trials as Topic; Combined Modality Therapy; Drug Resistance, Neoplasm; ErbB Receptors; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Prostatic Neoplasms; Urinary Bladder Neoplasms | 2009 |
[Imaging procedures for gastrointestinal stromal tumors].
Topics: Blood Glucose; Chemotherapy, Adjuvant; Diagnosis, Differential; Disease Progression; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrointestinal Stromal Tumors; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed | 2009 |
Novel imaging modalities in gynecologic cancer.
Topics: Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
18F-FDG PET/CT of transitional cell carcinoma.
Topics: Carcinoma, Transitional Cell; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2009 |
Spectrum of (18)F-FDG PET/CT appearances in peritoneal disease.
Topics: False Positive Reactions; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
[Metabolic imaging with positron-emission tomography in the advanced-stage ovarian cancers].
Topics: CA-125 Antigen; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2009 |
Present and future of PET and PET/CT in gynaecologic malignancies.
Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Forecasting; Genital Diseases, Female; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Role of PET/CT in ovarian cancer.
Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2010 |
The role of functional imaging in colorectal cancer.
Topics: Colorectal Neoplasms; Contrast Media; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neovascularization, Pathologic; Patient Selection; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Whole Body Imaging | 2010 |
Opportunities for PET to deliver clinical benefit in cancer: breast cancer as a paradigm.
Topics: Biomarkers, Tumor; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
[PET/CT for diagnostics and therapy stratification of lung cancer].
Topics: Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Diagnosis, Differential; Disease Progression; Energy Metabolism; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiographic Image Enhancement; Radiotherapy Planning, Computer-Assisted; Sensitivity and Specificity; Tomography, Spiral Computed; Tomography, X-Ray Computed | 2010 |
Limits of ¹⁸F-fluorodeoxyglucose positron emission tomography in recurrence diagnosis of borderline ovarian tumor.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Pregnancy; Pregnancy Complications, Neoplastic; Radiopharmaceuticals; Tomography, X-Ray Computed | 2010 |
Cervical tumors.
Topics: Cervix Uteri; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed; Uterine Cervical Diseases; Uterine Cervical Neoplasms | 2010 |
Therapy response evaluation with positron emission tomography-computed tomography.
Topics: Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Neoplasm Recurrence, Local; Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
[Assessment of residual tumours after systemic treatment of metastatic seminoma: ¹⁸F-2-fluoro-2-deoxy-D-glucose positron emission tomography - meta-analysis of diagnostic value].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Seminoma; Sensitivity and Specificity; Testicular Neoplasms; Treatment Outcome; Young Adult | 2011 |
[PET-CT in thoracic disease].
Topics: Bronchial Diseases; Contraindications; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Diseases; Mediastinal Diseases; Neoplasm Recurrence, Local; Neoplasm Staging; Pleural Diseases; Positron-Emission Tomography; Pregnancy; Radiopharmaceuticals; Thoracic Diseases; Tomography, X-Ray Computed | 2010 |
Positron emission tomography for benign and malignant disease.
Topics: Breast Neoplasms; Colorectal Neoplasms; Dermatitis, Contact; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Melanoma; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2011 |
Does positron emission tomography offer prognostic information in malignant pleural mesothelioma?
Topics: Benchmarking; Biopsy; Diagnosis, Differential; Evidence-Based Medicine; Fluorodeoxyglucose F18; Humans; Mesothelioma; Neoplasm Recurrence, Local; Neoplasm Staging; Pleural Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Risk Assessment; Risk Factors; Survival Rate; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Japanese Gastric Cancer Association Task Force for Research Promotion: clinical utility of ¹⁸F-fluoro-2-deoxyglucose positron emission tomography in gastric cancer. A systematic review of the literature.
Topics: Early Detection of Cancer; Fluorodeoxyglucose F18; Gastric Mucosa; Glucose Transporter Type 1; Humans; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Stomach Neoplasms; Treatment Outcome | 2011 |
Positron emission tomography in non-medullary thyroid cancer.
Topics: Biomarkers, Tumor; Early Detection of Cancer; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Population Surveillance; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyroid Nodule; Thyrotropin | 2011 |
The role of 18F-fluorodeoxyglucose positron emission tomography in thyroid neoplasms.
Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Gland; Thyroid Neoplasms; Thyroid Nodule | 2011 |
PET and SPECT in brain tumors and epilepsy.
Topics: Brain; Brain Neoplasms; Cell Proliferation; Dideoxynucleosides; Epilepsy; Flumazenil; Fluorodeoxyglucose F18; GABA Modulators; Humans; Necrosis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2011 |
Recurrent pancreatic carcinoma and cholangiocarcinoma: 18F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT).
Topics: Carcinoma; Cholangiocarcinoma; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
[Positron emission tomography - current role in the diagnosis and treatment of upper gastrointestinal carcinomas].
Topics: Adenocarcinoma; Combined Modality Therapy; Dideoxynucleosides; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
[Contribution of FDG-PET in the management of pediatric sarcomas in 2011].
Topics: Bone Neoplasms; Child; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Organ Specificity; Osteosarcoma; Positron-Emission Tomography; Practice Guidelines as Topic; Prognosis; Radiopharmaceuticals; Sarcoma | 2011 |
Multimodality assessment of brain tumors and tumor recurrence.
Topics: Amino Acids; Brain Neoplasms; Diffusion Magnetic Resonance Imaging; Education, Medical, Continuing; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Hypoxia, Brain; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Tomography, X-Ray Computed | 2011 |
18F-FDG PET or PET/CT for detecting extrahepatic metastases or recurrent hepatocellular carcinoma: a systematic review and meta-analysis.
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
18 F-fluorodeoxyglucose positron emission tomography to evaluate recurrent gastric cancer: a systematic review and meta-analysis.
Topics: Contrast Media; Fluorodeoxyglucose F18; Humans; Likelihood Functions; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed | 2012 |
The use and misuse of positron emission tomography in lung cancer evaluation.
Topics: Carcinoma, Non-Small-Cell Lung; Diagnostic Errors; Fluorodeoxyglucose F18; Health Services Misuse; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2011 |
The role of neck dissection in the setting of chemoradiation therapy for head and neck squamous cell carcinoma with advanced neck disease.
Topics: Biopsy, Fine-Needle; Carcinoma, Squamous Cell; Chemoradiotherapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Neck Dissection; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
[FDG-PET and endometrial cancer].
Topics: Endometrial Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Estrogen; Sensitivity and Specificity | 2012 |
The value of [18F]fluorodeoxyglucose-PET/CT in oesophageal cancer.
Topics: Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
Optimizing the role of FDG PET-CT for potentially operable metastatic colorectal cancer.
Topics: Carcinoembryonic Antigen; Colonography, Computed Tomographic; Colorectal Neoplasms; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
How has the management of medullary thyroid carcinoma changed with the advent of 18F-FDG and non-18F-FDG PET radiopharmaceuticals.
Topics: Carcinoma, Medullary; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Proto-Oncogene Mas; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms | 2012 |
¹⁸F-FDG-PET and ¹⁸F-FDG-PET/CT in the detection of recurrent or metastatic medullary thyroid carcinoma: a systematic review and meta-analysis.
Topics: Carcinoma, Medullary; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, X-Ray Computed | 2012 |
FDG-PET for detecting local tumor recurrence of ablated liver metastases: a diagnostic meta-analysis.
Topics: Area Under Curve; Catheter Ablation; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Radiosurgery; ROC Curve; Tomography, X-Ray Computed | 2012 |
18[F]FDG-PET/CT is a useful molecular marker in evaluating tumour aggressiveness: a revised understanding of an in-vivo FDG-PET imaging that alludes the alteration of cancer biology.
Topics: Biomarkers, Tumor; Cell Dedifferentiation; Early Detection of Cancer; Fluorodeoxyglucose F18; Glycolysis; Humans; Multimodal Imaging; Mutation; Neoplasm Recurrence, Local; Neoplasms; Predictive Value of Tests; Sensitivity and Specificity; Survival Analysis | 2013 |
FDG PET and FDG PET/CT in patients with gastrointestinal stromal tumours.
Topics: Antineoplastic Agents; Benzamides; Blood Glucose; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Indoles; Molecular Targeted Therapy; Multimodal Imaging; Neoplasm Recurrence, Local; Piperazines; Positron-Emission Tomography; Prognosis; Pyrimidines; Pyrroles; Sensitivity and Specificity; Sunitinib; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
A head and neck radiologist's perspective on best practices for the usage of PET/CT scans for the diagnosis and treatment of head and neck cancers.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Lymphatic Metastasis; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Unknown Primary; Patient Care Planning; Positron-Emission Tomography; Practice Guidelines as Topic; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
A head and neck surgeon's perspective on best practices for the use of PET/CT scans for the diagnosis and treatment of head and neck cancers.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Unknown Primary; Patient Care Planning; Positron-Emission Tomography; Practice Guidelines as Topic; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Imaging of anal carcinoma.
Topics: Anus Neoplasms; Chemoradiotherapy; Endoscopy, Gastrointestinal; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Comparison of different positron emission tomography tracers in patients with recurrent medullary thyroid carcinoma: our experience and a review of the literature.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2013 |
Molecular imaging in the management of cervical cancer.
Topics: Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Uterine Cervical Neoplasms | 2012 |
Anal carcinoma: FDG PET/CT in staging, response evaluation, and follow-up.
Topics: Anus Neoplasms; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Treatment Outcome | 2013 |
Skull base chordomas: clinical features, prognostic factors, and therapeutics.
Topics: Biomarkers, Tumor; Chondrosarcoma; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neurosurgical Procedures; Positron-Emission Tomography; Postoperative Complications; Prognosis; Skull Base Neoplasms; Survival; Tomography, X-Ray Computed | 2013 |
Performance of FDG PET/CT in the clinical management of breast cancer.
Topics: Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sentinel Lymph Node Biopsy; Tomography, X-Ray Computed | 2013 |
PET/CT in the imaging of ovarian Cancer.
Topics: Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
Positron emission tomography for evaluation of colorectal carcinoma.
Topics: Carcinoma; Colorectal Neoplasms; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
Positron emission tomography imaging in melanoma and lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Melanoma; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
Esophageal cancer and head and neck cancer.
Topics: Esophageal Neoplasms; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
Evaluation of breast and gynecologic cancers by positron emission tomography.
Topics: Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
[Value of [18F]-fluorodeoxyglucose (FDG) positron emission tomography in digestive cancerology].
Topics: Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Neoplasm Recurrence, Local; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Overview of clinical PET.
Topics: Brain; Coronary Disease; Cost-Benefit Analysis; Epilepsy; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Myocardial Revascularization; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms; Patient Selection; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
Positron emission tomography in lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
Positron emission tomography scanning in gynecologic and breast cancers.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Predictive Value of Tests; Prognosis; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Value of whole-body FDG PET in management of lung cancer.
Topics: Drug Therapy, Computer-Assisted; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Reproducibility of Results; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, Emission-Computed; Whole-Body Counting | 2003 |
[Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in cancer of the upper aerodigestive tract].
Topics: Esophageal Neoplasms; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Second Primary; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed | 2003 |
[Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in urological cancers].
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Neoplasm Recurrence, Local; Prostatic Neoplasms; Radiopharmaceuticals; Seminoma; Testicular Neoplasms; Tomography, Emission-Computed; Urinary Bladder Neoplasms; Urologic Neoplasms | 2003 |
[Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in sarcomas].
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Radiopharmaceuticals; Sarcoma; Tomography, Emission-Computed; Treatment Outcome | 2003 |
PET imaging of osteosarcoma.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Osteosarcoma; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
Positron emission tomography of soft tissue sarcomas.
Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2003 |
PET/CT imaging in recurrent head and neck cancer.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray | 2003 |
PET in the follow-up of differentiated thyroid cancer.
Topics: Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Neoplasm Recurrence, Local; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms | 2003 |
Nuclear medicine imaging for the assessment of primary and recurrent head and neck carcinoma using routinely available tracers.
Topics: Carcinoma, Squamous Cell; Clinical Trials as Topic; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Nuclear Medicine; Radioisotopes; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2003 |
[Diagnosis of colorectal cancer with FDG-PET].
Topics: Colorectal Neoplasms; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
The role of positron emission tomographic imaging in breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed; Women's Health | 2004 |
The role of positron emission tomography in the management of colorectal cancer.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiography; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
PET/CT in oncology: integration into clinical management of lymphoma, melanoma, and gastrointestinal malignancies.
Topics: Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lymphoma; Melanoma; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Care Management; Radiopharmaceuticals; Subtraction Technique; Systems Integration; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
FDG PET and alternative imaging in the management of thyroid carcinoma.
Topics: Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Neoplasm Metastasis; Neoplasm Recurrence, Local; Patient Care Management; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed; Whole-Body Counting | 2003 |
PET imaging in pediatric Hodgkin's lymphoma.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Protocols; Child; Dose-Response Relationship, Drug; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
The role of positron emission tomography in germ cell cancer.
Topics: Antineoplastic Agents; Cisplatin; Fluorodeoxyglucose F18; Germinoma; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
[The interest of 18FDG-PET in the management of testicular cancer].
Topics: Adolescent; Adult; Diagnosis, Differential; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prognosis; Radiopharmaceuticals; Retrospective Studies; Seminoma; Testicular Neoplasms; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography | 2004 |
Positron emission tomography and colorectal carcinoma: an update.
Topics: Adenocarcinoma; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Mass Screening; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
Positron-emission tomography for head and neck cancer.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
FDG PET and tumour markers in the diagnosis of recurrent and metastatic breast cancer.
Topics: Biomarkers, Tumor; Breast Neoplasms; Clinical Trials as Topic; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity | 2004 |
Positron emission tomography in gastric and esophageal cancer.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Remission Induction; Stomach Neoplasms; Tomography, Emission-Computed | 2004 |
Positron emission tomography in the evaluation of lymphoma.
Topics: Citrates; Fluorodeoxyglucose F18; Gallium; Humans; Lymphatic Metastasis; Lymphoma; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
Positron emission imaging of head and neck cancer, including thyroid carcinoma.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Prognosis; Radiography; Radiopharmaceuticals; Subtraction Technique; Thyroid Neoplasms; Tomography, Emission-Computed | 2004 |
Neoplasms of the esophagus and stomach.
Topics: Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Stomach Neoplasms; Tomography, Emission-Computed; Treatment Outcome; Ultrasonography | 2004 |
PET and PET-CT for evaluation of colorectal carcinoma.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Subtraction Technique; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 2004 |
Current and future uses of positron emission tomography in breast cancer imaging.
Topics: Axilla; Biomarkers, Tumor; Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Receptors, Estrogen; Tomography, Emission-Computed; Treatment Outcome | 2004 |
Role of FDG-PET in the diagnosis and treatment of colorectal liver metastases.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neoplasm Recurrence, Local; Patient Care Planning; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
Molecular imaging in breast cancer.
Topics: Breast; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiation Dosage; Radioimmunodetection; Radiopharmaceuticals; Sentinel Lymph Node Biopsy; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2004 |
Positron-emission tomography in prognostic and therapeutic assessment of lung cancer: systematic review.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
Investigation of thyroid, head, and neck cancers with PET.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Treatment Outcome | 2004 |
Fluorodeoxyglucose-PET in the management of breast cancer.
Topics: Breast Neoplasms; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome | 2004 |
Clinical use of positron emission tomography in the management of cutaneous melanoma.
Topics: Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymphatic Metastasis; Melanoma; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prognosis; Radiopharmaceuticals; Skin Neoplasms; Treatment Outcome | 2004 |
Musculoskeletal system.
Topics: Bone Neoplasms; Clinical Trials as Topic; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prognosis; Radiopharmaceuticals; Soft Tissue Neoplasms | 2004 |
Positron emission tomography for prostate, bladder, and renal cancer.
Topics: Carcinoma, Renal Cell; Clinical Trials as Topic; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prognosis; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Treatment Outcome; Urinary Bladder Neoplasms | 2004 |
Role of 18FFDG PET/CT in the treatment of head and neck cancers: posttherapy evaluation and pitfalls.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Radiography, Interventional; Radiopharmaceuticals; Tomography, X-Ray Computed | 2005 |
PET imaging for differentiating recurrent brain tumor from radiation necrosis.
Topics: Brain; Brain Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Necrosis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiation Injuries; Radiopharmaceuticals | 2005 |
Functional imaging in head and neck cancer.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Prognosis | 2005 |
FDG-PET and beyond: molecular breast cancer imaging.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reference Standards; Sensitivity and Specificity; Sentinel Lymph Node Biopsy | 2005 |
Evolving role of positron emission tomography in breast cancer imaging.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Risk Assessment; Risk Factors; Treatment Outcome | 2005 |
A meta-analysis of FDG-PET for the evaluation of breast cancer recurrence and metastases.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2005 |
[Current applications and future developments of positron emission tomography in head and neck cancer].
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2005 |
Imaging for lung cancer restaging.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2005 |
FDG-PET in the management of germ cell tumor.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Male; Mediastinal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Neoplasms, Germ Cell and Embryonal; Positron-Emission Tomography; Predictive Value of Tests; Retroperitoneal Neoplasms; Testicular Neoplasms; Treatment Outcome | 2005 |
[Role of [18F]-fluorodeoxyglucose positron emission tomography for the initial detection, staging, search for recurrences and restaging of gynaecological and breast cancers].
Topics: Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Uterine Cervical Neoplasms; Uterine Neoplasms | 2005 |
Imaging in breast cancer: Single-photon computed tomography and positron-emission tomography.
Topics: Amino Acids; Breast Neoplasms; Cell Proliferation; Female; Fluorodeoxyglucose F18; Humans; Ligands; Lymphatic Metastasis; Neoplasm Recurrence, Local; Nucleosides; Positron-Emission Tomography; Protein Biosynthesis; Radiopharmaceuticals; Receptors, Estrogen; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2005 |
PET in lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mesothelioma; Neoplasm Recurrence, Local; Neoplasm Staging; Pleural Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2005 |
PET-scan in colorectal cancer.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Glucose; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
[Clinical application of positron emission tomography and 18FDG to brain tumor].
Topics: Aged; Astrocytoma; Brain Diseases; Brain Neoplasms; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Humans; Lymphoma; Methionine; Necrosis; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiation Injuries; Radiopharmaceuticals; Radiotherapy | 2005 |
Imaging of cervical lymph nodes in head and neck cancer: the basics.
Topics: Adult; Carcinoma, Squamous Cell; Contrast Media; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Neck; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Palpation; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2006 |
The emerging role of 18F-fluorodeoxyglucose positron emission tomography in the management of primary and recurrent rectal cancer.
Topics: Carcinoembryonic Antigen; Combined Modality Therapy; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Rectal Neoplasms; Recurrence; Tomography, X-Ray Computed | 2005 |
The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases.
Topics: Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Risk Assessment; Sensitivity and Specificity; Survival Analysis; Treatment Outcome | 2005 |
[Current status of 18F-FDG PET in predicting outcome of cancer therapy].
Topics: Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Positron-Emission Tomography; Treatment Outcome | 2004 |
[FDG (18 fluorodeoxyglucose) positron emission tomography and breast cancer].
Topics: Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
Positron-emission tomography and assessment of cancer therapy.
Topics: Cost-Benefit Analysis; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Radiation Dosage | 2006 |
PET imaging for evaluation of metastatic colorectal cancer of the liver.
Topics: Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
Gastrointestinal tract malignancies and positron emission tomography: an overview.
Topics: Colorectal Neoplasms; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2006 |
[Usefulness of 18F-FDG PET in the diagnosis for breast cancer patients].
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis | 2006 |
The current status of positron-emission tomography scanning in the evaluation and follow-up of patients with head and neck cancer.
Topics: Carcinoma, Squamous Cell; Combined Modality Therapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Unknown Primary; Radionuclide Imaging; Radiopharmaceuticals; Tomography, X-Ray Computed | 2006 |
Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
Topics: Adenocarcinoma, Follicular; Biomarkers, Tumor; Biopsy, Fine-Needle; Carcinoma, Papillary; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Preoperative Care; Radiometry; Radiopharmaceuticals; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyroid Nodule; Thyrotropin; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Ultrasonography | 2006 |
Positron emission tomography in gynecological malignancies.
Topics: Adult; Aged; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2006 |
[PET in head and neck cancers].
Topics: Antineoplastic Agents; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
Evolving role of (18)F-fluorodeoxyglucose positron emission tomography in the management of esophageal carcinoma.
Topics: Adenocarcinoma; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2006 |
Current and future use of positron emission tomography (PET) in breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Forecasting; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Sensitivity and Specificity; Sentinel Lymph Node Biopsy | 2006 |
The role of positron emission tomography in the management of recurrent colorectal cancer: a review.
Topics: Colorectal Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2007 |
The role of 18F-fluoro-deoxy-glucose positron emission tomography (FDG-PET) in the management of patients with colorectal cancer.
Topics: Colorectal Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2007 |
[Impact of FDG-PET in therapeutic management of patients with suspected recurrence of head and neck cancer].
Topics: Aged; Carcinoma; Case Management; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Surveys and Questionnaires | 2006 |
Early detection of cancer recurrence: 18F-FDG PET/CT can make a difference in diagnosis and patient care.
Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Subtraction Technique; Systems Integration; Technology Assessment, Biomedical; Tomography, X-Ray Computed; Treatment Outcome; Whole Body Imaging | 2007 |
The role of PET in follow-up of patients treated for differentiated epithelial thyroid cancers.
Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms | 2007 |
The expanding role of PET technology in the management of patients with colorectal cancer.
Topics: Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Forecasting; Humans; Immunohistochemistry; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Risk Factors; Role; Sensitivity and Specificity; Survival Analysis | 2007 |
Usefulness of FDG PET for diagnosis and radiotherapy of the patient with malignant lymphoma involving bone marrow.
Topics: Aged; Bone Marrow Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymphoma; Neoplasm Recurrence, Local; Radiopharmaceuticals; Tomography, Emission-Computed | 2007 |
[Clinical usefulness of positron emission tomography in prostate cancer].
Topics: Bone Neoplasms; Choline; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals | 2007 |
[Usefulness of 18F-FDG-PET in breast cancer imaging].
Topics: Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2007 |
Clinical applications of PET in brain tumors.
Topics: Adult; Amino Acids; Biopsy; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
Diagnosis of recurrent and metastatic disease using f-18 fluorodeoxyglucose-positron emission tomography in breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity | 2007 |
Normal and abnormal patterns of 18F-fluorodeoxyglucose PET/CT in lymphoma.
Topics: False Negative Reactions; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lymphoma; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole Body Imaging | 2007 |
PET imaging in differentiated thyroid cancer: where does it fit and how do we use it?
Topics: Carcinoma, Medullary; Cell Differentiation; Fluorodeoxyglucose F18; Humans; Incidental Findings; Iodine Radioisotopes; Lung Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyroid Nodule; Whole Body Imaging | 2007 |
PET/CT in oncology: for which tumours is it the reference standard?
Topics: Breast Neoplasms; Colorectal Neoplasms; Contrast Media; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms; Radiopharmaceuticals; Reference Standards; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2007 |
Colorectal cancer: imaging surveillance following resection of primary tumour.
Topics: Biomarkers, Tumor; Carcinoembryonic Antigen; Colonography, Computed Tomographic; Colorectal Neoplasms; Contrast Media; Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Practice Guidelines as Topic; Radiopharmaceuticals; Sensitivity and Specificity | 2007 |
[PET and digestive cancers].
Topics: Digestive System Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2008 |
FDG-PET, CT, MRI for diagnosis of local residual or recurrent nasopharyngeal carcinoma, which one is the best? A systematic review.
Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Management of recurrent colorectal cancer with positron emission tomography.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
[Positron emission tomography in oncology: an update].
Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasms; Patient Selection; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
Systematic review: accuracy of imaging tests in the diagnosis of recurrent laryngeal carcinoma after radiotherapy.
Topics: Carcinoma, Squamous Cell; Confidence Intervals; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Observer Variation; Positron-Emission Tomography; Probability; Risk Assessment; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Case report: Solitary plasmacytoma of bone with oncogenic osteomalacia: recurrence of tumour confirmed by PET/CT. A case report with a review of the radiological literature.
Topics: Adult; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Hypophosphatemia; Indium Radioisotopes; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Osteomalacia; Plasmacytoma; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Thoracic Vertebrae; Tomography, X-Ray Computed | 2008 |
Breast cancer follow-up in the adjuvant setting.
Topics: Antigens, Tumor-Associated, Carbohydrate; Biomarkers, Tumor; Breast Neoplasms; Breast Self-Examination; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Risk Reduction Behavior; Tomography, X-Ray Computed | 2008 |
Positron emission tomography using F-18 fluorodeoxyglucose pre- and post-autologous stem cell transplant in non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Stem Cell Transplantation; Transplantation, Autologous | 2008 |
[[18F]-FDG-PET in the diagnostics of gastrointestinal tumors].
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Colonic Neoplasms; Esophageal Neoplasms; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Liver Neoplasms; Meta-Analysis as Topic; Neoplasm Recurrence, Local; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Response evaluation of gastrointestinal stromal tumors.
Topics: Antineoplastic Agents; Benzamides; Contrast Media; Disease Progression; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Neoplasm Recurrence, Local; Piperazines; Positron-Emission Tomography; Pyrimidines; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
The lessons of GIST--PET and PET/CT: a new paradigm for imaging.
Topics: Benzamides; Contrast Media; Disease Progression; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Neoplasm Recurrence, Local; Piperazines; Positron-Emission Tomography; Pyrimidines; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
PET for sarcomas other than gastrointestinal stromal tumors.
Topics: Biopsy; Dideoxynucleosides; Disease Progression; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Misonidazole; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Sarcoma; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome | 2008 |
[Systematic review and meta-analysis of diagnostic accuracy of 18F-FDG PET in suspected recurrent head and neck cancer].
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2008 |
Positron emission tomography scanning is coming to a hospital near you soon!
Topics: Colorectal Neoplasms; Diagnosis, Differential; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms; Outcome and Process Assessment, Health Care; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; United Kingdom | 2008 |
Current status of FDG-PET for head and neck cancer.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted | 2008 |
[Positron-emission tomography: role of 18F-fluorodeoxyglucose (18FDG) imaging in oncology].
Topics: Cell Transformation, Neoplastic; Deoxyglucose; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gamma Cameras; Humans; Lymphatic Metastasis; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Predictive Value of Tests; Tomography, Emission-Computed | 1995 |
PET scanning in head and neck oncology: a review.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Tomography, Emission-Computed | 1998 |
Impact of the diagnostic methods on the therapeutic strategies.
Topics: Age Factors; Breast Neoplasms; Chemotherapy, Adjuvant; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Node Excision; Magnetic Resonance Imaging; Mammography; Mass Screening; Mastectomy, Segmental; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Care Planning; Radiographic Image Enhancement; Radiopharmaceuticals; Survival Rate; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1998 |
Positron emission tomography in lung cancer.
Topics: Carcinoma, Bronchogenic; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome | 1998 |
The use of imaging studies in the diagnosis and management of thyroid cancer and hyperparathyroidism.
Topics: Carcinoma; Carcinoma, Medullary; Diagnostic Imaging; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Hyperparathyroidism; Iodine Radioisotopes; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Parathyroid Hormone; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Thyroglobulin; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography | 1999 |
Role of PET FDG in the management of head and neck squamous cell cancer.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Patient Care Planning; Radiopharmaceuticals; Tomography, Emission-Computed | 1998 |
[Positron emission tomography (PET) in diagnosis of breast carcinoma].
Topics: Blood Glucose; Breast; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Tomography, Emission-Computed | 1998 |
Positron emission tomography (PET) in the evaluation of patients with cancer.
Topics: Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
[FDG-PET in oncology. Methodological principles and clinical applications].
Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
Oncological applications of FDG PET imaging.
Topics: Breast Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms; Pancreatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
Positron emission tomography imaging in the thorax.
Topics: Blood Glucose; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Tomography, Emission-Computed; Treatment Outcome | 1999 |
Lung cancer and positron emission tomography with fluorodeoxyglucose.
Topics: Combined Modality Therapy; Costs and Cost Analysis; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Survival Rate; Tomography, Emission-Computed | 2000 |
Contralateral cortical diaschisis in a patient with cerebellar astrocytoma after radiation therapy.
Topics: Adult; Astrocytoma; Brain Diseases; Cerebellar Neoplasms; Cerebral Cortex; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Hypesthesia; Male; Neoplasm Recurrence, Local; Parietal Lobe; Radiopharmaceuticals; Temporal Lobe; Tomography, Emission-Computed; Trigeminal Nerve Diseases | 2000 |
A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neoplasm Recurrence, Local; Pelvic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
A review of the literature for whole-body FDG PET in the management of patients with melanoma.
Topics: Confidence Intervals; Cost-Benefit Analysis; Decision Support Techniques; False Negative Reactions; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Melanoma; Neoplasm Recurrence, Local; Neoplasm Staging; Peer Review, Research; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms; Technology Assessment, Biomedical; Tomography, Emission-Computed; Whole-Body Irradiation | 2000 |
A new imaging technique for colorectal cancer: positron emission tomography.
Topics: Carcinoembryonic Antigen; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed; Whole-Body Irradiation | 2000 |
Positron emission tomography and colorectal cancer.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
[The role of diagnostic PET in treatment planning before tumor surgery].
Topics: Breast Neoplasms; Carcinoma, Bronchogenic; Clinical Trials as Topic; Colorectal Neoplasms; Combined Modality Therapy; Diagnosis, Differential; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Humans; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasms; Prognosis; Prospective Studies; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Thyroid Neoplasms; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
[Clinical value of positron emission tomography (PET) in the diagnosis of bone and soft tissue tumors. 3rd Interdisciplinary Consensus Conference "PET in Oncology": results of the Bone and Soft Tissue Study Group].
Topics: Age Factors; Bone Neoplasms; Child; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Osteosarcoma; Prognosis; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2001 |
[Influence of positron emission tomography on surgical therapy planning in recurrent colorectal cancer].
Topics: Adult; Colorectal Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
Selection of patients for resection of hepatic metastases: improved detection of extrahepatic disease with FDG pet.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local; Patient Selection; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
The clinical application of positron emission tomography to colorectal cancer management.
Topics: Colorectal Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
PET imaging in breast cancer.
Topics: Axilla; Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome | 2001 |
From tumor biology to clinical Pet: a review of positron emission tomography (PET) in oncology.
Topics: Amino Acids; Cell Hypoxia; Fluorodeoxyglucose F18; Glucose; Humans; Methionine; Models, Chemical; Neoplasm Recurrence, Local; Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome; Whole-Body Counting | 2001 |
Whole-body FDG-PET imaging in the management of patients with cancer.
Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Whole-Body Counting | 2002 |
[Positron emission tomography (PET) in clinical oncology. Part II].
Topics: Adult; Aged; Colorectal Neoplasms; False Negative Reactions; False Positive Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphoma; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
[Positron emission tomography (PET) with [18F]-FDG in bronchopulmonary cancer and its impact on medical decision at the time of diagnosis, staging, or recurrence evaluation].
Topics: Diagnosis, Differential; False Negative Reactions; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Positron emission tomography in colorectal cancer.
Topics: Adenocarcinoma; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Positron emission tomography for the diagnosis of breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
150 trial(s) available for fluorodeoxyglucose f18 and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Identifying the location of locoregional recurrences after definitive radiotherapy for head and neck cancer using metabolic parameters of baseline and mid-treatment 18F-FDG-PET scans.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Squamous Cell Carcinoma of Head and Neck | 2023 |
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiotherapy Dosage | 2023 |
Topics: Acetogenins; Acute Disease; Acute Kidney Injury; Administration, Intravenous; Aged; Albumins; Alcoholism; Aldehyde Dehydrogenase; Aldehyde Dehydrogenase, Mitochondrial; alpha-Glucosidases; Anemia; Animals; Anthozoa; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bacterial; Antigens, Bacterial; Antihypertensive Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Ascites; Asthma; Bacteria; beta-Lactamases; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Binding Sites; Biological Availability; Biomass; Borderline Personality Disorder; Brain; Brucella abortus; Brucella melitensis; Brucellosis; Calcium; Carbapenems; Case-Control Studies; Caseins; Cattle; CD8-Positive T-Lymphocytes; Ceftaroline; Cell Line; Cell Line, Tumor; Cell Physiological Phenomena; Cell Proliferation; Cephalosporins; Chemotherapy, Adjuvant; China; Chitin; Chlorella; Chlorophyll; Chlorophyll A; Chlorophyta; Cholangiocarcinoma; Cisplatin; Conotoxins; Contrast Media; Conus Snail; Cross-Sectional Studies; Cytokines; Decapodiformes; Deoxycytidine; Diagnostic and Statistical Manual of Mental Disorders; Dietary Fiber; Diterpenes; DNA Methylation; Dogs; Double-Blind Method; Drug Design; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Screening Assays, Antitumor; Eicosapentaenoic Acid; Enzyme-Linked Immunosorbent Assay; Epidermis; Escherichia coli; Escherichia coli Infections; Extraintestinal Pathogenic Escherichia coli; Fatty Acids; Fatty Acids, Unsaturated; Fatty Acids, Volatile; Feasibility Studies; Feces; Female; Ferritins; Fluorodeoxyglucose F18; Gastrectomy; Gastrointestinal Microbiome; Gemcitabine; Glomerular Filtration Rate; Glucose; Glycerol; Granulocyte-Macrophage Colony-Stimulating Factor; HeLa Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia-Inducible Factor-Proline Dioxygenases; Immunoassay; Immunoglobulin G; India; Infant, Newborn; Infertility; Inflammation; Intensive Care Units; Iron; Iron Deficiencies; Kidney; Lacticaseibacillus rhamnosus; Laurencia; Leukocytes; Lipids; Liver Cirrhosis; Long Interspersed Nucleotide Elements; Longitudinal Studies; Male; Mesenchymal Stem Cells; Methicillin-Resistant Staphylococcus aureus; Mice; Microalgae; Microbial Sensitivity Tests; Microscopy; Middle Aged; Minerals; Molecular Conformation; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Myeloid Cells; Myeloid-Derived Suppressor Cells; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Nephropidae; Nicotinic Antagonists; Nitrogen; Obesity; Oxaliplatin; Paclitaxel; Panax; Pancreatic Neoplasms; Pancreatitis; Personality; Personality Disorders; Personality Inventory; Photobioreactors; Plant Extracts; Plasmalogens; Plasmids; Polymorphism, Genetic; Polynesia; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prebiotics; Predictive Value of Tests; Prognosis; Prolyl-Hydroxylase Inhibitors; Rabbits; Radiopharmaceuticals; Rats; Rats, Wistar; Receptors, Nicotinic; Recombinant Proteins; Retrospective Studies; Rifampin; Risk Factors; RNA, Ribosomal, 16S; Salinity; Seaweed; Sensitivity and Specificity; Sepsis; Sesquiterpenes; Severity of Illness Index; Shock, Septic; Silicones; Single Photon Emission Computed Tomography Computed Tomography; Skin; Snails; Solubility; Solvents; Sputum; Staphylococcal Infections; Stomach Neoplasms; Stramenopiles; Structure-Activity Relationship; Technetium Tc 99m Exametazime; Technology; Terpenes; Tuberculosis; Tuberculosis, Multidrug-Resistant; Urinary Catheters; Urinary Tract Infections; Vascular Endothelial Growth Factor A; Virulence Factors; Water; Wound Healing | 2023 |
[PET/CT and PET/MRI in Head and Neck Cancer].
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2020 |
Early
Topics: Analysis of Variance; Antineoplastic Agents; Cisplatin; Docetaxel; Female; Fluorodeoxyglucose F18; Human papillomavirus 16; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Treatment Outcome; Tumor Burden | 2020 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea | 2022 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Comparison of 18FDG-PET/CT and conventional follow-up methods in colorectal cancer: A randomised prospective study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; France; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prospective Studies | 2021 |
Diffusion-weighted MRI is not superior to FDG-PET/CT for the detection of neck recurrence in well-differentiated thyroid carcinoma.
Topics: Adult; Aged; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neck; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Thyroid Neoplasms; Whole Body Imaging; Young Adult | 2019 |
Heterogeneous FDG-guided dose-escalation for locally advanced NSCLC (the NARLAL2 trial): Design and early dosimetric results of a randomized, multi-centre phase-III study.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Dose-Response Relationship, Radiation; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted | 2017 |
Proposal of a New Preoperative Prognostic Model for Solitary Hepatocellular Carcinoma Incorporating
Topics: Adult; Aged; Aged, 80 and over; Bilirubin; Biomarkers, Tumor; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Preoperative Care; Prognosis; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Serum Albumin; Survival Rate | 2018 |
Patterns of locoregional failure in locally advanced non-small cell lung cancer treated with definitive conformal radiotherapy: Results from the Gating 2006 trial.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal | 2018 |
Prospective evaluation of plasma Epstein-Barr virus DNA clearance and fluorodeoxyglucose positron emission scan in assessing early response to chemotherapy in patients with advanced or recurrent nasopharyngeal carcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; DNA, Viral; Drug Monitoring; Epstein-Barr Virus Infections; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Herpesvirus 4, Human; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Response Evaluation Criteria in Solid Tumors; Time Factors; Treatment Outcome; Tumor Burden; Viral Load | 2018 |
A feasibility study on adaptive
Topics: Adult; Aged; Carcinoma, Squamous Cell; Cetuximab; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Otorhinolaryngologic Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiation Injuries; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided; Radiotherapy, Intensity-Modulated | 2018 |
Quantification of FDG-PET/CT with delayed imaging in patients with newly diagnosed recurrent breast cancer.
Topics: Aged; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Retrospective Studies; Time Factors; Whole Body Imaging | 2018 |
Rationale and Protocol for a Canadian Multicenter Phase II Randomized Trial Assessing Selective Metabolically Adaptive Radiation Dose Escalation in Locally Advanced Non-small-cell Lung Cancer (NCT02788461).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Canada; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Prospective Studies; Quality of Life; Radiopharmaceuticals; Radiotherapy, Conformal; Research Design; Survival Rate; Young Adult | 2018 |
Topics: Activities of Daily Living; Acute Disease; Adalimumab; Adaptation, Physiological; Adenosine Triphosphate; Adipose Tissue; Administration, Intravaginal; Adolescent; Adsorption; Adult; Adverse Childhood Experiences; Age Distribution; Age Factors; Aged; Aged, 80 and over; Air Pollution, Indoor; Aldehyde Oxidase; Alginates; Alloys; alpha-Globins; Aluminum Hydroxide; Alveolar Bone Loss; Anaerobiosis; Anesthesia, General; Anesthetics; Animals; Anovulation; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Apoptosis; Bacillus cereus; Bacterial Typing Techniques; Bacteroidetes; Base Composition; Biocompatible Materials; Biofilms; Biological Availability; Biological Transport; Biosensing Techniques; Bipolar Disorder; Blood Glucose; Body Mass Index; Bone Regeneration; Boranes; Brachial Artery; Butyric Acid; Candida albicans; Carbon; Carcinoembryonic Antigen; Cell Differentiation; Cell Line, Tumor; Cell Respiration; Cell Survival; Cells, Cultured; Cerebrovascular Circulation; Charcoal; Child; Child Health; China; Chloride Channels; Chlorides; CHO Cells; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromium; Chronic Disease; Chronic Periodontitis; Circular Dichroism; Cities; Cohort Studies; Comamonadaceae; Comorbidity; Coronary Artery Disease; Corrosion; Cricetinae; Cricetulus; Cross Infection; Cross-Sectional Studies; Crowding; Culture Media; Cytokines; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetes, Gestational; Diarylheptanoids; Diclofenac; Disability Evaluation; Diterpene Alkaloids; DNA; DNA Mutational Analysis; DNA, Bacterial; Drug Liberation; Drug Resistance, Multiple, Bacterial; Electrochemical Techniques; Electrodes; Electrolytes; Endothelium, Vascular; Enterococcus faecalis; Epithelial Cell Adhesion Molecule; Epithelial Cells; Erbium; Erythropoietin; Ethanol; Ethylenediamines; Fast Foods; Fatty Acids; Female; Fermentation; Ferric Compounds; Fibroblasts; Flavobacteriaceae; Fluorides; Fluorodeoxyglucose F18; Food Microbiology; Formaldehyde; Furaldehyde; Gamma Cameras; Gene Expression; Geologic Sediments; Glucose Tolerance Test; Glycated Hemoglobin; Glycolipids; Glycosylation; Gracilaria; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Guanine; Health Surveys; HeLa Cells; Hemoglobins, Abnormal; Hexosamines; High Fructose Corn Syrup; High-Intensity Interval Training; Hip Fractures; Hippocampus; HLA-B27 Antigen; Hospitalization; Housing; Humans; Hydrogen-Ion Concentration; Hydrolysis; Hydroxides; Hypercapnia; Hypertension; Hypocreales; Hypromellose Derivatives; Image Processing, Computer-Assisted; Incidence; Indole Alkaloids; Indonesia; Inflammation Mediators; Infrared Rays; Insulin Resistance; Intercalating Agents; Ion Transport; Ionophores; Japan; Kinetics; Kluyveromyces; Letrozole; Linear Models; Lipopolysaccharides; Liposomes; Liver; Lung Diseases; Magnesium Hydroxide; Magnetic Resonance Spectroscopy; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice, Inbred BALB C; Microbial Sensitivity Tests; Microbial Viability; Microscopy, Electron, Transmission; Middle Aged; Mitochondria; Mitochondria, Muscle; Molecular Docking Simulation; Molecular Structure; Muscle, Skeletal; Mutant Proteins; Mutation; Mutation, Missense; Nanocomposites; Nanoparticles; Neoplasm Recurrence, Local; Neoplastic Cells, Circulating; Nucleic Acid Hybridization; Obesity; Occupational Exposure; Oceans and Seas; Odds Ratio; Organometallic Compounds; Osteogenesis; Ovulation Induction; Oxidation-Reduction; Particle Size; Periodontal Ligament; Permeability; Phaseolus; Phenotype; Philippines; Phosphatidylethanolamines; Phospholipids; Photochemical Processes; Phylogeny; Pichia; Pigmentation; Plant Extracts; Polycystic Ovary Syndrome; Polysaccharides; Postprandial Period; Pregnancy; Pregnancy Rate; Prevalence; Product Surveillance, Postmarketing; Progesterone; Progestins; Protein Engineering; Pseudomonas aeruginosa; Psoriasis; Public Facilities; Rats; Rats, Wistar; Receptors, Thyrotropin; Recombinant Proteins; Reproducibility of Results; Republic of Korea; Retrospective Studies; Rhodobacteraceae; Risk; Risk Assessment; Risk Factors; RNA, Ribosomal, 16S; ROC Curve; Saccharomyces cerevisiae; Salinity; Saliva; Seawater; Seaweed; Sensitivity and Specificity; Sequence Analysis, DNA; Sex Factors; Silver Compounds; Smokers; Social Class; Socioeconomic Factors; Soil Microbiology; Solubility; Soy Foods; Spectrometry, Mass, Electrospray Ionization; Spondylitis, Ankylosing; Staphylococcus aureus; Static Electricity; Steroids; Strontium; Sucrose; Surface Properties; Survival Rate; Sweden; Swine; Synapses; Synchrotrons; Tandem Mass Spectrometry; Tannins; Tea; Temperature; Terpenes; Thalidomide; Thermodynamics; Thiadiazoles; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyroidectomy; Time Factors; Tissue Distribution; Titanium; Toilet Facilities; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Ubiquinone; Urinary Tract Infections; Vaginal Creams, Foams, and Jellies; Venezuela; Vitamin K 2; Waist Circumference; Waste Disposal, Fluid; Wastewater; Water Microbiology; Water Pollutants, Chemical; Whole Body Imaging; X-Ray Diffraction; Young Adult; Ytterbium; Yttrium; Yttrium Radioisotopes; Zinc Compounds | 2018 |
Comparing Two Imaging Methods for Follow-Up of Lung Cancer Treatment: A Randomized Pilot Study.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Incidence; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Switzerland; Tomography, X-Ray Computed | 2019 |
Role of 18F-FLT PET/CT in suspected recurrent or residual lymphoma: final results of a pilot prospective trial.
Topics: Adult; Aged; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2019 |
Changes on Midchemoradiation Therapy Fluorodeoxyglucose Positron Emission Tomography for Cervical Cancer Are Associated with Prognosis.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Chemoradiotherapy; Cisplatin; Confidence Intervals; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lymph Nodes; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Prospective Studies; Radiation-Sensitizing Agents; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Treatment Outcome; Uterine Cervical Neoplasms; Young Adult | 2019 |
Randomised phase 3 study of adjuvant chemotherapy with or without nadroparin in patients with completely resected non-small-cell lung cancer: the NVALT-8 study.
Topics: Aged; Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Nadroparin; Neoplasm Recurrence, Local; Neoplasm Staging; Pemetrexed; Pneumonectomy; Positron-Emission Tomography | 2019 |
Regional PET/CT after water gastric inflation for evaluating loco-regional disease of gastric cancer.
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Republic of Korea; Risk Assessment; Sensitivity and Specificity; Stomach Neoplasms; Survival Analysis; Survival Rate; Tomography, X-Ray Computed; Water | 2013 |
Clinical implications of initial FDG-PET/CT in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
Topics: Adult; Aged; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Rectal Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Multicenter phase II trial of topotecan, cisplatin and bevacizumab for recurrent or persistent cervical cancer.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Topotecan; Uterine Cervical Neoplasms; Young Adult | 2013 |
Diagnostic accuracy of 18F-FDG PET/CT for assessing response to radiofrequency ablation treatment in lung metastases: a multicentre prospective study.
Topics: Ablation Techniques; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radio Waves; Radiofrequency Therapy; Reference Standards; ROC Curve; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Positron emission tomography/computed tomography for optimized colon cancer staging and follow up.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoembryonic Antigen; Carcinoma; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Receptors, Urokinase Plasminogen Activator; Survival Analysis; Tissue Inhibitor of Metalloproteinase-1; Tomography, X-Ray Computed | 2014 |
Prospective evaluation of 18F-fluorodeoxyglucose positron emission tomography-computed tomography for response evaluation in recurrent carcinoma cervix: does metabolic response predict survival?
Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; India; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Survival; Uterine Cervical Neoplasms | 2014 |
Assessment of relapse in patients with peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy using F-18-FDG-PET/CT.
Topics: Antineoplastic Agents; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Hyperthermia, Induced; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Advanced-stage Hodgkin lymphoma: US/chest radiography for detection of relapse in patients in first complete remission--a randomized trial of routine surveillance imaging procedures.
Topics: Adolescent; Adult; Aged; Algorithms; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiation Dosage; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography, Doppler | 2014 |
Recurrent differentiated thyroid cancer: towards personalized treatment based on evaluation of tumor characteristics with PET (THYROPET Study): study protocol of a multicenter observational cohort study.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Precision Medicine; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Ultrasonography | 2014 |
A phase II study of radiofrequency ablation therapy for thoracic malignancies with evaluation by FDG-PET.
Topics: Adult; Aged; Aged, 80 and over; Catheter Ablation; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiation Injuries; Radiopharmaceuticals | 2014 |
BAY 1075553 PET-CT for Staging and Restaging Prostate Cancer Patients: Comparison with [18F] Fluorocholine PET-CT (Phase I Study).
Topics: Aged; Aged, 80 and over; Bone Marrow; Choline; Fluorodeoxyglucose F18; Glutarates; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Organophosphonates; Positron-Emission Tomography; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Radiometry; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Phase II trial evaluating the efficacy of sorafenib (BAY 43-9006) and correlating early fluorodeoxyglucose positron emission tomography-CT response to outcome in patients with recurrent and/or metastatic head and neck cancer.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Niacinamide; Phenylurea Compounds; Positron-Emission Tomography; Sorafenib; Squamous Cell Carcinoma of Head and Neck; Survival Analysis; Treatment Outcome; Young Adult | 2016 |
Increased relapse rates in early stage hodgkin lymphoma (HL) patients without radiotherapy: the German Society of Radiooncology (DEGRO) advises to treat all early stage HL patients with radiotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Therapy; Dacarbazine; Doxorubicin; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Positron-Emission Tomography; Radiation Injuries; Radiotherapy, Adjuvant; Risk Factors; Survival Rate; Vinblastine; Young Adult | 2014 |
Prognostic significance of metabolic tumor burden by positron emission tomography/computed tomography in patients with relapsed/refractory diffuse large B-cell lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Nitrogen Mustard Compounds; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Rituximab; Tomography, X-Ray Computed; Tumor Burden; Young Adult | 2015 |
(18)F-fluorodeoxyglucose positron-emission tomography-computed tomography to diagnose recurrent cancer.
Topics: Adult; Aged; Aged, 80 and over; Canada; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasms; Positron-Emission Tomography; Radiography | 2015 |
Additional Prognostic Value of SUVmax Measured by F-18 FDG PET/CT over Biological Marker Expressions in Surgically Resected Cervical Cancer Patients.
Topics: Adult; Aged; Aged, 80 and over; Antigens, Neoplasm; Biomarkers; Carbonic Anhydrase IX; Carbonic Anhydrases; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2015 |
Effectiveness of an (18)F-FDG-PET based strategy to optimize the diagnostic trajectory of suspected recurrent laryngeal carcinoma after radiotherapy: The RELAPS multicenter randomized trial.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Laryngoscopy; Larynx; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Salvage Therapy; Treatment Outcome | 2016 |
Randomized phase II study of axitinib versus physicians best alternative choice of therapy in patients with recurrent glioblastoma.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Agents, Alkylating; Axitinib; Bevacizumab; Brain Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Imidazoles; Indazoles; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Radiopharmaceuticals; Steroids; Treatment Outcome; Young Adult | 2016 |
18F-FDG PET for Measurement of Response and Prediction of Outcome to Relapsed or Refractory Mantle Cell Lymphoma Therapy with Bendamustine-Rituximab.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Disease-Free Survival; Drug Monitoring; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Mantle-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Reproducibility of Results; Rituximab; Sensitivity and Specificity; Survival Rate; Treatment Outcome | 2017 |
Whole body PET/CT in the follow-up of asymptomatic patients with stage IIB-IIIB cutaneous melanoma
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Skin Neoplasms; Young Adult | 2016 |
Clinical outcomes of IMRT planned with or without PET/CT simulation for patients with pharyngeal cancers.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Pharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2017 |
Metabolic tumor volume predicts overall survival and local control in patients with stage III non-small cell lung cancer treated in ACRIN 6668/RTOG 0235.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Survival Rate; Treatment Outcome; Tumor Burden; United States | 2017 |
Incremental Value of Cocktail 18F-FDG and 18F-NaF PET/CT Over 18F-FDG PET/CT Alone for Characterization of Skeletal Metastases in Breast Cancer.
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Sodium Fluoride | 2017 |
Fluorine-18 fluorodeoxyglucose positron emission tomography predicts lymph node metastasis, P-glycoprotein expression, and recurrence after resection in mass-forming intrahepatic cholangiocarcinoma.
Topics: Adult; Aged; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Risk Factors; Sensitivity and Specificity; Tomography, Emission-Computed | 2008 |
Lack of fludeoxyglucose F 18 uptake in posttreatment positron emission tomography as a significant predictor of survival after subsequent surgery in multimodality treatment for patients with locally advanced esophageal squamous cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Positron-Emission Tomography; Postoperative Period; Predictive Value of Tests; Prognosis; Prospective Studies; Radiotherapy, Adjuvant; Risk Factors; Survival Rate; Treatment Outcome | 2008 |
2-Deoxy-2[F-18]FDG-PET for detection of recurrent laryngeal carcinoma after radiotherapy: interobserver variability in reporting.
Topics: Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Observer Variation; Positron-Emission Tomography; Sensitivity and Specificity | 2008 |
Use of positron emission tomography in surgery follow-up of esophageal cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Disease-Free Survival; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals | 2009 |
Does 18F-FDG PET/CT improve the detection of posttreatment recurrence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up?
Topics: Carcinoma, Squamous Cell; False Negative Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
The impact of PET-CT in suspected recurrent ovarian cancer: A prospective multi-centre study as part of the Australian PET Data Collection Project.
Topics: Adult; Aged; Aged, 80 and over; Australia; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
Prediction of tumor recurrence by 18F-FDG PET in liver transplantation for hepatocellular carcinoma.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2009 |
Stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: results of a phase I dose-escalation trial.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Confidence Intervals; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Quality of Life; Radiation Injuries; Radiopharmaceuticals; Radiosurgery; Radiotherapy Dosage; Remission Induction; Retreatment; Tomography, X-Ray Computed; Tumor Burden | 2009 |
Influence of 2-(18F) fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography on recurrent ovarian cancer diagnosis and on selection of patients for secondary cytoreductive surgery.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography; Young Adult | 2009 |
Methodologies for localizing loco-regional hypopharyngeal carcinoma recurrences in relation to FDG-PET positive and clinical radiation therapy target volumes.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Tumor Burden | 2010 |
Randomized follow-up study of resected NSCLC patients: conventional versus 18F-DG coincidence imaging.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gamma Cameras; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 2010 |
Phase II study of cisplatin and imatinib in advanced salivary adenoid cystic carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Carcinoma, Adenoid Cystic; Cisplatin; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Imatinib Mesylate; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Piperazines; Positron-Emission Tomography; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-kit; Pyrimidines; Radiography, Thoracic; Radiopharmaceuticals; Remission Induction; Salivary Gland Neoplasms; Survival Rate; Tomography, X-Ray Computed; Young Adult | 2011 |
Relevance of monitoring metabolic reduction in patients with relapsed or refractory follicular and mantle cell lymphoma receiving bendamustine: a multicenter study.
Topics: Adult; Aged; Antineoplastic Agents; Bendamustine Hydrochloride; Clinical Trials, Phase II as Topic; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Nitrogen Mustard Compounds; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve | 2011 |
Early FDG PET at 10 or 20 Gy under chemoradiotherapy is prognostic for locoregional control and overall survival in patients with head and neck cancer.
Topics: Adolescent; Adult; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiation Dosage; Time Factors; Treatment Outcome; Tumor Burden; Young Adult | 2011 |
Tumor volume as a potential imaging-based risk-stratification factor in trimodality therapy for locally advanced non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cohort Studies; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Risk Assessment; Risk Factors; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
13N-NH3 versus F-18 FDG in detection of intracranial meningioma: initial report.
Topics: Adult; Aged; Ammonia; Female; Fluorodeoxyglucose F18; Humans; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Neoplasm Recurrence, Local; Nitrogen Radioisotopes; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
Multimodal imaging and detection approach to 18F-FDG-directed surgery for patients with known or suspected malignancies: a comprehensive description of the specific methodology utilized in a single-institution cumulative retrospective experience.
Topics: Adult; Aged; Aged, 80 and over; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
Value of dual time point F-18 FDG-PET/CT imaging for the evaluation of prognosis and risk factors for recurrence in patients with stage I non-small cell lung cancer treated with stereotactic body radiation therapy.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Radiosurgery; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Positron emission tomography/computed tomography imaging of residual skull base chordoma before radiotherapy using fluoromisonidazole and fluorodeoxyglucose: potential consequences for dose painting.
Topics: Adult; Cell Hypoxia; Chordoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Misonidazole; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Skull Base Neoplasms; Tomography, X-Ray Computed; Young Adult | 2012 |
A pilot comparison of 18F-fluorodeoxyglucose and 18F-fluorocholine PET/CT to predict early recurrence of unifocal hepatocellular carcinoma after surgical resection.
Topics: Aged; Carcinoma, Hepatocellular; Choline; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Low-dose non-enhanced CT versus full-dose contrast-enhanced CT in integrated PET/CT scans for diagnosing ovarian cancer recurrence.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Prognosis; Radiation Dosage; Radiation Protection; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Predictive role of post-treatment [18F]FDG PET/CT in patients with uterine cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Outcome Assessment, Health Care; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Uterine Neoplasms; Young Adult | 2012 |
18F-FDG PET/CT can predict nodal metastases but not recurrence in early stage uterine cervical cancer.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Survival Analysis; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2012 |
Early prediction of survival following induction chemotherapy with DCF (docetaxel, cisplatin, 5-fluorouracil) using FDG PET/CT imaging in patients with locally advanced head and neck squamous cell carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Disease-Free Survival; Docetaxel; Female; Fluorodeoxyglucose F18; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Taxoids; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
FDG uptake correlates with recurrence and survival after treatment of unresectable stage III non-small cell lung cancer with high-dose proton therapy and chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Proportional Hazards Models; Proton Therapy; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Early FDG PET response assessment of preoperative radiochemotherapy in locally advanced rectal cancer: correlation with long-term outcome.
Topics: Adult; Aged; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Preoperative Period; Radiopharmaceuticals; Rectal Neoplasms; Remission Induction; Treatment Outcome | 2012 |
Early diagnosis of recurrent breast cancer with FDG-PET in patients with progressive elevation of serum tumor markers.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Breast Neoplasms; Carcinoembryonic Antigen; False Positive Reactions; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Mucin-1; Neoplasm Recurrence, Local; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
[F-18 fluorodeoxyglucose positron emission tomography in evaluation of tumors of the ENT area: personal results and review of the literature].
Topics: Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Otorhinolaryngologic Neoplasms; Prognosis; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Clinical impact of whole body FDG-PET on the staging and therapeutic decision making for malignant lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Citrates; Decision Making; Female; Fluorodeoxyglucose F18; Gallium; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Care Management; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome; Whole-Body Counting | 2002 |
FDG-PET improves the management of patients with suspected recurrence of colorectal cancer.
Topics: Abdomen; Adult; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Recurrence, Local; Pain; Radionuclide Imaging; Radiopharmaceuticals; Tomography, X-Ray Computed | 2002 |
Brain metastases after stereotactic radiosurgery using the Leksell gamma knife: can FDG PET help to differentiate radionecrosis from tumour progression?
Topics: Adult; Aged; Brain; Brain Neoplasms; Diagnosis, Differential; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Radiation Injuries; Radiopharmaceuticals; Radiosurgery; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Staging of recurrent and advanced lung cancer with 18F-FDG PET in a coincidence technique (hybrid PET).
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carcinoma; Carcinoma, Large Cell; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pleural Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Positron emission tomography with 11C-acetate and 18F-FDG in prostate cancer patients.
Topics: Acetates; Aged; Aged, 80 and over; Bone Neoplasms; Carbon; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse.
Topics: Acetates; Adenocarcinoma; Aged; Carbon; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Single-Blind Method; Tomography, Emission-Computed | 2003 |
PET-FDG as predictor of therapy response in patients with colorectal carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Liver Neoplasms; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Organoplatinum Compounds; Radiopharmaceuticals; Risk Assessment; Tomography, Emission-Computed; Treatment Outcome | 2003 |
[18F]FDG imaging of head and neck tumours: comparison of hybrid PET and morphological methods.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Feasibility Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Imaging of gynecologic tumors: comparison of (11)C-choline PET with (18)F-FDG PET.
Topics: Adenocarcinoma; Adult; Aged; Carbon Radioisotopes; Carcinoma, Squamous Cell; Carcinosarcoma; Choline; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sarcoma; Sarcoma, Clear Cell; Sensitivity and Specificity; Tomography, Emission-Computed; Uterine Neoplasms; Whole-Body Counting | 2003 |
Advanced ovarian carcinoma: usefulness of [(18)F]FDG-PET in combination with CT for lesion detection after primary treatment.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 2003 |
The clinical impact of 18F-FDG gamma PET in patients with recurrent well differentiated thyroid carcinoma.
Topics: Adult; Aged; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Gamma Cameras; Head and Neck Neoplasms; Humans; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed; Treatment Outcome; Whole-Body Counting | 2003 |
Detection of recurrent oral squamous cell carcinoma by [18F]-2-fluorodeoxyglucose-positron emission tomography: implications for prognosis and patient management.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Survival Analysis | 2003 |
Recombinant human thyrotropin stimulation of fluoro-D-glucose positron emission tomography uptake in well-differentiated thyroid carcinoma.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Recombinant Proteins; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyrotropin; Tomography, Emission-Computed | 2004 |
FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: comparison with MRI/CT.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Combined Modality Therapy; Drug Therapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Treatment Outcome | 2004 |
The role of 18F-FDG PET in staging and early prediction of response to therapy of recurrent gastrointestinal stromal tumors.
Topics: Adult; Aged; Aged, 80 and over; Benzamides; False Positive Reactions; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Piperazines; Prognosis; Pyrimidines; Radiography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Stromal Cells; Tomography, Emission-Computed; Treatment Outcome | 2004 |
18F-FDG uptake in squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Middle Aged; Monosaccharide Transport Proteins; Neoplasm Recurrence, Local; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Uterine Cervical Neoplasms | 2004 |
[Diagnosis with (18)F-FDG PET scan after larynx preservation by primary radiochemotherapy].
Topics: Aged; Blood Glucose; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Image Processing, Computer-Assisted; Laryngeal Neoplasms; Laryngectomy; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiation Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Adjuvant; Salvage Therapy; Tomography, Emission-Computed; Treatment Outcome | 2004 |
[F-18] fluorodeoxyglucose positron emission tomography as a tool for early recognition of incomplete tumor destruction after radiofrequency ablation for liver metastases.
Topics: Breast Neoplasms; Catheter Ablation; Colonic Neoplasms; Disease-Free Survival; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrointestinal Neoplasms; Hepatectomy; Humans; Liver; Liver Neoplasms; Neoplasm Recurrence, Local; Postoperative Period; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
PET and SPECT for detection of tumor progression in irradiated low-grade astrocytoma: a receiver-operating-characteristic analysis.
Topics: Adult; Astrocytoma; Female; Fluorodeoxyglucose F18; Humans; Male; Methyltyrosines; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Postoperative Care; Predictive Value of Tests; Radiopharmaceuticals; ROC Curve; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2004 |
[18F]FDG PET as a substitute for second-look laparotomy in patients with advanced ovarian carcinoma.
Topics: Adult; Aged; Analgesics; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Korea; Laparotomy; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Second-Look Surgery; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome | 2004 |
[18F]FDG in recurrent breast cancer: diagnostic performances, clinical impact and relevance of induced changes in management.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Decision Making; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Patient Care Management; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
Detection of recurrent colorectal carcinoma by 18F-FDG: comparison of the clinical performances of FDG PET and FDG CDET.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gamma Cameras; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
Usefulness of FDG-PET to detect recurrent cervical cancer based on asymptomatically elevated tumor marker serum levels--a preliminary report.
Topics: Adult; Antigens, Neoplasm; Biomarkers, Tumor; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2004 |
Positron emission tomography for unexplained elevation of serum squamous cell carcinoma antigen levels during follow-up for patients with cervical malignancies: a phase II study.
Topics: Antigens, Neoplasm; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Predictive Value of Tests; Serpins; Tomography, Emission-Computed; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2004 |
Is 18F-FDG PET more accurate than standard diagnostic procedures in the detection of suspected recurrent melanoma?
Topics: Abdominal Neoplasms; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
Defining the priority of using 18F-FDG PET for recurrent cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Analysis; Treatment Outcome; Uterine Cervical Neoplasms | 2004 |
Clinical usefulness of 18F-FDG PET in nasopharyngeal carcinoma patients with questionable MRI findings for recurrence.
Topics: Adolescent; Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2004 |
[Evaluation of positron emission tomography by using F-18-fluorodeoxyglucose in diagnosis of recurrent colorectal cancer].
Topics: Adult; Carcinoma; Colon; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Rectum; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2004 |
The value of 18F-FDG PET in the detection of stage M0 carcinoma of the nasopharynx.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Single-Blind Method; Whole-Body Counting | 2005 |
FDG-PET findings in barium aspiration.
Topics: Artifacts; Barium; Contrast Media; Diagnosis, Differential; Diagnostic Errors; Fluorodeoxyglucose F18; Humans; Lung; Male; Middle Aged; Neoplasm Recurrence, Local; Pneumonia, Aspiration; Positron-Emission Tomography; Radiography; Radiopharmaceuticals | 2005 |
Detection of recurrent pancreatic cancer: comparison of FDG-PET with CT/MRI.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
Detection of residual tumor after radiofrequency ablation of liver metastasis with dual-modality PET/CT: initial results.
Topics: Aged; Catheter Ablation; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iohexol; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
(18)F-FDG PET/CT in the evaluation of recurrent ovarian cancer: a prospective study on forty-one patients.
Topics: Adult; Aged; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
Diagnostic accuracy of FDG PET imaging for the detection of recurrent or metastatic gynecologic cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2005 |
Early restaging whole-body (18)F-FDG PET during induction chemotherapy predicts clinical outcome in patients with locoregionally advanced nasopharyngeal carcinoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Analysis; Survival Rate; Taiwan; Treatment Outcome; Whole Body Imaging | 2005 |
Selective mediastinal node irradiation based on FDG-PET scan data in patients with non-small-cell lung cancer: a prospective clinical study.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Irradiation; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiography; Radiopharmaceuticals | 2005 |
Positron emission tomography with 18F-fluoro-2-deoxyglucose for the detection of recurrent ovarian cancer.
Topics: Adult; Aged; CA-125 Antigen; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
Diagnostic performance and prognostic impact of FDG-PET in suspected recurrence of surgically treated non-small cell lung cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Germany; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Rate; Treatment Outcome | 2006 |
The prognostic value of FDG PET in head and neck cancer. Correlation with histopathology.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Cisplatin; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Treatment Outcome | 2005 |
Findings on 18F-FDG PET scans after neoadjuvant chemoradiation provides prognostic stratification in patients with locally advanced rectal carcinoma subsequently treated by radical surgery.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy, Adjuvant; Rectal Neoplasms; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Analysis; Survival Rate; Treatment Outcome | 2006 |
Fluorine-18-fluorodeoxyglucose positron emission tomography for assessment of patients with unresectable recurrent or metastatic lung cancers after CT-guided radiofrequency ablation: preliminary results.
Topics: Adult; Aged; Aged, 80 and over; Catheter Ablation; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Surgery, Computer-Assisted; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
[Evaluation of efficacy and clinical impact of positron emission tomography with 18F fluoro-deoxyglucose (FDG) in patients with suspicion of recurrent laryngeal carcinoma].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2006 |
Advantages and pitfalls of 18F-fluoro-2-deoxy-D-glucose positron emission tomography in detecting locally residual or recurrent nasopharyngeal carcinoma: comparison with magnetic resonance imaging.
Topics: Adult; Brachytherapy; Diagnostic Errors; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2006 |
Differential roles of 18F-FDG PET in patients with locoregional advanced nasopharyngeal carcinoma after primary curative therapy: response evaluation and impact on management.
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Outcome Assessment, Health Care; Positron-Emission Tomography; Practice Patterns, Physicians'; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2006 |
Stereotactic hypofractionated radiotherapy in stage I (T1-2 N0 M0) non-small-cell lung cancer (NSCLC).
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Dose Fractionation, Radiation; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiation Injuries; Radiosurgery; Radiotherapy Dosage; Survival Analysis | 2006 |
Early FDG-PET assessment in combination with clinical risk scores determines prognosis in recurring lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Remission Induction; Risk Factors; Sensitivity and Specificity; Survival Rate; Transplantation, Autologous; Treatment Outcome | 2007 |
Role of [18F]FDG PET/CT in the assessment of suspected recurrent ovarian cancer: correlation with clinical or histological findings.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Population Surveillance; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Subtraction Technique; Systems Integration; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Post-therapy surveillance of patients with uterine cancers: value of integrated FDG PET/CT in the detection of recurrence.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Population Surveillance; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Systems Integration; Tomography, X-Ray Computed; Treatment Outcome; Uterine Neoplasms | 2007 |
[11C] methionine and [18F] fluorodeoxyglucose PET in the follow-up of glioblastoma multiforme.
Topics: Brain Neoplasms; Carbon Radioisotopes; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glioblastoma; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Methionine; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Survival Rate | 2007 |
Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy.
Topics: Adult; Aged; Aged, 80 and over; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy, Adjuvant; Rectal Neoplasms; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Prospective comparison of two gamma probes for intraoperative detection of 18F-FDG: in vitro assessment and clinical evaluation in differentiated thyroid cancer patients with iodine-negative recurrence.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Intraoperative Care; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Surgery, Computer-Assisted; Thyroid Neoplasms; Treatment Outcome | 2007 |
18fluorodeoxyglucose positron emission tomography in the prediction of relapse in patients with high-risk, clinical stage I nonseminomatous germ cell tumors: preliminary report of MRC Trial TE22--the NCRI Testis Tumour Clinical Study Group.
Topics: Adolescent; Adult; Biopsy, Needle; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease-Free Survival; Fluorodeoxyglucose F18; Germinoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Orchiectomy; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Risk Assessment; Salvage Therapy; Sensitivity and Specificity; Survival Analysis; Testicular Neoplasms | 2007 |
HI-CHART: a phase I/II study on the feasibility of high-dose continuous hyperfractionated accelerated radiotherapy in patients with inoperable non-small-cell lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Dose Fractionation, Radiation; Esophagus; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy, Conformal; Survival Analysis | 2008 |
Therapeutic impact of 18FDG-PET/CT in the management of iodine-negative recurrence of differentiated thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Adenoma, Oxyphilic; Adolescent; Adult; Aged; Aged, 80 and over; Cell Differentiation; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Patient Selection; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed | 2007 |
Early detection of recurrence by 18FDG-PET in the follow-up of patients with colorectal cancer.
Topics: Adult; Aged; Colorectal Neoplasms; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies | 2008 |
Preoperative radiation response evaluated by 18-fluorodeoxyglucose positron emission tomography predicts survival in locally advanced rectal cancer.
Topics: Colectomy; Colostomy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Japan; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Rectal Neoplasms; Survival Rate; Tomography, Emission-Computed | 2008 |
Pet-FDG imaging in the clinical evaluation of head and neck cancer.
Topics: Aged; Deoxyglucose; False Positive Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Tomography, Emission-Computed | 1995 |
Neuroblastoma: positron emission tomography with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose compared with metaiodobenzylguanidine scintigraphy.
Topics: 3-Iodobenzylguanidine; Adult; Child; Child, Preschool; Contrast Media; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Neoplasm Recurrence, Local; Neuroblastoma; Tomography, Emission-Computed | 1996 |
The role of whole-body positron emission tomography with [18F]fluorodeoxyglucose in identifying operable colorectal cancer metastases to the liver.
Topics: Colorectal Neoplasms; Deoxyglucose; Double-Blind Method; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neoplasm Recurrence, Local; Radiography; Tomography, Emission-Computed | 1996 |
A clinical evaluation of FDG-PET to assess the response in radiation therapy for bronchogenic carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Bronchogenic; Carcinoma, Large Cell; Carcinoma, Squamous Cell; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Predictive Value of Tests; Prognosis; Tomography, Emission-Computed | 1996 |
Fluorine-18-fluorodeoxyglucose positron emission tomography is useless for the detection of local recurrence after radical prostatectomy.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Cicatrix; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prostatectomy; Prostatic Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
Imaging of locally recurrent and metastatic thyroid cancer with positron emission tomography.
Topics: Carcinoma, Medullary; Carcinoma, Papillary, Follicular; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Retrospective Studies; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
Fluorodeoxyglucose PET in the evaluation of amputations for soft tissue sarcoma.
Topics: Adolescent; Adult; Aged; Amputation Stumps; Amputation, Surgical; Arm; Child; Female; Fluorodeoxyglucose F18; Humans; Leg; Male; Middle Aged; Neoplasm Recurrence, Local; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Sarcoma; Whole-Body Counting | 1999 |
Value of FDG-PET in detecting residual or recurrent nonsmall cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
Surveillance for recurrent head and neck cancer using positron emission tomography.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carboplatin; False Positive Reactions; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Prospective Studies; Radiopharmaceuticals; Salvage Therapy; Tomography, Emission-Computed | 2000 |
Early evaluation of tumour metabolic response using [18F]fluorodeoxyglucose and positron emission tomography: a pilot study following the phase II chemotherapy schedule for temozolomide in recurrent high-grade gliomas.
Topics: Adult; Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Evaluation Studies as Topic; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Radiopharmaceuticals; Temozolomide; Tomography, Emission-Computed | 2000 |
Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse.
Topics: Adolescent; Adult; alpha-Fetoproteins; Biomarkers, Tumor; Chorionic Gonadotropin, beta Subunit, Human; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Germinoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Radiopharmaceuticals; Retrospective Studies; Seminoma; Sensitivity and Specificity; Teratoma; Testicular Neoplasms; Tomography, Emission-Computed | 2000 |
Angiography effectively supports the diagnosis of hepatic metastases in medullary thyroid carcinoma.
Topics: Adult; Aged; Angiography; Calcitonin; Carcinoma, Medullary; Diagnosis, Differential; Diarrhea; Female; Fluorodeoxyglucose F18; Flushing; Humans; Liver; Liver Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed | 2001 |
Comparing 18-fluoro-2-deoxyglucose positron emission tomography with a combination of technetium 99m tetrofosmin single photon emission computed tomography and computed tomography to detect recurrent or persistent nasopharyngeal carcinomas after radiother
Topics: Adolescent; Adult; Aged; Carcinoma; Diagnosis, Differential; Drug Resistance, Neoplasm; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2001 |
Fluorodeoxyglucose positron emission tomography for detection of recurrent or metastatic breast cancer.
Topics: Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
2-[Fluorine-18]-fluoro-2-deoxy-d-glucose positron emission tomography in the diagnosis of recurrent ovarian cancer.
Topics: CA-125 Antigen; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
The utility of (18)F-FDG PET for suspected recurrent non-small cell lung cancer after potentially curative therapy: impact on management and prognostic stratification.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Predictive Value of Tests; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Survival Analysis | 2001 |
Prognostic value of positron emission tomography using F-18-fluorodeoxyglucose in patients with cervical cancer undergoing radiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2002 |
FDG-PET for detection of recurrences from malignant primary bone tumors: comparison with conventional imaging.
Topics: Adolescent; Adult; Biopsy; Child; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Bone Tissue; Recurrence; Tomography, Emission-Computed | 2002 |
Early prediction of treatment response to high-dose salvage chemotherapy in patients with relapsed germ cell cancer using [(18)F]FDG PET.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Prognosis; Prospective Studies; Radiopharmaceuticals; Salvage Therapy; Seminoma; Sensitivity and Specificity; Testicular Neoplasms; Tomography, Emission-Computed; Treatment Outcome | 2002 |
Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with technetium-99m methoxyisobutylisonitrile single photon emission computed tomography and computed tomography: comparison with 18-fluoro-2-deoxyglucose positron emission
Topics: Adolescent; Adult; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm, Residual; Radiopharmaceuticals; Reproducibility of Results; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2002 |
Reproducibility and clinical value of 18F-fluorodeoxyglucose positron emission tomography in recurrent melanoma.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Observer Variation; Patient Care; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Skin Neoplasms; Statistics as Topic; Surveys and Questionnaires; Tomography, Emission-Computed; Whole-Body Counting | 2002 |
Ovarian cancer recurrence: role of whole-body positron emission tomography using 2-[fluorine-18]-fluoro-2-deoxy- D-glucose.
Topics: Adenocarcinoma; Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Adult; Aged; CA-125 Antigen; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Granulosa Cell Tumor; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Postoperative Care; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Whole-Body Counting | 2002 |
1405 other study(ies) available for fluorodeoxyglucose f18 and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Retroperitoneal Recurrence of Melanotic Schwannoma on 18F-FDG PET/CT.
Topics: Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neurilemmoma; Positron Emission Tomography Computed Tomography; Retroperitoneal Neoplasms | 2021 |
Monitoring of Programmed Cell Death Ligand-1 Blockade Using FDG PET/CT for Microsatellite Instability-High Metastatic Breast Cancer.
Topics: Adult; Apoptosis; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Immunotherapy; Ligands; Mastectomy; Microsatellite Instability; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography | 2022 |
Metabolic positron emission tomography/CT response after induction chemotherapy and chemo(re)irradiation is associated with higher negative resection margin rate in patients with locally recurrent rectal cancer.
Topics: Fluorodeoxyglucose F18; Humans; Induction Chemotherapy; Margins of Excision; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Treatment Outcome | 2022 |
Spontaneous Regression of a Middle Ear Melanoma.
Topics: Aged; Ear, Middle; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
Diagnostic and prognostic value of FDG PET-CT in patients with suspected recurrent thymic epithelial tumors.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Retrospective Studies; Thymoma; Thymus Neoplasms; Young Adult | 2021 |
Elevated CEA with negative PET scan on surveillance of colorectal cancers-a role of CEA kinetics.
Topics: Carcinoembryonic Antigen; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Kinetics; Neoplasm Recurrence, Local; Positron-Emission Tomography; Retrospective Studies | 2022 |
Prognostic Radiological Tools for Clinical Stage IA Pure Solid Lung Cancer.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Retrospective Studies | 2021 |
Prognostic value of metabolic activity of the psoas muscle evaluated by preoperative
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Humans; Insulin Resistance; Liver; Mastectomy; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Preoperative Care; Prognosis; Proportional Hazards Models; Psoas Muscles; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome; Triple Negative Breast Neoplasms | 2021 |
Utility of FDG-PET CT scan to detect an incidental rare recurrence of carcinoma urinary bladder following radical cystectomy.
Topics: Carcinoma; Cystectomy; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; Urinary Bladder; Urinary Bladder Neoplasms | 2021 |
Rare Presentation of Late Complications After Undiagnosed Perforated Appendicitis Mimicking Recurrent Endometrial Carcinoma on 18F-FDG PET/CT.
Topics: Aged; Appendectomy; Appendicitis; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography | 2022 |
Lumbosacral Plexus Neurolymphomatosis: A Typical 18FDG PET/CT Pattern to Recognize.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Lumbosacral Plexus; Lymphoma, Large B-Cell, Diffuse; Male; Neoplasm Recurrence, Local; Neurolymphomatosis; Positron Emission Tomography Computed Tomography | 2022 |
Topics: Aged; Aged, 80 and over; Asymptomatic Diseases; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Skin Neoplasms | 2022 |
Diagnosis of bone metastases in breast cancer: Lesion-based sensitivity of dual-time-point FDG-PET/CT compared to low-dose CT and bone scintigraphy.
Topics: Bone and Bones; Bone Neoplasms; Breast; Breast Neoplasms; Diagnostic Tests, Routine; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radionuclide Imaging; Sensitivity and Specificity; Tomography, X-Ray Computed | 2021 |
New mimic of relapse or regional lymph node metastasis in a cancer survivor: a case of mRNA COVID-19 vaccine-induced lymphadenitis with high FDG uptake.
Topics: Adult; Cancer Survivors; COVID-19; COVID-19 Vaccines; Female; Fluorodeoxyglucose F18; Humans; Lymphadenitis; Lymphatic Metastasis; Neoplasm Recurrence, Local; RNA, Messenger; SARS-CoV-2 | 2022 |
Hypermetabolic abdominal and cervical lymph nodes mimicking Hodgkin lymphoma relapse on FDG PET/CT after adenovirus-vectored COVID-19 vaccine.
Topics: Adenoviridae; Adult; COVID-19; COVID-19 Vaccines; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymph Nodes; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; SARS-CoV-2 | 2021 |
Which will carry more weight when CTR > 0.5, solid component size, CTR, tumor size or SUVmax?
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2022 |
68Ga-Pentixafor PET/CT Improves the Detection of Recurrent Myeloma in the Temporal Bone Masked by the Physiological 18F-FDG Uptake of the Brain and Extraocular Muscles.
Topics: Aged; Brain; Coordination Complexes; Female; Fluorodeoxyglucose F18; Humans; Multiple Myeloma; Neoplasm Recurrence, Local; Oculomotor Muscles; Peptides, Cyclic; Positron Emission Tomography Computed Tomography; Temporal Bone | 2022 |
Benign Parathyroid Hyperplasia With Incidental Pulmonary Seeding on 99mTc-MIBI Scintigraphy and FDG PET/CT.
Topics: Female; Fluorodeoxyglucose F18; Humans; Hyperplasia; Lung; Middle Aged; Neoplasm Recurrence, Local; Parathyroid Glands; Positron Emission Tomography Computed Tomography; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2022 |
177Lu-FAPI Therapy in a Patient With End-Stage Metastatic Pancreatic Adenocarcinoma.
Topics: Adenocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography | 2022 |
Tumor Imaging With 68Ga-DOTA-FAPI-04 PET/CT: Comparison With 18F-FDG PET/CT in 22 Different Cancer Types.
Topics: Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Quinolines | 2022 |
The diagnostic accuracy and clinical impact of FDG-PET/CT follow-up for patients on adjuvant immunotherapy for high-risk malignant melanoma.
Topics: Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunotherapy; Melanoma; Melanoma, Cutaneous Malignant; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Skin Neoplasms | 2022 |
Recurrent Ovarian Cancer Presenting as a Solitary Chest Wall Metastasis Revealed by FDG PET/CT.
Topics: Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Thoracic Wall | 2022 |
PET/CT With 68Ga-PSMA and 18F-FDG in Metastatic Adenoid Cystic Carcinoma: Report of 2 Cases.
Topics: Carcinoma, Adenoid Cystic; Edetic Acid; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms | 2022 |
Cystic Intracranial Recurrence of Olfactory Neuroblastoma without Accumulation on Fluorine-18-fluorodeoxyglucose Positron Emission Tomography.
Topics: Aged; Aged, 80 and over; Esthesioneuroblastoma, Olfactory; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Nasal Cavity; Neoplasm Recurrence, Local; Nose Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2022 |
18F-Labeled WBC PET/CT Scan in a Case of Recurrent Glioblastoma Multiforme, Presented as Pyrexia of Unknown Origin.
Topics: Fever; Fever of Unknown Origin; Fluorodeoxyglucose F18; Glioblastoma; Humans; Leukocytes; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
Qualitative and quantitative methods in post-chemoradiation PET for head and neck cancer.
Topics: Chemoradiotherapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2022 |
Pituitary Metastasis of Non-Small Cell Lung Cancer With High FDG Uptake on PET/CT Pituitary Metastasis of Non-Small Cell Lung Carcinoma.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Pituitary Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2022 |
Significance of mid-radiotherapy 18F-fluorodeoxyglucose positron emission tomography/computed tomography in esophageal cancer.
Topics: Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2022 |
Long term survival in patients with human papillomavirus-positive oropharyngeal cancer and equivocal response on 12-week PET-CT is not compromised by the omission of neck dissection.
Topics: Alphapapillomavirus; Carcinoma, Squamous Cell; Chemoradiotherapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neck Dissection; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Papillomaviridae; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2022 |
FDG PET/CT in differentiated thyroid cancer patients with low thyroglobulin levels.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Thyroglobulin; Thyroid Neoplasms | 2022 |
Combined 18 F-FDG PET/CT Radiomics and Sarcopenia Score in Predicting Relapse-Free Survival and Overall Survival in Patients With Esophagogastric Cancer.
Topics: Adenocarcinoma; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sarcopenia; Stomach Neoplasms | 2022 |
68 Ga-FAPI Versus 18 F-FDG PET/CT in Recurrent Undifferentiated Pleomorphic Sarcoma of Colon Mesentery.
Topics: Colon; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Mesentery; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Sarcoma | 2022 |
FDG-PET/CT-guided rebiopsy may find clinically unsuspicious transformation of follicular lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2023 |
Prognostic value of pre-transplantation total metabolic tumor volume on
Topics: Fluorodeoxyglucose F18; Glucose; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Tumor Burden | 2022 |
68 Ga-FAPI-46 and 18 F-FDG in Advanced Metastatic Pancreatic Cancer.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Quinolines | 2022 |
Added value of repeat sentinel lymph node biopsy in FDG-PET/CT node-negative patients with ipsilateral breast cancer recurrence.
Topics: Axilla; Breast Neoplasms; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sentinel Lymph Node; Sentinel Lymph Node Biopsy | 2022 |
[18F]FDG PET/CT and CA-125 in the evaluation of ovarian cancer relapse or persistence: is there any correlation?
Topics: CA-125 Antigen; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2022 |
Metabolic activity determines survival depending on the level of lymph node involvement in cervical cancer.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Uterine Cervical Neoplasms | 2022 |
Posttreatment FDG-PET/CT Hopkins criteria predict locoregional recurrence after definitive radiotherapy for oropharyngeal squamous cell carcinoma.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2022 |
Dual-phase FDG PET/CT for predicting prognosis in operable breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2022 |
Full automation of total metabolic tumor volume from FDG-PET/CT in DLBCL for baseline risk assessments.
Topics: Artificial Intelligence; Automation; Clinical Trials, Phase III as Topic; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Risk Assessment; Tumor Burden | 2022 |
Utility of pre-treatment FDG PET/CT-derived machine learning models for outcome prediction in classical Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Machine Learning; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Young Adult | 2022 |
Added value of quantitative, multiparametric 18F-FDG PET/MRI in the locoregional staging of rectal cancer.
Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Rectal Neoplasms; Retrospective Studies; Tumor Burden | 2022 |
Patterns of relapse and long-term outcome in patients treated with a curative intent for advanced Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Neoplasm Recurrence, Local; Survival Analysis; Tomography, X-Ray Computed | 2022 |
Role of 18F-FDG PET/CT in the postoperative follow-up in patients with stage I-III NSCLC: A retrospective single-institution study.
Topics: Carcinoma, Non-Small-Cell Lung; Early Detection of Cancer; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2022 |
Multi-scale characterization of tumor-draining lymph nodes in resectable lung cancer treated with neoadjuvant immune checkpoint inhibitors.
Topics: Adolescent; China; Fluorodeoxyglucose F18; Humans; Immune Checkpoint Inhibitors; Lung Neoplasms; Lymph Nodes; Neoadjuvant Therapy; Neoplasm Recurrence, Local | 2022 |
Diagnostic performance of F-18 FDG PET/CT in recurrent adenocarcinoma gallbladder and its impact on post-recurrence survival.
Topics: Adenocarcinoma; Biomarkers, Tumor; Cicatrix; Fluorodeoxyglucose F18; Gallbladder; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2023 |
The role of 18F-FDG PET/CT in patients with diffuse large B-cell lymphoma after radioimmunotherapy using 131I-rituximab as consolidation therapy.
Topics: Adult; Aged; Consolidation Chemotherapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prednisolone; Prognosis; Radioimmunotherapy; Retrospective Studies; Rituximab; Vincristine | 2022 |
[18F-fluorodesoxyglucose positron emission tomography/computed tomography in extramedullary multiple myeloma].
Topics: Fluorodeoxyglucose F18; Humans; Multiple Myeloma; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
[Postoperative Recurrent Lung Cancer Successfully Treated with Alternate Day Administration of Gefitinib].
Topics: ErbB Receptors; Exanthema; Fluorodeoxyglucose F18; Gefitinib; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local | 2022 |
Total Lesion Glycolysis Levels as Predictive Indicators in Patients With Metastatic and Recurrent Breast Cancer Undergoing Endocrine Therapy With or Without CDK4/6 Inhibitor.
Topics: Breast Neoplasms; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Protein Kinase Inhibitors; Radiopharmaceuticals; Receptors, Estrogen; Retrospective Studies; Tumor Burden | 2022 |
Association between Serum Carcino-embryonic Antigen Levels and Micropapillary Bladder Cancer Metastasis in an Elderly Male.
Topics: Adenocarcinoma, Papillary; Aged; BCG Vaccine; Carcinoembryonic Antigen; Carcinoma, Papillary; Carcinoma, Transitional Cell; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Urinary Bladder; Urinary Bladder Neoplasms | 2022 |
Regional lymph node metastasis detected on preoperative CT and/or FDG-PET may predict early recurrence of pancreatic adenocarcinoma after curative resection.
Topics: Adenocarcinoma; CA-19-9 Antigen; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2022 |
Can 18 F-FDG-Positron Emission Tomography be a Prognostic Tool in Children With Rhabdomyosarcoma Treated With Definitive Radiotherapy?
Topics: Adolescent; Child; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Rhabdomyosarcoma | 2023 |
[18F]-FDG PET and MRI radiomic signatures to predict the risk and the location of tumor recurrence after re-irradiation in head and neck cancer.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Re-Irradiation | 2023 |
Diagnostic efficacy of positron emission computerized tomography scans in suspicious laryngeal findings postorgan preservation treatment.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Larynx; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck | 2023 |
Benefit of [
Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Salvage Therapy; Sensitivity and Specificity | 2023 |
FDG PET-CT as an important diagnostic tool and prognostic marker in suspected recurrent cervical carcinoma after radiotherapy: comparison with MRI.
Topics: Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Uterine Cervical Neoplasms | 2022 |
18F-FDG and 18F-Fluciclovine Uptake in Poorly Differentiated Lung Adenocarcinoma in the Setting of Biochemically Recurrent Prostatic Adenocarcinoma.
Topics: Adenocarcinoma of Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Solitary Pulmonary Nodule | 2022 |
Radiographic Response of Solitary Plasmacytomas After Conformal Radiotherapy May Be Delayed: Outcomes in the 3D Era.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Plasmacytoma; Radiotherapy, Conformal; Retrospective Studies; Treatment Outcome | 2022 |
The usefulness of the total metabolic tumor volume for predicting the postoperative recurrence of thoracic esophageal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Retrospective Studies; Tumor Burden | 2022 |
Combination of Deauville score and quantitative positron emission tomography parameters as a predictive tool of anti-CD19 chimeric antigen receptor T-cell efficacy.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Prospective Studies; Receptors, Chimeric Antigen; Retrospective Studies; T-Lymphocytes | 2023 |
Evaluation of functional and metabolic tumor volume using voxel-wise analysis in childhood rhabdomyosarcoma.
Topics: Child; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Rhabdomyosarcoma; Tumor Burden | 2023 |
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies | 2023 |
Application of 18 F-fluorodeoxyglucose PET/CT radiomic features and machine learning to predict early recurrence of non-small cell lung cancer after curative-intent therapy.
Topics: Bayes Theorem; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Machine Learning; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies | 2023 |
Prognostic role of baseline
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2023 |
Clinical outcomes of neoadjuvant therapy followed by selective inguinal lymph node dissection and total mesorectal excision for metastasized low rectal cancer.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Rectal Neoplasms; Retrospective Studies | 2022 |
Prognostic value of baseline and early response FDG-PET/CT in patients with refractory and relapsed aggressive B-cell lymphoma undergoing CAR-T cell therapy.
Topics: Cell- and Tissue-Based Therapy; Fluorodeoxyglucose F18; Humans; Immunotherapy, Adoptive; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Receptors, Chimeric Antigen | 2023 |
Visualization of tumor hypoxia and re-oxygenation after stereotactic body radiation therapy in early peripheral lung cancer: A prospective study.
Topics: Fluorodeoxyglucose F18; Humans; Hypoxia; Lung; Lung Neoplasms; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiosurgery; Tumor Hypoxia | 2023 |
Chimeric Antigen Receptor T-Cell Therapy of Neurolymphomatosis Monitored by FDG PET/CT.
Topics: Adult; Cell- and Tissue-Based Therapy; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Male; Neoplasm Recurrence, Local; Neurolymphomatosis; Positron Emission Tomography Computed Tomography; Receptors, Chimeric Antigen | 2023 |
Is 18 F-FDG/ 18 F-Choline Dual-Tracer PET Behavior a Surrogate of Tumor Differentiation in Hepatocellular Carcinoma : A Tertiary Center Dedicated Study.
Topics: Carcinoma, Hepatocellular; Choline; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2023 |
The value of PET/CT for cytoreductive surgery selection in recurrent ovarian carcinoma.
Topics: Carcinoma, Ovarian Epithelial; Chronic Disease; Cytoreduction Surgical Procedures; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2023 |
PET-positive suture granuloma of abdominal wall 56 years post-appendicectomy mimicking recurrence of lymphoma.
Topics: Abdominal Wall; Fluorodeoxyglucose F18; Foreign-Body Reaction; Granuloma; Humans; Lymphoma, Follicular; Neoplasm Recurrence, Local; Positron-Emission Tomography; Sutures | 2023 |
Earlier Recurrence Detection Using Routine FDG PET-CT Scans in Surveillance of Stage IIB to IIID Melanoma: A National Cohort Study of 1480 Patients.
Topics: Cohort Studies; Fluorodeoxyglucose F18; Humans; Melanoma; Melanoma, Cutaneous Malignant; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Skin Neoplasms | 2023 |
Malignant diagnosis and prognostic analysis of 89 GIST patients using preoperative FDG-PET.
Topics: Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2023 |
Comparison of 18 F-FDG and 68 Ga-FAPI-04 Uptake in Postoperative Re-evaluation of Gastric, Duodenal, and Colorectal Cancers.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2023 |
The prognostic value of splenic abnormalities in pretreatment
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Retrospective Studies; Splenic Diseases; Splenomegaly | 2023 |
PET/CT standardized uptake value and EGFR expression predicts treatment failure in nasopharyngeal carcinoma.
Topics: ErbB Receptors; Fluorodeoxyglucose F18; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Treatment Failure | 2023 |
Diagnostic Performance of Response Assessment FDG-PET/CECT in HNSCC Treated With Definitive Radio(chemo)therapy Using NI-RADS.
Topics: Adult; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2023 |
Baseline PET radiomics outperforms the IPI risk score for prediction of outcome in diffuse large B-cell lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Retrospective Studies; Risk Factors | 2023 |
Utility of 68 Ga-FAPI-04 PET/CT in Adenoid Cystic Carcinoma Compared With 18 F-FDG PET/CT : Two Case Reports.
Topics: Carcinoma, Adenoid Cystic; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography | 2023 |
Differentiation between rebound thymic hyperplasia and thymic relapse after chemotherapy in pediatric Hodgkin lymphoma.
Topics: Child; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Thymus Hyperplasia; Thymus Neoplasms; Tomography, X-Ray Computed | 2023 |
Pretreatment 18-FDG-PET/CT parameters can serve as prognostic imaging biomarkers in recurrent NSCLC patients treated with reirradiation-chemoimmunotherapy.
Topics: Biomarkers; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Re-Irradiation; Retrospective Studies; Tumor Burden | 2023 |
Post-treatment 18F-fludeoxyglocuse-positron emission tomography in human papillomavirus-associated oropharyngeal cancer.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Human Papillomavirus Viruses; Humans; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Retrospective Studies | 2023 |
Consolidative radiotherapy for residual fluorodeoxyglucose activity on day +30 post CAR T-cell therapy in non-Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Humans; Immunotherapy, Adoptive; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Receptors, Chimeric Antigen; Retrospective Studies | 2023 |
FDG Localization in Acellular Dermal Matrix, a Potential Cause of Nonpernicious Uptake Following Breast Reconstruction Surgery.
Topics: Acellular Dermis; Breast Implantation; Breast Implants; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Mammaplasty; Mastectomy; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2023 |
Imaging Biomarkers to Predict Outcomes in Patients With Large B-Cell Lymphoma With a Day 28 Partial Response by
Topics: Antigens, CD19; Biomarkers; Clinical Decision-Making; Fluorodeoxyglucose F18; Humans; Immunotherapy, Adoptive; Lymphoma, Large B-Cell, Diffuse; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Receptors, Chimeric Antigen; Retrospective Studies; Uncertainty | 2023 |
The value of [18F]FDG PET/CT examination in the detection and differentiation of recurrent ovarian cancer.
Topics: Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2023 |
An Intensive 18F-Fludeoxyglucose-Positron Emission Tomography With Computed Tomography-Based Strategy of Follow-Up in Patients Treated for Head and Neck Squamous Cell Carcinoma Who Are Clinically Asymptomatic.
Topics: Adult; Case-Control Studies; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Squamous Cell Carcinoma of Head and Neck | 2023 |
Impact of retention index on the neoadjuvant chemotherapy effect and the prognosis in oesophageal cancer.
Topics: Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2023 |
Inflammatory reactions mimic residual or recurrent lymphoma on [18F]FDG-PET/CT after CD19-directed CAR T-cell therapy.
Topics: Antigens, CD19; Fluorodeoxyglucose F18; Humans; Immunotherapy, Adoptive; Lymphoma; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography | 2023 |
Comparison of early and late
Topics: Adenocarcinoma; Carcinoma, Pancreatic Ductal; Cholestasis; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Quinolines; Retrospective Studies; Tomography, X-Ray Computed | 2023 |
68 Ga-PSMA-11 PET/CT Imaging in Brain Gliomas and Its Correlation With Clinicopathological Prognostic Parameters.
Topics: Adult; Aged; Brain; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Glioma; Humans; Ki-67 Antigen; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Young Adult | 2023 |
Prognostic Impact of Cancer Inflammation Prognostic Index for Non-small Cell Lung Cancer.
Topics: Carcinoembryonic Antigen; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Inflammation; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Retrospective Studies | 2023 |
The utility of PET-CT in the staging and management of advanced and recurrent malignant melanoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Skin Neoplasms; Young Adult | 2019 |
Topics: Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Proportional Hazards Models; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Survival Rate | 2020 |
S-100B as an extra selection tool for FDG PET/CT scanning in follow-up of AJCC stage III melanoma patients.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; S100 Calcium Binding Protein beta Subunit | 2019 |
Significance of CT attenuation and F-18 fluorodeoxyglucose uptake of visceral adipose tissue for predicting survival in gastric cancer patients after curative surgical resection.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Signet Ring Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrectomy; Humans; Intra-Abdominal Fat; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms; Survival Rate | 2020 |
Multiparametric PET/MR (PET and MR-IVIM) for the evaluation of early treatment response and prediction of tumor recurrence in patients with locally advanced cervical cancer.
Topics: Adult; Aged; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multiparametric Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Pelvis; Positron-Emission Tomography; Treatment Outcome; Uterine Cervical Neoplasms | 2020 |
Detection of Recurrence in Retromolar Trigone using "Puffed Cheek" F-18 FDG PET-CT Scan.
Topics: Cheek; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Tongue Neoplasms | 2019 |
The prognostic value of PET/CT evaluation with Deauville score on the recurrence and survival in diffuse large B-cell lymphoma: a multi-institutional study of KROG 17-02.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prednisone; Prognosis; Propensity Score; Republic of Korea; Retrospective Studies; Rituximab; Survival Rate; Vincristine | 2020 |
Restaging [
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Proportional Hazards Models; Retrospective Studies; Skin Neoplasms; Treatment Outcome | 2020 |
Clinical and Prognostic Value of
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Skin Neoplasms | 2020 |
FDG PET-CT in pediatric Langerhans cell histiocytosis.
Topics: Adolescent; Child; Child, Preschool; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Histiocytosis, Langerhans-Cell; Humans; Infant; Infant, Newborn; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2020 |
Case Report: Sarcoidosis mimicking head and neck cancer progression.
Topics: Adult; Diagnosis, Differential; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Neoplasm Recurrence, Local; Radiopharmaceuticals; Sarcoidosis | 2019 |
FDG-PET reflects tumor viability on SUV in colorectal cancer liver metastasis.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carrier Proteins; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Hepatectomy; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Ki-67 Antigen; Liver Neoplasms; Male; Membrane Proteins; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Thyroid Hormone-Binding Proteins; Thyroid Hormones | 2020 |
Prognostic utility of serial
Topics: Aged; Chemoradiotherapy; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Rectal Neoplasms; Tumor Burden | 2020 |
Role of 18F-FDG PET/CT in restaging and follow-up of patients with GIST.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrointestinal Stromal Tumors; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity | 2020 |
FDG-PET/CT in the surveillance of head and neck cancer following radiotherapy.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Population Surveillance; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals | 2020 |
Value of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and Sentinel Lymph Node Biopsy in Endometrial Cancer Patients: A Prospective Study.
Topics: Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Neoplasm Recurrence, Local; Obesity, Morbid; Positron Emission Tomography Computed Tomography; Prospective Studies; Sentinel Lymph Node Biopsy | 2021 |
Multiclonality and Radiosensitivity of Granulocyte-colony Stimulating Factor-Producing Lung Adenocarcinoma Positive for an Activating EGFR Mutation.
Topics: Adenocarcinoma of Lung; Clonal Evolution; ErbB Receptors; Fluorodeoxyglucose F18; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiation Tolerance; Radiopharmaceuticals; Treatment Outcome | 2020 |
High nodal FDG uptake increases risk of distant metastasis in patients with oropharyngeal squamous cell carcinoma.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2020 |
Individualized discrimination of tumor recurrence from radiation necrosis in glioma patients using an integrated radiomics-based model.
Topics: Fluorodeoxyglucose F18; Glioma; Humans; Necrosis; Neoplasm Recurrence, Local; Tomography, X-Ray Computed | 2020 |
Prognostic value of 18F-FDG PET parameters in patients with locally advanced non-small cell lung cancer treated with induction chemotherapy.
Topics: Adenocarcinoma of Lung; Adult; Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Induction Chemotherapy; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate | 2020 |
Muscle Recurrence of a Primarily Nodal Follicular Lymphoma Studied by Contrast-Enhanced 18F-FDG PET/CT.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Middle Aged; Muscle Neoplasms; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2020 |
Hypoxia-induced modulation of glucose transporter expression impacts
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glucose Transporter Type 3; Humans; Hypoxia; Liver Neoplasms; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2020 |
[Primary biliary cholangitis complicated by primary hepatic extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue].
Topics: Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Liver Cirrhosis, Biliary; Lymphoid Tissue; Lymphoma, B-Cell, Marginal Zone; Neoplasm Recurrence, Local | 2019 |
Modified hydrodissection for percutaneuous biopsy of small lesions: the "marshmallow" technique.
Topics: Aged; Dissection; Female; Fluorodeoxyglucose F18; Humans; Image-Guided Biopsy; Lymph Nodes; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiology, Interventional; Safety | 2020 |
Two cases of granuloma mimicking local recurrence after pulmonary segmentectomy.
Topics: Aged; Carcinoembryonic Antigen; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Granuloma; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Pneumonectomy; Polyglycolic Acid; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sutures | 2020 |
Tumour and pelvic lymph node metabolic activity on FDG-PET/CT to stratify patients for para-aortic surgical staging in locally advanced cervical cancer.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Uterine Cervical Neoplasms | 2020 |
Preoperative PET-CT is useful for predicting recurrent extrahepatic metastasis of hepatocellular carcinoma after resection.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Preoperative Care; Proportional Hazards Models; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2020 |
Limited Usefulness of 18F-FDG PET/CT in Predicting Tumor Regression After Preoperative Chemotherapy for Noncardia Gastric Cancer: The Italian Research Group for Gastric Cancer (GIRCG) Experience.
Topics: Aged; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Membrane Glycoproteins; Neoplasm Recurrence, Local; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Postoperative Complications; Predictive Value of Tests; Radiopharmaceuticals; Stomach Neoplasms | 2020 |
Prognostic Value of 18F-FDG PET/CT-Metabolic Parameters at Baseline and Interim Assessment in Pediatric Anaplastic Large Cell Lymphoma.
Topics: Child; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lymphoma, Large-Cell, Anaplastic; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals | 2020 |
The early prediction of pathological response to neoadjuvant chemotherapy and prognosis: comparison of PET Response Criteria in Solid Tumors and European Organization for Research and Treatment of Cancer criteria in breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Early Diagnosis; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Kaplan-Meier Estimate; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Progression-Free Survival; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors | 2020 |
Significance of 18F-FDG PET/CT in Characterization of Equivocal Lesions in High-Risk Testicular Carcinoma in Restaging Setting.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Seminoma; Testicular Neoplasms; Young Adult | 2020 |
The Value of PET-CT in Ovarian Epithelial Carcinoma: A Population-Based Study in British Columbia, Canada.
Topics: British Columbia; Carcinoma, Ovarian Epithelial; Cytoreduction Surgical Procedures; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2020 |
Diagnostic value of navigation-guided core needle biopsy in deep regions of the head and neck with focal FDG uptake on
Topics: Biopsy, Large-Core Needle; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2020 |
[A Case of Subphrenic Lymph Node Metastasis from Gastric Cancer in Which FDG-PET/CT Was Useful for Diagnosis].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Gastrectomy; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Stomach Neoplasms | 2019 |
Successful treatment of combined thymic epithelial tumor with hepatic metastasis: a long disease-free survival case.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thymectomy; Thymoma; Thymus Neoplasms | 2020 |
Early recurrence detected by 18F-FDG PET/CT in patients with resected pancreatic ductal adenocarcinoma.
Topics: Adenocarcinoma; China; Female; Fluorodeoxyglucose F18; Humans; Male; Margins of Excision; Middle Aged; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Postoperative Period; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Survival Analysis | 2020 |
A prospective comparative study of contrast-enhanced CT, contrast-enhanced MRI and 18F-FDG PET/CT in the preoperative staging of colorectal cancer patients.
Topics: Aged; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2020 |
Predictive value of FDG-PET imaging for relapse in metastatic melanoma patients treated with immunotherapy.
Topics: Fluorodeoxyglucose F18; Humans; Immunotherapy; Melanoma; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome | 2020 |
Alpha-fetoprotein and
Topics: alpha-Fetoproteins; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplastic Cells, Circulating; Portal Vein; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Period; Radiopharmaceuticals; Risk Factors; Survival Rate; Tumor Burden | 2020 |
[A Case of 18FDG PET/CT-Positive Adrenal Adenoma Suspected of Being Adrenal Metastasis of Synchronous Triple Cancer].
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenocortical Adenoma; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2020 |
Predictions of Pathological Features and Recurrence Based on FDG-PET Findings of Esophageal Squamous Cell Carcinoma after Trimodal Therapy.
Topics: Chemoradiotherapy; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2020 |
Topics: Adult; Female; Fluorodeoxyglucose F18; Giant Cell Tumors; Humans; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2020 |
Positive Predictive Value of Neck Imaging Reporting and Data System Categories 3 and 4 Posttreatment FDG-PET/CT in Head and Neck Squamous Cell Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Treatment Failure | 2020 |
How Useful Are Tumor Markers in Detecting Metastases with FDG-PET/CT during Breast Cancer Surveillance?
Topics: Biomarkers, Tumor; Breast Neoplasms; Carcinoembryonic Antigen; Female; Fluorodeoxyglucose F18; Humans; Mucin-1; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2020 |
Different roles of surveillance positron emission tomography according to the histologic subtype of non-Hodgkin's lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2021 |
Diagnostic accuracy of positron emission tomography/computed tomography-driven biopsy for the diagnosis of lymphoma.
Topics: Biopsy; Fluorodeoxyglucose F18; Humans; Lymphoma; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2020 |
Involved node radiation therapy in the combined modality treatment for early-stage Hodgkin lymphoma: Analysis of relapse location and long-term outcome.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiotherapy Dosage; Treatment Outcome | 2020 |
Can FDG-PET replace biopsy for the evaluation of residual tumor in pediatric mature B-cell non-Hodgkin lymphoma?
Topics: Adolescent; Biopsy; Child; Child, Preschool; Cross-Sectional Studies; Egypt; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Male; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sensitivity and Specificity | 2020 |
PET-detected asymptomatic recurrence is associated with improved survival in recurrent cervical cancer.
Topics: Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Uterine Cervical Neoplasms | 2021 |
FDG-PET/CT Radiomics Models for The Early Prediction of Locoregional Recurrence in Head and Neck Cancer.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2021 |
Fluorodeoxyglucose positron emission tomography/computed tomography findings after percutaneous cryoablation of early breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Cryosurgery; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Postoperative Complications; Radiopharmaceuticals | 2020 |
Predictive value of interim 18F-FDG-PET in patients with non-small cell lung cancer treated with definitive radiation therapy.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Progression-Free Survival; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tumor Burden | 2020 |
Clinical Evaluation of (4S)-4-(3-[
Topics: Aged; Fluorodeoxyglucose F18; Humans; Hyaluronan Receptors; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Tissue Distribution | 2020 |
The value of 18F-FDG PET/CT imaging combined with detection of CA125 and HE4 in the diagnosis of recurrence and metastasis of ovarian cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biopsy; CA-125 Antigen; Chemotherapy, Adjuvant; Cytoreduction Surgical Procedures; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Membrane Proteins; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Time Factors; Treatment Outcome; WAP Four-Disulfide Core Domain Protein 2 | 2020 |
The use of FDG-PET/CT to detect early recurrence after resection of high-risk stage III melanoma.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals | 2020 |
Primary hepatic diffuse large B-cell lymphoma presenting unusual imaging features.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2020 |
[Imaging modalities in the assessment of presacral recurrent rectal cancer].
Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Tomography, X-Ray Computed | 2020 |
Timing of fluorodeoxyglucose positron emission tomography maximum standardized uptake value for diagnosis of local recurrence of non-small cell lung cancer after stereotactic body radiation therapy.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiosurgery; Retrospective Studies; Time Factors | 2020 |
Progression Free Survival and Predictor of Recurrence in DLBCL patients with Negative Interim 18FDG PET/CT Using Standardized Imaging and Reporting Protocols.
Topics: Adult; Aged; Aged, 80 and over; Documentation; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Interpretation, Computer-Assisted; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Progression-Free Survival; Prospective Studies; Radiopharmaceuticals; ROC Curve; Survival Rate; Young Adult | 2020 |
Diagnosis of recurrence and follow-up using FDG-PET/CT for postoperative non-small-cell lung cancer patients.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2021 |
An unusual presentation of recurrent T cell lymphoma: angiocentric pattern of cutaneous uptake on [
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, T-Cell; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2021 |
A rare case of cranial and spinal leptomeningeal dissemination of recurrent ethmoid carcinoma detected by [18F]-FDG PET/CT.
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
Prognostic Role of Early Interim Fluorodeoxyglucose Positron Emission Tomography in Patients With Advanced Seminoma Undergoing Standard Treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Seminoma; Testicular Neoplasms | 2021 |
Risk assessment of osteoradionecrosis associated with periodontitis using
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Osteoradionecrosis; Periodontitis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Risk Assessment | 2020 |
Predictive value of suvmax changes between two sequential post-therapeutic FDG-pet in head and neck squamous cell carcinomas.
Topics: Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2020 |
Identifying optimal candidates for induction chemotherapy among stage II-IVa nasopharyngeal carcinoma based on pretreatment Epstein-Barr virus DNA and nodal maximal standard uptake values of [
Topics: Clinical Decision-Making; Disease Progression; DNA, Viral; Epstein-Barr Virus Infections; Female; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Induction Chemotherapy; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Progression-Free Survival; Radiopharmaceuticals; Retrospective Studies; Time Factors | 2020 |
Machine learning-based FDG PET-CT radiomics for outcome prediction in larynx and hypopharynx squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Hypopharynx; Laryngeal Neoplasms; Machine Learning; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2021 |
Comparative effectiveness of posttreatment imaging modalities for Medicare patients with advanced head and neck cancer.
Topics: Aged; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Larynx; Male; Medicare; Middle Aged; Mouth; Neoplasm Recurrence, Local; Oropharynx; Positron-Emission Tomography; Squamous Cell Carcinoma of Head and Neck; United States | 2021 |
[Primary Pericardial Dedifferentiated Liposarcoma Detected by Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography;Report of a Case].
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Liposarcoma; Neoplasm Recurrence, Local; Pericardium; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Tomography, X-Ray Computed | 2020 |
Glycolytic phenotypes in an evaluation of ovarian carcinoma based on carcinogenesis and BRCA mutation.
Topics: Carcinogenesis; Carcinoma, Ovarian Epithelial; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Mutation; Neoplasm Recurrence, Local; Ovarian Neoplasms; Phenotype; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2020 |
[Experience with High-grade Fetal Lung Adenocarcinoma;Report of a Case].
Topics: Adenocarcinoma of Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals | 2020 |
Risk stratification in diffuse large B-cell lymphoma using lesion dissemination and metabolic tumor burden calculated from baseline PET/CT
Topics: Aged; Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Retrospective Studies; Risk Assessment; Tumor Burden | 2021 |
Maintained survival outcome after reducing lymphadenectomy rates and optimizing adjuvant treatment in endometrial cancer.
Topics: Aged; Aged, 80 and over; Chemoradiotherapy, Adjuvant; Chemotherapy, Adjuvant; Disease-Free Survival; Endometrial Neoplasms; Endometrium; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Hysterectomy; Lymph Node Excision; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Practice Guidelines as Topic; Preoperative Care; Radiotherapy, Adjuvant; Risk Assessment | 2021 |
[Informativeness of whole-body diffusion-weighted magnetic resonance imaging and positron emission tomography with computed tomography in follicular lymphoma].
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies | 2020 |
Ovarian Inflammation Mass Mimicking Recurrent Rectal Cancer 17 Years After Surgery: PET/CT and MRI Findings.
Topics: Female; Fluorodeoxyglucose F18; Humans; Inflammation; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Rectal Neoplasms | 2021 |
RADIOISOTOPE DIAGNOSTIC ALGORITHM FOR THE RELAPSE AND METASTASES DETECTION IN THE IODINE-NEGATIVE DIFFERENTIATED THYROID CANCER.
Topics: Algorithms; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Neoplasm Metastasis; Neoplasm Recurrence, Local; Organotechnetium Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Sodium Pertechnetate Tc 99m; Survival Analysis; Technetium Tc 99m Dimercaptosuccinic Acid; Thyroid Gland; Thyroid Neoplasms; Ukraine; Whole-Body Counting | 2020 |
F-18 fluorodeoxyglucose positron emission tomography/computed tomography in conjunctival melanoma with recurrence.
Topics: Conjunctival Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals | 2020 |
Investigating the value of pre-treatment
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2021 |
Performance of Long-Term CT and PET/CT Surveillance for Detection of Distant Recurrence in Patients with Resected Stage IIIA-D Melanoma.
Topics: Australia; Fluorodeoxyglucose F18; Humans; Melanoma; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2021 |
Low value of whole-body dual-modality [18f]fluorodeoxyglucose positron emission tomography/computed tomography in primary staging of stage I-II nasopharyngeal carcinoma: a nest case-control study.
Topics: Case-Control Studies; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2021 |
PET-CT scan-based maximum standardized uptake value as a prognostic predictor in oropharynx squamous cell cancer.
Topics: Adult; Aged; Chemoradiotherapy; Disease-Free Survival; Feasibility Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Risk Assessment; Squamous Cell Carcinoma of Head and Neck; Tissue Distribution | 2021 |
F-18 FDG PET/CT and F-18 FLT PET/CT as predictors of outcome in patients with multiple myeloma. A pilot study.
Topics: Dideoxynucleosides; Fluorodeoxyglucose F18; Humans; Multiple Myeloma; Neoplasm Recurrence, Local; Pilot Projects; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
Prediction of local recurrence and distant metastasis using radiomics analysis of pretreatment nasopharyngeal [18F]FDG PET/CT images.
Topics: Adolescent; Adult; Age Factors; Aged; Algorithms; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Multivariate Analysis; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; ROC Curve; Sex Factors | 2021 |
Positron Emission Tomography in Segmentectomy for cT1N0M0 Nonsmall Cell Lung Cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Tumor Burden | 2021 |
Clinical impact of endoscopic ultrasound in the study of adrenal gland: cytomegalovirus infection mimicking a neoplasic hypercaptation in PET.
Topics: Adrenal Glands; Aged; Cytomegalovirus Infections; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Neoplasm Recurrence, Local; Positron-Emission Tomography | 2021 |
Primary Malignant Melanoma of the Oropharynx Presented on 18F-FDG PET/CT.
Topics: Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Oropharynx; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2021 |
Clinical utility of FDG PET/CT for primary and recurrent papillary renal cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; Young Adult | 2021 |
Elective neck dissection versus positron emission tomography-computed tomography-guided management of the neck in clinically node-negative early oral cavity cancer: A cost-utility analysis.
Topics: Cost-Benefit Analysis; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Neck Dissection; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2021 |
[The 485th case: fever of undetermined origin and hypoxemia].
Topics: Fluorodeoxyglucose F18; Humans; Hypoxia; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography | 2021 |
Functional 4-D clustering for characterizing intratumor heterogeneity in dynamic imaging: evaluation in FDG PET as a prognostic biomarker for breast cancer.
Topics: Biomarkers; Breast Neoplasms; Cluster Analysis; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis | 2021 |
Value of regular endosonography and [18F]fluorodeoxyglucose PET-CT after surgery for gastro-oesophageal junction, stomach or pancreatic cancer.
Topics: Adenocarcinoma; Aged; Biopsy, Fine-Needle; Endosonography; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2021 |
Prognostic value of positron emission tomography in resected stage IA non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2021 |
Analysis of PET parameters as prognosticators of survival and tumor extent in Oropharyngeal Cancer treated with surgery and postoperative radiotherapy.
Topics: Adult; Aged; Disease Progression; Disease-Free Survival; Feasibility Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Oropharynx; Pharyngectomy; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy, Adjuvant; Retrospective Studies; Tumor Burden | 2021 |
[
Topics: Bayes Theorem; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Uterine Cervical Neoplasms | 2021 |
Total metabolic tumor volume and spleen metabolism on baseline [18F]-FDG PET/CT as independent prognostic biomarkers of recurrence in resected breast cancer.
Topics: Biomarkers; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Spleen; Tumor Burden; Tumor Microenvironment | 2021 |
Detection and staging of recurrent or metastatic nasopharyngeal carcinoma in the era of FDG PET/MR.
Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2022 |
Have Volume-based Parameters of Positron Emission Tomography/Computed Tomography Prognostic Relevance for Patients With Potentially Platinum-responsive Recurrent Ovarian Cancer? A Single Center Italian Study.
Topics: Adult; Aged; Carcinoma, Ovarian Epithelial; Drug Resistance, Neoplasm; Female; Fluorodeoxyglucose F18; Humans; Italy; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Platinum Compounds; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Retrospective Studies; Treatment Outcome; Tumor Burden | 2021 |
An FDG PET/CT metabolic parameter-based nomogram for predicting the early recurrence of hepatocellular carcinoma after liver transplantation.
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Neoplasm Recurrence, Local; Nomograms; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2021 |
Case Report: Abdominal Lymph Node Metastases of Parathyroid Carcinoma: Diagnostic Workup, Molecular Diagnosis, and Clinical Management.
Topics: Antibodies, Monoclonal, Humanized; Calcium; Cinacalcet; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Immune System; Immunotherapy; Liver Neoplasms; Lymphatic Metastasis; Middle Aged; Molecular Biology; Neoplasm Metastasis; Neoplasm Recurrence, Local; Parathyroid Hormone; Parathyroid Neoplasms; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography | 2021 |
Intratumor heterogeneity is biomarker specific and challenges the association with heterogeneity in multimodal functional imaging in head and neck squamous cell carcinoma.
Topics: Biomarkers; Biomarkers, Tumor; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Squamous Cell Carcinoma of Head and Neck | 2021 |
Staging, recurrence and follow-up of uterine cervical cancer using MRI: Updated Guidelines of the European Society of Urogenital Radiology after revised FIGO staging 2018.
Topics: Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiology; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2021 |
Can surgical adhesives may cause false positivity in follow-up positron emission tomography after lung cancer resection?
Topics: Aged; Carcinoma, Non-Small-Cell Lung; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2021 |
The Diagnostic Value of FDG-PET/CT for Urachal Cancer.
Topics: Carcinoma, Transitional Cell; Electrons; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2021 |
Preoperative 2-[
Topics: Ampulla of Vater; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2021 |
Predicting tumor response and prognosis to neoadjuvant chemotherapy in esophageal squamous cell carcinoma patients using PERCIST: a multicenter study in Japan.
Topics: Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Japan; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2021 |
Lymphoma involving the brain and adrenals: A chicken and egg situation.
Topics: Brain; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
COVID arm and PET/FDG imaging.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; BNT162 Vaccine; Deltoid Muscle; Female; Fluorodeoxyglucose F18; Humans; Immunization, Secondary; Incidental Findings; Lymphadenopathy; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2021 |
[Effectiveness of Osimertinib for Postoperative Recurrence of Lung Cancer with L861Q Activating EGFR Mutation:Report of a Case].
Topics: Acrylamides; Aged; Aniline Compounds; ErbB Receptors; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mutation; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography | 2021 |
Topics: Adult; Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Kidney Neoplasms; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2021 |
[Surgical Cases of Solitary Lesion after Surgery for Primary Lung Cancer].
Topics: Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2021 |
Bone Marrow Activation After Chemotherapy Presenting as Diffuse Skeletal Uptake on 18F-Fluorocholine PET/CT.
Topics: Bone Marrow; Choline; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2021 |
68Ga-FAPI PET/CT Versus 18F-FDG PET/CT for Detecting Metastatic Lesions in a Case of Radioiodine-Refractory Differentiated Thyroid Cancer.
Topics: Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Quinolines; Thyroid Neoplasms | 2021 |
Role of F-18 FDG PET/CT in the follow-up of asymptomatic renal cell carcinoma patients for postoperative surveillance: based on conditional survival analysis.
Topics: Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Kidney; Kidney Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Postoperative Period; Radiometry; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed | 2022 |
Prognostic value of PET parameters in patients with pleomorphic lung cancer: Results from a single institution.
Topics: Carcinoma; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2021 |
Radiofrequency ablation for treatment of thyroid follicular neoplasm with low SUV in PET/CT study.
Topics: Catheter Ablation; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiofrequency Ablation; Thyroid Gland; Thyroid Neoplasms | 2021 |
Surveillance Imaging Following Head and Neck Cancer Treatment and Microvascular Reconstruction.
Topics: Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Microsurgery; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2021 |
Osteogenic and brain metastases after non-small cell lung cancer resection.
Topics: Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Quality of Life; Retrospective Studies | 2021 |
Preoperative Maximum Standardized Uptake Value Associated With Recurrence Risk in Early Lung Cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2022 |
Identifying Patients Who May Benefit from Liver Resection Compared to Living Donor Liver Transplantation for Hepatocellular Carcinoma Using
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Living Donors; Neoplasm Recurrence, Local; Positron-Emission Tomography; Retrospective Studies; Treatment Outcome | 2021 |
FDG-PET predicts bone invasion and prognosis in patients with oral squamous cell carcinoma.
Topics: Adult; Aged; Bone Neoplasms; Cohort Studies; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Mouth Neoplasms; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Taiwan | 2021 |
PSMA Expression in Differentiated Thyroid Cancer: Association With Radioiodine, 18FDG Uptake, and Patient Outcome.
Topics: Adenocarcinoma; Adult; Antigens, Surface; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glutamate Carboxypeptidase II; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Thyroid Neoplasms | 2021 |
Outcomes Related to FDG-PET-CT Response in Patients With Hodgkin Lymphoma Treated With Brentuximab-Vedotin at Relapse or Consolidation.
Topics: Adult; Brentuximab Vedotin; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Immunoconjugates; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Retrospective Studies; Transplantation, Autologous | 2021 |
Recurrent Subcutaneous Ewing Sarcoma on 18F-FDG PET/CT.
Topics: Adult; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sarcoma, Ewing; Young Adult | 2021 |
18F-FDG and 68GA-Prostate-Specific Membrane Antigen PET/CT Perform Better Than CT Alone in Restaging Papillary Renal Cell Carcinoma Recurrence.
Topics: Aged; Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prostate | 2021 |
Metabolic activity by FDG-PET/CT after neoadjuvant chemotherapy in borderline resectable and locally advanced pancreatic cancer and association with survival.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Pancreas; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Survival Analysis; Tomography, X-Ray Computed | 2021 |
Value of [18F]FDG PET-CT in the follow-up of surgically treated oral tongue squamous cell carcinoma: single centre cohort analysis on 87 patients.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tongue Neoplasms | 2021 |
[18F]FDG PET-CT findings in an unusual case of synchronous double primary lung cancer of different histologies.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
Diagnostic performance of
Topics: Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Retrospective Studies; Sensitivity and Specificity | 2021 |
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Treatment Outcome | 2022 |
Three-Dimensional Image Fusion of
Topics: Carcinoma, Squamous Cell; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Maxillary Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Otorhinolaryngologic Surgical Procedures; Positron Emission Tomography Computed Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Surgery, Computer-Assisted; Tomography, X-Ray Computed | 2017 |
Random forests to predict tumor recurrence following cervical cancer therapy using pre- and per-treatment
Topics: Aged; Algorithms; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Uterine Cervical Neoplasms | 2016 |
Flourodeoxyglucose positron emission tomography scan may be helpful in the case of ductal variant prostate cancer when prostate specific membrane antigen ligand positron emission tomography scan is negative.
Topics: Aged; Biomarkers, Tumor; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals | 2017 |
Association of circulating tumour cells with early relapse and 18F-fluorodeoxyglucose positron emission tomography uptake in resected non-small-cell lung cancers.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunohistochemistry; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplastic Cells, Circulating; Pneumonectomy; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Time Factors | 2017 |
Prognostic significance of preoperative ¹⁸F-FDG PET/CT in uterine leiomyosarcoma.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Leiomyosarcoma; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Preoperative Period; Radiopharmaceuticals; Retrospective Studies; Uterine Neoplasms | 2017 |
18F-deoxyglucose positron emission tomography/computed tomography to predict local failure in esophageal squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Treatment Failure | 2017 |
Comparison of standardized uptake value of 18F-FDG-PET-CT with 21-gene recurrence score in estrogen receptor-positive, HER2-negative breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genetic Predisposition to Disease; Humans; Logistic Models; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Reference Standards; Reference Values; Reverse Transcriptase Polymerase Chain Reaction | 2017 |
Carcinoembryonic antigen directed PET-CECT scanning for postoperative surveillance of colorectal cancer.
Topics: Adult; Aged; Carcinoembryonic Antigen; Colectomy; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postoperative Period; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2017 |
Stereotactic Robotic Body Radiotherapy for Patients With Unresectable Hepatic Oligorecurrence.
Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Monte Carlo Method; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiosurgery; Retrospective Studies; Survival Rate; Treatment Outcome | 2017 |
Irreversible Electroporation to Treat Malignant Tumor Recurrences Within the Pelvic Cavity: A Case Series.
Topics: Aged; Carcinoma, Renal Cell; Electroporation; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Rectal Neoplasms; Retrospective Studies; Sigmoid Neoplasms; Treatment Outcome; Uterine Cervical Neoplasms | 2017 |
Metastatic Neuroendocrine Carcinoma of Unknown Origin Arising in the Femoral Nerve Sheath.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Etoposide; Female; Femoral Nerve; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Nerve Sheath Neoplasms; Palliative Care; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
Significance of baseline FDG-PET/CT scan as a method of staging regional lymph nodes in patients with operable distal oesophageal or gastroesophageal junction adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2017 |
Clinical Predictors of Nodal Metastases in Peripherally Clinical T1a N0 Non-Small Cell Lung Cancer.
Topics: Academic Medical Centers; Adult; Aged; Biopsy, Needle; Carcinoma, Non-Small-Cell Lung; Cause of Death; Databases, Factual; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Lung Neoplasms; Lymph Node Excision; Lymph Nodes; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Pneumonectomy; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Retrospective Studies; ROC Curve; Statistics, Nonparametric; Survival Analysis | 2017 |
Integrated 18F-FDG PET/MRI compared to MRI alone for identification of local recurrences of soft tissue sarcomas: a comparison trial.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms | 2017 |
Prediction of cervical cancer recurrence using textural features extracted from 18F-FDG PET images acquired with different scanners.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2017 |
Extracranial bone metastases from recurrent anaplastic astrocytoma on FDG PET/CT: A case report a care-compliant article.
Topics: Adult; Astrocytoma; Bone Neoplasms; Brain Neoplasms; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Whole Body Imaging | 2017 |
Port site recurrence after laparoscopic radical nephrectomy: a case report.
Topics: Aged; Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Laparoscopy; Male; Neoplasm Recurrence, Local; Nephrectomy; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Treatment Outcome | 2017 |
Increased FDG uptake on late-treatment PET in non-tumour-affected oesophagus is prognostic for pathological complete response and disease recurrence in patients undergoing neoadjuvant radiochemotherapy.
Topics: Carcinoma; Chemoradiotherapy, Adjuvant; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals | 2017 |
Role of [
Topics: Adult; Carcinoma, Hepatocellular; Clinical Decision-Making; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Patient Selection; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2017 |
Prediction of breast cancer recurrence using lymph node metabolic and volumetric parameters from
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Triple Negative Breast Neoplasms | 2017 |
Indications for sublobar resection of clinical stage IA radiologic pure-solid lung adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Pneumonectomy; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2017 |
The clinical outcome correlations between radiation dose and pretreatment metabolic tumor volume for radiotherapy in head and neck cancer: A retrospective analysis.
Topics: Adult; Aged; Chemoradiotherapy; Disease-Free Survival; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiometry; Radiotherapy Dosage; Retrospective Studies; Treatment Outcome; Tumor Burden | 2017 |
Prognostic value of primary gross tumor volume and standardized uptake value of
Topics: Adult; Aged; Carcinoma; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Tomography, X-Ray Computed; Tumor Burden | 2017 |
Is post-treatment standardized uptake value a prognostic factor in unresectable non-small cell lung carcinoma?
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals | 2017 |
Clinical usefulness of F-18 FDG PET in lymphoepithelioma-like gastric carcinoma.
Topics: Aged; Epstein-Barr Virus Infections; Female; Fluorodeoxyglucose F18; Gastrectomy; Herpesvirus 4, Human; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Stomach Neoplasms | 2017 |
Role of FDG-PET/MRI, FDG-PET/CT, and Dynamic Susceptibility Contrast Perfusion MRI in Differentiating Radiation Necrosis from Tumor Recurrence in Glioblastomas.
Topics: Adult; Aged; Aged, 80 and over; Brain; Brain Neoplasms; Diagnosis, Differential; Disease Progression; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiation Injuries; Retrospective Studies; Tomography, X-Ray Computed | 2018 |
Sclerosing mesenteritis mimicking metachronous peritoneal metastases from descending colon adenocarcinoma.
Topics: Adenocarcinoma; Aged; Biopsy; Colon, Descending; Colonic Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Jejunum; Laparotomy; Male; Mesentery; Neoplasm Recurrence, Local; Neoplasm Staging; Panniculitis, Peritoneal; Peritoneal Neoplasms; Peritoneum; Prognosis; Tomography, X-Ray Computed | 2017 |
Patterns-of-failure guided biological target volume definition for head and neck cancer patients: FDG-PET and dosimetric analysis of dose escalation candidate subregions.
Topics: Adult; Aged; Aged, 80 and over; Dose-Response Relationship, Radiation; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed; Treatment Failure; Tumor Burden | 2017 |
Regarding "Survival Outcomes in Asymptomatic Patients with Normal Conventional Imaging but Raised Carcinoembryonic Antigen Levels in Colorectal Cancer Following Positron Emission Tomography-Computed Tomography Imaging".
Topics: Carcinoembryonic Antigen; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2017 |
Local recurrence of squamous cell carcinoma of the head and neck after radio(chemo)therapy: Diagnostic performance of FDG-PET/MRI with diffusion-weighted sequences.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck | 2018 |
Mid-radiotherapy PET/CT for prognostication and detection of early progression in patients with stage III non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2017 |
FDG PET/CT appearance of local osteosarcoma recurrences in pediatric patients.
Topics: Adolescent; Amputation, Surgical; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; Leg; Limb Salvage; Male; Neoplasm Recurrence, Local; Osteosarcoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2017 |
Utility of (18) F-FDG PET/CT and CECT in conjunction with serum CA 19-9 for detecting recurrent pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Aged; Biomarkers, Tumor; CA-19-9 Antigen; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Triiodobenzoic Acids | 2018 |
Diagnostic Challenges of Postsurgical Breast Cancer Recurrence.
Topics: Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Mammography; Neoplasm Recurrence, Local; Population Surveillance; Positron-Emission Tomography; Radiopharmaceuticals; Risk Factors | 2017 |
An Unusual Presentation of Cervical Carcinoma Metastasis as Mediastinal Adenopathy.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchoscopy; Female; Fluorodeoxyglucose F18; Humans; Lymphadenopathy; Mediastinal Diseases; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Treatment Outcome; Uterine Cervical Neoplasms | 2017 |
Role of
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Mastectomy; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Postoperative Period; Predictive Value of Tests; Preoperative Period; Prognosis; Prospective Studies; Radiopharmaceuticals; Receptor, ErbB-2; ROC Curve; Triple Negative Breast Neoplasms | 2018 |
SUVmax after (18)fluoro-deoxyglucose positron emission tomography/computed tomography: A tool to define treatment strategies in pancreatic cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Pancreatic Ductal; Female; Fluorodeoxyglucose F18; Humans; Italy; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Survival Analysis | 2018 |
Surgical Resection for Pulmonary Carcinoid: Long-Term Results of Multicentric Study-The Importance of Pathological N Status, More Than We Thought.
Topics: Adult; Aged; Carcinoid Tumor; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Pneumonectomy; Positron Emission Tomography Computed Tomography; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Survival Rate; Time Factors | 2017 |
Hypoxic volume evaluated by
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Misonidazole; Mouth Neoplasms; Neck Dissection; Neoplasm Grading; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate; Treatment Outcome; Tumor Hypoxia | 2018 |
Investigation of Association Between Borderline Pancreatic Head Cancer and Glucose Uptake by Using Positron-Emission Tomographic Studies.
Topics: Adenocarcinoma; Adult; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron-Emission Tomography; Retrospective Studies; Treatment Outcome | 2017 |
Reclassifying patients with early-stage Hodgkin lymphoma based on functional radiographic markers at presentation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Young Adult | 2018 |
Hypermetabolic Vocal Cord Focus With Recurrent Oral Cancer History.
Topics: Aged, 80 and over; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Laryngitis; Mouth Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Vocal Cords | 2018 |
The role of F18-FDG PET/CT in predicting secondary optimal de-bulking in patients with recurrent ovarian cancer.
Topics: Adult; Aged; Carcinoma, Ovarian Epithelial; Cytoreduction Surgical Procedures; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Patient Selection; Positron Emission Tomography Computed Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2017 |
Clinical Usefulness of
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron-Emission Tomography; Prognosis; Retrospective Studies; Survival Rate | 2018 |
Post-radiochemotherapy PET radiomics in head and neck cancer - The influence of radiomics implementation on the reproducibility of local control tumor models.
Topics: Carcinoma, Squamous Cell; Chemoradiotherapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Prognosis; Reproducibility of Results; Squamous Cell Carcinoma of Head and Neck | 2017 |
Topics: Adenocarcinoma; Aged; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2018 |
Relapsed/refractory HL: FDG-PET is the trump card.
Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography | 2017 |
Comparison of
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Pelvic Neoplasms; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Whole Body Imaging | 2018 |
18F-FDG PET/CT Imaging of Hidradenocarcinoma Arising From Preexisting Hidradenoma of the Knee.
Topics: Acrospiroma; Fluorodeoxyglucose F18; Humans; Knee; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Sweat Gland Neoplasms | 2018 |
Is the 18F-FDG PET/CT the definite resource to detect the recurrence on high-risk thyroid cancer patients?
Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, X-Ray Computed | 2017 |
Preoperative prediction of microvascular invasion of hepatocellular carcinoma using
Topics: Aged; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2018 |
The relationship between
Topics: Aged; Biomarkers, Tumor; Colorectal Neoplasms; Databases, Factual; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Inflammation; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Postoperative Period; Prognosis; Prospective Studies; Radiopharmaceuticals; Tumor Burden | 2018 |
Prediction of outcome using pretreatment
Topics: Adult; Aged; Aged, 80 and over; Bayes Theorem; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2018 |
Diagnostic accuracy of
Topics: Carcinoma, Adenoid Cystic; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2017 |
Comparison between the diagnostic accuracies of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and conventional imaging in recurrent urothelial carcinomas: a retrospective, multicenter study.
Topics: Aged; Carcinoma, Transitional Cell; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Italy; Magnetic Resonance Imaging; Male; Minnesota; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2018 |
Utility of 3-Month Surveillance F-18 FDG PET/CT in Surgically Resected Oral Squamous Cell Carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Dimensional Measurement Accuracy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Iowa; Male; Middle Aged; Multimodal Imaging; Neck Dissection; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Surgical Procedures, Operative; Tomography, X-Ray Computed | 2018 |
A SUV
Topics: Adenocarcinoma; Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Case-Control Studies; Clinical Decision-Making; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Pneumonectomy; Positron Emission Tomography Computed Tomography; Prognosis; Propensity Score; Radiopharmaceuticals; Radiosurgery; Survival Rate | 2018 |
Combination of baseline FDG PET/CT total metabolic tumour volume and gene expression profile have a robust predictive value in patients with diffuse large B-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Gene Expression Profiling; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Transcriptome; Tumor Burden | 2018 |
Value of FDG-PET/CT Volumetry After Chemoradiotherapy in Rectal Cancer.
Topics: Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Cohort Studies; Cone-Beam Computed Tomography; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Rectal Neoplasms; Retrospective Studies; Survival Rate; Treatment Outcome | 2018 |
Diagnostic value of integrated ¹⁸F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in recurrent epithelial ovarian cancer: accuracy of patient selection for secondary cytoreduction in 134 patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Ovarian Epithelial; Cytoreduction Surgical Procedures; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Patient Selection; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Young Adult | 2018 |
FDG-PET metabolic tumor parameters for the reirradiation of recurrent head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Re-Irradiation; Retrospective Studies; Survival Rate; Treatment Outcome | 2018 |
Increased Prostate Cancer Glucose Metabolism Detected by
Topics: Aged; Case-Control Studies; Disease-Free Survival; Fluorodeoxyglucose F18; Glucose; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Preoperative Period; Prognosis; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Risk Assessment; Severity of Illness Index | 2019 |
(
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Survival Rate; Uterine Cervical Neoplasms | 2018 |
Prognostic stratification model for patients with stage I non-small cell lung cancer adenocarcinoma treated with surgical resection without adjuvant therapies using metabolic features measured on F-18 FDG PET and postoperative pathologic factors.
Topics: Adenocarcinoma; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Models, Theoretical; Neoplasm Recurrence, Local; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Postoperative Complications; Prognosis; Retrospective Studies | 2018 |
Surveillance imaging with FDG-PET/CT in the post-operative follow-up of stage 3 melanoma.
Topics: Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Melanoma; Neoplasm Recurrence, Local; Population Surveillance; Positron Emission Tomography Computed Tomography; Postoperative Period; Prognosis; Radiopharmaceuticals | 2018 |
Prognostic value of diffuse splenic FDG uptake on PET/CT in patients with gastric cancer.
Topics: Aged; Area Under Curve; C-Reactive Protein; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Hematocrit; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; ROC Curve; Spleen; Stomach Neoplasms; Survival Rate | 2018 |
Value of [18F]FDG-PET/CT and CA125, serum levels and kinetic parameters, in early detection of ovarian cancer recurrence: Influence of histological subtypes and tumor stages.
Topics: Aged; Biomarkers, Tumor; CA-125 Antigen; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Retrospective Studies; ROC Curve | 2018 |
Added prognostic value of FDG-PET/CT in relapsing multiple myeloma patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multiple Myeloma; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Progression-Free Survival; Radiopharmaceuticals; Stem Cell Transplantation; Transplantation, Autologous | 2019 |
Clinical usefulness of 2-deoxy-2-[18F] fluoro-d-glucose-positron emission tomography/computed tomography for assessing early oral squamous cell carcinoma (cT1-2N0M0).
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Multiple Primary; Positron Emission Tomography Computed Tomography; Retrospective Studies; Tumor Burden | 2018 |
Impact of
Topics: Adult; Aged; Brain Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Glioma; Heavy Ion Radiotherapy; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiotherapy, Computer-Assisted; Retrospective Studies; Sensitivity and Specificity; Survival Analysis; Tumor Burden | 2018 |
Detection of loco-regional recurrence in malignant head and neck tumors: a comparison of CT, MRI, and FDG PET-CT.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2019 |
Diffuse hepatic epithelioid hemangioendothelioma with multiple splenic metastasis and delayed multifocal bone metastasis after liver transplantation on FDG PET/CT images: A case report.
Topics: Adult; Bone Neoplasms; Diagnosis, Differential; Fatal Outcome; Fluorodeoxyglucose F18; Hemangioendothelioma, Epithelioid; Hospitalization; Humans; Liver; Liver Neoplasms; Liver Transplantation; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Spleen; Splenic Neoplasms; Tomography, X-Ray Computed | 2018 |
Assessment of tumor response to chemoradiotherapy and predicting prognosis in patients with head and neck squamous cell carcinoma by PERCIST.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Young Adult | 2018 |
Metastasizing pleomorphic adenoma in the multiple organs: A case report on FDG-PET/CT imaging.
Topics: Adenoma, Pleomorphic; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Liver Neoplasms; Lumbar Vertebrae; Lung Neoplasms; Magnetic Resonance Imaging; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Osteolysis; Parotid Gland; Parotid Neoplasms; Positron Emission Tomography Computed Tomography; Salivary Glands; Tomography, X-Ray Computed | 2018 |
Diagnostic Performance of 11C-choline PET/CT and FDG PET/CT in Prostate Cancer.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms | 2018 |
Image-based multichannel vaginal cylinder brachytherapy for the definitive treatment of gynecologic malignancies in the vagina.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided; Treatment Outcome; Vaginal Neoplasms | 2018 |
Surgical outcomes in 13 patients with bronchopulmonary carcinoid tumors including one recurrent oncocytic carcinoid tumor.
Topics: Adult; Aged; Carcinoid Tumor; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2019 |
FDG-PET/MRI in patients with pelvic recurrence of rectal cancer: first clinical experiences.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Pelvis; Positron-Emission Tomography; Rectal Neoplasms; Reproducibility of Results; Retrospective Studies | 2019 |
Recurrent inflammatory myofibroblastic tumour of the lung: FDG PET/CT scan findings.
Topics: Child; Female; Fluorodeoxyglucose F18; Humans; Image-Guided Biopsy; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasms, Muscle Tissue; Positron-Emission Tomography; Radiopharmaceuticals | 2018 |
Patterns of Failure Following Dose-escalated Chemoradiotherapy for Fluorodeoxyglucose Positron Emission Tomography Staged Squamous Cell Carcinoma of the Oesophagus.
Topics: Adult; Aged; Chemoradiotherapy; Disease Progression; Disease-Free Survival; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Retrospective Studies; Survival Rate; Treatment Failure | 2018 |
Prognostic Value of Pretreatment Metabolic PET Parameters in Cervical Cancer Patients With Metabolic Complete Response After Concurrent Chemoradiotherapy.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2018 |
[Fetal Adenocarcinoma of the Lung].
Topics: Adenocarcinoma; Chemotherapy, Adjuvant; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Node Excision; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Tomography, X-Ray Computed | 2018 |
Pretreatment metabolic tumor volume as a prognostic factor in HPV-associated oropharyngeal cancer in the context of AJCC 8th edition staging.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Tumor Burden | 2018 |
Can Quantitative Volumetric Analysis Predict Tumor Recurrence in the Patients with Mucinous Adenocarcinoma of the Lung After Surgical Resection?
Topics: Adenocarcinoma of Lung; Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed | 2019 |
Diagnostic value of F-18 FDG PET/CT for local and distant disease relapse surveillance in surgically treated RCC patients: Can it aid in establishing consensus follow up strategy?
Topics: Adult; Aged; Carcinoma, Renal Cell; Consensus; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Nephrectomy; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2018 |
FDG/PET-CT-Based Lymph Node Atlas in Breast Cancer Patients.
Topics: Breast; Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiation Oncology; Radiopharmaceuticals; Radiotherapy | 2019 |
Negative Predictive Value of NI-RADS Category 2 in the First Posttreatment FDG-PET/CT in Head and Neck Squamous Cell Carcinoma.
Topics: Adult; Aged; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Treatment Failure | 2018 |
Association of Fludeoxyglucose F 18-Labeled Positron Emission Tomography and Computed Tomography With the Detection of Oropharyngeal Cancer Recurrence.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome | 2018 |
A new strategy based on fluorodeoxyglucose-positron emission tomography for managing liver metastasis from colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Colorectal Neoplasms; Decision Support Techniques; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2018 |
What is the diagnostic performance of 18-FDG-PET/MR compared to PET/CT for the N- and M- staging of breast cancer?
Topics: Adult; Aged; Axilla; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2019 |
[Value of
Topics: B-Lymphocytes; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies | 2018 |
Hypermetabolism Caused by Seizure Mimicking Tumor Recurrence.
Topics: Adult; Brain Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Glioma; Humans; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Seizures | 2018 |
Is C-11 Methionine PET an alternative to 18-F FDG-PET for identifying recurrent laryngeal cancer after radiotherapy?
Topics: Aged; Carcinoma; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Male; Methionine; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2019 |
Less Than Whole Uterus Irradiation for Locally Advanced Cervical Cancer Maintains Locoregional Control and Decreases Radiation Dose to Bowel.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Cervix Uteri; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Intestines; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Organs at Risk; Positron Emission Tomography Computed Tomography; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided; Radiotherapy, Intensity-Modulated; Retrospective Studies; Treatment Outcome; Uterine Cervical Neoplasms | 2019 |
18F-FDG PET/CT predicts microvascular invasion and early recurrence after liver resection for hepatocellular carcinoma: A prospective observational study.
Topics: Aged; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Male; Microvessels; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Postoperative Period; Prognosis; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Time Factors; Vascular Neoplasms | 2019 |
Relapsed subcutaneous panniculitis-like T cell lymphoma evaluated by FDG PET/CT: A clinical case report.
Topics: Adolescent; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, T-Cell; Neoplasm Recurrence, Local; Panniculitis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
Intensity Modulated Radiation Therapy and Image-Guided Adapted Brachytherapy for Cervix Cancer.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrointestinal Tract; Humans; Kaplan-Meier Estimate; Lymph Nodes; Middle Aged; Neoplasm Recurrence, Local; Pelvis; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Image-Guided; Radiotherapy, Intensity-Modulated; Survival Rate; Time Factors; Urogenital System; Uterine Cervical Neoplasms; Young Adult | 2019 |
Definitive radiotherapy for localized follicular lymphoma staged by
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Follicular; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy; Retrospective Studies; Survival Rate; Young Adult | 2019 |
Do Deauville Scores Improve the Clinical Utility of End-of-Therapy FDG PET Scans for Pediatric Hodgkin Lymphoma?
Topics: Adolescent; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Time Factors; Young Adult | 2019 |
FDG-avid presacral soft tissue mass in previously treated rectal cancer: Diagnostic outcome and additional value of MRI, including diffusion-weighted imaging.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Area Under Curve; Chemoradiotherapy, Adjuvant; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Proctectomy; Radiopharmaceuticals; Rectal Neoplasms; Retrospective Studies; ROC Curve; Sacrum; Soft Tissue Neoplasms | 2019 |
Extensive bony metastases from facial metatypical basal cell carcinoma: a case report.
Topics: Adult; Carcinoma, Basal Cell; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Skin Neoplasms | 2019 |
Utility of a repeat PET/CT scan in HPV-associated Oropharyngeal Cancer following incomplete nodal response from (chemo)radiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Papillomaviridae; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2019 |
Routinely staging gastric cancer with
Topics: Adenocarcinoma; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Gastrectomy; Humans; Incidence; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Postoperative Period; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms; Survival Rate; United Kingdom | 2019 |
B-cell peripheral neurolymphomatosis: MRI and
Topics: Aged; B-Lymphocytes; Biopsy; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neurolymphomatosis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2019 |
FDG-PET/CT for Spontaneous Regression of Metastatic Merkel Cell Carcinoma: Friend or Foe?
Topics: Aged, 80 and over; Carcinoma, Merkel Cell; Eyelids; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Parotid Neoplasms; Positron Emission Tomography Computed Tomography; Remission, Spontaneous; Skin Neoplasms | 2019 |
Prospective comparative study of MRI including diffusion-weighted images versus FDG PET-CT for the detection of recurrent head and neck squamous cell carcinomas after (chemo)radiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prospective Studies; Squamous Cell Carcinoma of Head and Neck | 2019 |
Clinical Utility of Pretreatment and 3-Month
Topics: Adult; Aged; Antineoplastic Agents; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2019 |
[18F] FDG Positron Emission Tomography (PET) Tumor and Penumbra Imaging Features Predict Recurrence in Non-Small Cell Lung Cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Observer Variation; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment | 2019 |
Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis | 2019 |
Beware of False-Positive FDG PET/CT Interpretations for Presacral Recurrent Rectal Cancer.
Topics: Aged; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Rectal Neoplasms | 2019 |
Comparison of prognostic values of primary tumor and nodal
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2019 |
Early evaluation of tumor response to
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; B-Lymphocytes; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prospective Studies; Radioimmunotherapy; Radionuclide Imaging | 2019 |
Clinical outcomes after isolated pelvic failure in cervical cancer patients treated with definitive radiation.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Aorta; Bone Neoplasms; Brachytherapy; Female; Fluorodeoxyglucose F18; Humans; Hysterectomy; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Pelvic Exenteration; Pelvis; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Salvage Therapy; Survival Rate; Uterine Cervical Neoplasms | 2019 |
FDG PET in Diffuse Spinal Carcinomatous Meningitis.
Topics: Aged; Brain; Fluorodeoxyglucose F18; Humans; Lymphatic Irradiation; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Meningeal Carcinomatosis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Skull Base Neoplasms; Spinal Cord Neoplasms | 2019 |
Screening for distant metastases in patients with ipsilateral breast tumor recurrence: the impact of different imaging modalities on distant recurrence-free interval.
Topics: Adult; Aged; Aged, 80 and over; Breast; Breast Neoplasms; Combined Modality Therapy; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Mastectomy; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Netherlands; Palliative Care; Positron Emission Tomography Computed Tomography; Radionuclide Imaging | 2019 |
Risk factors of malignant fluorodeoxyglucose-avid lymph node on preablation positron emission tomography in patients with papillary thyroid cancer undergoing radioiodine ablation therapy.
Topics: Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Republic of Korea; Retrospective Studies; Risk Factors; Survival Analysis; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2019 |
Prognostic utility of pre- and post-treatment FDG-PET parameters in anal squamous cell carcinoma.
Topics: Adult; Aged; Anus Neoplasms; Carcinoma, Squamous Cell; Chemoradiotherapy; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2019 |
Volumetric assessment of apparent diffusion coefficient predicts outcome following chemoradiation for cervical cancer.
Topics: Adult; Aged; Chemoradiotherapy; Diffusion Magnetic Resonance Imaging; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Retrospective Studies; Uterine Cervical Neoplasms | 2019 |
Merkel cell carcinoma: an aggressive cutaneous carcinoma with rare metastasis to the thyroid gland.
Topics: Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; B7-H1 Antigen; Carcinoma, Merkel Cell; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Skin Neoplasms; Thyroid Gland; Thyroid Neoplasms | 2019 |
Role of interim and end of treatment positron emission tomography for response assessment and prediction of relapse in posttransplant lymphoproliferative disorder.
Topics: Adult; Aged; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Organ Transplantation; Positron-Emission Tomography; Predictive Value of Tests; Prednisone; Prognosis; Progression-Free Survival; Radiopharmaceuticals; Retrospective Studies; Rituximab; Vincristine; Young Adult | 2019 |
Volumetric and texture analysis on FDG PET in evaluating and predicting treatment response and recurrence after chemotherapy in follicular lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2019 |
Upfront PET/CT affects management decisions in patients with recurrent head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Clinical Decision-Making; Disease Management; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Interdisciplinary Communication; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prospective Studies; Squamous Cell Carcinoma of Head and Neck | 2019 |
Temporal validation of metabolic nodal response of esophageal cancer to neoadjuvant chemotherapy as an independent predictor of unresectable disease, survival, and recurrence.
Topics: Aged; Disease-Free Survival; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals; Reproducibility of Results; Treatment Outcome | 2019 |
PET/CT prior to salvage surgery in recurrent head and neck squamous cell carcinoma.
Topics: Antineoplastic Protocols; Bone Neoplasms; Denmark; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Salvage Therapy; Squamous Cell Carcinoma of Head and Neck; Survival Analysis | 2019 |
[Basaloid Squamous Cell Carcinoma;Report of a Case].
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Tomography, X-Ray Computed | 2019 |
FDG-PET parameters predict for recurrence in anal cancer - results from a prospective, multicentre clinical trial.
Topics: Adult; Aged; Anus Neoplasms; Australia; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Incidence; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated | 2019 |
Surgical salvage for recurrent retropharyngeal lymph node metastasis in nasopharyngeal carcinoma.
Topics: Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Pharynx; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Salvage Therapy | 2013 |
Diagnosis of metastases from postoperative differentiated thyroid cancer: comparison between FDG and FLT PET/CT studies.
Topics: Adult; Aged; Chi-Square Distribution; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Sensitivity and Specificity; Statistics, Nonparametric; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed; Whole Body Imaging | 2013 |
Intramuscular myxoma in the chest wall.
Topics: Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Intercostal Muscles; Muscle Neoplasms; Myxoma; Neoplasm Recurrence, Local; Positron-Emission Tomography; Thoracic Surgery, Video-Assisted; Thoracic Wall | 2014 |
Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Chi-Square Distribution; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Japan; Kaplan-Meier Estimate; Logistic Models; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multidetector Computed Tomography; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Selection; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Propensity Score; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2013 |
FDG PET differentiation of tumor recurrence from post-stereotactic radiosurgical scar in a central neurocytoma.
Topics: Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neurocytoma; Positron-Emission Tomography; Radiosurgery | 2013 |
Recurrent prostatic adenocarcinoma with perineural spread to the lumbosacral plexus and sciatic nerve: comparing high resolution MRI with torso and endorectal coils and F-18 FDG and C-11 choline PET/CT.
Topics: Adenocarcinoma; Aged, 80 and over; Biopsy; Choline; Fluorodeoxyglucose F18; Humans; Lumbosacral Plexus; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Sciatic Nerve; Tomography, X-Ray Computed; Vascular Neoplasms | 2013 |
Comparison of 99mTc-HYNIC-TOC and HYNIC-TATE octreotide scintigraphy with FDG PET and 99mTc-MIBI in local recurrent or distant metastatic thyroid cancers.
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Octreotide; Organotechnetium Compounds; Positron-Emission Tomography; Radiation Dosage; Technetium Tc 99m Sestamibi; Thyroid Neoplasms; Young Adult | 2013 |
Improvement in the detection of locoregional recurrence in head and neck malignancies: F-18 fluorodeoxyglucose-positron emission tomography/computed tomography compared to high-resolution contrast-enhanced computed tomography and endoscopic examination.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Endoscopy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Physical Examination; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, Spiral Computed; Tomography, X-Ray Computed | 2013 |
Condyloma acuminata induces focal intense FDG uptake mimicking vaginal stump recurrence from uterine cervical cancer: a case report.
Topics: Adult; Condylomata Acuminata; Female; Fluorodeoxyglucose F18; Humans; Hysterectomy; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Vagina | 2013 |
Diagnosis of recurrence and assessment of post-recurrence survival in patients with extracranial non-small cell lung cancer evaluated by 18F-FDG PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
(99m)Tc-MDP- and (18F)-FDG-avid florid reactive periostitis ossificans mimicking recurrent osteosarcoma.
Topics: Child; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Osteosarcoma; Periostitis; Radionuclide Imaging; Technetium Tc 99m Medronate | 2013 |
Prognostic impact of FDG-PET in surgically treated pathological stage I lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Lymphatic Vessels; Male; Middle Aged; Multivariate Analysis; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2014 |
The Maximum standardized uptake value is more reliable than size measurement in early follow-up to evaluate potential pulmonary malignancies following radiofrequency ablation.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Catheter Ablation; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrointestinal Neoplasms; Humans; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Tomography, X-Ray Computed | 2013 |
Impact of PET staging in limited-stage small-cell lung cancer.
Topics: Adult; Aged; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Small Cell Lung Carcinoma; Survival Rate | 2013 |
Value of ¹⁸F-FDG-PET/CT in the detection of recurrent hepatocellular carcinoma after hepatectomy or radiofrequency ablation: a comparative study with contrast-enhanced ultrasound.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Catheter Ablation; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2013 |
Predictive value of [¹⁸F]fluoro-2-deoxy-D-glucose positron emission tomography for clinical outcome in patients with relapsed/refractory diffuse large B-cell lymphoma prior to and after autologous stem cell transplant.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Resistance, Neoplasm; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Outcome Assessment, Health Care; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Radiotherapy; Salvage Therapy; Stem Cell Transplantation; Transplantation, Autologous; Young Adult | 2014 |
Breast implant foreign body reaction mimicking breast cancer recurrence on FDG PET/CT.
Topics: Breast Implants; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Foreign-Body Reaction; Humans; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Radiography; Radionuclide Imaging | 2013 |
2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography examination in patients with chronic lymphocytic leukemia may reveal Richter transformation.
Topics: Adult; Aged; Disease Progression; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Male; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Prospective Studies; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
[Foreign body granuloma with positive 18-fluorodeoxyglucose positoron emission tomography( FDGPET)3 years after thymectomy].
Topics: Aged; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Granuloma, Foreign-Body; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Thymectomy; Thymoma; Time Factors | 2013 |
PET/ultrasound fusion for differentiation of Vox implant silicone particles from recurrent cancer.
Topics: Artifacts; Diagnosis, Differential; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prostheses and Implants; Radiopharmaceuticals; Silicones; Subtraction Technique; Thyroid Neoplasms; Ultrasonography | 2013 |
Non-FDG-avid primary papillary thyroid carcinoma may not differ from FDG-avid papillary thyroid carcinoma.
Topics: Adult; Aged; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Glucose; Glucose Transporter Type 1; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Mutation; Neoplasm Recurrence, Local; Positron-Emission Tomography; Proto-Oncogene Proteins B-raf; Radiopharmaceuticals; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed | 2013 |
Which is the most reliable diagnostic modality for detecting locally residual or recurrent laryngeal squamous cell carcinoma after (chemo)radiotherapy?
Topics: Carcinoma, Squamous Cell; Chemoradiotherapy; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Magnetic Resonance Imaging; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed | 2013 |
Pre-transplant FDG-PET-based survival model in relapsed and refractory Hodgkin's lymphoma: outcome after high-dose chemotherapy and auto-SCT.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Young Adult | 2013 |
Prognostic factors affecting disease-specific survival in patients with recurrent and/or metastatic differentiated thyroid carcinoma detected by positron emission tomography/computed tomography.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Remission Induction; Retrospective Studies; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed | 2014 |
Prognostic value of preoperative metabolic tumor volume measured by ¹⁸F-FDG PET/CT and MRI in patients with endometrial cancer.
Topics: Adenocarcinoma; Adult; Age Factors; Aged; Aged, 80 and over; Area Under Curve; Disease-Free Survival; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden | 2013 |
Prognostic value of pretreatment 18F-fluorodeoxyglucose uptake in patients with cervical cancer treated with definitive chemoradiotherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Young Adult | 2013 |
Detection of a metastatic lesion and tiny yolk sac tumors in two teenage patients by FDG-PET: report of two cases.
Topics: Adolescent; alpha-Fetoproteins; Biomarkers, Tumor; Bone Neoplasms; Endodermal Sinus Tumor; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Mediastinal Neoplasms; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2014 |
PET-CT and the detection of the asymptomatic recurrence or second primary lesions in the treated head and neck cancer patient.
Topics: Adult; Aged; Cohort Studies; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron-Emission Tomography; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Survival Analysis; Tomography, X-Ray Computed | 2013 |
[Fusion of Continuously Moving Table MRI and PET Improves Lesion Detection in Recurrent Rectal Cancer].
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Enhancement; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Rectal Neoplasms; Rectum; Retrospective Studies; Sensitivity and Specificity | 2015 |
Accuracy of multi-detector computed tomography, fluorodeoxyglucose positron emission tomography-CT, and CA 19-9 levels in detecting recurrent pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; CA-19-9 Antigen; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multidetector Computed Tomography; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Surgical management of patients with bowel obstructions secondary to gastric cancer.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Intestinal Obstruction; Kaplan-Meier Estimate; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Recurrence, Local; Patient Selection; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reoperation; Retrospective Studies; Risk Factors; Stomach Neoplasms; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Rectal lymph node metastasis in recurrent ovarian carcinoma: essential role of 18F-FDG PET/CT in treatment planning.
Topics: Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Rectal Neoplasms; Tomography, X-Ray Computed | 2013 |
New positron emission tomography derived parameters as predictive factors for recurrence in resected stage I non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Odds Ratio; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Recurrence; Risk Assessment; Risk Factors; Tomography, X-Ray Computed | 2013 |
Detection of recurrent colorectal cancer by 18F-FDG PET/CT comparison with contrast enhanced CT scan.
Topics: Adult; Aged; Aged, 80 and over; Colonic Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Rectal Neoplasms; Retrospective Studies; Tomography, X-Ray Computed | 2013 |
Preoperative consolidation-to-tumor ratio and SUVmax stratify the risk of recurrence in patients undergoing limited resection for lung adenocarcinoma ≤2 cm.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed | 2013 |
Patterns of disease progression on 18F-fluorodeoxyglucose positron emission tomography-computed tomography in patients with malignant pleural mesothelioma undergoing multimodality therapy with pleurectomy/decortication.
Topics: Aged; Combined Modality Therapy; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Mesothelioma; Middle Aged; Neoplasm Recurrence, Local; Pleural Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
18FDG-PET to assess recurrence and long term survival in patients with malignant melanoma.
Topics: Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Germany; Humans; Male; Melanoma; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; S100 Calcium Binding Protein beta Subunit; Sensitivity and Specificity; Skin Neoplasms; Survival Analysis; Survivors; Tomography, X-Ray Computed | 2013 |
[The compared study in detecting the recurrence and metastases of breast cancer patients post treatment between (18)F-FDG PET/CT and conventional workup].
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Localization and prediction of malignant potential in recurrent pheochromocytoma/paraganglioma (PCC/PGL) using 18F-FDG PET/CT.
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Predictive Value of Tests; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Early detection of recurrent disease by FDG-PET/CT leads to management changes in patients with squamous cell cancer of the head and neck.
Topics: Adult; Aged; Aged, 80 and over; Early Diagnosis; Endoscopy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Squamous Cell; Positron-Emission Tomography; Radiography; Survival Analysis | 2013 |
Prediction for recurrence using F-18 FDG PET/CT in pathologic N0 lung adenocarcinoma after curative surgery.
Topics: Adenocarcinoma; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate | 2014 |
Volume-based parameters of 18F-fluorodeoxyglucose positron emission tomography/computed tomography improve disease recurrence prediction in postmastectomy breast cancer patients with 1 to 3 positive axillary lymph nodes.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Agents; Axilla; Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lymph Nodes; Lymphatic Metastasis; Mastectomy; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Care; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Receptors, Estrogen; Risk Assessment; ROC Curve; Tomography, X-Ray Computed; Triple Negative Breast Neoplasms; Tumor Burden | 2013 |
Is FDG -PET-CT a valuable tool in prediction of persistent disease in head and neck cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed; Young Adult | 2013 |
Pediatric Burkitt's lymphoma and diffuse B-cell lymphoma: are surveillance scans required?
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Chemoradiotherapy; Child; Child, Preschool; Cohort Studies; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, B-Cell; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiation Dosage; Radiopharmaceuticals; Remission Induction; Tomography, X-Ray Computed | 2014 |
¹⁸F-Fluorodeoxyglucose uptake and clinicopathological features of recurrent or metastatic endometrial stromal sarcoma.
Topics: Adult; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Estrogen; Receptors, Progesterone; Sarcoma, Endometrial Stromal | 2014 |
Clinical value of technetium-99m-labeled octreotide scintigraphy in local recurrent or metastatic medullary thyroid cancers: a comparison of lesions with 18F-FDG-PET and MIBI images.
Topics: Adolescent; Adult; Aged; Carcinoma, Neuroendocrine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Octreotide; Positron-Emission Tomography; Technetium Tc 99m Sestamibi; Thyroid Neoplasms; Young Adult | 2013 |
Utility of 18F-FDG PET/CT in supracricoid partial laryngectomy.
Topics: Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Laryngectomy; Larynx; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Republic of Korea; Retrospective Studies; Tomography, X-Ray Computed | 2013 |
Value of fusion of PET and MRI in the detection of intra-pelvic recurrence of gynecological tumor: comparison with 18F-FDG contrast-enhanced PET/CT and pelvic MRI.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Pelvis; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Urogenital Neoplasms | 2014 |
(18)F-FDG PET/CT surveillance at 3-6 and 12 months for detection of recurrence and second primary cancer in patients with head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Young Adult | 2013 |
The added clinical value of 18F-FDG PET/CT in evaluating intratracheal recurrence of differentiated thyroid carcinoma: implications for planning surgery, assessing its completeness, and planning radioiodine therapy.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Thyroid Neoplasms; Tomography, X-Ray Computed; Trachea | 2013 |
Has integrated 18F FDG PET/CT improved staging, reduced early recurrence or increased survival in oesophageal cancer?
Topics: Adult; Aged; Aged, 80 and over; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Incidence; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; United Kingdom | 2015 |
Pretreatment (18)F-FDG PET/CT in whole-body total lesion glycolysis to predict survival in patients with pharyngeal cancer treated with definitive radiotherapy.
Topics: Adult; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Pharyngeal Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2014 |
Recurrent breast cancer in the subpectoral space after implant reconstruction.
Topics: Adult; Breast Implantation; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Mastectomy, Modified Radical; Neoplasm Recurrence, Local; Pectoralis Muscles; Positron-Emission Tomography; Radiopharmaceuticals; Reoperation; Surgical Flaps; Tomography, X-Ray Computed | 2014 |
Therapeutic impact of (18)F-FDG PET/CT in recurrent differentiated thyroid carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Fine-Needle; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Iodine Radioisotopes; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Care Planning; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed | 2014 |
FDG PET/CT is useful for detecting infiltration to the port site in patients with malignant pleural mesothelioma.
Topics: Biopsy; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Seeding; Neoplasm Staging; Pleural Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Thoracic Surgery, Video-Assisted; Tomography, X-Ray Computed; Vascular Access Devices | 2014 |
Preoperative 18F-fluorodeoxyglucose positron emission tomography can predict the tumor malignancy of small peripheral lung cancer.
Topics: Aged; Aged, 80 and over; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Japan; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2014 |
Comparison of (11)C-methionine, (11)C-choline, and (18)F-fluorodeoxyglucose-PET for distinguishing glioma recurrence from radiation necrosis.
Topics: Adult; Aged; Area Under Curve; Brain; Brain Neoplasms; Carbon Isotopes; Choline; Combined Modality Therapy; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Neuroimaging; Positron-Emission Tomography; Radiation Injuries; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tissue Distribution | 2014 |
Comparison of visual and semiquantitative analysis of 18F-FDOPA-PET/CT for recurrence detection in glioblastoma patients.
Topics: Adult; Aged; Aged, 80 and over; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed; Young Adult | 2014 |
Recurrent thyroid cancer diagnosis: ROC study of the effect of a high-resolution head and neck 18F-FDG PET/CT scan.
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, X-Ray Computed | 2014 |
Cost-effectiveness analysis of 18F-FDG PET/CT in detecting suspected recurrence or metastasis in well-differentiated thyroid carcinoma patients with negative diagnostic total body scan in Thailand: a decision analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Cost-Benefit Analysis; Decision Trees; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Thailand; Thyroid Neoplasms; Whole Body Imaging | 2013 |
Clinical utility and limitations of FDG PET in detecting recurrent hepatocellular carcinoma in postoperative patients.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Period; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2014 |
Negative 18F-2-fluorodeoxyglucose PET/CT predicts good cancer specific survival in patients with a suspicion of recurrent ovarian cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Germany; Humans; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Minimally invasive secondary cytoreduction plus HIPEC for recurrent ovarian cancer: a case series.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ovarian Epithelial; Cisplatin; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cohort Studies; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Hyperthermia, Induced; Infusions, Parenteral; Middle Aged; Minimally Invasive Surgical Procedures; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Organoplatinum Compounds; Ovarian Neoplasms; Oxaliplatin; Positron-Emission Tomography; Radiopharmaceuticals; Randomized Controlled Trials as Topic; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
Reliability of post-chemoradiotherapy F-18-FDG PET/CT for prediction of locoregional failure in human papillomavirus-associated oropharyngeal cancer.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Papillomaviridae; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Incarcerated umbilical hernia of unexpected origin: a primitive neuroectodermal tumor with early recurrence.
Topics: Abdominal Neoplasms; Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Neoplasms; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Hernia, Umbilical; Herniorrhaphy; Humans; Multimodal Imaging; Neoplasm Recurrence, Local; Neuroectodermal Tumors, Primitive, Peripheral; Palliative Care; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Adjuvant; Reoperation; Sarcoma, Ewing; Time Factors; Treatment Outcome | 2014 |
Metabolic tumour volume and total lesion glycolysis, measured using preoperative 18F-FDG PET/CT, predict the recurrence of endometrial cancer.
Topics: Adult; Aged; Disease-Free Survival; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2014 |
Pretreatment [18F]-fluoro-2-deoxy-glucose positron emission tomography maximum standardized uptake value as predictor of distant metastasis in early-stage non-small cell lung cancer treated with definitive radiation therapy: rethinking the role of positro
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome | 2014 |
Is [F-18]-fluorodeoxy-D-glucose positron emission tomography of value in the management of patients with craniofacial bone sarcomas undergoing neo-adjuvant treatment?
Topics: Adult; Bone Neoplasms; Chemotherapy, Adjuvant; Disease Progression; Disease-Free Survival; Facial Bones; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Necrosis; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Osteosarcoma; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Skull; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2014 |
Sarcoma mid-therapy [F-18]fluorodeoxyglucose positron emission tomography (FDG PET) and patient outcome.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Monitoring, Physiologic; Multivariate Analysis; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Risk Assessment; Sarcoma; Soft Tissue Neoplasms; Survival Analysis; Time Factors; Treatment Outcome; Young Adult | 2014 |
Diagnostic accuracy of ¹⁸F-FDG PET/CT for detection of suspected recurrence in patients with oesophageal carcinoma.
Topics: Adult; Aged; Carcinoma; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Recurrent parathyroid carcinoma appearing as FDG negative but MIBI positive.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Neck Dissection; Neoplasm Recurrence, Local; Parathyroid Neoplasms; Radionuclide Imaging; Technetium Tc 99m Sestamibi | 2014 |
A risk-adapted approach using US features and FNA results in the management of thyroid incidentalomas identified by 18F-FDG PET.
Topics: Adenocarcinoma, Follicular; Age Factors; Aged; Algorithms; Biomarkers, Tumor; Biopsy, Fine-Needle; Diagnosis, Differential; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron-Emission Tomography; Risk Adjustment; Risk Factors; Sensitivity and Specificity; Sex Factors; Thyroid Gland; Thyroid Neoplasms; Thyroid Nodule; Tomography, X-Ray Computed; Tumor Burden; Ultrasonography | 2014 |
(18)F-FDG PET as a single imaging modality in pediatric neuroblastoma: comparison with abdomen CT and bone scintigraphy.
Topics: Bone and Bones; Bone Neoplasms; Child, Preschool; Female; Fluorodeoxyglucose F18; Ganglioneuroblastoma; Humans; Image Interpretation, Computer-Assisted; Infant; Infant, Newborn; Lymph Nodes; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neuroblastoma; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Follow-up after gastrectomy for cancer: an appraisal of the Italian research group for gastric cancer.
Topics: Adult; Aged; Aged, 80 and over; Endoscopy, Gastrointestinal; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrectomy; Humans; Italy; Liver Neoplasms; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Physical Examination; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Stomach; Stomach Neoplasms; Survival Rate; Time Factors; Tomography, X-Ray Computed; Ultrasonography | 2014 |
Utility of 18F-FDG PET/CT in follow-up of patients with low-grade serous carcinoma of the ovary.
Topics: Adolescent; Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2014 |
Prognostic value of metabolic parameters in patients with synchronous colorectal cancer liver metastasis following curative-intent colorectal and hepatic surgery.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Endpoint Determination; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Image Processing, Computer-Assisted; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Regression Analysis; Risk Factors; Survival Analysis | 2014 |
Recurrent temporal bone tenosynovial giant cell tumor with chondroid metaplasia: the use of imaging to assess recurrence.
Topics: Cartilage; Fluorodeoxyglucose F18; Giant Cell Tumor of Bone; Hearing Loss; Humans; Magnetic Resonance Imaging; Male; Metaplasia; Middle Aged; Neoplasm Recurrence, Local; Neuroimaging; Positron-Emission Tomography; Radiopharmaceuticals; Skull Neoplasms; Temporal Bone; Temporomandibular Joint Disorders; Tinnitus; Tomography, X-Ray Computed | 2014 |
Repeatability of quantitative FDG-PET/CT and contrast-enhanced CT in recurrent ovarian carcinoma: test-retest measurements for tumor FDG uptake, diameter, and volume.
Topics: Adult; Aged; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden | 2014 |
Impact of 18F-fluoride PET in patients with known prostate cancer: initial results from the National Oncologic PET Registry.
Topics: Aged; Aged, 80 and over; Cohort Studies; Data Interpretation, Statistical; Fluorodeoxyglucose F18; Humans; Male; Medical Oncology; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Registries; Sodium Fluoride; Tomography, X-Ray Computed; United States | 2014 |
Inflammatory myofibroblastic tumours of the liver: gadoxetic acid-enhanced and diffusion-weighted MRI findings with 18F-FDG PET/CT and clinical significance of regression on follow-up.
Topics: Adult; Aged; Contrast Media; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gadolinium DTPA; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2014 |
Prognostic impact of 18F-FDG uptake on PET in non-small cell lung cancer patients with postoperative recurrence following platinum-based chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Platinum Compounds; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals | 2014 |
IMRT with ¹⁸FDG-PET\\CT based simultaneous integrated boost for treatment of nodal positive cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Survival Rate; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2014 |
Appearance of recurrent cardiac myxofibrosarcoma on FDG PET/CT.
Topics: Adult; Fibroma; Fibrosarcoma; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
The preoperative maximum standardized uptake value measured by 18F-FDG PET/CT as an independent prognostic factor of overall survival in endometrial cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Tomography, X-Ray Computed | 2014 |
The utility and limitations of (18)F-fluorodeoxyglucose positron emission tomography with computed tomography in patients with primary mediastinal B-cell lymphoma: single institution experience and literature review.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymphoma, B-Cell; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Patient Outcome Assessment; Positron-Emission Tomography; Prognosis; Radiotherapy; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2015 |
Correlation of (18)F-FDG avid volumes on pre-radiation therapy and post-radiation therapy FDG PET scans in recurrent lung cancer.
Topics: Aged; Aged, 80 and over; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Paclitaxel; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Conformal; Sensitivity and Specificity; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2014 |
Response from authors of "reliability of post-chemoradiotherapy F-18-FDG PET/CT for prediction of locoregional failure in human papillomavirus-associated oropharyngeal cancer".
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Reliability of post-chemo radiotherapy F-18-FDG PET/CT for prediction of loco regional failure in human papillomavirus-associated oropharyngeal cancer: misconception and misinterpretation.
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Preoperative 18F-FDG PET-CT maximum standardized uptake value predicts recurrence of biliary tract cancer.
Topics: Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Preoperative Care; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
The influence of FDG PET-CT on the detection of extrahepatic disease in patients being considered for resection of colorectal liver metastasis.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Precancerous Conditions; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Correlation of standardized uptake value and apparent diffusion coefficient in integrated whole-body PET/MRI of primary and recurrent cervical cancer.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Reproducibility of Results; Uterine Cervical Neoplasms | 2014 |
Prediction of survival and cancer recurrence using metabolic volumetric parameters measured by 18F-FDG PET/CT in patients with surgically resected rectal cancer.
Topics: Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Rectal Neoplasms; Survival Analysis; Tomography, X-Ray Computed; Tumor Burden | 2014 |
Inferior glucose metabolism and chemosensitivity of post-radiotherapy local recurrence in comparison with distant metastases as assessed by sequential (18)F-FDG PET/CT imaging.
Topics: Adult; Aged; Biological Transport; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Positron-Emission Tomography; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Clinical significance of FDG-PET/CT at the postoperative surveillance in the breast cancer patients.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Breast; Breast Neoplasms; Breast Neoplasms, Male; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Male; Mammography; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Care; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography, Mammary; Young Adult | 2016 |
Comparison between endobronchial ultrasound-guided transbronchial needle aspiration and 18F-fluorodeoxyglucose positron emission tomography in the diagnosis of postoperative nodal recurrence in patients with lung cancer.
Topics: Aged; Aged, 80 and over; Biopsy, Needle; Bronchoscopy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Retrospective Studies; Ultrasonography, Interventional | 2015 |
Comparison of (68)Ga DOTATATE to 18F-FDG uptake is useful in the differentiation of residual or recurrent pituitary adenoma from the remaining pituitary tissue after transsphenoidal adenomectomy.
Topics: Adenoma; Adult; Cicatrix; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Organometallic Compounds; Pituitary Gland; Pituitary Neoplasms; Radionuclide Imaging; Sphenoid Bone | 2014 |
The more you look, the more you find: challenging results on FDG-PET CT in a patient with neurofibromatosis type I.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Neurilemmoma; Neurofibromatosis 1; Positron-Emission Tomography; Radiopharmaceuticals; Seminoma; Testicular Neoplasms; Tomography, X-Ray Computed | 2014 |
Diagnostic accuracy of integrated (18)F-FDG PET/CT for restaging patients with malignant germ cell tumours.
Topics: Adolescent; Adult; Aged; Biomarkers, Tumor; Child; Child, Preschool; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Infant; Iohexol; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Value of ¹⁸F-FDG PET-CT in surveillance of postoperative colorectal cancer patients with various carcinoembryonic antigen concentrations.
Topics: Adult; Aged; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Period; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Primary Epstein-Barr virus infection diffusing F18-fluorodeoxyglucose-positron emission tomography/computed tomography response monitoring of Hodgkin's disease: a case report.
Topics: Asymptomatic Infections; Epstein-Barr Virus Infections; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lung Neoplasms; Lymph Nodes; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Spleen; Tomography, X-Ray Computed; Young Adult | 2014 |
Performance of (18)F-FDG PET/CT as a postoperative surveillance imaging modality for asymptomatic advanced gastric cancer patients.
Topics: Adult; Aged; Anastomosis, Surgical; False Positive Reactions; Female; Fluorodeoxyglucose F18; Gastrectomy; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed | 2014 |
Sternal intraosseous schwannoma mimicking breast cancer metastasis.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Neurilemmoma; Positron-Emission Tomography; Radiopharmaceuticals; Sternum; Tomography, X-Ray Computed | 2014 |
Early detection of disease progression after palliative chemotherapy in NSCLC patients by (18)F-FDG-PET.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Germany; Humans; Incidence; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Palliative Care; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity | 2014 |
Perfusion-metabolism coupling in recurrent gliomas: a prospective validation study with 13N-ammonia and 18F-fluorodeoxyglucose PET/CT.
Topics: Adolescent; Adult; Ammonia; Brain Neoplasms; Child; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Nitrogen Radioisotopes; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult | 2014 |
Recurrences after intensity modulated radiotherapy for head and neck squamous cell carcinoma more likely to originate from regions with high baseline [18F]-FDG uptake.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2014 |
Simultaneous positron emission tomography/magnetic resonance imaging for whole-body staging in patients with recurrent gynecological malignancies of the pelvis: a comparison to whole-body magnetic resonance imaging alone.
Topics: Adult; Aged; Cervix Uteri; Contrast Media; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Image Enhancement; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Observer Variation; Ovarian Neoplasms; Ovary; Positron-Emission Tomography; Prospective Studies; Reproducibility of Results; Uterine Cervical Neoplasms; Whole Body Imaging; Young Adult | 2014 |
Clinical usefulness of ¹⁸F-fluorodeoxyglucose-positron emission tomography in patients with locally advanced pancreatic cancer planned to undergo concurrent chemoradiation therapy.
Topics: Aged; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2014 |
Prediction of recurrence for non-small cell lung cancer by combined analysis of molecular markers and 18F 2-fluoro-2-deoxy-D-glucose positron emission tomography.
Topics: Aged; Aged, 80 and over; Biomarkers; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tissue Array Analysis | 2014 |
Interim FDG PET/CT for predicting the outcome in patients with head and neck cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Disease-Free Survival; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; ROC Curve; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2014 |
FDG volumetric parameters and survival outcomes after definitive chemoradiotherapy in patients with recurrent head and neck squamous cell carcinoma.
Topics: Biomarkers, Tumor; Biopsy; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed | 2014 |
CA 15.3 measurements for separating FDG PET/CT positive from negative findings in breast carcinoma recurrence. Factors influencing the area under the ROC curve.
Topics: Adult; Aged; Biomarkers, Tumor; Breast Neoplasms; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Mucin-1; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Unusual loss of FDG uptake in recurrent GIST.
Topics: Adult; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution; Tomography, X-Ray Computed | 2014 |
The role of FDG-PET/CT in differentiated thyroid cancer patients with negative iodine-131 whole-body scan and elevated anti-Tg level.
Topics: Adult; Aged; Autoantibodies; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed; Treatment Outcome; Whole Body Imaging; Young Adult | 2014 |
Small lesion, severe consequences. An intriguing ventilation-perfusion scintigraphy.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Combined Modality Therapy; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Neoplasm Recurrence, Local; Perfusion Imaging; Positron-Emission Tomography; Pulmonary Embolism; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Diffusion weighted magnetic resonance imaging demonstrates tumor response following palliative embolization of a recurrent shoulder plasmacytoma.
Topics: Diffusion Magnetic Resonance Imaging; Embolization, Therapeutic; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Plasmacytoma; Radiopharmaceuticals; Shoulder; Treatment Outcome; Tumor Burden | 2014 |
Recurrence and metastasis of lung cancer demonstrate decreased diffusion on diffusion-weighted magnetic resonance imaging.
Topics: Aged; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
Preoperative FDG-PET predicts early recurrence and a poor prognosis after resection of pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; ROC Curve; Survival Analysis | 2015 |
Value of CT, FDG PET-CT and serum tumor markers in staging recurrent colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden; Young Adult | 2015 |
Impact of pretreatment imaging on survival of esophagectomy after induction therapy for esophageal cancer: who should be given the benefit of the doubt?: esophagectomy outcomes of patients with suspicious metastatic lesions.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Combined Modality Therapy; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Survival Rate | 2015 |
Prognostic evaluations of small size lung cancers by 18F-FDG PET/CT and thin-section CT.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2014 |
Mediastinal sarcoidosis mimicking lymph malignancy recurrence after anti-neoplastic therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast Neoplasms; Carcinoma; Diagnosis, Differential; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Gastrectomy; Granuloma; Humans; Hysterectomy; Lymphatic Irradiation; Lymphatic Metastasis; Mastectomy, Segmental; Mediastinal Diseases; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Stomach Neoplasms; Tissue Distribution; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2015 |
¹⁸F-FDG PET/contrast enhanced CT in the standard surveillance of high risk colorectal cancer patients.
Topics: Adult; Aged; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed | 2014 |
Total 18F-FDG PET/CT Metabolic Tumor Volume Is Associated With Postoperative Biochemical Response in Patients With Metastatic Pheochromocytomas and Paragangliomas.
Topics: Adrenal Gland Neoplasms; Adult; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Whole Body Imaging | 2016 |
Usefulness of increased 18F-FDG uptake for detecting local recurrence in patients with extremity osteosarcoma treated with surgical resection and endoprosthetic replacement.
Topics: Adolescent; Bone Neoplasms; Extremities; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Osteosarcoma; Positron-Emission Tomography; Prostheses and Implants; Prosthesis Implantation; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Clinical validation of FDG-PET/CT in the radiation treatment planning for patients with oesophageal cancer.
Topics: Adult; Aged; Aged, 80 and over; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Tomography, X-Ray Computed | 2014 |
Volume-based metabolic tumor response to neoadjuvant chemotherapy is associated with an increased risk of recurrence in breast cancer.
Topics: Adult; Aged; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Mastectomy; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Registries; Retrospective Studies; Risk; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Carcinoma, Medullary; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tissue Distribution; Tomography, X-Ray Computed | 2014 |
Clinical utility of multimodality imaging with dynamic contrast-enhanced MRI, diffusion-weighted MRI, and 18F-FDG PET/CT for the prediction of neck control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Contrast Media; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neck; Neoplasm Recurrence, Local; Neoplasm Staging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Tissue Distribution; Tomography, X-Ray Computed; Tumor Burden | 2014 |
The early predictive value of a decrease of metabolic tumor volume in repeated (18)F-FDG PET/CT for recurrence of locally advanced non-small cell lung cancer with concurrent radiochemotherapy.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Cisplatin; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Prospective Studies; Regression Analysis; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Standardized uptake value of ¹⁸F-fluorodeoxyglucose positron emission tomography for prediction of tumor recurrence in breast cancer beyond tumor burden.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cohort Studies; Decision Support Techniques; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2014 |
Pretreatment screening on distant metastases and head and neck cancer patients: Validation of risk factors and influence on survival.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Time Factors; Tomography, X-Ray Computed | 2015 |
Long-term results of positron emission tomography-directed management of the neck in node-positive head and neck cancer after organ preservation therapy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck; Neck Dissection; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Differences in the prognostic significance of the SUVmax between patients with resected pulmonary Adenocarcinoma and squamous cell carcinoma.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Pneumonectomy; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve | 2014 |
Quantitative metabolic parameters measured on F-18 FDG PET/CT predict survival after relapse in patients with relapsed epithelial ovarian cancer.
Topics: Adult; Aged; Biomarkers, Tumor; Carcinoma, Ovarian Epithelial; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Survival Analysis; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Unabsorbed polylactide adhesion barrier mimicking recurrence of gynecologic malignant diseases with increased ¹⁸F-FDG uptake on PET/CT.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Polyesters; Positron-Emission Tomography; Tomography, X-Ray Computed; Young Adult | 2015 |
Areas of high 18F-FDG uptake on preradiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for non-small cell lung cancer.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Clinical Trials as Topic; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Risk Factors; ROC Curve; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Correlation of 18F-FDG PET avid volumes on pre-radiation therapy and post-radiation therapy FDG PET scans in recurrent lung cancer. In regard to Shusharina et al.
Topics: Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Small Cell Lung Carcinoma | 2014 |
Correlation of 18F-FDG PET avid volumes on pre-radiation therapy and post-radiation therapy FDG PET scans in recurrent lung cancer. In reply to Saraiya et al.
Topics: Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Small Cell Lung Carcinoma | 2014 |
Physiologic facial muscle uptake on 18F-FDG PET/CT by chewing-like habitual movement in patient with Sjögren syndrome.
Topics: Aged, 80 and over; Diagnosis, Differential; Facial Muscles; Female; Fluorodeoxyglucose F18; Humans; Mastication; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sjogren's Syndrome; Tomography, X-Ray Computed; Uterine Neoplasms | 2015 |
The utility of 18 F-FDG PET/CT for suspected recurrent breast cancer: impact and prognostic stratification.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Risk stratification of metastatic neck nodes by CT and PET in patients with head and neck cancer receiving definitive radiotherapy.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Disease-Free Survival; Drug Therapy; Female; Fluorodeoxyglucose F18; Glycolysis; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Necrosis; Neoplasm Recurrence, Local; Pilot Projects; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Risk; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Malignant transformation of a lacrimal gland pleomorphic adenoma with pulmonary metastases.
Topics: Adenoma, Pleomorphic; Aged; Carcinoma, Adenoid Cystic; Cell Transformation, Neoplastic; Eye Neoplasms; Fluorodeoxyglucose F18; Humans; Lacrimal Apparatus Diseases; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Predictive value of 18F-FDG PET and CT morphologic features for recurrence in pathological stage IA non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
What are the radiologic findings predictive of indolent lung adenocarcinoma?
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed | 2015 |
Patterns of Recurrence and Survival after Surgery or Stereotactic Radiotherapy for Early Stage NSCLC.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Health Status; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Selection; Pneumonectomy; Positron-Emission Tomography; Radiosurgery; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed | 2015 |
Extended Ischemia Times Promote Risk of HCC Recurrence in Liver Transplant Patients.
Topics: Adult; Aged; alpha-Fetoproteins; Carcinoma, Hepatocellular; Cold Ischemia; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reperfusion Injury; Retrospective Studies; Risk Factors; Survival Rate; Time Factors; Warm Ischemia | 2015 |
Diagnostic accuracy of F-18 FDG PET/CECT vs. CECT for detecting recurrence of periampullary carcinoma and its prognostic significance.
Topics: Bile Duct Neoplasms; Bile Ducts; Carcinoma; Cholangiography; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiographic Image Enhancement; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Survival Analysis; Tomography, X-Ray Computed | 2015 |
The role of positron emission tomography/computed tomography in planning radiotherapy in endometrial cancer.
Topics: Adult; Aged; Aged, 80 and over; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Adjuvant; Survival Rate; Tomography, X-Ray Computed | 2015 |
High FDG uptake areas on pre-radiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for locally advanced oesophageal cancer.
Topics: Aged; Chemoradiotherapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospecti
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Incidental Findings; Inflammation; Lymph Nodes; Male; Mediastinum; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Regression Analysis; Solitary Pulmonary Nodule; Statistics, Nonparametric; Time Factors; Tomography, X-Ray Computed | 2015 |
Evaluation of several FDG PET parameters for prediction of soft tissue tumour grade at primary diagnosis and recurrence.
Topics: Female; Fluorodeoxyglucose F18; Humans; Liver; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms | 2015 |
Post-treatment surveillance of head and neck cancer: pitfalls in the interpretation of FDG PET-CT/MRI.
Topics: Adult; Aged; Aged, 80 and over; Disease Progression; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Population Surveillance; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
FDG PET/CT imaging of desmoplastic small round cell tumor: findings at staging, during treatment and at follow-up.
Topics: Adolescent; Adult; Child; Child, Preschool; Desmoplastic Small Round Cell Tumor; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2015 |
[False-positive local recurrences on FDG-PET/CT due to postoperative infection - a case report].
Topics: Abdominal Abscess; Aged; Colorectal Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
Very low utility of surveillance imaging in early-stage classic Hodgkin lymphoma treated with a combination of doxorubicin, bleomycin, vinblastine, and dacarbazine and radiation therapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherapy; Dacarbazine; Diagnostic Imaging; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Vinblastine; Young Adult | 2015 |
Impact of radical surgery on outcome in locally advanced breast cancer patients without metastasis at the time of diagnosis.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
An FDG-PET/CT-positive lesion mimicking local recurrence of colon cancer 5 years after radical colectomy.
Topics: Adenocarcinoma; Aged; Cicatrix; Colectomy; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sigmoid Neoplasms; Time Factors; Tomography, X-Ray Computed | 2015 |
Prognostic value of (18)F-FDG PET/CT in liver transplantation for hepatocarcinoma.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Detection of subclinical recurrence or second primary cancer using (18) F-FDG PET/CT in patients treated curatively for head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2016 |
Correlation Between F-18 Fluorodeoxyglucose Positron Emission Tomography Metabolic Parameters and Dynamic Contrast-Enhanced MRI-Derived Perfusion Data in Patients with Invasive Ductal Breast Carcinoma.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Contrast Media; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies | 2015 |
FDG Uptake on Positron Emission Tomography Correlates with Survival and Time to Recurrence in Patients with Stage I Non-Small-Cell Lung Cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Analysis | 2015 |
(18)F-choline PET/CT for early detection of metastases in biochemical recurrence following radical prostatectomy.
Topics: Aged; Choline; Combined Modality Therapy; Diagnosis, Differential; Early Diagnosis; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Care; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed | 2015 |
Different prognostic values of plasma Epstein-Barr virus DNA and maximal standardized uptake value of 18F-FDG PET/CT for nasopharyngeal carcinoma patients with recurrence.
Topics: Adolescent; Adult; Aged; Carcinoma; Child; DNA, Viral; Epstein-Barr Virus Infections; Female; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed | 2015 |
Comparison of CE-FDG-PET/CT with CE-FDG-PET/MR in the evaluation of osseous metastases in breast cancer patients.
Topics: Bone Neoplasms; Breast Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
The diagnostic value of 18F-FDG PET/CT in association with serum tumor marker assays in breast cancer recurrence and metastasis.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Breast Neoplasms; CA-125 Antigen; Carcinoembryonic Antigen; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Mucin-1; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiography | 2015 |
Baseline Tumor 18F-FDG Uptake and Modifications After 2 Cycles of Neoadjuvant Chemotherapy Are Prognostic of Outcome in ER+/HER2- Breast Cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Estrogen Receptor alpha; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Immunohistochemistry; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Receptor, ErbB-2; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Can EBUS-TBNA provide an accurate diagnosis in patients found to have enlarged or FDG-avid lymph nodes during surveillance of previously treated lung cancer? A retrospective study.
Topics: Adenocarcinoma; Aged; Bronchoscopy; Carcinoma, Squamous Cell; Databases, Factual; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Small Cell Lung Carcinoma | 2015 |
The value of (18) F-FDG-PET/CT imaging in oral cavity cancer patients following surgical reconstruction.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Neoplasm Recurrence, Local; Otorhinolaryngologic Surgical Procedures; Plastic Surgery Procedures; Positron-Emission Tomography; Postoperative Period; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Surgical Flaps; Tomography, X-Ray Computed | 2015 |
Textural features in pre-treatment [F18]-FDG-PET/CT are correlated with risk of local recurrence and disease-specific survival in early stage NSCLC patients receiving primary stereotactic radiation therapy.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Area Under Curve; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Kaplan-Meier Estimate; Lung Neoplasms; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed | 2015 |
Standardized Uptake Values in the Primary Lesions of Non-Small-Cell Lung Cancer in FDG-PET/CT Can Predict Regional Lymph Node Metastases.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Survival Rate; Tomography, X-Ray Computed | 2015 |
Volume-based quantitative FDG PET/CT metrics and their association with optimal debulking and progression-free survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery.
Topics: Aged; Aged, 80 and over; Carcinoma, Ovarian Epithelial; Cone-Beam Computed Tomography; Cytoreduction Surgical Procedures; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Simultaneous PET/MR head-neck cancer imaging: Preliminary clinical experience and multiparametric evaluation.
Topics: Diffusion Magnetic Resonance Imaging; Feasibility Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
[Value of FDG PET-CT associated with pathology in diagnosing residual tumor in patients with nasopharyngeal carcinoma after radiotherapy].
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Benefits of fluorine-18 fludeoxyglucose positron emission tomography in secondary cytoreductive surgery for patients with recurrent epithelial ovarian cancer.
Topics: Adult; Aged; Blood Loss, Surgical; Carcinoma, Ovarian Epithelial; Case-Control Studies; Cytoreduction Surgical Procedures; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Positron-Emission Tomography; Postoperative Complications; Radiopharmaceuticals | 2015 |
18F-FDG PET CT as a prognostic factor in hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; alpha-Fetoproteins; Aspartate Aminotransferases; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Would you bet on PET? Evaluation of the significance of positive PET scan results post-microwave ablation for non-small cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Catheter Ablation; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Microwaves; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2015 |
Radiologic findings to predict low-grade malignant tumour among clinical T1bN0 lung adenocarcinomas: lessons from histological subtypes.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed | 2015 |
Prognostic Value of (18)F-FDG PET-CT in Nasopharyngeal Carcinoma: Is Dynamic Scanning Helpful?
Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiography | 2015 |
Utility of PET/CT in the diagnosis of recurrent ovarian cancer depending on CA 125 serum level.
Topics: Adult; Aged; Biomarkers, Tumor; CA-125 Antigen; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
FDG-PET maximum standardized uptake value is prognostic for recurrence and survival after stereotactic body radiotherapy for non-small cell lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiosurgery; Treatment Outcome | 2015 |
Predicting location of recurrence using FDG, FLT, and Cu-ATSM PET in canine sinonasal tumors treated with radiotherapy.
Topics: Animals; Coordination Complexes; Dideoxynucleosides; Dog Diseases; Dogs; Fluorodeoxyglucose F18; Multimodal Imaging; Neoplasm Recurrence, Local; Nose Neoplasms; Organometallic Compounds; Paranasal Sinus Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Thiosemicarbazones; Tomography, X-Ray Computed | 2015 |
Interpretation and Prognostic Value of Positron Emission Tomography-Computed Tomography After Induction Chemotherapy With or Without Radiation in IIIA-N2 Non-small Cell Lung Cancer Patients Who Receive Curative Surgery.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Induction Chemotherapy; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed | 2015 |
Incidence of Internal Mammary Lymph Nodes with Silicone Breast Implants at MR Imaging after Oncoplastic Surgery.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Implants; Breast Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Incidence; Lymph Node Excision; Lymph Nodes; Magnetic Resonance Imaging; Mammaplasty; Mastectomy; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Silicones; Tomography, X-Ray Computed | 2015 |
The Effects of Pulsed Radiation Therapy on Tumor Oxygenation in 2 Murine Models of Head and Neck Squamous Cell Carcinoma.
Topics: Animals; Carcinoma, Squamous Cell; Cell Hypoxia; Coloring Agents; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Heterografts; Mice; Mice, Nude; Misonidazole; Neoplasm Recurrence, Local; Nitroimidazoles; Oxygen Consumption; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Tumor Burden | 2015 |
Preoperative Contrast-Enhanced CT Versus ¹⁸F-FDG PET/CT Evaluation and the Prognostic Value of Extranodal Extension for Surgical Patients with Head and Neck Squamous Cell Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Contrast Media; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymph Nodes; Male; Middle Aged; Multimodal Imaging; Neck Dissection; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed | 2015 |
FDG-PET/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: comparison with FDG-PET/non-contrast-enhanced CT and contrast-enhanced CT.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Contrast Media; Face; Female; Fluorodeoxyglucose F18; Head; Head and Neck Neoplasms; Humans; Image Enhancement; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2016 |
Prognostic Factors and Treatment Outcomes of Parotid Gland Cancer: A 10-Year Single-Center Experience.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Acinar Cell; Carcinoma, Mucoepidermoid; Child; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Parotid Neoplasms; Prognosis; Retrospective Studies; Tomography, Emission-Computed; Treatment Outcome | 2015 |
A General Cutoff Level Combined With Personalized Dynamic Change of Serum Carcinoembryonic Antigen Can Suggest Timely Use of FDG PET for Early Detection of Recurrent Colorectal Cancer.
Topics: Adult; Aged; Biomarkers, Tumor; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Precision Medicine; Radiopharmaceuticals | 2015 |
Volumetric parameters changes of sequential 18F-FDG PET/CT for early prediction of recurrence and death in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Cone-Beam Computed Tomography; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms | 2015 |
Mapping of failures after radiochemotherapy in patients with non-metastatic esophageal cancer: A posteriori analysis of the dose distribution in the sites of loco-regional relapse.
Topics: Aged; Aged, 80 and over; Chemoradiotherapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Middle Aged; Neoplasm Recurrence, Local; Radiotherapy Dosage; Tomography, X-Ray Computed; Treatment Failure | 2015 |
Evaluation of the prognostic role of tumour-associated macrophages in newly diagnosed classical Hodgkin lymphoma and correlation with early FDG-PET assessment.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cohort Studies; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Immunohistochemistry; Macrophages; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Recurrence; Treatment Outcome; Vinblastine; Young Adult | 2017 |
Relationship Between 18F-FDG Uptake on PET and Recurrence Patterns After Curative Surgical Resection in Patients with Advanced Gastric Cancer.
Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Gastrectomy; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms; Young Adult | 2015 |
Diagnostic value of (18)F-FDG PET/CT as first choice in the detection of recurrent colorectal cancer due to rising CEA.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoembryonic Antigen; Colonic Neoplasms; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Sigmoid Neoplasms; Tomography, X-Ray Computed | 2015 |
Recurrent renal cell carcinoma: clinical and prognostic value of FDG PET/CT.
Topics: Aged; Carcinoma, Renal Cell; Decision Making; Decision Support Systems, Clinical; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Kidney Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2016 |
Impact of radiation dose and standardized uptake value of (18)FDG PET on nodal control in locally advanced cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Aorta; Brachytherapy; Carcinoma, Squamous Cell; Cisplatin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Pelvis; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Tomography, X-Ray Computed; Treatment Failure; Uterine Cervical Neoplasms; Young Adult | 2015 |
(68)Ga-DOTA-peptide: A novel molecular biomarker for nasopharyngeal carcinoma.
Topics: Adult; Aged; Biomarkers; Biomarkers, Tumor; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Prospective Studies; Receptors, Somatostatin | 2016 |
Comparative study of ¹⁸F-FDG-PET/CT imaging and serum hTERT mRNA quantification in cancer diagnosis.
Topics: Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Positron-Emission Tomography; Prospective Studies; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sensitivity and Specificity; Telomerase; Tomography, X-Ray Computed | 2015 |
Whole Body Metabolic Tumor Volume and Total Lesion Glycolysis Predict Survival in Patients with Adrenocortical Carcinoma.
Topics: Adolescent; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Aged; Bone Neoplasms; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tissue Distribution; Tomography, X-Ray Computed; Tumor Burden; Whole Body Imaging; Young Adult | 2015 |
FDG PET/CT Imaging of an Isolated Recurrence in the Eyelid of a Patient With Follicular Lymphoma.
Topics: Aged, 80 and over; Eye Neoplasms; Eyelids; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Multimodal Imaging; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Primary Pulmonary Synovial Sarcoma in a Tertiary Referral Center: Clinical Characteristics, CT, and 18F-FDG PET Findings, With Pathologic Correlations.
Topics: Adult; Biopsy; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Pneumonectomy; Positron-Emission Tomography; Radiopharmaceuticals; Republic of Korea; Retrospective Studies; Sarcoma, Synovial; Tertiary Care Centers; Tomography, X-Ray Computed | 2015 |
Accuracy of (18) FDG PET-CT for treatment evaluation 3 months after completion of chemoradiotherapy for head and neck squamous cell carcinoma: 2-year minimum follow-up.
Topics: Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2016 |
False-positive finding of retropharyngeal lymph node recurrence in both fluorine (18)FDG PET and MRI in a patient with nasopharyngeal carcinoma.
Topics: Adult; Biopsy; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography | 2016 |
Single organ metastatic disease and local disease status, prognostic factors for overall survival in stage IV non-small cell lung cancer: Results from a population-based study.
Topics: Adenocarcinoma; Aged; Bone Neoplasms; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Tomography, X-Ray Computed | 2015 |
Radiologic Predictors for Clinical Stage IA Lung Adenocarcinoma with Ground Glass Components: A Multi-Center Study of Long-Term Outcomes.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Area Under Curve; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiography; Regression Analysis; Retrospective Studies; ROC Curve; Survival Analysis; Tumor Burden | 2015 |
18F-FDG PET/CT in the post-operative monitoring of patients with adrenocortical carcinoma.
Topics: Abdominal Neoplasms; Adolescent; Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Carcinoma; Adult; Aged; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Period; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2015 |
[The prognostic impact of preoperative PET-CT on postoperative recurrence for completely resected stage I non-small cell lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Postoperative Period; Prognosis; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
SERIAL NECK ULTRASOUND IS MORE LIKELY TO IDENTIFY FALSE-POSITIVE ABNORMALITIES THAN CLINICALLY SIGNIFICANT DISEASE IN LOW-RISK PAPILLARY THYROID CANCER PATIENTS.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Papillary; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Population Surveillance; Retrospective Studies; Risk Factors; Thyroid Cancer, Papillary; Thyroid Gland; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography; Young Adult | 2015 |
Correlation between pretreatment FDG-PET biological target volume and location of T-site failure after definitive radiation therapy for head and neck cancers.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Tomography, X-Ray Computed; Treatment Failure; Tumor Burden | 2015 |
Desmoid-Type Fibromatosis of the Thorax: CT, MRI, and FDG PET Characteristics in a Large Series From a Tertiary Referral Center.
Topics: Female; Fibromatosis, Aggressive; Fluorodeoxyglucose F18; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Patient Acuity; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Republic of Korea; Retrospective Studies; Tertiary Care Centers; Thoracic Neoplasms; Tomography, X-Ray Computed | 2015 |
(18)F-FDG/PET May Help to Identify a Subgroup of Patients with T1-T2 Breast Cancer and 1-3 Positive Lymph Nodes Who Are at a High Risk of Recurrence after Mastectomy.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Mastectomy; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Risk Assessment; Risk Factors; Tumor Burden | 2016 |
18F-FDG PET in Liver Transplantation Setting of Hepatocellular Carcinoma: Predicting Histology?
Topics: Adult; Aged; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
Simultaneous [18F]FDG-PET/MRI: Correlation of Apparent Diffusion Coefficient (ADC) and Standardized Uptake Value (SUV) in Primary and Recurrent Cervical Cancer.
Topics: Adult; Aged; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2015 |
Prediction of Central Nervous System Relapse of Diffuse Large B-Cell Lymphoma Using Pretherapeutic [18F]2-Fluoro-2-Deoxyglucose (FDG) Positron Emission Tomography/Computed Tomography.
Topics: Central Nervous System Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Alpha-fetoprotein and (18)F-FDG positron emission tomography predict tumor recurrence better than Milan criteria in living donor liver transplantation.
Topics: Adult; Aged; alpha-Fetoproteins; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Living Donors; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography | 2016 |
Primary Tumor ¹⁸F-FDG Avidity Affects the Performance of ¹⁸F-FDG PET/CT for Detecting Gastric Cancer Recurrence.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrectomy; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Stomach Neoplasms; Treatment Outcome | 2016 |
Monitoring bone and soft-tissue tumors after carbon-ion radiotherapy using ¹⁸F-FDG positron emission tomography: a retrospective cohort study.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Bone Neoplasms; Cohort Studies; Female; Fluorodeoxyglucose F18; Heavy Ion Radiotherapy; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Soft Tissue Neoplasms | 2015 |
¹⁸F-FDG PET/CT for the Early Evaluation of Response to Neoadjuvant Treatment in Triple-Negative Breast Cancer: Influence of the Chemotherapy Regimen.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Epirubicin; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Treatment Outcome; Triple Negative Breast Neoplasms | 2016 |
Combined PET/CT-perfusion in patients with head and neck cancers might predict failure after radio-chemotherapy: a proof of concept study.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed | 2015 |
Diagnostic and prognostic value of (18)F-FDG PET/CT for axillary lymph node staging in patients with breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2016 |
Weighted quantification of ¹⁸F-FDG tumor metabolism activity using fuzzy-thresholding to predict post-treatment tumor recurrence.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Area Under Curve; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; ROC Curve; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2015 |
Prognostic value of preoperative intratumoral FDG uptake heterogeneity in early stage uterine cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden; Uterine Cervical Neoplasms | 2016 |
The clinical usefulness of 18F-fluorodeoxyglucose positron emission tomography-computed tomography (PET-CT) in follow-up of curatively resected pancreatic cancer patients.
Topics: Adult; Aged; Aged, 80 and over; CA-19-9 Antigen; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pancreatectomy; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2016 |
Evaluation of ¹⁸F-FDG PET/MRI, ¹⁸F-FDG PET/CT, MRI, and CT in whole-body staging of recurrent breast cancer.
Topics: Adult; Aged; Breast; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Mammography; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Whole Body Imaging | 2016 |
Risk factors associated with recurrence of surgically resected node-positive non-small cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Patient Selection; Pneumonectomy; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Survival Rate | 2016 |
Surgical Scar Site Recurrence in Patients With Cervical Cancer on 18F-FDG PET-CT: A Case-Control Study.
Topics: Adult; Aged; Carcinoma; Case-Control Studies; Cicatrix; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Uterine Cervical Neoplasms | 2016 |
Massive Pelvic Lymphadenopathy Due to Recurrent Non-Hodgkin Lymphoma Incidentally Revealed on a 99mTc-MDP Bone Scintigraphy.
Topics: Bone and Bones; Fluorodeoxyglucose F18; Humans; Lymphadenopathy; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Pelvis; Positron Emission Tomography Computed Tomography; Radionuclide Imaging; Radiopharmaceuticals; Scrotum; Technetium Tc 99m Medronate; Tomography, X-Ray Computed; Urinary Bladder | 2016 |
Initial [18F]FDG PET/CT in high-risk DTC patients. A three-year follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Germany; Humans; Longitudinal Studies; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Radiotherapy, Adjuvant; Remission Induction; Reproducibility of Results; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Survival Rate; Thyroid Neoplasms; Treatment Outcome; Young Adult | 2016 |
Dual-time point 18FDG-PET/CT imaging may be useful in assessing local recurrent disease in high grade bone and soft tissue sarcoma.
Topics: Adult; Aged; Bone Neoplasms; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Recurrence, Local; Positron-Emission Tomography; Sarcoma; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed | 2016 |
Prediction of Recurrence and Mortality of Locally Advanced Esophageal Cancer Patients Using Pretreatment F-18 FDG PET/CT Parameters: Intratumoral Heterogeneity, SUV, and Volumetric Parameters.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tissue Distribution; Tomography, X-Ray Computed; Tumor Burden | 2016 |
The predictive value of preoperative
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Gastrointestinal Tract; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Period; Predictive Value of Tests; Preoperative Care; Radiopharmaceuticals; Retrospective Studies | 2016 |
FDG PET/CT as a prognostic biomarker in the era of molecular-targeting therapies: max SUVmax predicts survival of patients with advanced renal cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Molecular Targeted Therapy; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Nephrectomy; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed; Treatment Outcome | 2016 |
FDG-PET/CT as a post-treatment restaging tool in urothelial carcinoma: Comparison with contrast-enhanced CT.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiographic Image Enhancement; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Urologic Neoplasms; Urothelium | 2016 |
New Perspectives Offered by Nuclear Medicine for the Imaging and Therapy of Multiple Myeloma.
Topics: Fluorodeoxyglucose F18; Humans; Multiple Myeloma; Neoplasm Recurrence, Local; Nuclear Medicine; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
Prognostic value of total lesion glycolysis on preoperative
Topics: Adult; Aged; Aged, 80 and over; Carcinosarcoma; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Kaplan-Meier Estimate; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden; Uterine Neoplasms | 2016 |
Use of Positron Emission Tomography to Detect Recurrence and Associations With Survival in Patients With Lung and Esophageal Cancers.
Topics: Aged; Aged, 80 and over; Cohort Studies; Confounding Factors, Epidemiologic; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Medical Overuse; Medicare; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; SEER Program; Sensitivity and Specificity; Survival Analysis; United States | 2016 |
Detection of Local Cancer Recurrence After Stereotactic Ablative Radiation Therapy for Lung Cancer: Physician Performance Versus Radiomic Assessment.
Topics: Aged; Aged, 80 and over; Area Under Curve; Carcinoma, Non-Small-Cell Lung; Clinical Competence; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Observer Variation; Positron-Emission Tomography; Radiation Oncology; Radiology; Radiopharmaceuticals; Radiosurgery; Response Evaluation Criteria in Solid Tumors; ROC Curve; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed | 2016 |
18F-FDG PET/CT Is an Immediate Imaging Biomarker of Treatment Success After Liver Metastasis Ablation.
Topics: Adult; Aged; Biomarkers; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiology, Interventional; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Treatment Outcome | 2016 |
Preoperative Volume-Based PET Parameter, MTV2.5, as a Potential Surrogate Marker for Tumor Biology and Recurrence in Resected Pancreatic Cancer.
Topics: Aged; Carcinoma, Pancreatic Ductal; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Pancreatectomy; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2016 |
Prognostic Value of the Sum of Metabolic Tumor Volume of Primary Tumor and Lymph Nodes Using 18F-FDG PET/CT in Patients With Cervical Cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Aorta; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Pelvis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Tumor Burden; Uterine Cervical Neoplasms | 2016 |
Prediction of Posttransplantation Recurrence of Hepatocellular Carcinoma Using Metabolic and Volumetric Indices of 18F-FDG PET/CT.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; ROC Curve; Treatment Outcome; Young Adult | 2016 |
The value of fourth and subsequent post-treatment 18F-FDG PET/CT scans in the management of patients with non-Hodgkin's lymphoma.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome | 2016 |
[18F]Fluorodeoxyglucose (FDG)-Positron Emission Tomography (PET)/Computed Tomography (CT) in Suspected Recurrent Breast Cancer: A Prospective Comparative Study of Dual-Time-Point FDG-PET/CT, Contrast-Enhanced CT, and Bone Scintigraphy.
Topics: Bone and Bones; Breast Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiographic Image Enhancement; Tomography, X-Ray Computed | 2016 |
FDG Avidity and Tumor Burden: Survival Outcomes for Patients With Recurrent Breast Cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Tumor Burden | 2016 |
The Prognostic Impact of Early Change in 18F-FDG PET SUV After Neoadjuvant Chemotherapy in Patients with Locally Advanced Breast Cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Chemotherapy, Adjuvant; Drug Monitoring; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Republic of Korea; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Survival Rate; Treatment Outcome | 2016 |
Prognostic value of midtreatment FDG-PET in oropharyngeal cancer.
Topics: Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Disease-Free Survival; Fluorodeoxyglucose F18; Glycolysis; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Retrospective Studies; Tumor Burden | 2016 |
Prognostic value of total lesion glycolysis measured by 18F-FDG PET/CT in patients with locally advanced cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Longitudinal Studies; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Treatment Outcome; Uterine Cervical Neoplasms | 2016 |
Predictive prognostic value of local and distant recurrence of F-fluorodeoxyglucose positron emission tomography for pancreatic neuroendocrine tumors with reference to World Health Organization classifications (2004, 2010). Case series study.
Topics: Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Mitotic Index; Neoplasm Grading; Neoplasm Recurrence, Local; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden; World Health Organization | 2016 |
[Correlation analysis between 18F-FDG uptake features and the prognosis in patients with pathologic stage Ⅰ lung adenocarcinoma].
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sex Factors; Statistics, Nonparametric; Tomography, X-Ray Computed; Tumor Burden | 2016 |
Anisakiasis mimics cancer recurrence: two cases of extragastrointestinal anisakiasis suspected to be recurrence of gynecological cancer on PET-CT and molecular biological investigation.
Topics: Adult; Anisakiasis; Diagnosis, Differential; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver; Lymph Nodes; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma, Endometrial Stromal; Tomography, X-Ray Computed | 2016 |
Maximum Standard Uptake Value as a Clinical Biomarker for Detecting Loss of SMAD4 Expression and Early Systemic Tumor Recurrence in Resected Left-Sided Pancreatic Cancer.
Topics: Aged; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Gene Silencing; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Pancreas; Pancreatectomy; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Smad4 Protein; Statistics as Topic; Survival Analysis; Tomography, X-Ray Computed | 2016 |
Prognostic Value of Metabolic and Volumetric Parameters of Preoperative FDG-PET/CT in Patients With Resectable Pancreatic Cancer.
Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Preoperative Period; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2016 |
Validation of metabolic tumor volume as a prognostic factor for oral cavity squamous cell carcinoma treated with primary surgery.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Reproducibility of Results; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Tumor Burden | 2016 |
18F-FDG-PET/CT in Patients Affected by Differentiated Thyroid Carcinoma with Positive Thyroglobulin Level and Negative 131I Whole Body Scan. It's Value Confirmed by a Bicentric Experience.
Topics: Biomarkers, Tumor; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Whole Body Imaging | 2016 |
Clinicopathological Features of Cases with Primary Breast Cancer not Identified by 18F-FDG-PET.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Retrospective Studies | 2016 |
Prognostic Value of 68Ga-NOTA-RGD PET/CT for Predicting Disease-Free Survival for Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy and Surgery: A Comparison Study With Dynamic Contrast Enhanced MRI.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Contrast Media; Coordination Complexes; Cyclophosphamide; Disease-Free Survival; Docetaxel; Doxorubicin; Epirubicin; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Kaplan-Meier Estimate; Lymph Node Excision; Magnetic Resonance Imaging; Mastectomy; Mastectomy, Segmental; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neovascularization, Pathologic; Oligopeptides; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Taxoids | 2016 |
Combination of FDG-PET and UCSF Criteria for Predicting HCC Recurrence After Living Donor Liver Transplantation.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Chi-Square Distribution; Decision Support Techniques; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Liver Transplantation; Living Donors; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome | 2016 |
Estimation of Recurrence Risk After Normal (18)F-FDG PET/CT in Nonsmall-Cell Lung Cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Risk Factors | 2016 |
18F-FDG PET/CT and Melanoma: Value of Fourth and Subsequent Posttherapy Follow-up Scans for Patient Management.
Topics: Adult; Aftercare; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Skin Neoplasms | 2016 |
The usefulness of fluorine-18 fluorodeoxyglucose PET in the detection of recurrence in patients with differentiated thyroid cancer with elevated thyroglobulin and negative radioiodine whole-body scan.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thyroglobulin; Thyroid Neoplasms; Young Adult | 2016 |
Metabolic tumour volume of anal carcinoma on (18)FDG PET/CT before combined radiochemotherapy is the only independant determinant of recurrence free survival.
Topics: Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinoma; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Forecasting; Humans; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Survival Rate; Tumor Burden | 2016 |
JOURNAL CLUB: Value of Quantitative FDG PET/CT Volumetric Biomarkers in Recurrent Colorectal Cancer Patient Survival.
Topics: Aged; Biopsy; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Tumor Burden | 2016 |
[Is FDG TEP CT practice changing in the management of sarcomas in adults?].
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoma; Sensitivity and Specificity | 2016 |
Maximum Standardized Uptake Value of Pelvic Lymph Nodes in [18F]-Fluorodeoxyglucose Positron Emission Tomography Is a Prognostic Factor for Para-Aortic Lymph Node Recurrence in Pelvic Node-Positive Cervical Cancer Treated With Definitive Chemoradiotherapy
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Republic of Korea; Retrospective Studies; Uterine Cervical Neoplasms | 2016 |
Prognostic Significance of FDG Uptake of Bone Marrow on PET/CT in Patients With Non-Small-Cell Lung Cancer After Curative Surgical Resection.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Bone Marrow; Bone Marrow Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate | 2017 |
The role of FDG-PET in localization of recurrent lesions of differentiated thyroid cancer (DTC) in patients with asymptomatic hyperthyroglobulinemia in a real clinical practice.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Young Adult | 2016 |
Relation between primary tumor FDG avidity and site of first distant metastasis in patients with breast cancer.
Topics: Adult; Breast Neoplasms; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Palliative Care; Positron Emission Tomography Computed Tomography; Prognosis; Sensitivity and Specificity; Survival Rate | 2016 |
The Added Prognostic Value of Metabolic Tumor Size on FDG-PET at First Suspected Recurrence of Glioblastoma Multiforme.
Topics: Disease Progression; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2017 |
Analysis of predictability of F-18 fluorodeoxyglucose-PET/CT in the recurrence of papillary thyroid carcinoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyroidectomy; Tumor Burden; Young Adult | 2016 |
Impact of pre- and early per-treatment FDG-PET based dose-escalation on local tumour control in fractionated irradiated FaDu xenograft tumours.
Topics: Animals; Carcinoma, Squamous Cell; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Male; Mice, Nude; Neoplasm Recurrence, Local; Positron-Emission Tomography; Proportional Hazards Models; Radiotherapy Dosage; Xenograft Model Antitumor Assays | 2016 |
Prognostic significance of clinical and
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Survival Analysis; Young Adult | 2016 |
Prognostic value of metabolic parameters on preoperative 18F-fluorodeoxyglucose positron emission tomography/ computed tomography in patients with stage III gastric cancer.
Topics: Adult; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Liver; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms; Treatment Outcome | 2016 |
Recurrent bladder carcinoma: clinical and prognostic role of 18 F-FDG PET/CT.
Topics: Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Italy; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Survival Rate; Urinary Bladder Neoplasms | 2017 |
Prognostic significance of preoperative
Topics: Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Gonadotropin-Releasing Hormone; Humans; Ki-67 Antigen; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Preoperative Period; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Tamoxifen; Tumor Burden | 2016 |
[A Case of Metastatic Seminomatous Testicular Tumor with Complicated Diagnosis by FDG-PET].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm, Residual; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Positron-Emission Tomography; Radiopharmaceuticals; Seminoma; Testicular Neoplasms; Treatment Outcome | 2016 |
Pre- and per-treatment 18F-FDG PET/CT parameters to predict recurrence and survival in cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Prospective Studies; Tumor Burden; Uterine Cervical Neoplasms | 2016 |
[(18)F-FDG PET/CT for extranodular natural killer/T-cell lymphoma nasal type: imaging findings and clinical value].
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Extranodal NK-T-Cell; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography | 2016 |
Detection of a second malignancy in prostate cancer patients by using [(18)F]Choline PET/CT: a case series.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Choline; Fluorodeoxyglucose F18; Humans; Kallikreins; Lung Neoplasms; Lymph Nodes; Male; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Rectal Neoplasms; Soft Tissue Neoplasms | 2016 |
FDG-PET in the evaluation of response to nivolumab in recurrent non-small-cell lung cancer.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Antibodies, Monoclonal; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Carcinoma, Non-Small-Cell Lung; Cisplatin; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Monitoring, Physiologic; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Neutrophil Infiltration; Nivolumab; Pemetrexed; Pneumonectomy; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
Incremental Value of a Dedicated Head and Neck Acquisition during 18F-FDG PET/CT in Patients with Differentiated Thyroid Cancer.
Topics: Adenocarcinoma; Adult; Aged; Area Under Curve; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Observer Variation; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Thyroid Neoplasms | 2016 |
Recurrent Olfactory Neuroblastoma in Remote Leptomeninges, Mimicking Intracranial Meningioma.
Topics: Aged; Biopsy; Diagnosis, Differential; Esthesioneuroblastoma, Olfactory; Ethmoid Bone; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Meningeal Neoplasms; Meningioma; Nasal Cavity; Neoplasm Recurrence, Local; Nose Neoplasms; Positron Emission Tomography Computed Tomography; Skull Neoplasms | 2016 |
Intensity-modulated radiotherapy for relapsed malignant pleural mesothelioma.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Neoplasm Recurrence, Local; Pleural Neoplasms; Positron Emission Tomography Computed Tomography; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Treatment Outcome; Tumor Burden | 2016 |
Value of
Topics: Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
Use of (18)F-FDG PET/CT in the preoperative evaluation of patients diagnosed with peritoneal carcinomatosis of ovarian origin, candidates to cytoreduction and hipec. A pending issue.
Topics: Adult; Aged; Carcinoma; Carcinoma, Ovarian Epithelial; Cytoreduction Surgical Procedures; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2016 |
High-risk interim PET negative patients in Hodgkin's lymphoma.
Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tomography, X-Ray Computed | 2016 |
Dose painting by numbers based on retrospectively determined recurrence probabilities.
Topics: Adult; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Probability; Radiotherapy Dosage; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Tumor Burden | 2017 |
Reply.
Topics: Adolescent; Child; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Neoplasm Recurrence, Local; Paraneoplastic Syndromes; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Risk Assessment | 2017 |
Prognostic value of tumoral heterogeneity and volumetric parameters as measured by F18-FDG PET/CT in sinonasal cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasal Cavity; Neoplasm Recurrence, Local; Nose Neoplasms; Paranasal Sinus Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Tumor Burden | 2017 |
[Multimodal imaging of breast cancer recurrence : Prospective intraindividual comparison of
Topics: Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2017 |
Do paraneoplastic changes in diffuse FDG organ uptake predict relapse? - Wait for confirmation study : Reply to Jorgov et al. Eur J Nucl Med Mol Imaging. 2016 Jul;43(7):1220--30.
Topics: Adolescent; Child; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Neoplasm Recurrence, Local; Paraneoplastic Syndromes; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Risk Assessment | 2017 |
Body Mass Index with Tumor 18F-FDG Uptake Improves Risk Stratification in Patients with Breast Cancer.
Topics: Adult; Biomarkers, Tumor; Body Mass Index; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Risk; Risk Factors | 2016 |
Significance of preoperative fluorodeoxyglucose-positron emission tomography in prediction of tumor recurrence after liver transplantation for hepatocellular carcinoma patients: a Japanese multicenter study.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Cause of Death; Cohort Studies; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Hospital Mortality; Humans; Japan; Kaplan-Meier Estimate; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Prognosis; Proportional Hazards Models; Retrospective Studies; Risk Assessment; ROC Curve; Survival Analysis; Tissue Donors; Treatment Outcome | 2017 |
Impact of combined FDG-PET/CT and MRI on the detection of local recurrence and nodal metastases in thyroid cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Reproducibility of Results; Retrospective Studies; Thyroid Neoplasms | 2016 |
A case of neuroendocrine carcinoma in the hepatic hilar lymph nodes concomitant with an adenocarcinoma of the gallbladder.
Topics: Adenocarcinoma; Aged; Bile Ducts, Extrahepatic; Biomarkers, Tumor; Biopsy; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Cholangiopancreatography, Magnetic Resonance; Cholecystectomy; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Endoscopy, Gastrointestinal; Fatal Outcome; Female; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Immunohistochemistry; Jejunostomy; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed | 2016 |
Diagnostic Value of 68Ga PSMA-11 PET/CT Imaging of Brain Tumors-Preliminary Analysis.
Topics: Adult; Aged; Brain Neoplasms; Child; Edetic Acid; Female; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Glioblastoma; Glioma; Humans; Lymphoma; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Neoplasm Recurrence, Local; Oligopeptides; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Whole Body Imaging; Young Adult | 2017 |
Improved Detection of Minimal Residual Disease by 11C-Methionine PET/CT in a Young Patient With Unusual Extramedullary Presentation of Recurrent Multiple Myeloma.
Topics: Adult; Carbon Radioisotopes; Female; Fluorodeoxyglucose F18; Humans; Methionine; Multiple Myeloma; Muscle Neoplasms; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
Prognostic value of pre-treatment F-18-FDG PET-CT in patients with hepatocellular carcinoma undergoing radioembolization.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Chi-Square Distribution; Disease Progression; Disease-Free Survival; Embolization, Therapeutic; Female; Florida; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Microspheres; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Yttrium Radioisotopes | 2016 |
Metabolic nodal response as a prognostic marker after neoadjuvant therapy for oesophageal cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals | 2017 |
Detection of extra-regional tumour recurrence with
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Salvage Therapy; Sensitivity and Specificity | 2017 |
The impact of intratumoral metabolic heterogeneity on postoperative recurrence and survival in resectable esophageal squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Postoperative Complications; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tumor Burden | 2017 |
Topics: Adult; Age Distribution; Asymptomatic Diseases; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Sex Distribution; Skin Neoplasms; South Africa | 2017 |
18F-FDG/18F-FES standardized uptake value ratio determined using PET predicts prognosis in uterine sarcoma.
Topics: Estradiol; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sarcoma; Survival Rate; Uterine Neoplasms | 2017 |
Mucosa-associated lymphoid tissue lymphoma with unusual
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy, Adjuvant; Colectomy; Colon, Sigmoid; Colonoscopy; Colorectal Neoplasms; Cyclophosphamide; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prednisone; Remission Induction; Rituximab; Sigmoid Neoplasms; Vincristine | 2017 |
Whole-body staging of female patients with recurrent pelvic malignancies: Ultra-fast 18F-FDG PET/MRI compared to 18F-FDG PET/CT and CT.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Pelvic Neoplasms; Pelvis; Positron Emission Tomography Computed Tomography; Whole Body Imaging | 2017 |
FDG PET/MR Imaging Coregistration Helps Predict Survival in Patients with Glioblastoma and Radiologic Progression after Standard of Care Treatment.
Topics: Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Survival Analysis; Virginia | 2017 |
Prognostic effect of transarterial chemoembolization-induced complete pathological response in patients undergoing liver resection and transplantation for hepatocellular carcinoma.
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Liver Transplantation; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Postoperative Period; Prognosis; Recurrence; Republic of Korea; Retrospective Studies; Time Factors; Treatment Outcome | 2017 |
Evaluation of PET and MR datasets in integrated 18F-FDG PET/MRI: A comparison of different MR sequences for whole-body restaging of breast cancer patients.
Topics: Adult; Aged; Breast; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Whole Body Imaging | 2017 |
Serial imaging using [18F]Fluorodeoxyglucose positron emission tomography and histopathologic assessment in predicting survival in a population of surgically resectable distal oesophageal and gastric adenocarcinoma following neoadjuvant therapy.
Topics: Adenocarcinoma; Adult; Aged; Disease-Free Survival; Esophageal Neoplasms; Esophagus; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastric Mucosa; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Stomach; Stomach Neoplasms | 2017 |
Whole-body PET/CT-mammography for staging breast cancer: initial results.
Topics: Algorithms; Axilla; Breast Neoplasms; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Mammography; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Whole Body Imaging | 2008 |
Use of positron emission tomography for staging, preoperative response assessment and posttherapeutic evaluation in children with Wilms tumour.
Topics: Adolescent; Adult; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Infant; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Recurrence; Wilms Tumor | 2008 |
AEG I and II: is it one tumor entity?
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Barrett Esophagus; Chemotherapy, Adjuvant; Disease-Free Survival; Esophageal Neoplasms; Esophagogastric Junction; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Complications; Radiopharmaceuticals; Remission Induction; Risk Assessment; Survival Rate; Treatment Outcome | 2008 |
FDG positron emission tomography imaging of drug-induced pneumonitis.
Topics: Aged; Anxiety Disorders; Brain Neoplasms; Breast Neoplasms; Dibenzothiazepines; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Pneumonia; Positron-Emission Tomography; Quetiapine Fumarate; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2008 |
Novel perioperative imaging with 18F-FDG PET/CT and intraoperative 18F-FDG detection using a handheld gamma probe in recurrent ovarian cancer.
Topics: Adult; Cystadenocarcinoma, Serous; Female; Fluorodeoxyglucose F18; Humans; Intraoperative Care; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
Detecting recurrence of gastric cancer: the value of FDG PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed | 2009 |
PET/CT fusion scan enhances CT staging in patients with pancreatic neoplasms.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Preoperative [18F] FDG-PET after chemotherapy in locally advanced breast cancer: prognostic value as compared with histopathology.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Breast Neoplasms; Cohort Studies; Combined Modality Therapy; Confidence Intervals; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Mastectomy, Segmental; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Survival Analysis; Treatment Outcome | 2008 |
A linear lesion along the brachial plexus on FDG-PET in neurolymphomatosis.
Topics: Brachial Plexus; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Peripheral Nervous System Neoplasms; Positron-Emission Tomography; Sural Nerve | 2008 |
The added benefit of a dedicated neck F-18 FDG PET-CT imaging protocol in patients with suspected recurrent differentiated thyroid carcinoma.
Topics: Carcinoma; Cell Differentiation; Contrast Media; DNA; Fluorodeoxyglucose F18; Humans; Neck; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Retrospective Studies; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2008 |
Whole-body positron emission tomography with 18F-fluorodeoxyglucose is an effective method to detect extra-pelvic recurrence in uterine sarcomas.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pelvis; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Sarcoma; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Uterine Neoplasms; Whole Body Imaging | 2008 |
Evaluation of the therapeutic effects and recurrence for head and neck cancer after chemoradiotherapy by FDG-PET.
Topics: Adolescent; Adult; Aged; Carcinoma; Child; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Otorhinolaryngologic Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2009 |
Utility of FDG-PET/CT in the follow-up of neuroblastoma which became MIBG-negative.
Topics: 3-Iodobenzylguanidine; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Infant; Neoplasm Recurrence, Local; Neoplasm, Residual; Neuroblastoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
Clinical role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in post-operative follow up of gastric cancer: initial results.
Topics: Adenocarcinoma; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms; Tomography, X-Ray Computed | 2008 |
Detection and restaging of residual and/or recurrent nasopharyngeal carcinoma after chemotherapy and radiation therapy: comparison of MR imaging and FDG PET/CT.
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2008 |
Central photopenic lesions on FDG-PET scan in a patient with peripheral T cell lymphoma.
Topics: Alcoholism; Antineoplastic Combined Chemotherapy Protocols; Asbestos; Biomarkers, Tumor; Biopsy; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Tomography, X-Ray Computed; Whole Body Imaging | 2008 |
Patterns of FDG uptake in post-thoracotomy surgical scars in patients with lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Cicatrix; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Thoracotomy; Treatment Outcome; Whole Body Imaging | 2008 |
Extrapulmonary small cell carcinoma: involvement of the brain without evidence of extracranial malignancy by serial PET/CT scans.
Topics: Antineoplastic Agents; Brain Neoplasms; Carcinoma, Small Cell; Combined Modality Therapy; Craniotomy; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Topotecan | 2008 |
Current role of radionuclide imaging in differentiated thyroid cancer.
Topics: Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Risk Factors; Sensitivity and Specificity; Thyroid Neoplasms; Thyroidectomy; Treatment Outcome | 2008 |
A treatment selection protocol for recurrent ovarian cancer patients: the role of FDG-PET/CT and staging laparoscopy.
Topics: Adult; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Laparoscopy; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Patient Selection; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Unique site- and time-specific patterns of recurrence following resection of colorectal carcinoma hepatic metastases in patients staged by FDG-PET.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Time Factors; Young Adult | 2008 |
The prognostic value of 18F-fluorodeoxyglucose uptake by using serial positron emission tomography and computed tomography in patients with stage III nonsmall cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
Surveillance FDG-PET detection of asymptomatic recurrences in patients with cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Registries; Uterine Cervical Neoplasms | 2009 |
Combined evaluation of preoperative FDG uptake on PET, ground-glass opacity area on CT, and serum CEA level: identification of both low and high risk of recurrence in patients with resected T1 lung adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoembryonic Antigen; Disease-Free Survival; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed | 2009 |
Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent uterine cancer: comparison with PET and enhanced CT.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Neoplasms | 2009 |
Thoracic chordoma: review and role of FDG-PET.
Topics: Aged; Back Pain; Biopsy; Chordoma; Diagnosis, Differential; Diagnostic Errors; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Neurosurgical Procedures; Positron-Emission Tomography; Predictive Value of Tests; Spinal Neoplasms; Thoracic Vertebrae; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
Combined use of perioperative TSH-stimulated (18)F-FDG PET/CT imaging and gamma probe radioguided surgery to localize and verify resection of iodine scan-negative recurrent thyroid carcinoma.
Topics: Carcinoma, Papillary; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Gamma Rays; Humans; Image Processing, Computer-Assisted; Iodine Radioisotopes; Middle Aged; Neck Dissection; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Radiotherapy, Adjuvant; Sensitivity and Specificity; Surgery, Computer-Assisted; Thyroid Neoplasms; Thyrotropin; Tomography, X-Ray Computed; Young Adult | 2008 |
Clinical significance of 18F-FDG uptake by primary sites in patients with diffuse large B cell lymphoma in the head and neck: a pilot study.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Incidence; Korea; Lymphoma, B-Cell; Neoplasm Recurrence, Local; Pilot Projects; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Analysis; Survival Rate | 2008 |
Clarifying the diagnosis of clinically suspected recurrence of cervical cancer: impact of 18F-FDG PET.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Analysis; Survival Rate; Uterine Cervical Neoplasms | 2008 |
Secretive and proliferative tumor profile helps to select the best imaging technique to identify postoperative persistent or relapsing medullary thyroid cancer.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Calcitonin; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Complications; Predictive Value of Tests; Radiopharmaceuticals; Receptors, Somatostatin; Retrospective Studies; Sensitivity and Specificity; Thyroid Neoplasms | 2009 |
Significance of 18F-fluorodeoxyglucose positron-emission tomography/computed tomography for the postoperative surveillance of advanced renal cell carcinoma.
Topics: Adult; Aged; Carcinoma, Renal Cell; Epidemiologic Methods; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
18F-FDG-PET in patients with malignant lymphoma having long-term follow-up: staging and restaging, and evaluation of treatment response and recurrence.
Topics: Adolescent; Adult; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Longitudinal Studies; Lymphoma; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Young Adult | 2008 |
The cost-effectiveness of 18FDG-PET in selecting patients with suspicion of recurrent laryngeal carcinoma after radiotherapy for direct laryngoscopy.
Topics: Aged; Aged, 80 and over; Cost-Benefit Analysis; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Laryngoscopy; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2009 |
Utility of FDG-PET/CT in the follow-up of neuroblastoma which became MIBG-negative.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Antineoplastic Agents; Combined Modality Therapy; Endocrine Surgical Procedures; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Infant; Neoplasm Recurrence, Local; Neuroblastoma; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy; Tomography, X-Ray Computed | 2009 |
The cost-utility analysis of 18-fluoro-2-deoxyglucose positron emission tomography in the diagnosis of recurrent nasopharyngeal carcinoma.
Topics: Adult; Cost-Benefit Analysis; Female; Fluorodeoxyglucose F18; Health Care Costs; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Taiwan | 2009 |
Unusual 2-[18F]-fluoro-2-deoxy-D-glucose accumulation induced by postoperative intestinocutaneous fistula in the patient with uterine cervical cancer and SLE.
Topics: Colostomy; Cutaneous Fistula; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Intestinal Fistula; Lupus Erythematosus, Systemic; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Complications; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2009 |
An unusual case of recurrent endometrial cancer presented with isolated cervical lymph node metastasis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Endometrioid; Combined Modality Therapy; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography | 2009 |
Arterial infusion chemotherapy in patient with repeated recurrent tumor of cecal cancer: report of a case.
Topics: Antimetabolites, Antineoplastic; Cecal Neoplasms; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Infusions, Intra-Arterial; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
False-positive positron emission tomography appearance with 18F-fluorodeoxyglucose after definitive radiotherapy for cancer of the mobile tongue.
Topics: Adult; Brachytherapy; Carcinoma, Squamous Cell; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Tongue Neoplasms; Young Adult | 2009 |
18F-fluorodeoxyglucose positron emission tomography-computed tomography for suspected recurrent papillary thyroid cancer: early experience at Sunnybrook Health Sciences Centre.
Topics: Adult; Aged; Biomarkers; Cancer Care Facilities; Carcinoma, Papillary; Cohort Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ontario; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Time Factors; Treatment Outcome; Young Adult | 2008 |
Abnormal FDG uptake on 18F-fluorodeoxyglucose positron emission tomography in patients with cancer diagnosis: case reports of tuberculous lymphadenitis.
Topics: Antitubercular Agents; Breast Neoplasms; Colonic Neoplasms; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Lymphoma; Middle Aged; Neoplasm Recurrence, Local; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tuberculosis, Lymph Node | 2009 |
Association between [18F]fluorodeoxyglucose uptake and prognostic parameters in breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Statistics, Nonparametric; Young Adult | 2009 |
Is pre-therapeutical FDG-PET/CT capable to detect high risk tumor subvolumes responsible for local failure in non-small cell lung cancer?
Topics: Aged; Aged, 80 and over; Analysis of Variance; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Survival Rate; Tomography, Emission-Computed; Tomography, X-Ray Computed; Tumor Burden | 2009 |
Integrated contrast-enhanced diagnostic whole-body PET/CT as a first-line restaging modality in patients with suspected metastatic recurrence of breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Systems Integration; Tomography, X-Ray Computed; Triiodobenzoic Acids; Whole Body Imaging | 2010 |
Usefulness of 201TL SPECT/CT relative to 18F-FDG PET/CT in detecting recurrent skull base nasopharyngeal carcinoma.
Topics: Adult; Aged; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Logistic Models; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Probability; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Skull Base; Tomography, Emission-Computed, Single-Photon | 2009 |
Whole-body MRI at 1.5 T and 3 T compared with FDG-PET-CT for the detection of tumour recurrence in patients with colorectal cancer.
Topics: Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2009 |
Role of PET/CT in maxillo-facial surgery.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
Performance of integrated FDG-PET/contrast-enhanced CT in the staging and restaging of colorectal cancer: comparison with PET and enhanced CT.
Topics: Aged; Aged, 80 and over; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Systems Integration; Tomography, X-Ray Computed | 2010 |
[Positron-emission tomography (PET) and PET/CT in head and neck cancer - recommendations of an interdisciplinary consensus conference].
Topics: Blood Glucose; Chemotherapy, Adjuvant; Combined Modality Therapy; Consensus; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Otorhinolaryngologic Neoplasms; Patient Care Team; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Radiotherapy, High-Energy; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
[Merkel cell carcinoma: a rare tumor entity in an unusually young patient].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Merkel Cell; Combined Modality Therapy; Contrast Media; Disease Progression; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Knee; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Positron-Emission Tomography; Skin Neoplasms; Surgical Flaps; Whole Body Imaging | 2009 |
The role of PET/CT in detection of gastric cancer recurrence.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed | 2009 |
Is FDG-PET/CT useful for managing malignant pleural mesothelioma?
Topics: Aged; Aged, 80 and over; Colonic Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mesothelioma; Middle Aged; Neoplasm Recurrence, Local; Pleural Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
Clinical value of whole-body FDG-PET for recurrent gastric cancer: a multicenter study.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed; Whole-Body Counting | 2009 |
Diagnostic accuracy of serial CT/magnetic resonance imaging review vs. positron emission tomography/CT in colorectal cancer patients with suspected and known recurrence.
Topics: Carcinoembryonic Antigen; Colorectal Neoplasms; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Statistics, Nonparametric; Survival Analysis; Tumor Burden; Young Adult | 2009 |
Prognostic value of 18F-FDG PET in patients with head and neck squamous cell cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals | 2009 |
Positron emission tomography-computed tomography surveillance for the node-positive neck after chemoradiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Combined Modality Therapy; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Enhancement; Image Processing, Computer-Assisted; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Otorhinolaryngologic Neoplasms; Positron-Emission Tomography; Radiotherapy, Conformal; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Performance of integrated FDG PET/contrast-enhanced CT in the diagnosis of recurrent colorectal cancer: Comparison with integrated FDG PET/non-contrast-enhanced CT and enhanced CT.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Contrast Media; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
18F-FDG PET in the assessment of tumor grade and prediction of tumor recurrence in intracranial meningioma.
Topics: Adult; Aged; Brain Neoplasms; Disease-Free Survival; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Meningioma; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve | 2009 |
Relapse with malignant transformation after chemotherapy for primary mediastinal seminoma: case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cisplatin; Etoposide; Fluorodeoxyglucose F18; Humans; Male; Mediastinal Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Seminoma; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Integrated FDG-PET/CT vs. standard radiological examinations: comparison of capability for assessment of postoperative recurrence in non-small cell lung cancer patients.
Topics: Carcinoma, Non-Small-Cell Lung; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Systems Integration; Tomography, X-Ray Computed; X-Ray Film | 2010 |
Clinical and pathological factors related to 18F-FDG-PET positivity in the diagnosis of recurrence and/or metastasis in patients with differentiated thyroid cancer.
Topics: Adolescent; Adult; Aged; Child; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Young Adult | 2009 |
Differentiation of FDG-avid loco-regional recurrent and compromised benign lesions after surgery for breast cancer with dual-time point F-18-fluorodeoxy-glucose PET/CT scan.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; ROC Curve; Time Factors; Tomography, X-Ray Computed | 2009 |
FDG-PET/CT for the preoperative lymph node staging of invasive bladder cancer.
Topics: Aged; Aged, 80 and over; Belgium; Cystectomy; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Urinary Bladder Neoplasms | 2010 |
[The role of 18F-FDG SPECT-CT in detecting recurrence and metastases in breast cancer patients with elevated tumor markers].
Topics: Adult; Aged; Biomarkers, Tumor; Breast Neoplasms; Breast Neoplasms, Male; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed, Single-Photon; Whole Body Imaging | 2009 |
Mandibular lesion differential diagnoses in a patient with a previous history of locally advanced head and neck carcinoma.
Topics: Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Mandible; Middle Aged; Neoplasm Recurrence, Local; Osteoradionecrosis; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Tonsillar Neoplasms | 2009 |
Dual tracer 11C-choline and FDG-PET in the diagnosis of biochemical prostate cancer relapse after radical treatment.
Topics: Adult; Aged; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic Neoplasms | 2010 |
The diagnostic and prognostic utility of positron emission tomography/computed tomography-based follow-up after radiotherapy for head and neck cancer.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
18F-FDG uptake and its clinical relevance in primary gastric lymphoma.
Topics: Adult; Aged; Biopsy; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gastric Mucosa; Gastroscopy; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Stomach Neoplasms; Stomach Ulcer; Tomography, X-Ray Computed; Young Adult | 2010 |
The prognostic significance of the SUVmax (maximum standardized uptake value for F-18 fluorodeoxyglucose) of the cervical tumor in PET imaging for early cervical cancer: preliminary results.
Topics: Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Hysterectomy; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Adjuvant; Risk Factors; Uterine Cervical Neoplasms | 2009 |
Evaluation of 18fluoro-2-deoxyglucose positron emission tomography in iodine scan negative, differentiated thyroid cancer recurrence.
Topics: Adult; Aged; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Whole Body Imaging; Young Adult | 2009 |
Metabolic tumor volumes by [18F]-fluorodeoxyglucose PET/CT correlate with occult metastasis in oral squamous cell carcinoma of the tongue.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed; Tongue Neoplasms; Treatment Outcome; Tumor Burden; Young Adult | 2009 |
Elevated carcinoembryonic antigen and sarcoidosis masquerading as metastatic colon cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Colonic Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sarcoidosis, Pulmonary | 2009 |
S-100B concentrations predict disease-free survival in stage III melanoma patients.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Immunoenzyme Techniques; L-Lactate Dehydrogenase; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Nerve Growth Factors; Perioperative Care; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Skin Neoplasms; Tomography, X-Ray Computed; Young Adult | 2009 |
Comparison of (68)Ga-DOTATATE and (18)F-fluorodeoxyglucose PET/CT in the detection of recurrent medullary thyroid carcinoma.
Topics: Adult; Aged; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Thyroid Gland; Thyroid Neoplasms; Tomography, X-Ray Computed | 2010 |
[18F]FLT-PET and [18F]FDG-PET in the evaluation of radiotherapy for laryngeal cancer.
Topics: Aged; Aged, 80 and over; Dideoxynucleosides; Feasibility Studies; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2009 |
18F-Fluorodeoxyglucose-PET/CT to evaluate tumor, nodal disease, and gross tumor volume of oropharyngeal and oral cavity cancer: comparison with MR imaging and validation with surgical specimen.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
[Application of 18F-FDG PET/CT in cervical cancer with elevated levels of serum squamous cell carcinoma antigen during the follow-up].
Topics: Adult; Aged; Antigens, Neoplasm; Biomarkers, Tumor; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Serpins; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2009 |
Positron emission tomography in the diagnosis and management of intracranial germ cell tumours.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Pinealoma; Positron-Emission Tomography; Radiopharmaceuticals; Salvage Therapy; Soft Tissue Neoplasms | 2009 |
Recurrence detection in differentiated thyroid cancer patients with elevated serum level of antithyroglobulin antibody: special emphasis on using (18)F-FDG PET/CT.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Autoantibodies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prevalence; Thyroglobulin; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2010 |
Postoperative abdominal aspergilloma mimicking cervical cancer recurrence and diagnostic imaging, including F-fluorodeoxyglucose positron emission tomography, with false-positive findings.
Topics: Abdomen; Adult; Antigens, Neoplasm; Aspergillosis; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Complications; Radiopharmaceuticals; Serpins; Uterine Cervical Neoplasms | 2009 |
Early recurrence of papillary and follicular thyroid carcinoma predicts a worse outcome.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Biopsy, Fine-Needle; Carcinoma, Papillary; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neck; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Survival Analysis; Taiwan; Thyroid Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography | 2009 |
Recurrence-free long-term survival after liver transplantation in patients with 18F-FDG non-avid hilar cholangiocarcinoma on PET.
Topics: Adult; Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Liver Transplantation; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Retrospective Studies; Risk Factors; Survival Rate | 2009 |
Tumor relapse after pancreatic cancer resection is detected earlier by 18-FDG PET than by CT.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Pancreatectomy; Pancreatic Neoplasms; Pancreaticoduodenectomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed | 2010 |
Recurrence pattern after [(18)F]fluoroethyltyrosine-positron emission tomography-guided radiotherapy for high-grade glioma: a prospective study.
Topics: Adult; Aged; Astrocytoma; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Survival Analysis; Survival Rate | 2009 |
Comparison of iodine-123 metaiodobenzylguanidine (MIBG) scan and [18F]fluorodeoxyglucose positron emission tomography to evaluate response after iodine-131 MIBG therapy for relapsed neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Child; Child, Preschool; Clinical Trials, Phase I as Topic; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Neoplasm Recurrence, Local; Neuroblastoma; Outcome Assessment, Health Care; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Multiple (18)F-FDG, PET-CT for postoperative monitoring of breast cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole Body Imaging | 2009 |
Clinical outcomes of definitive intensity-modulated radiation therapy with fluorodeoxyglucose-positron emission tomography simulation in patients with locally advanced cervical cancer.
Topics: Brachytherapy; Combined Modality Therapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2010 |
Clinical usefulness of fluoro-2-deoxy-D-glucose PET in a case with multiple bone metastases of carcinoid tumor after ten years.
Topics: Aged, 80 and over; Biopsy; Bone Neoplasms; Carcinoid Tumor; Fluorodeoxyglucose F18; Humans; Lumbar Vertebrae; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Thymus Neoplasms; Time Factors | 2009 |
Detection and prediction of local recurrence of maxillary sinus cancer using F-18 FDG PET/CT.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Maxillary Sinus Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed | 2010 |
[Usefulness of PET scans in diagnosing recurrent prostate cancer. Prostate with PSA level < 5 ng/ml].
Topics: Adult; Aged; Choline; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals | 2009 |
Fluorodeoxyglucose-positron-emission tomography imaging of head and neck squamous cell cancer.
Topics: Biopsy, Fine-Needle; Carcinoma, Squamous Cell; Disease Progression; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Neoplasms, Multiple Primary; Neoplasms, Unknown Primary; Otorhinolaryngologic Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden; Ultrasonography | 2010 |
Prognostic value of 18F-FDG PET/CT before and after radiotherapy for locally advanced nasopharyngeal carcinoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Dosage; Remission Induction; Retrospective Studies; Risk Factors; Survival Rate; Tomography, X-Ray Computed; Young Adult | 2010 |
Hodgkin's lymphoma in remission after first-line therapy: which patients need FDG-PET/CT for follow-up?
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Remission Induction; Retrospective Studies; Risk Factors; Survival Rate; Tomography, X-Ray Computed | 2010 |
[18F]-Fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemoradiation in esophageal cancer.
Topics: Adult; Aged; Antineoplastic Agents; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals | 2009 |
Relative value of magnetic resonance spectroscopy, magnetic resonance perfusion, and 2-(18F) fluoro-2-deoxy-D-glucose positron emission tomography for detection of recurrence or grade increase in gliomas.
Topics: Adolescent; Adult; Aged; Brain; Brain Neoplasms; Diagnosis, Differential; Disease Progression; False Positive Reactions; Female; Fluorodeoxyglucose F18; Gadolinium; Glioma; Humans; Magnetic Resonance Angiography; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiotherapy; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2010 |
The role of FDG PET/CT in patients with locoregional breast cancer recurrence: a comparison to conventional imaging techniques.
Topics: Adult; Aged; Breast Neoplasms; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole Body Imaging | 2010 |
Usefulness of fluoro-2-deoxyglucose positron emission tomography for investigating unexplained rising carcinoembryonic antigen levels that occur during the postoperative surveillance of lung cancer patients.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoembryonic Antigen; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Postoperative Period; Radiopharmaceuticals | 2009 |
The potential clinical value of FDG-PET for recurrent renal cell carcinoma.
Topics: Aged; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Survival Rate | 2011 |
Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin?
Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Papillary; Child; Drug Administration Schedule; Female; Fluorodeoxyglucose F18; Hormone Replacement Therapy; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Recombinant Proteins; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Thyrotropin; Thyroxine; Young Adult | 2010 |
Detection of residual lymph node metastases in high-risk papillary thyroid cancer patients receiving adjuvant I-131 therapy: the usefulness of F-18 FDG PET/CT.
Topics: Adult; Aged; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy, Adjuvant; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Subtraction Technique; Thyroid Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Interesting image. Correlative imaging with FDG PET-CT and MRI of an unusual recurrence of urothelial cancer in an ileal conduit.
Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Rare Diseases; Subtraction Technique; Tomography, X-Ray Computed; Urinary Bladder Neoplasms; Urinary Diversion; Urothelium | 2010 |
Glioma recurrence versus radiation necrosis? A pilot comparison of arterial spin-labeled, dynamic susceptibility contrast enhanced MRI, and FDG-PET imaging.
Topics: Adult; Aged; Brain Injuries; Brain Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium; Glioma; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Pilot Projects; Positron-Emission Tomography; Radiation Injuries; Radiopharmaceuticals; Radiotherapy; Reproducibility of Results; Sensitivity and Specificity; Spin Labels; Young Adult | 2010 |
Remnant pancreatectomy for recurrent or metachronous pancreatic carcinoma detected by FDG-PET: two case reports.
Topics: Aged; Carcinoma; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Neoplasm, Residual; Neoplasms, Second Primary; Pancreatectomy; Pancreatic Neoplasms; Radionuclide Imaging | 2010 |
Early distant relapse in early stage triple-negative breast cancer: usefulness of FDG-PET for diagnosis of distant metastases.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Female; Fluorodeoxyglucose F18; Humans; Mastectomy, Segmental; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Dosage; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone | 2013 |
The impact of (18)F-FDG PET-CT scanning for staging and management of Merkel cell carcinoma: results from Westmead Hospital, Sydney, Australia.
Topics: Aged; Aged, 80 and over; Carcinoma, Merkel Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; New South Wales; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Tomography, X-Ray Computed | 2010 |
Role of integrated 18-fluorodeoxyglucose position emission tomography-computed tomography in patients surveillance after multimodality therapy of malignant pleural mesothelioma.
Topics: Aged; Antineoplastic Agents; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Male; Mesothelioma; Middle Aged; Neoplasm Recurrence, Local; Pleural Neoplasms; Population Surveillance; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
PET/CT pattern analysis for surgical staple line recurrence in patients with colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Sutures; Tomography, X-Ray Computed | 2010 |
Dual PET/CT with (18)F-DOPA and (18)F-FDG in metastatic medullary thyroid carcinoma and rapidly increasing calcitonin levels: Comparison with conventional imaging.
Topics: Adult; Aged; Biomarkers, Tumor; Calcitonin; Carcinoma, Medullary; Chi-Square Distribution; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Sensitivity and Specificity; Statistics, Nonparametric; Thyroid Neoplasms; Thyroidectomy | 2010 |
Assessment of tumor recurrence in patients with colorectal cancer and elevated carcinoembryonic antigen level: FDG PET/CT versus contrast-enhanced 64-MDCT of the chest and abdomen.
Topics: Adult; Aged; Aged, 80 and over; Carcinoembryonic Antigen; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiographic Image Interpretation, Computer-Assisted; Radiography, Abdominal; Radiography, Thoracic; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2010 |
FDG avid supraclavicular neck adenopathy of tubercular etiology masquerading as neck recurrence in differentiated thyroid carcinoma: potential source of false positive FDG-PET study.
Topics: Adolescent; Carcinoma, Papillary; Diagnosis, Differential; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Male; Neck; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed; Tuberculosis, Lymph Node | 2010 |
Value of combined interpretation of computed tomography response and positron emission tomography response for prediction of prognosis after neoadjuvant chemotherapy in non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Combined Modality Therapy; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
(18)F-fluorodeoxyglucose positron emission tomography immediately after chemoradiotherapy predicts prognosis in patients with locoregional postoperative recurrent esophageal cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Adjuvant; Time Factors; Treatment Outcome | 2010 |
[Combined functional and morphological imaging of sarcomas: significance for diagnostics and therapy monitoring].
Topics: Adult; Fluorodeoxyglucose F18; Germany; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sarcoma; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Combined positron emission tomography-computed tomography and tumor markers for detecting recurrent ovarian cancer.
Topics: Adenocarcinoma; Adult; Aged; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Recurrent colon cancer involving the urinary bladder identified with F-18 FDG PET/CT after forced diuresis.
Topics: Aged; Colonic Neoplasms; Diuretics; Fluorodeoxyglucose F18; Humans; Image Enhancement; Male; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2010 |
Varicose vein as a cause of increased FDG uptake.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lymphoma; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed; Varicose Veins | 2010 |
Clinical and survival impact of FDG PET in patients with suspicion of recurrent cervical carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2010 |
Clinical value of FDG PET/CT in the diagnosis of suspected recurrent ovarian cancer: is there an impact of FDG PET/CT on patient management?
Topics: Adult; Aged; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Whole Body Imaging | 2010 |
Focal dose escalation using FDG-PET-guided intensity-modulated radiation therapy boost for postoperative local recurrent rectal cancer: a planning study with comparison of DVH and NTCP.
Topics: Antimetabolites, Antineoplastic; Dose-Response Relationship, Radiation; Drug Combinations; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Oxonic Acid; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Rectal Neoplasms; Tegafur | 2010 |
[Fluoroethylthyrosine 18F PET in the detection of brain tumours].
Topics: Adult; Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioblastoma; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Oligodendroglioma; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Tyrosine | 2010 |
Comprehensive imaging of residual/ recurrent nasopharyngeal carcinoma using whole-body MRI at 3 T compared with FDG-PET-CT.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Whole Body Imaging; Young Adult | 2010 |
[(18)F]Fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) physiologic imaging of choroidal melanoma: before and after ophthalmic plaque radiation therapy.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Choroid Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Palladium; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden; Uveal Neoplasms | 2011 |
Prognostic value of FDG-PET in Hodgkin lymphoma for posttreatment evaluation. Long term follow-up results.
Topics: Adolescent; Adult; Aged; Cohort Studies; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Remission Induction; Retrospective Studies; Sensitivity and Specificity; Survival Rate; Time Factors; Treatment Outcome; Young Adult | 2010 |
Clinical and pathological factors related to 18F-FDG-PET positivity in the diagnosis of recurrence and/or metastasis in patients with differentiated thyroid cancer.
Topics: Adenocarcinoma; Cell Differentiation; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Thyroid Neoplasms | 2011 |
Radiofrequency ablation of non-small-cell carcinoma of the lung under real-time FDG PET CT guidance.
Topics: Aged; Biopsy; Carcinoma, Non-Small-Cell Lung; Catheter Ablation; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Multiple Primary; Pneumonectomy; Positron-Emission Tomography; Postoperative Complications; Reoperation; Surgery, Computer-Assisted; Tomography, X-Ray Computed | 2011 |
[Value of (18)F-FDG imaging and serum tumor markers in the diagnosis of recurrent endometrial carcinoma].
Topics: Adenocarcinoma; Adult; Aged; Biomarkers, Tumor; CA-125 Antigen; Cystadenocarcinoma, Serous; DNA-Binding Proteins; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Transcription Factors | 2010 |
Usefulness 18F-FDG positron emission tomography/computed tomography for detecting recurrence of hepatocellular carcinoma in posttransplant patients.
Topics: Adult; Bone Neoplasms; Brain Neoplasms; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reoperation; Republic of Korea; Time Factors; Tomography, Spiral Computed; Treatment Outcome | 2010 |
Prospective, blinded trial of whole-body magnetic resonance imaging versus computed tomography positron emission tomography in staging primary and recurrent cancer of the head and neck.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Whole Body Imaging; Young Adult | 2010 |
Non-small cell carcinoma: comparison of postoperative intra- and extrathoracic recurrence assessment capability of qualitatively and/or quantitatively assessed FDG-PET/CT and standard radiological examinations.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
The significance of size change of soft tissue sarcoma during preoperative radiotherapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Chemotherapy, Adjuvant; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Adjuvant; Sarcoma; Survival Analysis; Thallium Radioisotopes; Treatment Outcome; Victoria | 2010 |
Significance of 18F-fluorodeoxyglucose positron-emission tomography/computed tomography for the postoperative surveillance of advanced renal cell carcinoma.
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
[Diffuse subdural recurrence of an esthesioneuroblastoma].
Topics: Adolescent; Biopsy; Combined Modality Therapy; Cranial Fossa, Anterior; Esthesioneuroblastoma, Olfactory; Ethmoid Sinus; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Maxillary Sinus; Necrosis; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Orbit; Positron-Emission Tomography; Subdural Space; Tomography, X-Ray Computed | 2010 |
Impact of positron emission tomography/computed tomography in the management of patients with epithelial ovarian carcinoma after treatment.
Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2011 |
Detection of recurrence by 18F-FDG PET in patients with endometrial cancer showing no evidence of disease.
Topics: Adult; Aged; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity | 2010 |
Differentiating radiation necrosis from tumor recurrence in high-grade gliomas: assessing the efficacy of 18F-FDG PET, 11C-methionine PET and perfusion MRI.
Topics: Adult; Aged; Brain; Brain Neoplasms; Cerebrovascular Circulation; Female; Fluorodeoxyglucose F18; Glioma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Paresis; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy | 2010 |
Clinical use of combined positron emission tomography and computed tomography in thymoma recurrence.
Topics: Adolescent; Adult; Female; Fluorodeoxyglucose F18; Humans; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Thymoma; Thymus Neoplasms; Tomography, X-Ray Computed; Young Adult | 2010 |
Differentiation between peri-anastomotic inflammatory changes and local recurrence following neoadjuvant radiochemotherapy surgery for colorectal cancer using visual and semiquantitative analysis of PET-CT data.
Topics: Aged; Colorectal Neoplasms; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2010 |
Management of local recurrence of colorectal cancer: the role of PET/CT.
Topics: Adult; Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
18F-FDG-PET-CT imaging findings of recurrent intracranial haemangiopericytoma with distant metastases.
Topics: Adult; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Hemangiopericytoma; Humans; Liver Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2010 |
Clinical utility of positron emission tomography/computed tomography in the evaluation of suspected recurrent ovarian cancer in the setting of normal CA-125 levels.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; CA-125 Antigen; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reference Values; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
[Application of SPECT/PET in patients with lymphoma and its significance in monitoring relapse].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Tomography, Emission-Computed, Single-Photon; Young Adult | 2010 |
Dual phase FDG-PET imaging of brain metastases provides superior assessment of recurrence versus post-treatment necrosis.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2011 |
Prospective study on the FDG-PET/CT predictive and prognostic values in patients treated with neoadjuvant chemoradiation therapy and radical surgery for locally advanced rectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Rectal Neoplasms; ROC Curve; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Utility of TL-201 SPECT in clarifying false-positive FDG-PET findings due to osteoradionecrosis in head and neck cancer.
Topics: Adult; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Osteoradionecrosis; Otorhinolaryngologic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon | 2010 |
Diagnostic accuracy of ultrasound and 18-F-FDG PET or PET/CT for patients with suspected recurrent papillary thyroid carcinoma.
Topics: Adolescent; Adult; Aged; Carcinoma; Carcinoma, Papillary; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Thyroid Cancer, Papillary; Thyroid Gland; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography, Doppler, Color; Young Adult | 2010 |
Preoperative 18[F]-fluorodeoxyglucose positron emission tomography/computed tomography predicts early recurrence after pancreatic cancer resection.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron-Emission Tomography; Preoperative Period | 2011 |
Prognostic implication of (18)F FDG-PET in patients with extrahepatic metastatic hepatocellular carcinoma undergoing systemic treatment, a retrospective cohort study.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Cohort Studies; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Molecular Targeted Therapy; Neoplasm Recurrence, Local; Palliative Care; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate | 2011 |
[Tumor diagnosis with PET-CT. Are false hopes raised in cancer patients? (interview by Ute Kempf)].
Topics: Breast Neoplasms; Carcinoma, Bronchogenic; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Insurance Coverage; Lung Neoplasms; Male; National Health Programs; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prostatic Neoplasms; Sensitivity and Specificity; Tomography, X-Ray Computed; Unnecessary Procedures | 2010 |
18F-FDG PET/CT for the prediction and detection of local recurrence after radiofrequency ablation of malignant lung lesions.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Catheter Ablation; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Interpretation, Computer-Assisted; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Risk; Tomography, Emission-Computed; Treatment Outcome; Young Adult | 2010 |
Positron emission tomography/computed tomography and lymphovascular invasion predict recurrence in stage I lung cancers.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Cohort Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2011 |
Surgical treatment of local recurrence after stereotactic body radiotherapy for primary and metastatic lung cancers.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiosurgery; Retrospective Studies; Salvage Therapy | 2010 |
The role of 18F-FDG PET/CT in the evaluation of gastric cancer recurrence after curative gastrectomy.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Gastrectomy; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Stomach Neoplasms; Tomography, X-Ray Computed | 2011 |
A letter regarding diagnostic accuracy of ultrasound and 18-F-FDG PET or PET/CT for patients with suspected recurrent papillary thyroid carcinoma.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography | 2011 |
Combining FDG-PET/CT with laboratory data yields superior results for prediction of relapse in multiple myeloma.
Topics: Adult; Aged; beta 2-Microglobulin; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multiple Myeloma; Myeloma Proteins; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2011 |
FDG PET/CT patterns of treatment failure of malignant pleural mesothelioma: relationship to histologic type, treatment algorithm, and survival.
Topics: Abdomen; Adult; Aged; Aged, 80 and over; Algorithms; Biological Transport; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Mesothelioma; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Pleural Neoplasms; Positron-Emission Tomography; Radiography, Abdominal; Radiography, Thoracic; Retrospective Studies; Thorax; Tomography, X-Ray Computed; Treatment Failure | 2011 |
Can (18)F-FDG PET/CT predict recurrence in patients with cutaneous malignant melanoma?
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Skin Neoplasms; Subtraction Technique; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Prognostic value of 18F-fluorodeoxyglucose-positron emission tomography in patients with differentiated thyroid carcinoma and circulating antithyroglobulin autoantibodies.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Autoantibodies; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Retrospective Studies; Thyroid Neoplasms; Tomography, Emission-Computed | 2011 |
Clinical value of (18)F-FDG PET/CT in postoperative monitoring for patients with colorectal carcinoma.
Topics: Adolescent; Adult; Aged; Bone Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Monitoring, Physiologic; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Positron-Emission Tomography; Postoperative Care; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2011 |
Clinical impact of fluorodeoxyglucose-positron emission tomography scan/computed tomography in comparison with computed tomography on the detection of colorectal cancer recurrence.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
PET and PET-CT of lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Small Cell Lung Carcinoma; Tomography, Emission-Computed | 2011 |
PET and PET-CT in esophageal and gastric cancer.
Topics: Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, Emission-Computed | 2011 |
FDG PET and PET/CT for colorectal cancer.
Topics: Carcinoma; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed | 2011 |
Accuracy of 18-fluoro-2-deoxy-D-glucose positron emission tomography in the pretherapeutic detection of occult para-aortic node involvement in patients with a locally advanced cervical carcinoma.
Topics: Adenocarcinoma; Adenocarcinoma, Clear Cell; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Child; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Uterine Cervical Neoplasms; Young Adult | 2011 |
F-18 FDG PET-CT in patients with recurrent glioma: comparison with contrast enhanced MRI.
Topics: Adolescent; Adult; Aged; Biopsy; Brain Neoplasms; Child; Contrast Media; Female; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
PET tumor metabolism in locally advanced breast cancer patients undergoing neoadjuvant chemotherapy: value of static versus kinetic measures of fluorodeoxyglucose uptake.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Kinetics; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Outcome Assessment, Health Care; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Analysis | 2011 |
Prediction of survival and cancer recurrence using F-18 FDG PET/CT in patients with surgically resected early stage (Stage I and II) non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
18F-FDG PET/CT and 123I-metaiodobenzylguanidine imaging in high-risk neuroblastoma: diagnostic comparison and survival analysis.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Bone Marrow Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Kaplan-Meier Estimate; Liver Neoplasms; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neuroblastoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival; Survival Analysis; Tomography, Emission-Computed; Young Adult | 2011 |
Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT?
Topics: Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed | 2011 |
Plasma Epstein-Barr virus DNA screening followed by ¹⁸F-fluoro-2-deoxy-D-glucose positron emission tomography in detecting posttreatment failures of nasopharyngeal carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Combined Modality Therapy; DNA, Viral; Epstein-Barr Virus Infections; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Herpesvirus 4, Human; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Rate; Young Adult | 2011 |
Growing teratoma syndrome of the ovary: a case report with FDG-PET findings.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Reoperation; Teratoma; Treatment Outcome; Tumor Burden | 2011 |
F-18 FDG PET/CT imaging and bronchoscopic image of tracheal recurrence in patient with non-small-cell lung cancer.
Topics: Bronchoscopy; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Tomography, X-Ray Computed; Trachea | 2011 |
Evaluation of ¹⁸F-FDG-PET for early detection of suboptimal response of rectal cancer to preoperative chemoradiotherapy: a prospective analysis.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Rectal Neoplasms; Sensitivity and Specificity; Survival Rate; Treatment Outcome | 2011 |
Fluorine-18-fluorodeoxyglucose PET/CT for the evaluation of suspected recurrent uterine leiomyosarcomas.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Leiomyosarcoma; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Uterine Neoplasms | 2011 |
Neck dissection can be avoided after sequential chemoradiotherapy and negative post-treatment positron emission tomography-computed tomography in N2 head and neck squamous cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Survival Rate; Tomography, Emission-Computed | 2011 |
Usefulness of (13)N-NH (3) PET in the evaluation of brain lesions that are hypometabolic on (18)F-FDG PET.
Topics: Adult; Aged; Astrocytoma; Brain; Brain Neoplasms; Cohort Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Nitrogen Radioisotopes; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Rate; Young Adult | 2011 |
Early detection of recurrent ovarian cancer in patients with low-level increases in serum CA-125 levels by 2-[F-18]fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography.
Topics: Adult; Biomarkers, Tumor; CA-125 Antigen; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
Prediction of surgical outcome using plasma Epstein-Barr virus dna and (18)F-FDG PET-CT scan in recurrent nasopharyngeal carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; DNA, Viral; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Herpesvirus 4, Human; Humans; Male; Middle Aged; Multimodal Imaging; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Pharyngectomy; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Retrospective Studies; Risk Assessment; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
eComment: What is the best way to diagnose and stage malignant pleural mesothelioma?
Topics: Biopsy; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Mesothelioma; Neoplasm Recurrence, Local; Neoplasm Staging; Pleural Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Risk Assessment; Risk Factors; Survival Rate; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Detection of isolated ipsilateral regional lymph node recurrences by F18-fluorodeoxyglucose positron emission tomography-CT in follow-up of postoperative breast cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Asymptomatic Diseases; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Second Primary; Positron-Emission Tomography; Postoperative Period; Tomography, X-Ray Computed; Young Adult | 2011 |
Diagnostic performance of contrast enhanced CT and 18F-FDG PET/CT in suspicious recurrence of biliary tract cancer after curative resection.
Topics: Adult; Aged; Biliary Tract Neoplasms; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Prognostic value of fluorine-18 fluorodeoxyglucose positron-emission tomography imaging in patients with head and neck squamous cell carcinoma.
Topics: Aged; Analysis of Variance; Biopsy, Needle; Carcinoma, Squamous Cell; Cohort Studies; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Statistics, Nonparametric; Survival Analysis; Tomography, X-Ray Computed | 2012 |
Radiological changes after stereotactic radiotherapy for stage I lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Pulmonary Fibrosis; Radiation Pneumonitis; Radiopharmaceuticals; Radiosurgery; Retrospective Studies; Tomography, X-Ray Computed | 2011 |
[Usefulness of positron emission tomography in oncology].
Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Prognosis | 2011 |
Early prediction of local control in head and neck cancer after chemoradiotherapy by FDG-PET.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Retrospective Studies; Time Factors; Treatment Outcome | 2011 |
Detecting the recurrence of gastric cancer after curative resection: comparison of FDG PET/CT and contrast-enhanced abdominal CT.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed | 2011 |
F-18 FDG PET-CT for predicting survival in patients with recurrent glioma: a prospective study.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Child; Female; Fluorodeoxyglucose F18; Glioma; Humans; India; Male; Middle Aged; Neoplasm Recurrence, Local; Observer Variation; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Risk Assessment; Risk Factors; Survival Analysis; Survival Rate; Tomography, X-Ray Computed; Young Adult | 2011 |
The impact of ¹⁸F-fluorodeoxyglucose positron emission tomography positive lymph nodes on postoperative recurrence and survival in resectable thoracic esophageal squamous cell carcinoma.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Postoperative Period; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Survival Rate; Thoracic Neoplasms | 2012 |
The role of PET and PET/CT in managing the care of lymphoma patients.
Topics: Adult; Citrates; Female; Fluorodeoxyglucose F18; Gallium; Humans; Lymphoma; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Differentiating osteoradionecrosis from nasopharyngeal carcinoma tumour recurrence using ⁹⁹Tcm-sestamibi SPECT/CT.
Topics: Aged; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Osteoradionecrosis; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
The role of positron emission tomography with computed tomography in the follow-up of asymptomatic cutaneous malignant melanoma patients with a high risk of disease recurrence.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Skin Neoplasms; Tomography, X-Ray Computed; Young Adult | 2011 |
Preoperative FDG-PET predicts recurrence patterns in hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate | 2012 |
Relationship between serum thyroglobulin and 18FDG-PET/CT in 131I-negative differentiated thyroid carcinomas.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Tomography, X-Ray Computed; Young Adult | 2012 |
[Delineation of glioblastoma, simplicity to complexity, the contribution of imaging].
Topics: Carbon Radioisotopes; Central Nervous System Neoplasms; Clinical Trials as Topic; Diagnostic Imaging; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Methionine; Neoplasm Recurrence, Local; Organs at Risk; Positron-Emission Tomography; Radiopharmaceuticals; Societies, Medical; Tomography, X-Ray Computed; Tumor Burden | 2011 |
A clinical study of the prognostic factors for postoperative early recurrence in patients who underwent complete resection for pulmonary adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Chi-Square Distribution; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Japan; Lung Neoplasms; Lymphocyte Count; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neutrophils; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Tumor Burden | 2011 |
The maximum standardized uptake value (SUVmax) on FDG-PET is a strong predictor of local recurrence for localized non-small-cell lung cancer after stereotactic body radiotherapy (SBRT).
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiosurgery; Treatment Outcome | 2011 |
The role of preoperative [18F]fluorodeoxyglucose positron emission tomography in predicting early recurrence after curative resection of hepatocellular carcinomas.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Time Factors | 2011 |
Impact of ¹⁸F-FDG PET/CT for detecting recurrence of medullary thyroid carcinoma.
Topics: Adult; Aged; Calcitonin; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Lung; Lymph Nodes; Male; Mediastinum; Middle Aged; Multimodal Imaging; Neck; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Retrospective Studies; Sensitivity and Specificity; Thyroid Gland; Thyroid Neoplasms; Tomography, X-Ray Computed; Young Adult | 2011 |
18F-fluorodeoxyglucose and 131I radioguided surgical management of thyroid cancer.
Topics: Adult; Aged; Biopsy, Fine-Needle; Feasibility Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Radiosurgery; Retrospective Studies; Thyroid Neoplasms; Treatment Outcome; Young Adult | 2012 |
The clinical value of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in postoperative patients with gastrointestinal mucinous adenocarcinoma.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrointestinal Neoplasms; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Peritoneum; Positron-Emission Tomography; Postoperative Period; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Metabolic response on post-therapy FDG-PET predicts patterns of failure after radiotherapy for cervical cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Clear Cell; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Cervix Uteri; Cisplatin; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Treatment Failure; Uterine Cervical Neoplasms; Uterus; Young Adult | 2012 |
[Indications for the use of PET or PET/CT in patients with breast cancer].
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2011 |
FDG-PET/CT in the diagnosis of recurrent breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Predictive value of metabolic 18FDG-PET response on outcomes in patients with locally advanced pancreatic carcinoma treated with definitive concurrent chemoradiotherapy.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma; Chemoradiotherapy; Deoxycytidine; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gemcitabine; Humans; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
Histiocyte-rich xanthomatous pseudotumor mimicking relapse on positron emission tomography imaging in an adolescent with primary mediastinal diffuse large B-cell lymphoma.
Topics: Adolescent; Female; Fluorodeoxyglucose F18; Histiocytosis; Humans; Lymphoma, Large B-Cell, Diffuse; Mediastinal Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Xanthomatosis | 2012 |
The SUVmax (maximum standardized uptake value for F-18 fluorodeoxyglucose) and serum squamous cell carcinoma antigen (SCC-ag) function as prognostic biomarkers in patients with primary cervical cancer.
Topics: Adult; Aged; Antigens, Neoplasm; Biomarkers, Tumor; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Serpins; Survival Rate; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Young Adult | 2012 |
Local recurrence as immunoglobulin G4 (IgG4)-related disease 10 years after radiotherapy to ocular adnexal extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue.
Topics: B-Lymphocytes; Female; Fluorodeoxyglucose F18; Humans; Immunoglobulin G; Immunohistochemistry; Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Orbital Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
The benefit of early PET/CT surveillance in HPV-associated head and neck squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Diagnosis, Differential; Disease-Free Survival; DNA, Viral; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Human papillomavirus 16; Humans; In Situ Hybridization; Incidence; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Papillomavirus Infections; Pennsylvania; Population Surveillance; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Survival Rate; Tomography, X-Ray Computed | 2011 |
Role of FDG PET-CT in detecting recurrence in patients with uterine sarcoma: comparison with conventional imaging.
Topics: Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sarcoma; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Neoplasms | 2012 |
Lymph node assessment with (18)F-FDG-PET and MRI in uterine cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pelvis; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2011 |
Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis in patients with epithelial ovarian cancer.
Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Cystadenocarcinoma, Serous; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed | 2012 |
The usefulness of pre-radiofrequency ablation SUV(max) in 18F-FDG PET/CT to predict the risk of a local recurrence of malignant lung tumors after lung radiofrequency ablation.
Topics: Aged; Aged, 80 and over; Catheter Ablation; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
An immunoglobulin G4-related disease mimicking postoperative lung cancer recurrence.
Topics: Aged; Autoimmune Diseases; Diagnosis, Differential; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Immunoglobulin G; Lung Neoplasms; Lymphatic Diseases; Male; Mikulicz' Disease; Multimodal Imaging; Neoplasm Recurrence, Local; Plasma Cells; Pleura; Positron-Emission Tomography; Prednisolone; Submandibular Gland; Tomography, X-Ray Computed | 2012 |
Role of [(18)F]-fluorodeoxy-D-glucose positron emission tomography and computed tomography in the early detection of persistent/recurrent thyroid carcinoma in intermediate-to-high risk patients following initial radioactive iodine ablation therapy.
Topics: Adult; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Thyroglobulin; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography | 2012 |
Comparison of F-18 FDG and C-11 methionine PET/CT for the evaluation of recurrent primary brain tumors.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Child; Child, Preschool; Demography; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Recurrence, Local; Observer Variation; Positron-Emission Tomography; Tomography, X-Ray Computed; Young Adult | 2012 |
¹⁸F-Fluorodeoxyglucose positron emission tomography/computed tomography finds answers in cancer patients with increasing tumor markers and negative or equivocal conventional imaging modalities.
Topics: Adult; Aged; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2012 |
Predictive value of positron emission tomography-computed tomography image fusion in the diagnosis of head and neck cancer: does it really improve staging and management?
Topics: Biopsy; Carcinoma; Clinical Competence; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Incidental Findings; Lymphatic Metastasis; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Unknown Primary; Observer Variation; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
High incidence of peritoneal implants in recurrence of intra-abdominal cancer revealed by 18F-FDG PET/CT in patients with increased tumor markers and negative findings on conventional imaging.
Topics: Abdominal Neoplasms; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Peritoneum; Positron-Emission Tomography; Prospective Studies; Prostheses and Implants; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2012 |
Diagnostic value of PET/CT is similar to that of conventional MRI and even better for detecting small peritoneal implants in patients with recurrent ovarian cancer.
Topics: Abdominal Neoplasms; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Ovarian Neoplasms; Pelvic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
The role of 18F-FDG PET/CT in detecting colorectal cancer recurrence in patients with elevated CEA levels.
Topics: Aged; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2012 |
FDG-PET predicts survival in recurrent high-grade gliomas treated with bevacizumab and irinotecan.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Camptothecin; Female; Fluorodeoxyglucose F18; Glioma; Humans; Irinotecan; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate | 2012 |
[Outcome of cervical carcinoma with locoregional lymph node involvement by FDG-PET].
Topics: Adult; Aged; Combined Modality Therapy; Confidence Intervals; Disease-Free Survival; Female; Fluorodeoxyglucose F18; France; Humans; Lumbosacral Region; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Pelvis; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Uterine Cervical Neoplasms | 2012 |
Predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using 18FDG-PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemoradiotherapy; Chemotherapy, Adjuvant; Deoxycytidine; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Rectal Neoplasms; Retrospective Studies; Risk Factors; Survival Rate; Tomography, X-Ray Computed | 2012 |
Residual ¹⁸F-FDG-PET uptake 12 weeks after stereotactic ablative radiotherapy for stage I non-small-cell lung cancer predicts local control.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiosurgery; Survival Analysis; Time Factors; Tumor Burden | 2012 |
Role of 18F-FDG PET/CT in detecting recurrent gallbladder carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Reference Standards; Tomography, X-Ray Computed | 2012 |
18F-FDG PET/CT in a recurrent diffuse malignant peritoneal mesothelioma.
Topics: Female; Fluorodeoxyglucose F18; Humans; Mesothelioma; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Postorchiectomy intrascrotal hematoma mimicking local recurrence on 18F-FDG PET/CT: a diagnostic dilemma.
Topics: Adult; Diagnosis, Differential; Fluorodeoxyglucose F18; Hematoma; Humans; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Orchiectomy; Positron-Emission Tomography; Scrotum; Tomography, X-Ray Computed | 2012 |
¹⁸F-FDG and new positron emitter radiotracers for detecting recurrent medullary thyroid carcinoma.
Topics: Carcinoma, Medullary; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2012 |
Screening for distant metastases before salvage surgery in patients with recurrent head and neck squamous cell carcinoma: a retrospective case series comparing thoraco-abdominal CT, positron emission tomography and abdominal ultrasound.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Endoscopy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Liver Function Tests; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Salvage Therapy; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Prospective evaluation of 68Ga-DOTA-NOC PET-CT in patients with recurrent medullary thyroid carcinoma: comparison with 18F-FDG PET-CT.
Topics: Adult; Aged; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Middle Aged; Multimodal Imaging; Neck; Neoplasm Recurrence, Local; Organometallic Compounds; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, X-Ray Computed | 2012 |
Detection of neck recurrence in patients with differentiated thyroid cancer: comparison of ultrasound, contrast-enhanced CT and (18)F-FDG PET/CT using surgical pathology as a reference standard: (ultrasound vs. CT vs. (18)F-FDG PET/CT in recurre
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography | 2012 |
Positron emission tomography for assessing local failure after stereotactic body radiotherapy for non-small-cell lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Radiosurgery; Radiotherapy, Image-Guided; Tomography, X-Ray Computed | 2012 |
Early recurrence or submucosal residual of laryngeal squamous cell carcinoma: diagnosis by CT-guided endolaryngeal core biopsy on a transcutaneous approach.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Larynx; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2013 |
[18F-FDG PET/CT in patients, treated for ovarian cancer, with elevated CA 125 levels but no evidence of recurrence on conventional imaging].
Topics: Adult; CA-125 Antigen; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Ovarian Neoplasms; Ovary; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
FDG-PET SUVmax combined with IASLC/ATS/ERS histologic classification improves the prognostic stratification of patients with stage I lung adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2012 |
Accurate differentiation of recurrent gliomas from radiation injury by kinetic analysis of α-11C-methyl-L-tryptophan PET.
Topics: Adult; Aged; Brain Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glioma; Humans; Image Processing, Computer-Assisted; Ki-67 Antigen; Male; Middle Aged; Neoplasm Recurrence, Local; Radiation Injuries; Radionuclide Imaging; Radiopharmaceuticals; Reference Standards; Reproducibility of Results; ROC Curve; Tryptophan | 2012 |
18F-FDG PET/CT for detecting distant metastases in patients with recurrent head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2012 |
Utility of contrast-enhanced FDG-PET/CT in the clinical management of pancreatic cancer: impact on diagnosis, staging, evaluation of treatment response, and detection of recurrence.
Topics: Aged; Aged, 80 and over; Carcinoma, Pancreatic Ductal; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Linear Models; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Whole Body Imaging | 2013 |
Is [18F] fluorodeoxyglucose uptake by the primary tumor a prognostic factor in breast cancer?
Topics: Adult; Aged; Biomarkers, Tumor; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Grading; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Tumor Burden | 2013 |
Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Netherlands; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Radiosurgery; Retrospective Studies; Time Factors; Treatment Outcome | 2012 |
The use of intraoperative PET probe to resect metastatic melanoma.
Topics: Adult; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Intraoperative Period; Lymph Node Excision; Lymphatic Metastasis; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Whole Body Imaging | 2010 |
Value of fluoro-2-deoxy-D-glucose-positron emission tomography for detecting metastatic lesions in head and neck cancer.
Topics: Adenocarcinoma; Carcinoma, Adenoid Cystic; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
The additive clinical value of 18F-FDG PET/CT in defining the recurrence of disease in patients with differentiated thyroid cancer who have isolated increased antithyroglobulin antibody levels.
Topics: Autoantibodies; Cell Differentiation; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, X-Ray Computed | 2012 |
Impact of FDG-PET computed tomography for surgery of recurrent or persistent differentiated thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reoperation; Sensitivity and Specificity; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed; Young Adult | 2012 |
Recurrence of lung cancer after radiofrequency ablation detected by PET/CT and contrast enhanced CT scan.
Topics: Adenocarcinoma; Aged, 80 and over; Catheter Ablation; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiographic Image Enhancement; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Positron emission tomography/computed tomography predictors of overall survival in stage IIIC/IV ovarian cancer.
Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Cystadenocarcinoma, Serous; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed | 2012 |
Fat necrosis may mimic local recurrence of breast cancer in FDG PET/CT.
Topics: Aged; Breast; Breast Neoplasms; Diagnosis, Differential; False Positive Reactions; Fat Necrosis; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
Head-to-head comparison between SRS, (18)F-FDG and (18)F-FDOPA PET/CT in a patient with recurrent SDHC-related jugular paraganglioma.
Topics: Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Membrane Proteins; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Paraganglioma; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
18F-fluorodeoxyglucose positron emission tomography/computed tomography is useful in postoperative follow-up of asymptomatic non-small-cell lung cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Asymptomatic Diseases; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Pneumonectomy; Positron-Emission Tomography; Postoperative Care; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Survival Analysis; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Frequent relapse and irradiation strategy in primary cutaneous diffuse large B-cell lymphoma, leg-type.
Topics: Aged, 80 and over; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms | 2013 |
Effect of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography-guided management of suspected recurrent papillary thyroid carcinoma: long-term follow-up with tumour marker responses.
Topics: Adult; Aged; Autoantibodies; Biomarkers, Tumor; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed | 2012 |
Unusual isolated perineal recurrence in mucinous adenocarcinoma of the rectum after abdominoperineal resection: usefulness of dual-time-point FDG PET in evaluating mucinous tumors.
Topics: Abdomen; Adenocarcinoma, Mucinous; Adult; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Perineum; Positron-Emission Tomography; Rectal Neoplasms; Time Factors | 2012 |
Increasing the yield of recombinant thyroid-stimulating hormone-stimulated 2-(18-fluoride)-flu-2-deoxy-D-glucose positron emission tomography-CT in patients with differentiated thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Recombinant Proteins; Retrospective Studies; Sensitivity and Specificity; Thyroglobulin; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyrotropin Alfa; Tomography, X-Ray Computed; Young Adult | 2012 |
Fluorodeoxyglucose-positron emission tomography scan-positive recurrent papillary thyroid cancer and the prognosis and implications for surgical management.
Topics: Adult; Aged; Carcinoma; Carcinoma, Papillary; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Utility of 18-fluorodeoxyglucose positron emission/computed tomography in the management of recurrent colorectal cancer.
Topics: Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Histiocytic sarcoma in the bronchoalveolar lavage fluid.
Topics: Adult; Bronchoalveolar Lavage Fluid; Fluorodeoxyglucose F18; Histiocytic Sarcoma; Humans; Image-Guided Biopsy; Lung; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Radionuclide Imaging; Radiopharmaceuticals | 2013 |
Reactive tonsillar enlargement showing strong 18F-FDG uptake during the follow-up of follicular lymphoma.
Topics: Adult; Diagnostic Errors; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Hyperplasia; Lymphoma, Follicular; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tonsillar Neoplasms | 2013 |
Comparison of 18F-FDG positron emission tomography/computed tomography and computed tomography in patients with already-treated breast cancer: diagnostic and prognostic implications.
Topics: Breast Neoplasms; Breast Neoplasms, Male; Female; Fluorodeoxyglucose F18; Humans; Italy; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Prognostic value of 18-fluorodeoxyglucose positron emission tomography-computed tomography in resectable colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
Re-irradiation in recurrent malignant glioma: prognostic value of [18F]FET-PET.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Salvage Therapy; Survival Rate; Tyrosine; Young Adult | 2012 |
Impact of 18F-FDG PET/CT on target volume delineation in recurrent or residual gynaecologic carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Genital Neoplasms, Female; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm, Residual; Observer Variation; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2012 |
[Relapse of primary testicular non-Hodgkin's lymphoma detected by 18F-FDG-PET/CT].
Topics: Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Testicular Neoplasms; Tomography, X-Ray Computed | 2012 |
(18)F-FDG-PET/CT predicts early tumor recurrence in living donor liver transplantation for hepatocellular carcinoma.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Living Donors; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
Early interim FDG PET/CT prediction of treatment response and prognosis in pediatric Hodgkin disease-added value of low-dose CT.
Topics: Adolescent; Child; Child, Preschool; Disease Progression; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Radiation Dosage; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
[Value of (18)F-FDG PET/CT and CECT in detecting postoperative recurrence and extrahepatic metastasis of hepatocellular carcinoma in patients with elevated serum alpha-fetoprotein].
Topics: Adult; Aged; Aged, 80 and over; alpha-Fetoproteins; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
Circumferential resection margin involvement in stage III rectal cancer patients treated with curative resection followed by chemoradiotherapy: a surrogate marker for local recurrence?
Topics: Aged; Biomarkers; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Rectal Neoplasms; Recurrence; Surgical Procedures, Operative; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
(18) F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of recurrent bone and soft tissue sarcoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Sarcoma; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2013 |
[Esophageal cancer: outcome according to therapeutic strategy].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Dose-Response Relationship, Radiation; Esophageal Neoplasms; Esophagectomy; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Conformal; Retrospective Studies; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2013 |
Prognostic implications of serial 18-fluoro-deoxyglucose emission tomography in multiple myeloma treated with total therapy 3.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neoplasms; Clinical Trials as Topic; Fluorodeoxyglucose F18; Follow-Up Studies; Gene Expression Profiling; Humans; Magnetic Resonance Imaging; Multiple Myeloma; Multivariate Analysis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate | 2013 |
Radiation field design and patterns of locoregional recurrence following definitive radiotherapy for breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Proteins; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Tomography, X-Ray Computed | 2013 |
[Primary malignant melanoma of the vagina].
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Melanoma; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Vaginal Neoplasms | 2013 |
The value of 18F-FDG PET/CT in recurrent gynecologic malignancies prior to pelvic exenteration.
Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Pelvic Exenteration; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed | 2013 |
Food residue granuloma mimicking metastatic disease on FDG-PET/CT.
Topics: Adult; Colonic Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Food; Granuloma, Foreign-Body; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
FDG-PET improves the staging and selection of patients with recurrent colorectal cancer.
Topics: Colorectal Neoplasms; Endoscopy; False Negative Reactions; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Selection; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole-Body Counting | 2002 |
Fluorodeoxyglucose positron emission tomography and somatostatin receptor scintigraphy for diagnosing and staging carcinoid tumours: correlations with the pathological indexes p53 and Ki-67.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoid Tumor; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Octreotide; Pentetic Acid; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Single-Blind Method; Statistics as Topic; Tumor Suppressor Protein p53 | 2002 |
[Role of positron emission tomography in detecting recurrent epithelial ovarian carcinoma].
Topics: CA-125 Antigen; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Usefulness of FDG PET for assessment of early recurrent epithelial ovarian cancer.
Topics: Adolescent; Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
PET scan detects recurrent breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
Cost-effectiveness of dual-head 18F-fluorodeoxyglucose PET for the detection of recurrent laryngeal cancer.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Cost-Benefit Analysis; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Squamous Cell; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
[The value of F-18 fluorodeoxyglucose in positron emission tomography diagnosis of breast carcinoma].
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
[F-18 fluorodeoxyglucose positron emission tomography in colorectal carcinoma].
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome | 2002 |
FDG positron emission tomography for the detection of ovarian cancer.
Topics: Blue Cross Blue Shield Insurance Plans; Drug Approval; Female; Flow Cytometry; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Insurance Coverage; Neoplasm Recurrence, Local; Outcome Assessment, Health Care; Ovarian Neoplasms; Radiopharmaceuticals; Technology Assessment, Biomedical; Tomography, Emission-Computed; United States | 2002 |
Pelvic kidney mimicking recurrent colon cancer on FDG positron emission tomographic imaging.
Topics: Aged; Colonic Neoplasms; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Kidney; Neoplasm Recurrence, Local; Radiography; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
Recurrent lymphoma detected on F-18 FDG coincidence imaging with negative findings on Ga-67 citrate scintigraphy.
Topics: Adult; Citrates; False Negative Reactions; Fluorodeoxyglucose F18; Gallium; Hodgkin Disease; Humans; Lymph Nodes; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Radiography; Radionuclide Imaging; Radiopharmaceuticals | 2002 |
Fluorine-18 FDG-PET in detecting local recurrence and distant metastases in breast cancer--Taiwanese experiences.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
[F-18 FDG positron emission tomography in diagnosis and follow-up of patients with musculoskeletal tumors].
Topics: Adolescent; Adult; Aged; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Postoperative Complications; Radiotherapy, Adjuvant; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2002 |
Clinical impact of [(18)F]FDG-PET in patients with suspected recurrent breast cancer based on asymptomatically elevated tumor marker serum levels: a preliminary report.
Topics: Adult; Aged; Biomarkers, Tumor; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Tomography, Emission-Computed | 2002 |
Imaging of cutaneous recurrence of gastric cancer with F-18 FDG positron emission tomography.
Topics: Abdomen; Back; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Radiopharmaceuticals; Skin Neoplasms; Stomach Neoplasms; Tomography, Emission-Computed | 2002 |
Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Value of FDG positron emission tomography in conjunction with MR imaging for evaluating therapy response in patients with musculoskeletal sarcomas.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Radiopharmaceuticals; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2002 |
Re: Clinical role of f-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma.
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Neoplasm Recurrence, Local; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Efficacy of fluorine-18-deoxyglucose positron emission tomography in detecting tumor recurrence after local ablative therapy for liver metastases: a prospective study.
Topics: Aged; Carcinoembryonic Antigen; Catheter Ablation; Cryosurgery; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 2002 |
PET-CT localizes previously undetectable metastatic lesions in recurrent fallopian tube carcinoma.
Topics: Aged; Fallopian Tube Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
[Relevance of colour-duplex echography for detection and therapy of recurrences in the follow-up of head and neck cancer].
Topics: Adenocarcinoma; Carcinoma, Adenoid Cystic; Carcinoma, Squamous Cell; Combined Modality Therapy; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Leiomyosarcoma; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Otorhinolaryngologic Neoplasms; Sensitivity and Specificity; Survival Rate; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography, Doppler, Color | 2002 |
Early detection of relapse by whole-body positron emission tomography in the follow-up of patients with Hodgkin's disease.
Topics: Adolescent; Adult; Aged; False Negative Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; L-Lactate Dehydrogenase; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Prospective Studies; Radiopharmaceuticals; Thymus Gland; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Whole-body PET with FDG is useful for following up an ovarian cancer patient with only rising CA-125 levels within the normal range.
Topics: CA-125 Antigen; Cystadenocarcinoma, Serous; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed; Whole-Body Counting | 2002 |
Where can FDG-PET contribute most to anatomical imaging problems?
Topics: Brain Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
[The (11C) acetate positron emission tomography in prostatic carcinoma. New prospects in metabolic imaging].
Topics: Acetates; Adenocarcinoma; Amino Acids; Biopsy; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prostate; Prostatic Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Performance evaluation of principal component analysis in dynamic FDG-PET studies of recurrent colorectal cancer.
Topics: Colorectal Neoplasms; Data Interpretation, Statistical; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Neoplasm Recurrence, Local; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
[Clinical value of 18F-fluoro-2-deoxy-D-glucose positron emission tomography in detecting recurrent nasopharyngeal carcinoma at the parapharyngeal space after radiotherapy].
Topics: Adult; Aged; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Assessment of clinical utility of 18F-FDG PET in patients with head and neck cancer: a probability analysis.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Models, Biological; Models, Statistical; Neoplasm Recurrence, Local; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Switzerland; Tomography, Emission-Computed | 2003 |
FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Carcinoma, Transitional Cell; Catheter Ablation; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Insulinoma; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Pancreatic Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sarcoma; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome; Whole-Body Counting | 2003 |
FDG uptake by tongue and muscles of mastication reflecting increased metabolic activity of muscles after chewing gum.
Topics: Chewing Gum; Energy Metabolism; Exercise; Fluorodeoxyglucose F18; Humans; Male; Mastication; Masticatory Muscles; Middle Aged; Neoplasm Recurrence, Local; Parotid Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed; Tongue | 2003 |
Combined positron emission tomography/computed tomography imaging of recurrent thyroid cancer.
Topics: Adult; Aged; Calcitonin; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Posttherapy surveillance monitoring of cervical cancer by FDG-PET.
Topics: Adenocarcinoma; Carcinoma; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Multivariate Analysis; Neoplasm Recurrence, Local; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2003 |
Ventral hernia resulting in increased fluorodeoxyglucose uptake on positron emission tomographic imaging.
Topics: Cecal Neoplasms; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Hernia, Ventral; Humans; Middle Aged; Neoplasm Recurrence, Local; Radiography; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
Positron emission tomographic imaging of Merkel cell carcinoma.
Topics: Aged; Carcinoma, Merkel Cell; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Radiography; Radiopharmaceuticals; Scalp; Skin Neoplasms; Tomography, Emission-Computed | 2002 |
Detection of early recurrence with 18F-FDG PET in patients with cervical cancer.
Topics: Adult; Aged; Carcinoma; Carcinoma, Squamous Cell; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2003 |
Evaluation of recurrent gastric malignancy with [F-18]-FDG positron emission tomography.
Topics: Adenocarcinoma; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Leiomyosarcoma; Male; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
The role of [18F]fluorodeoxyglucose positron emission tomography imaging in the evaluation of hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Biopsy; Carcinoma, Hepatocellular; Decision Trees; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
An FDG positron emission tomographic study in a case of gastrointestinal stromal tumor.
Topics: Appendiceal Neoplasms; Benzamides; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Jejunal Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Piperazines; Pyrimidines; Radionuclide Imaging; Radiopharmaceuticals; Treatment Outcome | 2003 |
Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM: relationship to therapeutic response-a preliminary report.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cell Hypoxia; Combined Modality Therapy; Coordination Complexes; Copper Radioisotopes; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Life Tables; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Organometallic Compounds; Prospective Studies; Radiation Tolerance; Radiopharmaceuticals; Survival Rate; Thiosemicarbazones; Tomography, Emission-Computed; Treatment Outcome; Uterine Cervical Neoplasms | 2003 |
Retinoic acid for redifferentiation of thyroid cancer--does it hold its promise?
Topics: Adenocarcinoma, Follicular; Adult; Aged; Aged, 80 and over; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Isotretinoin; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Retrospective Studies; Thyroid Neoplasms; Tomography, Emission-Computed; Treatment Outcome | 2003 |
F-18-FDG-PET in a patient with Hashimoto's thyroiditis and MALT lymphoma recurrence of the thyroid.
Topics: Aged; Aged, 80 and over; Combined Modality Therapy; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Thyroid Gland; Thyroid Neoplasms; Thyroid Nodule; Thyroidectomy; Thyroiditis, Autoimmune; Tomography, Emission-Computed | 2003 |
[18F]-Fluorodeoxyglucose positron emission tomography in patients with suspected recurrence of breast cancer.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Mucin-1; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Evaluation of 18F-FDG PET in patients with advanced, metastatic, or recurrent gastric cancer.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Sensitivity and Specificity; Stomach Neoplasms; Tomography, Emission-Computed | 2003 |
F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging.
Topics: Biomarkers, Tumor; Breast Neoplasms; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
18F-FDG imaging of malignant pleural mesothelioma: scientiam impendere vero...
Topics: Castleman Disease; Fluorodeoxyglucose F18; Humans; Mesothelioma; Neoplasm Recurrence, Local; Neoplasm Staging; Pleural Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
The role of PET scanning in the detection of recurrent cervical cancer.
Topics: Adult; Aged; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2003 |
A case-controlled study of 18-fluorodeoxyglucose positron emission tomography in the detection of pelvic recurrence in previously irradiated rectal cancer patients.
Topics: Case-Control Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Pelvic Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Rectal Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome | 2003 |
Follow-up of women with breast cancer: comparison between MRI and FDG PET.
Topics: Breast Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Clinical value of FDG-PET in the follow up of post-operative patients with endometrial cancer.
Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Postoperative Care; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome | 2003 |
18-fluoro-2-deoxyglucose positron emission tomography in detecting residual/recurrent nasopharyngeal carcinomas and comparison with magnetic resonance imaging.
Topics: Adolescent; Adult; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm, Residual; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
The usefulness of a repeat study for differentiating between bowel activity and local tumor recurrence on FDG PET scans.
Topics: Colon; Diagnosis, Differential; Enema; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Quality Control; Rectal Neoplasms; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Prognostic value of PET using 18F-FDG in Hodgkin's disease for posttreatment evaluation.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Prognosis; Radiography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome | 2003 |
FGD-PET in the follow-up of recurrent colorectal cancer.
Topics: Adult; Aged; Colorectal Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome | 2003 |
Staging of head and neck tumors: [18F]fluorodeoxyglucose positron emission tomography compared with physical examination and conventional imaging modalities.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
F-18 FDG positron emission tomographic imaging in a case of ruptured breast implant: inflammation or recurrent tumor?
Topics: Breast Implants; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Prosthesis Failure; Radionuclide Imaging; Radiopharmaceuticals | 2003 |
Occult supraclavicular lymph node metastasis identified by FDG-PET in patients with carcinoma of the uterine cervix.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed; Uterine Neoplasms | 2003 |
Roles of positron emission tomography with fluorine-18-deoxyglucose in the detection of local recurrent and distant metastatic sarcoma.
Topics: Adolescent; Adult; Aged; Child; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sarcoma; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 2003 |
Is [18F]-2-fluoro-2-deoxy-d-glucose (FDG) scintigraphy with non-dedicated positron emission tomography useful in the diagnostic management of suspected metastatic thyroid carcinoma in patients with no detectable radioiodine uptake?
Topics: Adenocarcinoma, Follicular; Adenoma, Oxyphilic; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prospective Studies; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Tomography, Emission-Computed | 2003 |
PET imaging of Rosai-Dorfman disease: correlation with histopathology and ex-vivo beta-imaging.
Topics: Aged; Beta Particles; Diagnosis, Differential; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Histiocytosis, Sinus; Humans; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
F-18 fluorodeoxyglucose positron emission tomography in the evaluation of distant metastases from renal cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
[A case of local recurrence of rectal cancer in which trans-sacral resection and perineal reconstruction by femoral posterior flap were performed].
Topics: Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Perineum; Plastic Surgery Procedures; Radiopharmaceuticals; Rectal Neoplasms; Surgical Flaps; Tomography, Emission-Computed; Tomography, X-Ray Computed; Vagina | 2003 |
[A case of curative resection of local recurrence after abdominosacral resection of recurrent rectal cancer based on the diagnosis of PET/CT fusion images].
Topics: Aged; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Radiopharmaceuticals; Rectal Neoplasms; Rectum; Sacrococcygeal Region; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
FDG-PET scanning after radiation can predict tumor regrowth three months later.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
Metabolic significance of the pattern, intensity and kinetics of 18F-FDG uptake in malignant pleural mesothelioma.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Male; Mesothelioma; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pilot Projects; Pleural Neoplasms; Radionuclide Imaging; Radiopharmaceuticals | 2003 |
Surveillance of basaloid oral squamous cell carcinoma: the value of [18F]FDG-PET.
Topics: Adult; Aged; Carcinoma, Basosquamous; Carcinoma, Squamous Cell; Disease-Free Survival; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
Splenic infarction mimicking gastric remnant on PET imaging.
Topics: Adenocarcinoma; Aged; Diagnosis, Differential; Diagnostic Errors; Fluorodeoxyglucose F18; Gastrectomy; Humans; Neoplasm Recurrence, Local; Radiopharmaceuticals; Splenic Infarction; Stomach Neoplasms; Tomography, Emission-Computed | 2004 |
The clinical impact of camera-based positron emission tomography imaging in patients with recurrent colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
[[18F]-FDG imaging in apparently isolated pleural lesions].
Topics: Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Mesothelioma; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pleural Neoplasms; Radionuclide Imaging; Radiopharmaceuticals | 2003 |
[Early prediction of treatment response to high-dose chemotherapy in patients with relapsed germ cell tumors using [18F]FDG-PET, CT or MRI, and tumor marker].
Topics: Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chorionic Gonadotropin, beta Subunit, Human; Fluorodeoxyglucose F18; Follow-Up Studies; Germany; Germinoma; Humans; Karnofsky Performance Status; Logistic Models; Magnetic Resonance Imaging; Male; Middle Aged; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Patient Selection; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Seminoma; Sensitivity and Specificity; Testicular Neoplasms; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
[18FDG PET in the management of malignant lymphoma].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed | 2003 |
FDG-PET for evaluation of recurrent lymph node metastases in patients with surgically resected breast cancer: adding spot images to whole body images.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Mastectomy; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
Value of FDG PET imaging in the management of patients with thyroid, neuroendocrine, and neural crest tumors.
Topics: Fluorodeoxyglucose F18; Neoplasm Recurrence, Local; Nervous System Neoplasms; Neural Crest; Neuroendocrine Tumors; Patient Care Management; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed | 2004 |
Restaging of recurrent cervical carcinoma with dual-phase [18F]fluoro-2-deoxy-D-glucose positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Needle; Confidence Intervals; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Probability; Prospective Studies; Risk Assessment; Salvage Therapy; Sensitivity and Specificity; Survival Analysis; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome; Uterine Cervical Neoplasms | 2004 |
Combined positron emission tomography - computed tomography improves specificity for thyroid carcinoma by identifying vocal cord activity after laryngeal nerve paralysis.
Topics: Carcinoma, Papillary; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Middle Aged; Neck; Neoplasm Recurrence, Local; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed; Vocal Cord Paralysis; Vocal Cords | 2003 |
False-positive positron emission tomographic scan and computed tomography for recurrent vaginal cancer: pitfalls of modern imaging techniques.
Topics: Adult; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Radiopharmaceuticals; Tomography, Emission-Computed; Vaginal Neoplasms | 2004 |
18F-FLT PET for visualization of laryngeal cancer: comparison with 18F-FDG PET.
Topics: Aged; Biopsy; Carcinoma, Squamous Cell; Dideoxynucleosides; Feasibility Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Larynx; Male; Neoplasm Recurrence, Local; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
Preoperative evaluation of prognosis in breast cancer patients by [(18)F]2-Deoxy-2-fluoro-D-glucose-positron emission tomography.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Predictive Value of Tests; Preoperative Care; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
Assessment of recurrent colorectal cancer following 5-fluorouracil chemotherapy using both 18FDG and 18FLT PET.
Topics: Antineoplastic Agents; Colorectal Neoplasms; Dideoxynucleosides; Fluorodeoxyglucose F18; Fluorouracil; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome | 2004 |
Lymph node false-positive FDG-PET after recent surgery in primary melanoma.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Sensitivity and Specificity; Skin Neoplasms; Tomography, Emission-Computed | 2004 |
FDG positron emission tomography for evaluating breast cancer.
Topics: Blue Cross Blue Shield Insurance Plans; Breast Neoplasms; Device Approval; Female; Fluorodeoxyglucose F18; Humans; Insurance Coverage; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Outcome Assessment, Health Care; Technology Assessment, Biomedical; Tomography, Emission-Computed; United States; United States Food and Drug Administration | 2003 |
Recurrent hepatoblastoma in orthotopic transplanted liver: detection with FDG positron emission tomography.
Topics: Child, Preschool; Contrast Media; Fluorodeoxyglucose F18; Hepatoblastoma; Humans; Liver Neoplasms; Liver Transplantation; Male; Neoplasm Recurrence, Local; Tomography, Emission-Computed | 2004 |
Relapse after more than 20 years of follow-up for epithelial ovarian carcinoma.
Topics: Abdominal Pain; Adult; Appendicitis; Axilla; Cystadenocarcinoma, Serous; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Radiopharmaceuticals; Time Factors | 2004 |
Demonstration of increased FDG activity in Rosai-Dorfman disease on positron emission tomography.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Histiocytosis, Sinus; Humans; Incidental Findings; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
Posttherapy [18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome.
Topics: Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Risk; Survival Analysis; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2004 |
Retroperitoneal malignant peripheral nerve sheath tumor: evaluation with serial FDG-PET.
Topics: Adolescent; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Neoplasm Recurrence, Local; Nerve Sheath Neoplasms; Neurofibromatosis 1; Peripheral Nervous System Neoplasms; Radiopharmaceuticals; Retroperitoneal Neoplasms; S100 Proteins; Tomography, Emission-Computed | 2004 |
Staging in patients with locoregionally recurrent breast cancer: current practice and prospects for positron emission tomography.
Topics: Adult; Aged; Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Surveys and Questionnaires; Tomography, Emission-Computed | 2004 |
18F-FDG PET for detecting recurrent head and neck cancer, local lymph node involvement and distant metastases. Comparison of qualitative visual and semiquantitative analysis.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Software; Tissue Distribution; Treatment Outcome | 2004 |
Detection of recurrent cervical cancer by whole-body FDG PET scan in asymptomatic and symptomatic women.
Topics: Adult; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Uterine Cervical Neoplasms; Whole-Body Counting | 2004 |
Impact of FDG PET on defining the extent of disease and on the treatment of patients with recurrent or metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
Antibody-positive paraneoplastic neurologic syndromes: value of CT and PET for tumor diagnosis.
Topics: Adenocarcinoma; Adult; Aged; Antibody Specificity; Autoantibodies; Autoimmune Diseases of the Nervous System; Carcinoma; Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Neuroblastoma; Neurons; Ovarian Neoplasms; Paraneoplastic Polyneuropathy; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Spiral Computed | 2004 |
Value of positron emission tomography in the diagnosis of recurrent oesophageal carcinoma.
Topics: Adult; Aged; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
PET tracers for osteosarcoma.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Osteosarcoma; Radioisotopes; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value.
Topics: Adolescent; Adult; Aged; Belgium; Brain Neoplasms; Child; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Methionine; Middle Aged; Neoplasm Recurrence, Local; Observer Variation; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Analysis | 2005 |
Meningioma metastatic to the lung detected by FDG positron emission tomography.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Meningioma; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Skull Neoplasms; Solitary Pulmonary Nodule | 2004 |
Time benefit in the assessment of recurrences following fractionated radiotherapy in an experimental tumour system using positron-emission tomography with 18F-fluorodeoxyglucose.
Topics: Animals; Dose Fractionation, Radiation; Fluorodeoxyglucose F18; Neoplasm Recurrence, Local; Rats; Rhabdomyosarcoma; ROC Curve; Sarcoma, Experimental; Tomography, Emission-Computed | 2004 |
[Fluorodeoxiglucose F18 positron emission tomography imaging (F18FDG) for the assessment of rising levels of serum CA 19-9 in pancreatic mucinous cystadenocarcinoma. Report of one case].
Topics: Adult; CA-19-9 Antigen; Cystadenocarcinoma, Mucinous; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2004 |
PET/CT using 18F-FDG in suspected lung cancer recurrence: diagnostic value and impact on patient management.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Treatment Outcome | 2004 |
[18F]fluorodeoxyglucose uptake in recurrent thyroid cancer is related to hexokinase i expression in the primary tumor.
Topics: Adult; Aged; Animals; Female; Fluorodeoxyglucose F18; Hexokinase; Humans; Immunohistochemistry; Male; Mice; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Swine; Thyroid Neoplasms | 2005 |
[PET/CT imaging in head and neck tumors].
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Otorhinolaryngologic Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2004 |
[PET/CT for colorectal and hepatic tumors].
Topics: Adult; Aged; Colon; Colorectal Neoplasms; Disease Progression; Equipment Design; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Processing, Computer-Assisted; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Rectum; Sensitivity and Specificity; Tomography, X-Ray Computed | 2004 |
[PET/CT in lymphoma patients].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Artifacts; Child; Child, Preschool; Equipment Design; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Image Enhancement; Image Processing, Computer-Assisted; Lymphoma; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2004 |
18F-FDG PET for evaluation of the treatment response in patients with gastrointestinal tract lymphomas.
Topics: Adult; Aged; Antineoplastic Agents; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Lymphoma; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome | 2004 |
Uptake of 18F-fluorocholine, 18F-fluoroethyl-L-tyrosine, and 18F-FDG in acute cerebral radiation injury in the rat: implications for separation of radiation necrosis from tumor recurrence.
Topics: Acute Disease; Animals; Brain; Brain Injuries; Brain Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Male; Necrosis; Neoplasm Recurrence, Local; Quaternary Ammonium Compounds; Radiation Injuries, Experimental; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Tyrosine | 2004 |
[Application of 18F-FDG PET/CT scan in following-up of nasopharyngeal carcinoma after radiotherapy].
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2004 |
Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver?
Topics: Colorectal Neoplasms; Contrast Media; Databases, Factual; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Triiodobenzoic Acids | 2004 |
Is 18F-FDG PET/CT useful for imaging and management of patients with suspected occult recurrence of cancer?
Topics: Adult; Aged; Biomarkers; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms; Positron-Emission Tomography; Tomography, Emission-Computed | 2004 |
Laparoscopic resection of occult metastasis using the combination of FDG-positron emission tomography/computed tomography image fusion with intraoperative probe guidance in a woman with recurrent ovarian cancer.
Topics: Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Laparoscopy; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2005 |
Value of FDG PET in assessment of treatment response and surveillance in head-and-neck cancer patients after intensity modulated radiation treatment: a preliminary report.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Conformal; Retrospective Studies; Salvage Therapy | 2004 |
PET imaging for suspected residual tumour or thoracic recurrence of non-small cell lung cancer after pneumonectomy.
Topics: Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Databases, Factual; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Palliative Care; Pneumonectomy; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals | 2005 |
Positron emission tomography in cancer of the head and neck.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity | 2005 |
PET imaging with F-18 fluorodeoxyglucose for primary lymphoma of bone.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prednisone; Prognosis; Radiopharmaceuticals; Treatment Outcome; Vincristine | 2005 |
Results of radio frequency ablation of primary and secondary liver tumors: long-term follow-up with computed tomography and positron emission tomography-18F-deoxyfluoroglucose scanning.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiofrequency Therapy; Radiopharmaceuticals; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2004 |
Positron emission tomography (PET) in the management of oro-pharyngeal cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; False Negative Reactions; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
Modern multimodal neuroimaging for radiosurgery: the example of PET scan integration.
Topics: Adenoma; Brain; Brain Neoplasms; Contrast Media; Energy Metabolism; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Image Enhancement; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neuronavigation; Phantoms, Imaging; Pituitary Neoplasms; Positron-Emission Tomography; Quality Control; Radiosurgery; Sensitivity and Specificity; Tomography, X-Ray Computed | 2004 |
Gamma knife radiosurgery for patients with multiple cerebral metastases.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neuronavigation; Positron-Emission Tomography; Radiosurgery; Retrospective Studies; Survival Analysis | 2004 |
[The therapeutic impact of (18)F-FDG whole body PET. A radiooncologist's view].
Topics: Biopsy; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Whole-Body Irradiation | 2005 |
[18F]fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Retrospective Studies; Survival Rate | 2005 |
Tl-201 SPECT and F-18 FDG PET for assessment of glioma recurrence versus radiation necrosis.
Topics: Brain; Brain Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Glioblastoma; Humans; Male; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiation Injuries; Radiopharmaceuticals; Radiotherapy; Thallium | 2005 |
(18)F-fluorodeoxyglucose positron emission tomography detection of eccrine porocarcinoma.
Topics: Acrospiroma; Aged; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Sweat Gland Neoplasms; Thigh; Tomography, Emission-Computed | 2005 |
Feasibility study of the use of similarity maps in the evaluation of oncological dynamic positron emission tomography images.
Topics: Colorectal Neoplasms; Feasibility Studies; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Neoplasm Recurrence, Local; Neoplasms; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
FDG-PET for management of cervical and ovarian cancer.
Topics: CA-125 Antigen; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Uterine Cervical Neoplasms | 2005 |
Positron-emission tomography for surveillance of head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Radiotherapy, Adjuvant; Retrospective Studies; Sensitivity and Specificity; Time Factors; Treatment Outcome | 2005 |
Comparison between 18F-FDG PET, in-line PET/CT, and software fusion for restaging of recurrent colorectal cancer.
Topics: Algorithms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Software; Subtraction Technique; Tomography, X-Ray Computed | 2005 |
FDG uptake in a catheter-related thrombus simulating relapse of lymphoma.
Topics: Adolescent; Catheterization; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Venous Thrombosis | 2005 |
Positron emission tomography in recurrent hepatoblastoma.
Topics: Child; Female; Fluorodeoxyglucose F18; Hepatoblastoma; Humans; Infant; Liver Neoplasms; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2005 |
Head and neck malignancy: is PET/CT more accurate than PET or CT alone?
Topics: Adult; Aged; Aged, 80 and over; Artifacts; Blood Glucose; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Sensitivity and Specificity | 2005 |
Whole-body 18F-FDG PET in recurrent or metastatic nasopharyngeal carcinoma.
Topics: Adolescent; Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Treatment Outcome; Whole-Body Counting | 2005 |
Fusion image of positron emission tomography and computed tomography for the diagnosis of local recurrence of rectal cancer.
Topics: Adenocarcinoma; Adult; Aged; Colectomy; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Tomography, X-Ray Computed | 2005 |
Incidental detection of rounded atelectasis during tc-99m MIBI scintimammography.
Topics: Adult; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Neoplasm Recurrence, Local; Pulmonary Atelectasis; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2005 |
Initial experience in use of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in thyroid carcinoma patients with elevated serum thyroglobulin but negative iodine-131 whole body scans.
Topics: Adenoma, Oxyphilic; Adult; Aged; Aged, 80 and over; Carcinoma, Papillary; Carcinoma, Papillary, Follicular; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms | 2005 |
Correlation between serum CEA level and metabolic volume as determined by FDG PET in postoperative patients with recurrent colorectal cancer.
Topics: Biomarkers, Tumor; Carcinoembryonic Antigen; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Severity of Illness Index; Statistics as Topic; Tissue Distribution | 2005 |
The role of gastric distention in differentiating recurrent tumor from physiologic uptake in the remnant stomach on 18F-FDG PET.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Diagnosis, Differential; False Positive Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gastrectomy; Gastric Stump; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Whole-Body Counting | 2005 |
Utility of 2-fluoro-2-deoxy-D-glucose positron emission tomography in managing patients of colorectal cancer with unexplained carcinoembryonic antigen elevation at different levels.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reference Values; Retrospective Studies | 2005 |
Combined FDG-positron emission tomography and computed tomography for the detection of ovarian cancer recurrence in an inguinal hernia sac.
Topics: Female; Fluorodeoxyglucose F18; Hernia, Inguinal; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2005 |
Conventional gamma and high energy probe for radioguided dissection of metastases in a patient with recurrent thyroid carcinoma with (99m)Tc-MIBI and (18)F-FDG.
Topics: Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lung Neoplasms; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals; Radiosurgery; Technetium Tc 99m Sestamibi; Thyroid Neoplasms; Thyroidectomy; Treatment Outcome; Ultrasonography | 2005 |
2-[18F]fluoro-2-deoxyglucose positron emission tomography for the detection of disease in patients with prostate-specific antigen relapse after radical prostatectomy.
Topics: Aged; Bone Neoplasms; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Retrospective Studies; Sensitivity and Specificity | 2005 |
Extraordinarily high F-18 FDG uptake caused by radiation necrosis in a patient with nasopharyngeal carcinoma.
Topics: Carcinoma; Diagnosis, Differential; False Positive Reactions; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Nasopharynx; Necrosis; Neoplasm Recurrence, Local; Radiation Injuries; Radionuclide Imaging; Radiopharmaceuticals | 2005 |
MIBG and FDG PET findings in a patient with malignant pheochromocytoma: a significant discrepancy.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Care Planning; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
Solitary splenic metastasis in a patient with a malignant melanoma diagnosed with F-18-FDG PET scanning.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Melanoma; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Scapula; Splenic Neoplasms; Tomography, X-Ray Computed; Whole-Body Counting | 2005 |
The role of gamma-PET in the evaluation of patients with recurrent squamous cell cancer of the head and neck.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Gamma Cameras; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2005 |
FDG-PET in head and neck, and thyroid cancer.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Thyroid Neoplasms | 2005 |
False-positive fluorine-18 fluorodeoxy-D-glucose positron emission tomography imaging caused by retained gauze in a woman with recurrent ovarian cancer: a case report.
Topics: Adenocarcinoma, Papillary; False Positive Reactions; Female; Fluorodeoxyglucose F18; Foreign-Body Reaction; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Surgical Procedures, Operative; Surgical Sponges | 2005 |
18F-FDG PET in the management of endometrial cancer.
Topics: Adult; Aged; Aged, 80 and over; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Whole Body Imaging | 2006 |
Recurrent hepatoblastoma with localization by PET-CT.
Topics: alpha-Fetoproteins; Biomarkers, Tumor; Child, Preschool; Contrast Media; Fluorodeoxyglucose F18; Hepatoblastoma; Humans; Image Enhancement; Liver Neoplasms; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2005 |
Value of fluorodeoxyglucose positron emission tomography in women with breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2005 |
FDG-PET in the detection of recurrence of uterine cervical carcinoma following radiation therapy--tumor volume and FDG uptake value.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2006 |
The role of hybrid PET/CT in the evaluation of patients with cervical cancer.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography; Uterine Cervical Neoplasms; Whole Body Imaging | 2006 |
[18F]Fluorodeoxyglucose positron emission tomography predicts outcome for Ewing sarcoma family of tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Disease-Free Survival; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiotherapy, Adjuvant; Reproducibility of Results; Sarcoma, Ewing; Sensitivity and Specificity; Surgical Procedures, Operative; Treatment Outcome | 2005 |
The role of a positron- and high-energy gamma photon probe in intraoperative localization of recurrent melanoma.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Intraoperative Care; Male; Melanoma; Neoplasm Recurrence, Local; Photons; Pilot Projects; Positron-Emission Tomography; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Surgery, Computer-Assisted; Treatment Outcome | 2005 |
In-line (18)F-fluorodeoxyglucose positron emission tomography with computed tomography (PET/CT) in patients with carcinoma of the sinus/nasal area and orbit.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Neoplasms, Second Primary; Nose Neoplasms; Orbital Neoplasms; Paranasal Sinus Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, Spiral Computed; Whole Body Imaging | 2006 |
Recurrence of lymphoma presenting as asymmetrically increased testicular activity on FDG-PET/CT.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Testicular Neoplasms; Tomography, X-Ray Computed | 2006 |
[Value of 18F-fluorodeoxyglucose positron emission tomography in three-dimensional conformal radiotherapy for locally persistent or recurrent nasopharyngeal carcinoma].
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal | 2005 |
Malignant lesions can mimic gastric uptake on FDG PET.
Topics: Adult; Diagnosis, Differential; Esophageal Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Gastric Mucosa; Humans; Melanoma; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Stomach; Stomach Neoplasms | 2006 |
Medical Image. Combined FDG-PET/CT and CT-guided biopsy in diagnosing oesophageal cancer recurrence.
Topics: Aged; Biopsy, Fine-Needle; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
Intense 18-fluorodeoxyglucose uptake by the thymus on PET scan does not necessarily herald recurrence of thyroid carcinoma.
Topics: Adult; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Neoplasm Recurrence, Local; Radiopharmaceuticals; Thymus Gland; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Thyrotropin; Thyroxine; Tomography, Emission-Computed | 2005 |
FDG-PET on irradiated brain tumor: ten years' summary.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain; Brain Neoplasms; Carcinoma; Child; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Survival Analysis | 2006 |
Whole-body MRI and PET-CT in the management of cancer patients.
Topics: Early Diagnosis; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Processing, Computer-Assisted; Lymphatic Metastasis; Magnetic Resonance Imaging; Mass Screening; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Radiation Dosage; Radiopharmaceuticals; Tomography, Spiral Computed; Tomography, X-Ray Computed; Treatment Outcome; Whole Body Imaging | 2006 |
[The integrated PET/CT: technological advance in diagnostics of head and neck recurrencies and CUP?].
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Palpation; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed | 2006 |
An audit of fusion CT-PET in the management of colorectal liver metastases.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hepatectomy; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Medical Audit; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
Thyroid-stimulating hormone-stimulated fused positron emission tomography/computed tomography in the evaluation of recurrence in 131I-negative papillary thyroid carcinoma.
Topics: Adult; Carcinoma, Papillary; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Thyroglobulin; Thyroid Neoplasms; Thyrotropin; Tomography, Emission-Computed | 2006 |
Clinical impact of FDG-PET imaging in post-therapy surveillance of uterine cervical cancer: from diagnosis to prognosis.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Palliative Care; Pelvic Exenteration; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Salvage Therapy; Sensitivity and Specificity; Uterine Cervical Neoplasms | 2006 |
Integrated PET/CT in differentiated thyroid cancer: diagnostic accuracy and impact on patient management.
Topics: Adenocarcinoma, Follicular; Adenocarcinoma, Papillary; Adenoma, Oxyphilic; Adult; Aged; Disease Management; Drug Resistance; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Iodine Radioisotopes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Thyroglobulin; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2006 |
Diagnosis of aseptic deep venous thrombosis of the upper extremity in a cancer patient using fluorine-18 fluorodeoxyglucose positron emission tomography/computerized tomography (FDG PET/CT).
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sepsis; Tomography, X-Ray Computed; Upper Extremity; Venous Thrombosis | 2006 |
Modification of glucose metabolism in brain tumors by using cervical spinal cord stimulation.
Topics: Adult; Aged; Blood Glucose; Brain Neoplasms; Cerebral Cortex; Electric Stimulation Therapy; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Oxygen Consumption; Positron-Emission Tomography; Regional Blood Flow; Spinal Cord | 2006 |
Use of [18F]fluorodeoxyglucose positron emission tomography in evaluating locally recurrent and metastatic adrenocortical carcinoma.
Topics: Adrenal Cortex Neoplasms; Adult; Aged; Child; Child, Preschool; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography | 2006 |
The role of whole-body fluorine-18-FDG positron emission tomography in the detection of recurrence in symptomatic patients with stages II and III breast cancer.
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2006 |
Asymptomatic familial colon cancer with FDG-PET scanning for recurrent disease.
Topics: Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis | 2005 |
Use of 2-deoxy-2-[F-18]-fluoro-D-glucose positron emission tomography to monitor therapeutic response by rhabdomyosarcoma in children: report of a retrospective case study.
Topics: Child; Child, Preschool; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Jaw Neoplasms; Lung Neoplasms; Male; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Paranasal Sinus Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Retrospective Studies; Rhabdomyosarcoma; Skull Neoplasms | 2006 |
18F-fluorodeoxyglucose positron emission tomography in patients with recurrent ovarian cancer: in comparison with vascularity, Ki-67, p53, and histologic grade.
Topics: Adult; Aged; Analysis of Variance; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Immunohistochemistry; Ki-67 Antigen; Logistic Models; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Research Design; Retrospective Studies; Tumor Suppressor Protein p53 | 2007 |
Level of fluorodeoxyglucose uptake predicts risk for recurrence in melanoma patients presenting with lymph node metastases.
Topics: Adult; Aged; Aged, 80 and over; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Skin Neoplasms; Survival Rate | 2006 |
Risk assessment in liposarcoma patients based on FDG PET imaging.
Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Incidence; Liposarcoma; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Risk Assessment; Risk Factors; Washington | 2006 |
Early change in glucose metabolic rate measured using FDG-PET in patients with high-grade glioma predicts response to temozolomide but not temozolomide plus radiotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Alkylating; Brain; Brain Neoplasms; Combined Modality Therapy; Dacarbazine; Drug Administration Schedule; Female; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Temozolomide; Treatment Outcome | 2006 |
Positron emission tomography with 18F-fluoro-2-deoxyglucose for the detection of recurrent ovarian cancer.
Topics: Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
F-18 FDG PET imaging in a primitive neuroectodermal tumor.
Topics: Abdominal Neoplasms; Adult; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neuroectodermal Tumors, Primitive; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
18F-FDG-PET for evaluation of the response to concurrent chemoradiation therapy with intensity-modulated radiation technique for Stage T4 nasopharyngeal carcinoma.
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Statistics, Nonparametric | 2006 |
PET-Probe: Evaluation of Technical Performance and Clinical Utility of a Handheld High-Energy Gamma Probe in Oncologic Surgery.
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Gamma Rays; Humans; Intraoperative Period; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiometry; Radiopharmaceuticals; Young Adult | 2016 |
The BRAF mutation is useful for prediction of clinical recurrence in low-risk patients with conventional papillary thyroid carcinoma.
Topics: Adult; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Point Mutation; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Proto-Oncogene Proteins B-raf; Radiopharmaceuticals; Survival Analysis; Thyroid Neoplasms; Thyroidectomy | 2006 |
Usefulness of (18)F-fluorodeoxyglucose PET for radiosurgery planning and response monitoring in patients with recurrent spinal metastasis.
Topics: Adult; Breast Neoplasms; Cervical Vertebrae; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Radiosurgery; Radiotherapy Planning, Computer-Assisted; Sarcoma; Spinal Neoplasms; Thoracic Vertebrae | 2006 |
FDG-PET in the detection of residual disease and relapse in patients with Hodgkin's lymphoma. Experience from a Swedish centre.
Topics: Adult; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Retrospective Studies; Sweden; Tomography, X-Ray Computed | 2006 |
FDG-PET in a patient with gastric MALT lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Stomach Neoplasms; Taiwan | 2006 |
Clinical value of pre-and postoperative 18F-FDG PET/CT in patients undergoing liver transplantation for hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Recurrence, Local; Perioperative Care; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Spiral Computed | 2006 |
Recurrent thymoma: radiological (CT and FDG-PET) and histological (WHO criteria) features.
Topics: Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Thymoma; Thymus Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging; World Health Organization | 2006 |
The role of (18)F-FDG-PET imaging for the selection of liver transplantation candidates among hepatocellular carcinoma patients.
Topics: Adult; Aged; alpha-Fetoproteins; Blood Vessels; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Patient Selection; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Analysis | 2006 |
Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction.
Topics: Adenocarcinoma; Aged; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Selection; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Radiopharmaceuticals; Stomach Neoplasms; Survival Analysis | 2006 |
Pulmonary suture abscess with false-positive 18F-fluorodeoxyglucose positron emission scan mimicking lung cancer recurrence.
Topics: Adenocarcinoma; Breast Neoplasms; Carcinoma, Ductal, Breast; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Abscess; Lung Neoplasms; Mastectomy, Segmental; Middle Aged; Neoplasm Recurrence, Local; Pneumonectomy; Positron-Emission Tomography; Radiopharmaceuticals; Sutures | 2006 |
Actinomycosis mimicking anastomotic recurrent esophageal cancer on PET-CT.
Topics: Actinomycosis; Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2006 |
Potential time benefit in the assessment of recurrent rat rhabdomyosarcoma using positron emission tomography (PET) with (18)fluorodeoxyglucose depends on therapy-specific growth delay.
Topics: Animals; Feasibility Studies; Fluorodeoxyglucose F18; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Reproducibility of Results; Rhabdomyosarcoma; Sensitivity and Specificity; Time Factors | 2006 |
The diagnostic efficacy of FDG-PET in the local recurrence of hilar bile duct cancer.
Topics: Aged; Bile Duct Neoplasms; Cholangitis; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hepatic Duct, Common; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Tomography, X-Ray Computed | 2006 |
Genetic and metabolic predictors of chemosensitivity in oligodendroglial neoplasms.
Topics: Adult; Aged; Alleles; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Disease Progression; Female; Fluorodeoxyglucose F18; Genetic Predisposition to Disease; Genotype; Humans; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Oligodendroglioma; Procarbazine; Prospective Studies; Survival Rate; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2006 |
Clinical impact of integrated PET/CT on the management of suspected cervical cancer recurrence.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2007 |
Usefulness of [18F] fluoro-2-deoxyglucose-positron emission tomography-computed tomography (FDG-PET-CT) in the detection of lung cancer recurrence with paraneoplastic neurological syndrome.
Topics: Biomarkers, Tumor; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Paraneoplastic Syndromes, Nervous System; Positron-Emission Tomography; Tomography, X-Ray Computed | 2006 |
The role of FDG-PET/CT in suspected recurrence of breast cancer.
Topics: Adult; Aged; Biomarkers, Tumor; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2006 |
Unexpected finding of elevated glucose uptake in fibrous dysplasia mimicking malignancy: contradicting metabolism and morphology in combined PET/CT.
Topics: Adult; Blood Glucose; Carcinoma, Embryonal; Combined Modality Therapy; Diagnosis, Differential; Femoral Neoplasms; Fibrous Dysplasia, Polyostotic; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Complications; Sensitivity and Specificity; Testicular Neoplasms; Tomography, X-Ray Computed | 2007 |
Combined PET/CT in the follow-up of differentiated thyroid carcinoma: what is the impact of each modality?
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Population Surveillance; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Subtraction Technique; Systems Integration; Thyroid Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Sarcomatoid renal cell carcinoma: rapid dissemination detected on FDG PET-CT.
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Tomography, X-Ray Computed | 2006 |
F-18 FDG-PET as a routine surveillance tool for the detection of recurrent head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Time Factors | 2007 |
PET in face and neck tumours.
Topics: Facial Neoplasms; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Second Primary; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
FDG-PET in colorectal cancer.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Biomarkers, Tumor; Carcinoembryonic Antigen; Clinical Trials as Topic; Colorectal Neoplasms; Combined Modality Therapy; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Fluorouracil; Humans; Liver Neoplasms; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Treatment Outcome | 2006 |
Differentiation of recurrent astrocytoma from radiation necrosis: a pilot study with 13N-NH3 PET.
Topics: Adult; Astrocytoma; Brain Diseases; Brain Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Nitrogen Radioisotopes; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2007 |
Clinical value of manual fusion of PET and CT images in patients with suspected recurrent colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2007 |
Integrated PET/CT as a first-line re-staging modality in patients with suspected recurrence of ovarian cancer.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Clinical use of combined positron emission tomography and computed tomography (FDG-PET/CT) in recurrent ovarian cancer.
Topics: Adult; Aged; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2007 |
18F-fluorodeoxyglucose-Avid mammary mass in a patient with insulin-dependent diabetes mellitus and Hodgkin's lymphoma: relapse or pitfall?
Topics: Adult; Breast Neoplasms, Male; Diabetes Complications; Diabetes Mellitus, Type 1; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Neoplasm Recurrence, Local; Tomography, Emission-Computed | 2006 |
[The value of FDG PET/CT, ultrasound and CT in diagnosing recurrent ovarian carcinoma].
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Poland; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Women's Health | 2006 |
Evaluation of suspected local recurrence in head and neck cancer: a comparison between PET and PET/CT for biopsy proven lesions.
Topics: Adult; Aged; Biopsy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Research Design; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
[Comparison between 18F-FDG PET and conventional imaging techniques (CT SCAN and MRI) in the diagnosis of head and neck tumor suspicion of recurrence].
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
18F-fluorodeoxyglucose-positron emission tomography in the characterization of suspected rhabdoid renal tumor recurrence: a case report.
Topics: Child, Preschool; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Rhabdoid Tumor | 2007 |
Recurrent adrenocortical carcinoma after laparoscopic resection.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Carcinoma; Fluorodeoxyglucose F18; Humans; Laparoscopy; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome | 2007 |
FDG uptake, glucose transporter type 1, and Ki-67 expressions in non-small-cell lung cancer: correlations and prognostic values.
Topics: Aged; Analysis of Variance; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose Transporter Type 1; Humans; Ki-67 Antigen; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies | 2007 |
Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Recurrence; Retrospective Studies; Sarcoma; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
18F-FDG PET/CT in patients with suspected recurrent or metastatic well-differentiated thyroid cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Thyroglobulin; Thyroid Gland; Thyroid Neoplasms; Whole Body Imaging | 2007 |
Role of flourine-18 fluorodeoxyglucose positron emission tomography in thymic pathology.
Topics: Adolescent; Adult; Aged; Choristoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Hyperplasia; Male; Mediastinal Diseases; Mediastinum; Middle Aged; Myasthenia Gravis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Thymoma; Thymus Gland; Thymus Neoplasms; Tomography, X-Ray Computed | 2007 |
2-[18F]-Fluoro-2-deoxy-D-glucose positron emission tomography as guidance for primary treatment in patients with advanced-stage resectable squamous cell carcinoma of the larynx and hypopharynx.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cohort Studies; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Forecasting; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Care Planning; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Adjuvant; Salvage Therapy; Survival Rate; Treatment Outcome | 2007 |
Calyceal rupture secondary to ureteric obstruction by recurrent colorectal carcinoma.
Topics: Aged; Colorectal Neoplasms; Extravasation of Diagnostic and Therapeutic Materials; Fluorodeoxyglucose F18; Humans; Kidney Diseases; Male; Neoplasm Recurrence, Local; Radionuclide Imaging; Radiopharmaceuticals; Rupture; Tomography, X-Ray Computed; Ureteral Obstruction | 2007 |
Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography imaging in patients with carcinoma of the nasopharynx: diagnostic accuracy and impact on clinical management.
Topics: Adolescent; Adult; Aged; Carcinoma, Squamous Cell; Child; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2007 |
Influence of CA 15-3 blood level and doubling time on diagnostic performances of 18F-FDG PET in breast cancer patients with occult recurrence.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Metabolic Clearance Rate; Middle Aged; Mucin-1; Neoplasm Proteins; Neoplasm Recurrence, Local; Patient Selection; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2007 |
Meningeal recurrence of intravascular large B-cell lymphoma: early diagnosis with PET-CT.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Early Diagnosis; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Meningeal Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Stem Cell Transplantation; Treatment Outcome | 2007 |
Clinical impact of positron emission tomography (PET) with (18F)fluorodeoxyglucose (FDG) in head and neck tumours.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2007 |
FDG PET in detecting primary and recurrent malignant salivary gland tumors.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Salivary Gland Neoplasms; Sensitivity and Specificity | 2007 |
18F-choline and/or 11C-acetate positron emission tomography: detection of residual or progressive subclinical disease at very low prostate-specific antigen values (<1 ng/mL) after radical prostatectomy.
Topics: Acetates; Aged; Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Radiopharmaceuticals; Salvage Therapy; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
[Clinical value of 18FDG-PET in diagnosing and detecting residue or recurrence of nasopharyngeal carcinoma].
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography | 2007 |
Diagnostic impact of PET with 18F-FDG, 18F-DOPA and 3-O-methyl-6-[18F]fluoro-DOPA in recurrent or metastatic medullary thyroid carcinoma.
Topics: Adult; Aged; Carcinoma, Medullary; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroid Neoplasms | 2007 |
A prospective study of the accuracy of 18Fluorodeoxyglucose positron emission tomography (18FDG PET) in identifying sites of metastasis prior to pelvic exenteration.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pelvic Exenteration; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Vaginal Neoplasms; Vulvar Neoplasms | 2007 |
Pretransplant positive positron emission tomography/gallium scans predict poor outcome in patients with recurrent/refractory Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Salvage Therapy; Survival Rate; Treatment Outcome | 2007 |
FDG-PET/CT in restaging of patients with recurrent breast cancer: possible impact on staging and therapy.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed | 2007 |
Clinical stage I non-small cell lung cancer including FDG-PET Imaging: sites and time to recurrence.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Time Factors | 2007 |
Increased pulmonary FDG uptake in bleomycin-associated pneumonitis.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Pneumonia; Positron-Emission Tomography; Seminoma; Testicular Neoplasms; Testis; Tomography, X-Ray Computed | 2007 |
[Usefulness of FDG-PET for the diagnosis of postoperative recurrence of lung cancer].
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Retrospective Studies | 2007 |
FDG-PET scan in patients with clinically and/or radiologically suspicious colorectal cancer recurrence but normal CEA.
Topics: Adult; Aged; Aged, 80 and over; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2007 |
[Clinical application of (18)F-FDG PET/CT to staging and treatment effectiveness monitoring of nasopharyngeal carcinoma].
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Stomach Neoplasms; Thyroid Neoplasms; Tomography, X-Ray Computed; Young Adult | 2007 |
Diagnostic and prognostic value of 18F-FDG PET/CT for patients with suspected recurrence from squamous cell carcinoma of the esophagus.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Does 18fluoro-fluorodeoxyglucose positron emission tomography improve recurrence detection in patients treated for head and neck squamous cell carcinoma with negative clinical follow-up?
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Whole Body Imaging | 2007 |
18FDG uptake in oesophageal adenocarcinoma: linking biology and outcome.
Topics: Adenocarcinoma; Aged; Biomarkers, Tumor; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunoenzyme Techniques; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Tissue Array Analysis; Tissue Distribution; Treatment Outcome | 2008 |
Role of multidetector CT and FDG-PET/CT in the diagnosis of local and distant recurrence of resected rectal cancer.
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiopharmaceuticals; Rectal Neoplasms; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2007 |
Nonossifying fibroma can mimic residual lymphoma in FDG PET: additional value of combined PET/CT.
Topics: Antineoplastic Agents; Child; Diagnosis, Differential; False Positive Reactions; Female; Femoral Neoplasms; Fibroma; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Image Enhancement; Lymphoma; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed | 2007 |
[Diagnostic value of positron emission tomography/computed tomography with fluorine-18 fluordeoxyglucose in patients with differentiated thyroid gland carcinoma, high thyroglobulin serum levels and negative iodine whole body scan].
Topics: Adolescent; Adult; Aged; Biomarkers, Tumor; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2007 |
Aggressive and indolent non-Hodgkin's lymphoma: response assessment by integrated international workshop criteria.
Topics: Adolescent; Adult; Aged; Burkitt Lymphoma; Fluorodeoxyglucose F18; Humans; International Cooperation; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron-Emission Tomography; Practice Guidelines as Topic; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Hodgkin lymphoma: Response assessment by revised International Workshop Criteria.
Topics: Adolescent; Adult; Aged; Child; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; International Cooperation; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron-Emission Tomography; Practice Guidelines as Topic; Predictive Value of Tests; Radiopharmaceuticals; Remission Induction; Retrospective Studies; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Predictive value and diagnostic accuracy of F-18-fluoro-deoxy-glucose positron emission tomography treated grade 1 and 2 follicular lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Remission Induction; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone and Bones; Bone Neoplasms; Calcitonin; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Liver; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole-Body Counting | 2007 |
The role of FDG-PET/CT imaging after radiation therapy.
Topics: Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2007 |
Whole-body F-18 FDG PET for hepatocellular carcinoma patients after interventional treatment.
Topics: Aged; Aged, 80 and over; alpha-Fetoproteins; Carcinoma, Hepatocellular; Catheter Ablation; Ethanol; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2007 |
FDG-PET in cervical cancer: staging, re-staging and follow-up.
Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Outcome Assessment, Health Care; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2007 |
(18)F-DG PET/CT in detection of recurrence and metastasis of colorectal cancer.
Topics: Adult; Aged; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2007 |
Influence of FDG-PET on computed tomography-based radiotherapy planning for locally recurrent nasopharyngeal carcinoma.
Topics: Adult; Aged; Cyclic N-Oxides; Female; Fluorodeoxyglucose F18; Humans; Male; Mercaptoethanol; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Tomography, X-Ray Computed | 2007 |
Positron emission tomography/computer tomography in guidance of extrahepatic hepatocellular carcinoma metastasis management.
Topics: Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiography; Tomography, Emission-Computed | 2007 |
Combined [18F]Fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) for detection of recurrent, 131I-negative thyroid cancer.
Topics: Decision Making; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2008 |
Acute varicella infection mimics recurrent Hodgkin's disease on F-18 FDG PET/CT.
Topics: Adult; Chickenpox; Diagnosis, Differential; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2007 |
Possible chronic thyroiditis revealed by [18F]-FDG-PET/CT scan in a euthyroid patient with recurrent gallbladder carcinoma.
Topics: Aged; Antibodies; Female; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Iodide Peroxidase; Neoplasm Recurrence, Local; Positron-Emission Tomography; Thyroglobulin; Thyroiditis; Tomography, Emission-Computed | 2007 |
Utility of PET/CT imaging performed early after surgical resection in the adjuvant treatment planning for head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Biopsy; Carcinoma, Squamous Cell; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Adjuvant; Time Factors; Tomography, X-Ray Computed | 2008 |
The role of 18F-FDG PET/CT in detecting metastatic deposits of recurrent medullary thyroid carcinoma: a prospective study.
Topics: Calcitonin; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Thyroid Neoplasms; Tomography, X-Ray Computed | 2008 |
Induction chemotherapy in Barrett cancer: influence on surgical risk and outcome.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Barrett Esophagus; Chemotherapy, Adjuvant; Disease-Free Survival; Esophageal Neoplasms; Esophagogastric Junction; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Complications; Prospective Studies; Radiopharmaceuticals; Remission Induction; Risk Assessment; Survival Rate; Treatment Outcome | 2007 |
18F-FDG PET/CT in primary central nervous system lymphoma in HIV-negative patients.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Antineoplastic Agents; Central Nervous System Neoplasms; Cohort Studies; Female; Fluorodeoxyglucose F18; HIV Seronegativity; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Rituximab | 2007 |
Impact of FDG-PET to detect recurrence of head and neck squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Decision Making; Endoscopy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Integrated PET/CT for the evaluation of para-aortic nodal metastasis in locally advanced cervical cancer patients with negative conventional CT findings.
Topics: Adult; Aged; Aged, 80 and over; CA-125 Antigen; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2008 |
Fluorodeoxyglucose positron emission tomography in multiple myeloma, solitary plasmocytoma and monoclonal gammapathy of unknown significance.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Myeloma; Neoplasm Recurrence, Local; Neoplasm Staging; Paraproteinemias; Plasmacytoma; Positron-Emission Tomography; Tomography, Emission-Computed | 2007 |
Impact of FDG PET-CT imaging on the decision making in the biologic suspicion of ovarian carcinoma recurrence.
Topics: Adult; Aged; Aged, 80 and over; CA-125 Antigen; Decision Making; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Surveys and Questionnaires; Tomography, X-Ray Computed | 2008 |
PET/CT and histopathologic response to preoperative chemoradiation therapy in locally advanced rectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Chemotherapy, Adjuvant; Combined Modality Therapy; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Iohexol; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Radiotherapy, Adjuvant; Rectal Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
Dual-modality FDG-PET/CT in follow-up of patients with recurrent iodine-negative differentiated thyroid cancer.
Topics: Adult; Aged; Aged, 80 and over; Confidence Intervals; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Predictive Value of Tests; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms | 2007 |
Recurrent hepatic epithelioid hemangioendothelioma: detection by FDG PET/CT.
Topics: Adult; Fluorodeoxyglucose F18; Hemangioendothelioma, Epithelioid; Humans; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2007 |
Occult thyroid carcinoma detected by FDG-PET scan in elderly osteosarcoma patients: report of two cases.
Topics: Bone Neoplasms; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Incidental Findings; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Osteosarcoma; Osteotomy; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Thyroidectomy | 2007 |
[Comparison of 18F-FDG coincidence SPECT imaging and computed tomography in the initial staging and therapeutic evaluation of lymphomas].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Diagnosis, Differential; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Radiopharmaceuticals; Remission Induction; Retrospective Studies; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2007 |
Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3 T compared to FDG-PET-CT.
Topics: Adult; Aged; Breast Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Iohexol; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole Body Imaging | 2008 |
F-18 positron emission tomography and computed tomography image-fusion for image-guided detection of local recurrence in patients with head and neck cancer using a 3-dimensional navigation system: a preliminary report.
Topics: Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Jaw Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Surgery, Computer-Assisted; Tomography, X-Ray Computed; Tonsillar Neoplasms | 2008 |
Expression of Glut-1 in primary and recurrent head and neck squamous cell carcinomas, and compared with 2-[18F]fluoro-2-deoxy-D-glucose accumulation in positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Animals; Biomarkers, Tumor; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Rabbits; Radiopharmaceuticals | 2008 |
Multivoxel proton MRS for differentiation of radiation-induced necrosis and tumor recurrence after gamma knife radiosurgery for brain metastases.
Topics: Adult; Aged; Aged, 80 and over; Brain Chemistry; Brain Neoplasms; Diagnosis, Differential; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Spectroscopy; Male; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiation Injuries; Radiopharmaceuticals; Radiosurgery; Treatment Outcome | 2006 |
Enhanced detectability of recurrent brain tumor using glucose-loading F-18 FDG PET.
Topics: Adult; Brain Neoplasms; Contrast Media; Diagnosis, Differential; Fluorodeoxyglucose F18; Gadolinium DTPA; Glucose; Humans; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Radionuclide Imaging; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer.
Topics: Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Cholecystectomy; Diagnosis, Differential; Disease Progression; Female; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2008 |
Use of PET probe in surgical oncology.
Topics: Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Surgery, Computer-Assisted | 2008 |
Diagnostic accuracy of 201Thallium-SPECT and 18F-FDG-PET in the clinical assessment of glioma recurrence.
Topics: Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thallium; Tomography, Emission-Computed, Single-Photon | 2008 |
The clinical impact of [(18)F]FDG PET/CT for the management of recurrent endometrial cancer: correlation with clinical and histological findings.
Topics: Adult; Aged; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Outcome Assessment, Health Care; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
Multimodality approach of perioperative 18F-FDG PET/CT imaging, intraoperative 18F-FDG handheld gamma probe detection, and intraoperative ultrasound for tumor localization and verification of resection of all sites of hypermetabolic activity in a case of
Topics: Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Intraoperative Care; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Thigh; Tomography, X-Ray Computed; Treatment Outcome; Whole Body Imaging | 2008 |
Utility of sonographically guided biopsy in metabolically suspected recurrent lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography, Interventional | 2008 |
[Role of PET-CT with 18-FDG in the management of UADT squamous-cell carcinomas: a retrospective study of 43 cases].
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Care Planning; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
F-18 FDG PET findings in a port site recurrence after laparoscopic radical nephrectomy in a patient with renal cell carcinoma.
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Laparoscopy; Male; Middle Aged; Neoplasm Recurrence, Local; Nephrectomy; Radiopharmaceuticals; Tomography, Emission-Computed | 2008 |
Clinical outcomes of patients receiving integrated PET/CT-guided radiotherapy for head and neck carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Time Factors; Tomography, X-Ray Computed | 2008 |
Utility of PET/neck MRI digital fusion images in the management of recurrent or persistent thyroid cancer.
Topics: Adolescent; Adult; Aged; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Patient Selection; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Signal Processing, Computer-Assisted; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography | 2008 |
Staging pathways in recurrent colorectal carcinoma: is contrast-enhanced 18F-FDG PET/CT the diagnostic tool of choice?
Topics: Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
FDG PET/CT findings in recurrent malignant schwannoma.
Topics: Adult; Axilla; Fluorodeoxyglucose F18; Humans; Male; Muscle Neoplasms; Neoplasm Recurrence, Local; Neurilemmoma; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Thoracic Wall; Tomography, Emission-Computed | 2008 |
[F-18]-Fluorodeoxyglucose PET and PET-CT in diagnostic imaging evaluation of locally recurrent and metastatic bladder transitional cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Transitional Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2008 |
Performance of FDG-PET/CT in the diagnosis of recurrent endometrial cancer.
Topics: Adult; Aged; Aged, 80 and over; Endometrial Neoplasms; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Osteoradionecrosis after three-dimensional conformal radiotherapy for recurrent cervical cancer presenting as a progressive osteolytic lesion.
Topics: Bone Neoplasms; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Hysterectomy; Ilium; Middle Aged; Neoplasm Recurrence, Local; Osteolysis; Osteoradionecrosis; Positron-Emission Tomography; Radiotherapy, Conformal; Salvage Therapy; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Whole Body Imaging | 2008 |
Improved detection of recurrent laryngeal tumor after radiotherapy using (18)FDG-PET as initial method.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Laryngoscopy; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2008 |
(18)F-fluorodeoxyglucose positron emission tomography-based assessment of local failure patterns in non-small-cell lung cancer treated with definitive radiotherapy.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Tomography, X-Ray Computed; Treatment Failure; Tumor Burden | 2008 |
The prognostic significance of tumor vascular invasion and its association with plasma Epstein-Barr virus DNA, tumor volume and metabolic activity in locoregionally advanced nasopharyngeal carcinoma.
Topics: Cavernous Sinus; Combined Modality Therapy; DNA, Viral; Female; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Hong Kong; Humans; Magnetic Resonance Imaging; Male; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Treatment Outcome; Tumor Burden | 2008 |
Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent ovarian cancer: comparison with integrated FDG-PET/non-contrast-enhanced CT and enhanced CT.
Topics: Adult; Aged; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Iopamidol; Male; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Systems Integration; Tomography, X-Ray Computed | 2008 |
Performance of FDG-PET/CT for diagnosis of recurrent uterine cervical cancer.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Male; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2008 |
Costosternal chondrodynia simulating recurrent breast cancer unveiled by FDG PET.
Topics: Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sternum; Tietze's Syndrome | 2008 |
Whole-tumor perfusion CT parameters and glucose metabolism measurements in head and neck squamous cell carcinomas: a pilot study using combined positron-emission tomography/CT imaging.
Topics: Adult; Blood Flow Velocity; Blood Glucose; Blood Volume; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Otorhinolaryngologic Neoplasms; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Regional Blood Flow; Statistics as Topic; Tomography, X-Ray Computed | 2008 |
Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma.
Topics: Adult; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Survival Analysis; Thyroid Neoplasms | 2008 |
99mTc-Tetrofosmin SPECT for the detection of glioma recurrence.
Topics: Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thallium; Tomography, Emission-Computed, Single-Photon | 2008 |
Preliminary retrospective investigation of FDG-PET/CT timing in follow-up of ablated lung tumor.
Topics: Catheter Ablation; Clinical Protocols; Contrast Media; Disease Progression; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain.
Topics: Astrocytoma; Brain; Brain Neoplasms; Deoxy Sugars; Deoxyglucose; Diagnosis, Differential; Fluorine; Fluorodeoxyglucose F18; Humans; Necrosis; Neoplasm Recurrence, Local; Radiation Injuries; Radioisotopes; Tomography, Emission-Computed | 1982 |
Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography.
Topics: Adult; Aged; Brain Neoplasms; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiography; Tomography, Emission-Computed | 1982 |
Positron tomographic assessment of estrogen receptors in breast cancer: comparison with FDG-PET and in vitro receptor assays.
Topics: Breast; Breast Neoplasms; Deoxyglucose; Estradiol; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Radioligand Assay; Receptors, Estrogen; Tomography, Emission-Computed | 1995 |
Positron emission tomography in the detection of residual laryngeal carcinoma.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Deoxyglucose; Edema; Fibrosis; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Laryngeal Diseases; Laryngeal Neoplasms; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neoplasm, Residual; Predictive Value of Tests; Radiotherapy Dosage; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1995 |
Head and neck cancer: detection of recurrence with PET and 2-[F-18]fluoro-2-deoxy-D-glucose.
Topics: Deoxyglucose; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Neoplasm Recurrence, Local; Tomography, Emission-Computed | 1995 |
Detection of unsuspected metastasis in a melanoma patient with positron emission tomography.
Topics: Adult; Deoxyglucose; Female; Femoral Neoplasms; Fluorodeoxyglucose F18; Humans; Melanoma; Neoplasm Recurrence, Local; Tomography, Emission-Computed | 1995 |
Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET).
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Biopsy; Carcinoma; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Likelihood Functions; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 1995 |
Diffusely increased colonic F-18 FDG uptake in acute enterocolitis.
Topics: Acute Disease; Colon; Colonic Neoplasms; Deoxyglucose; Diagnosis, Differential; Enterocolitis; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Time Factors; Tomography, Emission-Computed | 1995 |
Detecting recurrent or residual lung cancer with FDG-PET.
Topics: Adult; Aged; Aged, 80 and over; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Sensitivity and Specificity; Tomography, Emission-Computed | 1995 |
Indium-111 OncoScint CR/OV and F-18 FDG in colorectal and ovarian carcinoma recurrences. Early observations.
Topics: Aged; Antibodies, Monoclonal; Colorectal Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Indium Radioisotopes; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Oligopeptides; Ovarian Neoplasms; Pentetic Acid; Tomography, Emission-Computed | 1995 |
Characterization of chest masses by FDG positron emission tomography.
Topics: Deoxyglucose; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Retrospective Studies; Sensitivity and Specificity; Thoracic Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1995 |
PET versus SPECT in distinguishing radiation necrosis from tumor recurrence in the brain.
Topics: Adult; Brain; Brain Neoplasms; Deoxyglucose; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Necrosis; Neoplasm Recurrence, Local; Radiation Injuries; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1995 |
PET-FDG of pleomorphic xanthoastrocytoma.
Topics: Adult; Astrocytoma; Brain Neoplasms; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Prognosis; Tomography, Emission-Computed | 1995 |
Clinical value of whole-body positron emission tomography with [18F]fluorodeoxyglucose in recurrent colorectal cancer.
Topics: Aged; Colorectal Neoplasms; Deoxyglucose; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1994 |
[Longitudinal analysis of glucose metabolism in recurrent meningioma].
Topics: Autoradiography; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Longitudinal Studies; Meningeal Neoplasms; Meningioma; Middle Aged; Neoplasm Recurrence, Local; Tomography, Emission-Computed | 1994 |
Diagnosis of recurrent brain tumor: value of 201Tl SPECT vs 18F-fluorodeoxyglucose PET.
Topics: Adult; Brain Neoplasms; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Sensitivity and Specificity; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1994 |
[Analysis of glucose metabolism in patients with esophageal cancer by PET: estimation of hexokinase activity in the tumor and usefulness for clinical assessment using 18F-fluorodeoxyglucose].
Topics: Aged; Deoxyglucose; Esophageal Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Hexokinase; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Prognosis; Retrospective Studies; Tomography, Emission-Computed | 1994 |
Functional imaging of head and neck tumors using positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cerebellum; Cicatrix; Deoxyglucose; Female; Fibrosis; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Necrosis; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Pituitary Neoplasms; Tomography, Emission-Computed; Tonsillar Neoplasms | 1994 |
Distinguishing tumor recurrence from irradiation sequelae with positron emission tomography in patients treated for larynx cancer.
Topics: Deoxyglucose; Diagnosis, Differential; Edema; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Laryngectomy; Larynx; Necrosis; Neoplasm Recurrence, Local; Radiation Injuries; Radiotherapy; Tomography, Emission-Computed | 1994 |
The promise FDG in diagnosis and surveillance of head and neck cancer.
Topics: Carcinoma, Squamous Cell; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Population Surveillance; Tomography, Emission-Computed | 1994 |
Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation.
Topics: Carcinoma; Carcinoma, Squamous Cell; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymph Node Excision; Lymph Nodes; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Oropharyngeal Neoplasms; Paranasal Sinus Neoplasms; Prognosis; Prospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1994 |
Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-[F-18]-2-deoxy-D-glucose.
Topics: Carcinoma, Bronchogenic; Deoxyglucose; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Pulmonary Fibrosis; Sensitivity and Specificity; Tomography, Emission-Computed | 1994 |
Brain tumor imaging with PET and 2-[carbon-11]thymidine.
Topics: Adolescent; Adult; Aged; Brain; Carbon Radioisotopes; Child; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Supratentorial Neoplasms; Thymidine; Tomography, Emission-Computed | 1994 |
Use of positron emission tomography with fluorodeoxyglucose in patients with extracranial head and neck cancers.
Topics: Adult; Aged; Deoxyglucose; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Tomography, Emission-Computed | 1994 |
Whole-body positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose can detect recurrent ovarian carcinoma.
Topics: Adult; Aged; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Tomography, Emission-Computed | 1993 |
Glucose consumption in recurrent gliomas.
Topics: Adult; Animals; Brain; Brain Neoplasms; Deoxyglucose; Diagnosis, Differential; False Negative Reactions; Female; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Life Tables; Magnetic Resonance Imaging; Male; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Radiation Injuries; Radiotherapy; Survival Analysis; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1993 |
Positron emission tomography with fluorodeoxyglucose to evaluate tumor response and control after radiation therapy.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Deoxyglucose; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Radiotherapy Dosage; Tomography, Emission-Computed | 1993 |
Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]fluoro-D-glucose PET and MR imaging diagnoses.
Topics: Aged; Aged, 80 and over; Contrast Media; Deoxyglucose; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Prospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1996 |
PET scans of abdominal malignancy.
Topics: Abdominal Neoplasms; Colonic Neoplasms; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Rectal Neoplasms; Tomography, Emission-Computed | 1996 |
Fluorine-18 fluoro-2-deoxyglucose positron emission tomography in recurrent rectal cancer: relation to tumour size and cellularity.
Topics: Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Rectal Neoplasms; Rectum; Tomography, Emission-Computed | 1996 |
Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Follicular; Carcinoma, Papillary; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prospective Studies; Sensitivity and Specificity; Thyroid Neoplasms; Thyroidectomy; Tomography, Emission-Computed | 1996 |
Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine PET in detection of malignant tumors.
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Methionine; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, Emission-Computed | 1996 |
Comparison of fluorine-18-FDG PET and technetium-99m-MIBI SPECT in evaluation of musculoskeletal sarcomas.
Topics: Adult; Bone Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Muscle Neoplasms; Neoplasm Recurrence, Local; Neoplasm, Residual; Sarcoma; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1996 |
C-11 methionine and F-18 FDG uptake in a patient with meningioma and glioblastoma multiforme.
Topics: Aged; Brain Neoplasms; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Humans; Male; Meningeal Neoplasms; Meningioma; Methionine; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Parietal Lobe; Tomography, Emission-Computed | 1996 |
Prognostic value positron emission tomography with [18F]fluoro-2-deoxy-D-glucose in the low-grade glioma.
Topics: Adolescent; Adult; Astrocytoma; Biopsy; Blood Glucose; Brain; Brain Neoplasms; Deoxyglucose; Energy Metabolism; Female; Fluorodeoxyglucose F18; Ganglioglioma; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Oligodendroglioma; Prognosis; Survival Rate; Tomography, Emission-Computed | 1996 |
Impact of fluorodeoxyglucose positron emission tomography on the clinical management of patients with glioma.
Topics: Brain; Brain Neoplasms; Deoxyglucose; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Humans; Neoplasm Recurrence, Local; Radiation Injuries; Retrospective Studies; Tomography, Emission-Computed | 1996 |
The use of positron emission tomography in the evaluation of orofacial malignancy and disease.
Topics: Ameloblastoma; Carcinoma, Squamous Cell; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Mandibular Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Tomography, Emission-Computed | 1996 |
F-18 FDG uptake by recurrent Hürthle cell carcinoma of the thyroid using high-energy planar scintigraphy.
Topics: Adenocarcinoma; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Obesity, Morbid; Radionuclide Imaging; Technetium Tc 99m Sestamibi; Thyroid Neoplasms | 1996 |
Recurrent postoperative parathyroid carcinoma: FDG-PET and sestamibi-SPECT findings.
Topics: Aged; Carcinoma; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Hyperparathyroidism; Male; Neoplasm Recurrence, Local; Parathyroid Neoplasms; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1996 |
Detection of local recurrence of soft-tissue sarcoma with positron emission tomography using [18F]fluorodeoxyglucose.
Topics: Adult; Aged; Aged, 80 and over; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Reproducibility of Results; Sarcoma; Sensitivity and Specificity; Statistics, Nonparametric; Tomography, Emission-Computed | 1997 |
[Metabolic characterization of ovarian tumors with positron-emission tomography and F-18 fluorodeoxyglucose].
Topics: Adult; Aged; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 1997 |
[Positron emission tomography (PET) in diagnosis and therapy planning of malignant lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Glucose; Combined Modality Therapy; Deoxyglucose; Energy Metabolism; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Tomography, Emission-Computed; Treatment Outcome | 1997 |
Fluorine-18-FDG PET and iodine-123-IMT SPECT in the evaluation of brain tumors.
Topics: Astrocytoma; Brain; Brain Neoplasms; Deoxyglucose; Evaluation Studies as Topic; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Humans; Iodine Radioisotopes; Male; Methyltyrosines; Middle Aged; Neoplasm Recurrence, Local; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1997 |
A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1997 |
FDG hypermetabolism associated with inflammatory necrotic changes following radiation of meningioma.
Topics: Aged; Brain; Brain Neoplasms; Combined Modality Therapy; Deoxyglucose; Diagnosis, Differential; Diagnostic Errors; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Meningioma; Necrosis; Neoplasm Recurrence, Local; Radiation Injuries; Tomography, Emission-Computed | 1997 |
Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study.
Topics: Adult; Aged; Aspartic Acid; Biomarkers, Tumor; Biopsy; Brain Neoplasms; Cell Transformation, Neoplastic; Choline; Creatine; Deoxyglucose; Disease Progression; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Glioma; Humans; Hydrogen; Lactic Acid; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neoplasm Recurrence, Local; Phosphocreatine; Prognosis; Protons; Radiopharmaceuticals; Tomography, Emission-Computed | 1997 |
Fluorodeoxyglucose whole-body positron emission tomography in colorectal cancer patients studied in routine daily practice.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Sensitivity and Specificity; Tomography, Emission-Computed | 1997 |
Potential role of fluorine-18-deoxyglucose (FDG) positron emission tomography (PET) in the staging of primitive and recurrent medullary thyroid carcinoma.
Topics: Adult; Aged; Carcinoma, Medullary; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Thyroid Neoplasms; Tomography, Emission-Computed | 1997 |
Detection of recurrent and metastatic colorectal cancer: comparison of positron emission tomography and computed tomography.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1997 |
[18F-fluorodeoxyglucose PET in ovarian carcinoma: methodology and preliminary results].
Topics: Adult; Aged; Cystadenocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Radiopharmaceuticals; Recurrence; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 1997 |
Elimination of artifactual accumulation of FDG in PET imaging of colorectal cancer.
Topics: Abdomen; Administration, Intravesical; Artifacts; Catheterization; Colon; Colonic Neoplasms; Diuretics; Fluid Therapy; Fluorodeoxyglucose F18; Furosemide; Humans; Image Enhancement; Injections, Intravenous; Kidney; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pelvis; Radiopharmaceuticals; Rectal Neoplasms; Sodium Chloride; Therapeutic Irrigation; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ureter; Urinary Bladder; Urinary Catheterization; Urinary Tract | 1998 |
Follow-up of sweat gland carcinoma by FDG-PET imaging.
Topics: Carcinoma; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Sweat Gland Neoplasms; Tomography, Emission-Computed | 1998 |
Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Animals; Carcinoembryonic Antigen; Colorectal Neoplasms; False Positive Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Predictive Value of Tests; Retrospective Studies; Tomography, Emission-Computed | 1998 |
Accuracy of whole-body fluorine-18-FDG PET for the detection of recurrent or metastatic breast carcinoma.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed | 1998 |
Detection of unsuspected recurrent lymphoma with fluorodeoxyglucose-positron emission tomographic imaging after induction chemotherapy: a case study.
Topics: Adult; Antineoplastic Agents; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
Differentiating recurrent tumor from radiation necrosis: time for re-evaluation of positron emission tomography?
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Necrosis; Neoplasm Recurrence, Local; Radiation Injuries; Radiography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 1998 |
What's your favorite PET story?
Topics: Brain Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Glioma; Humans; Necrosis; Neoplasm Recurrence, Local; Radiation Injuries; Radiopharmaceuticals; Tomography, Emission-Computed | 1998 |
Fluorine-18-fluorodeoxyglucose dual-head gamma camera coincidence imaging of recurrent colorectal carcinoma.
Topics: Adenocarcinoma; Aged; Colorectal Neoplasms; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Lymphatic Metastasis; Male; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Radionuclide Imaging; Radiopharmaceuticals; Urinary Bladder Neoplasms | 1998 |
Laryngeal radionecrosis versus recurrent cancer: a clinical approach.
Topics: Algorithms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Necrosis; Neoplasm Recurrence, Local; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Prospective Studies; Radiation Injuries; Radiotherapy; Tomography, Emission-Computed | 1998 |
Evaluation of primary pulmonary carcinoid tumors using FDG PET.
Topics: Adult; Aged; Biopsy; Carcinoid Tumor; Diagnosis, Differential; Disease-Free Survival; Evaluation Studies as Topic; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Retrospective Studies; Solitary Pulmonary Nodule; Tomography, Emission-Computed | 1998 |
Evaluation of fluorodeoxyglucose positron emission tomography in the management of soft-tissue sarcomas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Evaluation Studies as Topic; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Retrospective Studies; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole-Body Counting | 1998 |
Histological verification of positive fluorine-18 fluorodeoxyglucose findings in patients with differentiated thyroid cancer.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Biomarkers, Tumor; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Tomography, Emission-Computed | 1998 |
Computed tomography, magnetic resonance imaging and positron emission tomography in non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carbon Radioisotopes; Carcinoma; Diagnosis, Differential; Fluorodeoxyglucose F18; Forecasting; Gastroscopy; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Methionine; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Prognosis; Radiopharmaceuticals; Remission Induction; Stomach Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
FDG imaging of spinal cord primitive neuroectodermal tumor.
Topics: Adult; Feasibility Studies; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Neuroectodermal Tumors, Primitive; Radiopharmaceuticals; Spinal Cord Neoplasms; Tomography, Emission-Computed | 1998 |
[Value of 18F fluorodeoxyglucose positron emission tomography in radiotherapy planning of head-neck tumors].
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Irradiation; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Radiotherapy Planning, Computer-Assisted; Tomography, Emission-Computed | 1998 |
Fluorine-18-FDG detection of laryngeal cancer postradiotherapy using dual-head coincidence imaging.
Topics: Aged; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Time Factors; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1998 |
Clinical utility of positron emission tomography with 18F-fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cohort Studies; Evaluation Studies as Topic; False Negative Reactions; False Positive Reactions; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Mouth Neoplasms; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm, Residual; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Tongue Neoplasms; Tonsillar Neoplasms | 1998 |
The use of positron emission tomography scanning in occult and recurrent head and neck cancer.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
F-18 FDG whole-body positron emission tomography scan in primary breast sarcoma.
Topics: Adolescent; Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Phyllodes Tumor; Radiopharmaceuticals; Rhabdomyosarcoma, Alveolar; Sarcoma; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
Technetium-99m-furifosmin in the follow-up of differentiated thyroid carcinoma.
Topics: Carcinoma, Papillary; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Organophosphorus Compounds; Organotechnetium Compounds; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1998 |
Imaging of oncologic patients: benefit of combined CT and FDG PET in the diagnosis of malignancy.
Topics: Abdominal Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Thoracic Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
18FDG-PET for the assessment of primary head and neck tumors: clinical, computed tomography, and histopathological correlation in 38 patients.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1998 |
F-18 FDG PET scan after radiotherapy for early-stage larynx cancer.
Topics: Carcinoma in Situ; Carcinoma, Squamous Cell; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Time Factors; Tomography, Emission-Computed | 1998 |
Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with 18-fluoro-2-deoxyglucose positron emission tomography and comparison with computed tomography.
Topics: Adolescent; Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
Can dual-headed 18F-FDG SPET imaging reliably supersede PET in clinical oncology? A comparative study in lung and gastrointestinal tract cancer.
Topics: Colorectal Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Cameras; Gastrointestinal Neoplasms; Humans; Lung Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Pancreatic Neoplasms; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1998 |
Comparative value of thallium and glucose SPECT imaging in childhood brain tumors.
Topics: Brain Neoplasms; Child; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Necrosis; Neoplasm Recurrence, Local; Neoplasm, Residual; Predictive Value of Tests; Radiation Injuries; Radiopharmaceuticals; Sensitivity and Specificity; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon | 1998 |
Evaluation of l-3-[123I]iodo-alpha-methyltyrosine SPET and [18F]fluorodeoxyglucose PET in the detection and grading of recurrences in patients pretreated for gliomas at follow-up: a comparative study with stereotactic biopsy.
Topics: Adult; Aged; Astrocytoma; Biopsy; Brain; Female; Fluorodeoxyglucose F18; Glioblastoma; Glioma; Humans; Iodine Radioisotopes; Male; Methyltyrosines; Middle Aged; Neoplasm Recurrence, Local; Oligodendroglioma; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1999 |
Value of combined FDG PET and MR imaging in the evaluation of suspected recurrent local-regional breast cancer: preliminary experience.
Topics: Aged; Axilla; Brachial Plexus; Breast Neoplasms; Chemotherapy, Adjuvant; Clavicle; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Node Excision; Lymphatic Metastasis; Magnetic Resonance Imaging; Mastectomy, Modified Radical; Mastectomy, Segmental; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Care Planning; Peripheral Nervous System Diseases; Radiopharmaceuticals; Radiotherapy, Adjuvant; Retrospective Studies; Thoracic Neoplasms; Tomography, Emission-Computed | 1999 |
Uses and limitations of FDG positron emission tomography in patients with head and neck cancer.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neoplasm, Residual; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 1999 |
Detection of recurrent head and neck squamous cell carcinomas after radiation therapy with 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography.
Topics: Biopsy; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Neoplasm, Residual; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Treatment Outcome | 1999 |
[Imaging of an adrenal cortex carcinoma and its metastasis with FDG-PET].
Topics: Adrenal Cortex Neoplasms; Adult; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Neoplasm Recurrence, Local; Radiopharmaceuticals; Time Factors; Tomography, Emission-Computed | 1999 |
The detection of local recurrent head and neck cancer with fluorine-18 fluorodeoxyglucose dual-head positron emission tomography.
Topics: Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors; Tomography, Emission-Computed | 1999 |
Fluorine-18 fluorodeoxyglucose imaging using dual-head coincidence positron emission tomography without attenuation correction in patients with head and neck cancer.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Gamma Cameras; Head; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neck; Neoplasm Recurrence, Local; Neoplasm, Residual; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
Head and neck cancer: detection of recurrence with three-dimensional principal components analysis at dynamic FDG PET.
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Recurrence, Local; Reproducibility of Results; Tomography, Emission-Computed | 1999 |
Normal thymic uptake of 2-deoxy-2[F-18]fluoro-D-glucose.
Topics: Adenocarcinoma, Follicular; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Thymus Gland; Thyroid Neoplasms; Tomography, Emission-Computed | 1999 |
Primary and recurrent early stage laryngeal cancer: preliminary results of 2-[fluorine 18]fluoro-2-deoxy-D-glucose PET imaging.
Topics: Carcinoma in Situ; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Laryngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed; Vocal Cords | 1999 |
False-positive positron emission tomographic scan for recurrent breast cancer resulting from a bee sting.
Topics: Adult; Animals; Axilla; Breast Neoplasms; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Hymenoptera; Insect Bites and Stings; Neoplasm Recurrence, Local; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
[Diagnosis of recurrent or persistent nasopharyngeal cancers inspite of radiotherapy: Comparison of F-18-deoxyglucose positron emission tomography with computed tomography].
Topics: Fluorodeoxyglucose F18; Humans; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Failure | 1999 |
Comparison of different tracers in the follow up of differentiated thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Aged; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Thyroid Neoplasms; Tomography, Emission-Computed | 1999 |
Positron emission tomography with 18fluorine-labelled deoxyglucose: utility in localized and advanced prostate cancer.
Topics: Adenocarcinoma; Aged; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
FDG positron emission tomography in head and neck cancer: pitfall or pathology?
Topics: Adult; Aged; Artifacts; Blood Glucose; Diagnosis, Differential; Fasting; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Iatrogenic Disease; Image Processing, Computer-Assisted; Middle Aged; Muscle Contraction; Muscle, Skeletal; Neoplasm Recurrence, Local; Neoplasm Staging; Papilloma; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Wound Healing | 1999 |
Diagnostic evaluation of malignant head and neck cancer by F-18-FDG PET compared to CT/MRI.
Topics: Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Reproducibility of Results; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
The detection of small carcinoma with 18F-FDG using a dual head coincidence camera.
Topics: Adult; Aged; Carcinoma, Papillary; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Male; Neoplasm Recurrence, Local; Thyroid Neoplasms; Tomography, Emission-Computed | 1999 |
Evaluation of FDG uptake by renal malignancies (primary tumor or metastases) using a coincidence detection gamma camera.
Topics: Carcinoma, Renal Cell; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Nephrectomy; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
Use of [F]-fluorodeoxyglucose positron emission tomography in monitoring response of recurrent neurotropic desmoplastic melanoma to radiotherapy.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Male; Mandibular Neoplasms; Melanoma; Mouth Neoplasms; Neoplasm Recurrence, Local; Radiopharmaceuticals; Skin Neoplasms; Tomography, Emission-Computed | 2000 |
Clinical value of [18-F]] fluorodeoxyglucose positron emission tomography imaging in soft tissue sarcomas.
Topics: Adolescent; Adult; Aged; Evaluation Studies as Topic; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Statistics, Nonparametric; Tomography, Emission-Computed | 2000 |
[Value of positron emission tomography with 18-fluorodeoxyglucose (FDG-PET) in diagnosis of recurrent bronchial carcinoma].
Topics: Aged; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Tomography, Emission-Computed | 2000 |
Whole-body PET with (fluorine-18)-2-deoxyglucose for detecting recurrent primary serous peritoneal carcinoma: An initial report.
Topics: Adult; CA-125 Antigen; Cystadenocarcinoma, Papillary; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
Positron emission tomography: an independent indicator of radiocurability in head and neck carcinomas.
Topics: Adult; Aged; Aged, 80 and over; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Prognosis; Risk Assessment; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
[Value of positron emission tomography with 18-fluorodeoxyglucose (FDG-PET) in early detection of residual tumor in oro-pharyngeal-laryngeal carcinoma].
Topics: Biopsy; Carcinoma, Squamous Cell; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Oropharyngeal Neoplasms; Predictive Value of Tests; Tomography, Emission-Computed | 2000 |
Experience in qualitative and quantitative FDG PET in follow-up of patients with suspected recurrence from head and neck cancer.
Topics: Adult; Aged; Denmark; Diagnosis, Differential; Female; Finland; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
Impact of 18F-FDG-positron emission tomography for decision making in colorectal cancer recurrences.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
Value of (18F)-FDG positron emission tomography, computed tomography, and magnetic resonance imaging in diagnosing primary and recurrent ovarian carcinoma.
Topics: Adult; Aged; Carcinoma; Colonic Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Laparotomy; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Peritoneal Neoplasms; Prospective Studies; Radiography, Abdominal; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole-Body Counting | 2000 |
[(18F)-2-fluorodeoxyglucose PET. Prospects for secondary prevention of mouth cavity carcinoma].
Topics: Blood Glucose; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Mouth Neoplasms; Neoplasm Recurrence, Local; Predictive Value of Tests; Tomography, Emission-Computed | 2000 |
FDG PET of recurrent or metastatic 131I-negative papillary thyroid carcinoma.
Topics: Adult; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Thyroglobulin; Thyroid Neoplasms; Tomography, Emission-Computed | 2000 |
Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Radiopharmaceuticals; Rectal Neoplasms; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
Evaluation of early response to SU101 target-based therapy in patients with recurrent supratentorial malignant gliomas using FDG PET and Gd-DTPA MRI.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Biological Transport, Active; Carmustine; Chemotherapy, Adjuvant; Combined Modality Therapy; Cranial Irradiation; Disease Progression; Disease-Free Survival; Energy Metabolism; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Glioblastoma; Glucose; Humans; Isoxazoles; Leflunomide; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Platelet-Derived Growth Factor; Prognosis; Signal Transduction; Supratentorial Neoplasms; Tomography, Emission-Computed; Treatment Outcome | 2000 |
[Fusion of CT and PET data: methods and clinical relevance for planning laser-induced thermotherapy of liver metastases].
Topics: Algorithms; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Hyperthermia, Induced; Image Processing, Computer-Assisted; Laser Therapy; Liver Neoplasms; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
Positron emission tomography with fluorodeoxyglucose for suspected head and neck tumor recurrence in the symptomatic patient.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
FDG positron emission tomography in head and neck cancer.
Topics: Blue Cross Blue Shield Insurance Plans; Clinical Trials as Topic; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Outcome Assessment, Health Care; Radiography; Radiopharmaceuticals; Technology Assessment, Biomedical; Tomography, Emission-Computed; United States; United States Food and Drug Administration | 2000 |
[Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) in ORL and pulmonary oncology].
Topics: Fluorodeoxyglucose F18; Glucose; Humans; Lung Neoplasms; Lymph Nodes; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Unknown Primary; Otorhinolaryngologic Neoplasms; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
Is (18)F-fluorodeoxyglucose positron emission tomography in recurrent colorectal cancer a contribution to surgical decision making?
Topics: Abdominal Neoplasms; Adult; Aged; Aged, 80 and over; Carcinoembryonic Antigen; Colonic Neoplasms; Decision Making; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Patient Care Planning; Radiopharmaceuticals; Rectal Neoplasms; Sensitivity and Specificity; Thoracic Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography | 2000 |
FDG PET and immunoscintigraphy with 99mTc-labeled antibody fragments for detection of the recurrence of colorectal carcinoma.
Topics: Antibodies, Monoclonal; Bone Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Organotechnetium Compounds; Predictive Value of Tests; Radioimmunodetection; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2000 |
Imaging of malignant lymphomas with F-18 FDG coincidence detection positron emission tomography.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gamma Cameras; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
Clinical PET in oncology.
Topics: Artifacts; Blood Glucose; Cooperative Behavior; Cyclotrons; False Positive Reactions; Female; Fluorodeoxyglucose F18; Germany; Humans; Inflammation; Lymphatic Metastasis; Male; Medical Oncology; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms; Nuclear Medicine; Organ Specificity; Practice Guidelines as Topic; Private Practice; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Universities | 2000 |
The utility of positron emission tomography for the diagnosis and staging of recurrent esophageal cancer.
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Endosonography; Esophageal Neoplasms; Esophagectomy; Esophagostomy; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrectomy; Gastrostomy; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Sensitivity and Specificity; Survival Analysis; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
Value of preoperative diagnostic modalities in patients with recurrent thyroid carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Needle; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Prospective Studies; Thyroglobulin; Thyroid Neoplasms; Tomography, Emission-Computed | 2000 |
Influence of thyroid-stimulating hormone levels on uptake of FDG in recurrent and metastatic differentiated thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Aged; Aged, 80 and over; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Radiopharmaceuticals; Thyroglobulin; Thyroid Neoplasms; Thyrotropin; Thyroxine; Tomography, Emission-Computed | 2000 |
Direct comparison of F-18-FDG PET and ultrasound in the follow-up of patients with squamous cell cancer of the head and neck.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Predictive Value of Tests; Radiography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Ultrasonography | 2000 |
Impact of FDG PET on patients with differentiated thyroid cancer who present with elevated thyroglobulin and negative 131I scan.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Time Factors; Tomography, Emission-Computed | 2001 |
Clinical usefulness of FDG PET in differentiated thyroid cancer.
Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed | 2001 |
Role of repeated F-18 fluorodeoxyglucose imaging in management of patients with bone and soft tissue sarcoma.
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Posture; Radiopharmaceuticals; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2001 |
Clinical relevance of positron emission tomography (PET) in treatment control and relapse of Hodgkin's disease.
Topics: Adult; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Predictive Value of Tests; Tomography, Emission-Computed; Treatment Outcome | 2001 |
Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor.
Topics: Antineoplastic Agents; Benzamides; Enzyme Inhibitors; Female; Fluorodeoxyglucose F18; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Liver Neoplasms; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Sarcoma; Stomach Neoplasms; Stromal Cells; Tomography, Emission-Computed | 2001 |
F-18-fluorodeoxyglucose positron emission tomography as a presurgical evaluation modality for I-131 scan-negative thyroid carcinoma patients with local recurrence in cervical lymph nodes.
Topics: Adult; Aged; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Indium Radioisotopes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Preoperative Care; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Thyroidectomy; Tomography, Emission-Computed | 2001 |
Unexplained rising carcinoembryonic antigen (CEA) in the postoperative surveillance of colorectal cancer: the utility of positron emission tomography (PET).
Topics: Adult; Aged; Carcinoembryonic Antigen; Colorectal Neoplasms; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Postoperative Care; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
False-positive F-18 FDG gamma camera positron emission tomographic imaging resulting from inflammation of an anterior mediastinal mass in a patient with non-Hodgkin's lymphoma.
Topics: Adolescent; Diagnosis, Differential; False Positive Reactions; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Lymphoma, Non-Hodgkin; Male; Mediastinal Diseases; Neoplasm Recurrence, Local; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
18F-labeled fluorodeoxyglucose positron emission tomography-guided surgery for recurrent colorectal cancer: a feasibility study.
Topics: Beta Particles; Colorectal Neoplasms; Feasibility Studies; Fluorodeoxyglucose F18; Gamma Rays; Half-Life; Humans; Intraoperative Period; Neoplasm Recurrence, Local; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
Comparison of (18)F-FDG, (131)I-Na, and (201)Tl in diagnosis of recurrent or metastatic thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Bone Neoplasms; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Iodine Radioisotopes; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Thallium Radioisotopes; Thyroid Neoplasms; Tomography, Emission-Computed | 2001 |
Dynamic PET 18F-FDG studies in patients with primary and recurrent soft-tissue sarcomas: impact on diagnosis and correlation with grading.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Radiopharmaceuticals; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2001 |
Uptake of cis-4-[18F]fluoro-L-proline in urologic tumors.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Penile Neoplasms; Pilot Projects; Proline; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Positron emission tomography detection of metastatic penile squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Penile Neoplasms; Penis; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Clinical value of positron emission tomography with FDG for recurrent ovarian cancer.
Topics: Case-Control Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
[Role of FDG-PET in oncological surgery].
Topics: Blood Glucose; Energy Metabolism; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasms; Predictive Value of Tests; Reoperation; Tomography, Emission-Computed | 2001 |
Relationship between expression of the sodium/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Bone Neoplasms; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Iodine Radioisotopes; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Symporters; Thyroid Neoplasms; Tomography, Emission-Computed | 2001 |
Positive emission tomography for evaluating a complete clinical response in patients with ovarian or peritoneal carcinoma: correlation with second-look laparotomy.
Topics: Adenocarcinoma, Mucinous; Adenofibroma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; CA-125 Antigen; Carcinoma, Endometrioid; Female; Fluorodeoxyglucose F18; Humans; Laparotomy; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Peritoneal Neoplasms; Radiopharmaceuticals; Reoperation; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
Diagnosis of recurrent astrocytoma with fludeoxyglucose F18 PET scanning.
Topics: Adult; Astrocytoma; Brain Neoplasms; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Pitfalls in imaging Hodgkin's disease with computed tomography and positron emission tomography using fluorine-18-fluorodeoxyglucose.
Topics: Adult; Animals; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Glucose; Hodgkin Disease; Humans; Immunocompromised Host; Neoplasm Recurrence, Local; Radiopharmaceuticals; Sensitivity and Specificity; Serologic Tests; Splenic Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed; Toxoplasma; Toxoplasmosis | 2001 |
Paraganglioma seen with FDG dual-head gamma camera coincidence imaging after false-negative results of I-123 MIBG imaging.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; False Negative Reactions; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Paraganglioma; Radionuclide Imaging; Radiopharmaceuticals | 2001 |
Fluorodeoxyglucose positron emission tomography as an adjunct to carcinoembryonic antigen in the management of patients with presumed recurrent colorectal cancer and nondiagnostic radiologic workup.
Topics: Adult; Aged; Carcinoembryonic Antigen; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Tomography, Emission-Computed | 2001 |
[Diagnosis and prognosis in neuro-oncology: contribution of positron emission tomography].
Topics: Brain Neoplasms; Carbon Radioisotopes; Diagnosis, Differential; Fluorodeoxyglucose F18; Follow-Up Studies; Glioma; Humans; Methionine; Neoplasm Recurrence, Local; Prognosis; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
[Positron emission tomography in head and neck oncology: five cases].
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Pharyngeal Neoplasms; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Dexamethasone; Diagnosis, Differential; Disease-Free Survival; Doxorubicin; Etoposide; False Negative Reactions; False Positive Reactions; Fibrosis; Fluorodeoxyglucose F18; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Life Tables; Mediastinal Neoplasms; Melphalan; Neoplasm Recurrence, Local; Predictive Value of Tests; Prednisone; Procarbazine; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Adjuvant; Remission Induction; Salvage Therapy; Tomography, Emission-Computed; Transplantation, Autologous; Vinblastine; Vincristine | 2001 |
[Diagnosis of the postoperative local recurrence of rectal cancer by FDG-PET--a case report].
Topics: Adenocarcinoma; Aged; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Postoperative Period; Radiopharmaceuticals; Rectal Neoplasms; Tomography, Emission-Computed | 2001 |
Preoperative diagnostic value of [(18)F] fluorodeoxyglucose positron emission tomography in patients with radioiodine-negative recurrent well-differentiated thyroid carcinoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Child; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Tomography, Emission-Computed | 2001 |
Diagnosis and localization of testosterone-producing ovarian tumors: imaging or biochemical evaluation.
Topics: Carbon Radioisotopes; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Radiopharmaceuticals; Testosterone; Tomography, Emission-Computed | 2001 |
The impact of FDG-PET on the management algorithm for recurrent colorectal cancer.
Topics: Aged; Algorithms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Accuracy of F-18 fluorodeoxyglucose positron emission tomography for the evaluation of malignancy in patients presenting with new lung abnormalities: a retrospective review.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Multiple Primary; Predictive Value of Tests; Retrospective Studies; Tomography, Emission-Computed | 2001 |
F-18-fluoro-deoxy-glucose positron-emission tomography scanning in detection of local recurrence after radiotherapy for laryngeal/ pharyngeal cancer.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Laryngoscopy; Male; Middle Aged; Neoplasm Recurrence, Local; Pharyngeal Neoplasms; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Survival Analysis; Tomography, Emission-Computed | 2002 |
Decision analysis for the cost-effective management of recurrent colorectal cancer.
Topics: Colorectal Neoplasms; Cost-Benefit Analysis; Decision Support Techniques; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
Practice, efficacy and cost of staging suspected non-small cell lung cancer: a retrospective study in two Dutch hospitals.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hospital Costs; Hospitals, Community; Humans; Lung Neoplasms; Male; Medical Futility; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Netherlands; Postoperative Care; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Treatment Outcome | 2002 |
Vocal cord muscle activity as a drawback to FDG-PET in the followup of differentiated thyroid cancer.
Topics: False Positive Reactions; Fluorodeoxyglucose F18; Larynx; Magnetic Resonance Imaging; Muscles; Neoplasm Recurrence, Local; Thyroid Neoplasms; Tomography, Emission-Computed; Vocal Cords; Voice | 2002 |
Positron emission tomography with [18F]2-fluoro-D-2-deoxyglucose (FDG-PET) predicts relapse of malignant lymphoma after high-dose therapy with stem cell transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Etoposide; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Podophyllotoxin; Prognosis; Radiopharmaceuticals; Survival Analysis; Survival Rate; Tomography, Emission-Computed; Transplantation Conditioning; Treatment Outcome; Whole-Body Irradiation | 2002 |
Detection of a recurrent parathyroid carcinoma with FDG positron emission tomography.
Topics: Adult; Calcium; Carcinoma; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Hyperparathyroidism; Magnetic Resonance Imaging; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Parathyroid Hormone; Parathyroid Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
[67-Gallium citrate gammagraphy in the study of lymphomas].
Topics: Citrates; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Gallium; Gallium Radioisotopes; Humans; Lymphoma; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2002 |
Clinical relevance of fusion images using (18)F-2-fluoro-2-deoxy-D-glucose positron emission tomography in local recurrence of rectal cancer.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Rectal Neoplasms; Tomography, Emission-Computed | 2002 |
Detection of occult disease in breast cancer using fluorodeoxyglucose camera-based positron emission tomography.
Topics: Adult; Aged; Biomarkers, Tumor; Biopsy; Breast Neoplasms; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Mucin-1; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Improved image interpretation with registered thoracic CT and positron emission tomography data sets.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Recurrence, Local; Radiography, Thoracic; Radiopharmaceuticals; Thoracic Neoplasms; Thorax; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Clinical value of positron emission tomography.
Topics: Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
[Positron emission tomography in head and neck oncology].
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Neoplasm Recurrence, Local; Radiopharmaceuticals; Risk Factors; Time Factors; Tomography, Emission-Computed; Tongue Neoplasms; Tonsillar Neoplasms | 2001 |
Tumor localization and image registration of F-18 FDG coincidence detection scans with computed tomographic scans.
Topics: Adenocarcinoma; Aged; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2002 |
Whole-body PET with FDG for the diagnosis of recurrent gastric cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Carcinoma, Signet Ring Cell; Databases, Factual; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Single-Blind Method; Stomach Neoplasms; Survival Analysis; Tomography, Emission-Computed; Whole-Body Counting | 2002 |
Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on 18F-FDG PET.
Topics: Brain Diseases; Brain Neoplasms; Carbon Radioisotopes; Diagnosis, Differential; Fluorodeoxyglucose F18; Glioma; Humans; Meningeal Neoplasms; Meningioma; Methionine; Mitotic Index; Neoplasm Recurrence, Local; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
The clinical impact of (18)F-FDG PET in patients with suspected or confirmed recurrence of colorectal cancer: a prospective study.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
The use of PET scanning in ovarian cancer.
Topics: Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
Role of (18)F-FDG dual-head gamma-camera coincidence imaging in recurrent or metastatic colorectal carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radionuclide Imaging; Retrospective Studies; Tomography, X-Ray Computed | 2002 |
18F-fluoro-2-deoxyglucose-positron emission tomography in the evaluation of nonseminomatous germ cell tumours at relapse.
Topics: Adolescent; Adult; Fluorodeoxyglucose F18; Follow-Up Studies; Germinoma; Humans; Male; Neoplasm Recurrence, Local; Orchiectomy; Radiography; Radiopharmaceuticals; Retroperitoneal Neoplasms; Testicular Neoplasms; Tomography, Emission-Computed | 2002 |
Measurement of tumor volume by PET to evaluate prognosis in patients with advanced cervical cancer treated by radiation therapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Analysis of Variance; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Radiopharmaceuticals; Survival Analysis; Tomography, Emission-Computed; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2002 |
[Correlation of FDG-PET and MRI/CT with histopathology in primary diagnosis, lymph node staging and diagnosis of recurrency of head and neck cancer].
Topics: Adult; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Unknown Primary; Otorhinolaryngologic Neoplasms; Prognosis; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Imaging of thoracic occupational and environmental malignancies.
Topics: Aged; Aged, 80 and over; Asbestos; Carcinogens, Environmental; Carcinoma, Bronchogenic; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Mesothelioma; Middle Aged; Mortality; Neoplasm Recurrence, Local; Neoplasm Staging; Occupational Diseases; Pulmonary Atelectasis; Radiography; Silicosis; Tomography Scanners, X-Ray Computed; Tomography, Emission-Computed | 2002 |
Differentiation of residual or recurrent tumors from post-treatment changes with F-18 FDG PET.
Topics: Abdominal Neoplasms; Brain; Brain Neoplasms; Deoxyglucose; Diagnosis, Differential; Diagnostic Techniques, Surgical; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Necrosis; Neoplasm Recurrence, Local; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1992 |
PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoembryonic Antigen; Colorectal Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Recurrence, Local; Palliative Care; Radiotherapy, High-Energy; Tomography, Emission-Computed | 1991 |
Recurrent rectal cancer and scar: differentiation with PET and MR imaging.
Topics: Adult; Aged; Cicatrix; Deoxyglucose; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Rectal Neoplasms; Tomography, Emission-Computed | 1992 |
Assessment of response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography.
Topics: Adult; Aged; Carcinoma, Bronchogenic; Combined Modality Therapy; Deoxyglucose; Esophageal Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Neoplasms; Rectal Neoplasms; Thyroid Neoplasms; Tomography, Emission-Computed | 1991 |
Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography.
Topics: Adult; Aged; Brain Neoplasms; Child; Child, Preschool; Deoxyglucose; Dexamethasone; Epilepsy; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Humans; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Postoperative Period; Radiation Injuries; Time Factors; Tomography, Emission-Computed | 1991 |
Clinical value of PET with 18F-fluorodeoxyglucose and L-methyl-11C-methionine for diagnosis of recurrent brain tumor and radiation injury.
Topics: Adolescent; Adult; Brain; Brain Neoplasms; Child; Child, Preschool; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Male; Methionine; Middle Aged; Neoplasm Recurrence, Local; Radiation Injuries; Radiography; Radiotherapy; Tomography, Emission-Computed; Vitamin U | 1991 |
[The value of positron emission tomography in the diagnosis of recurrent rectal cancer].
Topics: Deoxyglucose; Energy Metabolism; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Neoplasm Recurrence, Local; Rectal Neoplasms; Rectum; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1990 |
Scar or recurrent rectal cancer. Positron emission tomography is more helpful for diagnosis than immunoscintigraphy.
Topics: Antibodies, Monoclonal; Antigens, Tumor-Associated, Carbohydrate; Carcinoembryonic Antigen; Cicatrix; Deoxyglucose; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Neoplasm Recurrence, Local; Radiography; Rectal Neoplasms; Tomography, Emission-Computed | 1989 |
PET of malignant cerebral tumors after interstitial brachytherapy. Demonstration of metabolic activity and correlation with clinical outcome.
Topics: Astrocytoma; Brachytherapy; Brain Neoplasms; Deoxyglucose; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Glioma; Humans; Neoplasm Recurrence, Local; Radiation Injuries; Rubidium Radioisotopes; Tomography, Emission-Computed | 1988 |
Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studies.
Topics: Adolescent; Adult; Aged; Brain; Brain Neoplasms; Carmustine; Child; Child, Preschool; Deoxyglucose; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Radiation Injuries; Radiotherapy; Tomography, Emission-Computed | 1988 |
Glucose utilization by intracranial meningiomas as an index of tumor aggressivity and probability of recurrence: a PET study.
Topics: Adult; Aged; Brain; Deoxyglucose; Female; Fluorine; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Humans; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Neoplasm Recurrence, Local; Probability; Radioisotopes; Time Factors; Tomography, Emission-Computed | 1987 |